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Abstract 
The metabolic syndrome (MetS) is routinely operationalised as a cluster of adverse 
risk factors for both cardiovascular heart disease and type 2 diabetes. Amongst the 
risk factors which may contribute to the development (and consequences) of MetS is 
sleep. The overarching aim of the present thesis is to generate an improved 
understanding of the available evidence regarding the speculative relationship 
between sleep and MetS. 
After a systematic review and meta-analysis of previous empirical studies 
exploring the relationship between MetS and sleep, the present study draws on a 
large-scale, nationally representative survey of UK adults in which directly 
measured and self-reported MetS symptoms/components and self-reported sleep 
characteristics have been recorded; and assesses the reliability of self-reported 
indicators of MetS before re-evaluating the association between MetS and sleep. 
The systematic review suggested that, while there is some evidence of an association 
between MetS and sleep across a range of sleep-related characteristics, this evidence 
draws on a small number of non-UK cross-sectional studies, some of which involved 
methods that are prone to error and bias. On the other hand, the self-reported MetS 
components identified in the UKHLS questionnaires provided substantial agreement 
with direct measures thereof. The subsequent associations observed between three 
key components of MetS (elevated waist circumference; high blood pressure; and 
diabetes – and different combinations thereof) and seven self-reported sleep 
characteristics were dependent upon: the specific sleep characteristic examined; the 
choice of referent group used; adjustment for sociodemographic and/or lifestyle 
covariates; and the use of self-reported or directly measured MetS components. Key 
differences between these findings and those of previous studies suggest these 
associations remain speculative and subject to methodological and contextual 
variation between studies. 
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Chapter 1 Introduction  
This chapter sets out to provide the background and rationale underpinning the 
present thesis’ interest in the (theoretical) association between the metabolic 
syndrome (MetS) and sleep.  
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1.1 Background  
Metabolic syndrome (MetS) is routinely operationalised as a cluster of adverse 
risk factors for both cardiovascular heart disease and type 2 diabetes. Among these 
risk factors are abdominal/central obesity, insulin resistance, hypertension, and 
dyslipidaemia (Dunkley et al. 2012); although Reaven’s (1988) original hypothesis 
proposed that insulin resistance as the putative ‘single cause’ of the subsequent 
symptoms/components of MetS (i.e. central obesity, high blood pressure, 
dyslipidaemia and hyperglycaemia/diabetes) in which the ‘comorbidity’ these signify 
represent ‘more than the sum of their parts’ (Reaven 1988).  
While the prevalence of MetS among adults in the United States has steadily 
increased from 32.9% in 2003-2004 to 34.7% in 2011-2012 (Aguilar et al. 2015), and 
although insulin resistance, central obesity and glucose intolerance have all been 
considered possible causes behind the emergence of MetS, there are a range of other 
factors occurring at different times within the sequence of events leading up to the 
cardiovascular and metabolic diseases viewed as the principal clinical consequences 
of MetS, and there remains substantial uncertainty as to which of these (if any) 
constitute the single and/or multiple initial cause of MetS (Alberti, Zimmet and Shaw 
2006).  
Indeed, there is a growing body of evidence (and substantial interest) 
suggesting that sleep might play a central role in energy metabolism, reflected in part 
by the observation that both long and short sleep duration appears to have an 
association with (amongst other things) increased insulin resistance and increased 
appetite – both of which may contribute to the development to type 2 diabetes, a key 
symptom/component of MetS (Bartlett et al. 2008). 
1.2 Sleep  
Sleep is commonly defined on the basis of behavioral and physiological 
phenomena and processes: the behavioral involving a lack of movement, reduced 
responsiveness to the environment, and decreased cognitive function; the 
physiological changes evidenced by so-called ‘rapid eye movement’ (REM) and ‘non-
REM’ (NREM) sleep states which alternate cyclically (Carskadon and Dement 1994). 
In humans, normal ‘entry’ into sleep is through NREM – which itself can be subdivided 
into three stages N1, N2, and N3 (which account for 75-80% of sleep); while REM 
accounts for only 20-25% of sleep (Chokroverty 2010). To summarizes more of the 
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detail regarding the specific characteristics of NREM and REM sleep, these 
characteristics have been summarized in Table 1.1 (below). 
Table 1.1 A summary of the behavioral and physiological criteria used to determine 
wakefulness and sleep (Chokroverty 2010) 
Criteria 
 
Awake  Non–rapid eye 
movement sleep  
Rapid eye 
movement sleep 
Posture Erect, sitting, or 
recumbent 
Recumbent Recumbent 
Mobility Normal Slightly reduced or 
immobile; postural 
shifts 
Moderately reduced 
or immobile; 
myoclonic jerks 
Response to stimulation Normal Mildly to moderately 
reduced 
Moderately reduced 
to no response 
Level of alertness Alert Unconscious but 
reversible 
Unconscious but 
reversible 
Eyelids Open Closed Closed 
Eye movements Waking eye 
movements 
Slow rolling eye 
movements  
Rapid eye 
movements 
Electroencephalography Alpha waves; 
desynchronized 
Synchronized Theta or saw tooth 
waves; 
desynchronized 
Electromyography 
(muscle tone) 
Normal Mildly reduced  Moderately to 
severely reduced or 
absent 
Electro-oculography Waking eye 
movements 
Slow rolling eye 
movements 
Rapid eye 
movements 
The clinical assessment of sleep (and sleep-related disorders) requires both 
detailed history-taking and physical examination. Several subjective tools/instruments 
have been developed, including the: Epworth Sleepiness Scale (ESS) which assesses 
daytime sleepiness (Johns 1991); the popular Pittsburgh Sleep Quality Index (PSQI) 
which assesses sleep quality, ostensibly over the preceding month (Buysse et al. 
1989); and the Stanford Sleepiness Scale (SSS) which also provides a measure of 
daytime sleepiness (Hoddes, Zarcone and Dement 1972). In contrast, overnight 
polysomnography (PSG) is widely considered to be the most important objective 
‘laboratory test’ for the comprehensive assessment of sleep (Chesson Jr et al. 1997); 
which monitors brain function, muscle activity, heart rhythm and eye movement from 
subjects examined using a ‘polysomnograph’ while they are asleep. More recently, 
portable actigraphy (a less expensive and non-invasive technique) has increasingly 
been used and validated as a reliable alternative for measuring both sleep quality and 
sleep duration objectively, using accelerometry to record the movement of free-living 
subjects/study participants (Ferrie et al. 2011). The different characteristics of sleep 
are summarised and defined in Table (1.2). 
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Table 1.2 Definitions of commonly recognised ‘sleep characteristics’  
Sleep characteristic Definitions  
 
Sleep duration  Total hours of (usually, nocturnal) sleep attained 
Sleep latency Time taken to fall asleep (often set to < or > 30 minutes or some 
other time scale) 
Sleep disturbance 
and/or fragmentation 
Trouble sleeping due to waking up in the middle of the night or 
early in the morning 
Coughing/snoring 
while asleep 
Coughing or snoring loudly while asleep (often quantified as 
causing sleep fragmentation or disturbance) 
Sleep medication 
use 
Use of medicine(s) - either prescribed or over the counter – 
specifically to help with sleep 
Daytime sleepiness Difficulty experienced staying awake while conducting a range of 
daytime activities (including such activities as: driving; eating 
meals; or engaging in social activities) 
Sleep quality An assessment of the ‘overall quality’ of sleep 
 
Sleep patterns (particularly the characteristics of these associated with duration, 
periodicity and depth) are strongly influenced by sex, age and socioeconomic status; 
with variation in sleep duration and quality occurring at different stages of the life span. 
In adults 7-8 hours of sleep is widely considered to be that required to ‘maintain health’ 
with both ‘short’ and ‘prolonged’ sleep durations considered ‘unfavourable’ (Sharma 
and Kavuru 2010; Watson et al. 2015). Although, recent research has placed more 
emphasis on insomnia (comprising both protracted sleep latency and 
fragmented/poorly maintained sleep) and sleep apnoea, the ease with which sleep 
duration and quality can be assessed using validated (and self-administered) sleep 
tools/instruments has led to a growing number of studies suggesting that 
short/prolonged sleep duration and poor sleep quality are both associated with 
negative health outcomes; and, in particular, that all three sleep characteristics appear 
to be associated with diabetes, hypertension, cardiovascular disease and obesity 
(Bixler 2009; Youngstedt and Kripke 2004; Grandner et al. 2014). 
1.3 Metabolic syndrome 
 The metabolic syndrome (MetS) which, as we have seen, is rapidly becoming 
an important medical concern, is now widely operationalized simply as the clustering 
of multiple metabolic risk factors for both cardiovascular disease (CVD) and type 2 
diabetes (Ilanne-Parikka and Tuomilehto 2013; Grundy 2008). These factors include 
raised blood pressure, raised triglycerides levels, low high-density lipoprotein, 
hyperglycemia and obesity (particularly ‘central obesity’). Along with the specific 
clinical importance of the metabolic syndrome, there is a concern that MetS is more 
common among certain racialised social groups (such as those with salient ethnic 
identities). It has been suggested that each of the individual parameters in the 
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definition of MetS can often be clustered within such groups  and thereby reflects 
describes the embodiment of disadvantage or biogeographical heritage responsible 
(Mugo and Sowers 2004). For example, compared to groups with European ancestry, 
those with African ancestry are often found to have less visceral adipose tissue in 
some social contexts. They may also be more prevalent to hypertension. In contrast, 
those with Asian ancestry often appear to have greater adipose tissue in various 
contexts (Mugo and Sowers 2004; WHO 2011). Despite such differences, it remains 
unclear whether such differences in the prevalence of MetS-related components are 
the result of structural, cultural and/or biogeographic selection(Rampal et al. 2012). 
However, although the risk posed by each of these multiple metabolic risk 
factors has been recognized for some time, the most recent emphasis has been on 
their association with the possibility of insulin resistance (Alberti et al. 2009) as the 
‘single’ preceding cause (Reaven, 1988). Yet Reaven’s (1988) hypothesis is predated 
by several, much earlier attempts to define MetS including (as suggested by Alberti; 
2005) the definition first offered by Kylin in 1923, who recognized the way in which 
hypertension, hyperglycemia and gout tended to cluster. In 1947, Vague reportedly 
proposed that central obesity was the single feature most commonly associated with 
MetS-related ‘metabolic disturbances’ (Alberti 2005). By 1988 (Isomma et al., 1988), 
Reaven had labelled MetS “syndrome X”, defining this in its more familiar guise as a 
clustering of glucose intolerance, hypertension, low levels of high density lipoprotein 
(HDL), and high triglyceride (TG) levels (Isomaa et al. 2001). However, although (like 
‘syndrome x’) a number of different names have been proposed to describe the 
clustering of these metabolic risk factors (including the: ‘deadly quartet’; ‘plurimetabolic 
syndrome’; ‘insulin resistance syndrome’; and even ‘Reaven’s syndrome’) the 
‘metabolic syndrome’ (MetS) is now considered to be the most appropriate and widely 
accepted label for this particular suite of cardiovascular risk factors (Alberti, Zimmet 
and Shaw 2006) – hence the decision to use this term in the present thesis. 
Elsewhere, the commonest definitions in use today are those provided by the 
World Health Organization (WHO): which considers insulin resistance to be the 
dominant feature of MetS, and diagnosis this as present when it is accompanied by 
any two of the other risk factors (albeit with ‘central obesity’ determined using waist to 
hip ratios [WHR]) (Organization 1999). The European Group for the Study of Insulin 
Resistance (EGIR) has a similar definition to that proposed by the WHO, except that 
their obesity criterion relies on waist circumference measurements (WC) rather than 
WHR (Balkau et al. 2002). In contrast, the definition of MetS put forward by the 
International Diabetes Federation (IDF) interprets WC as a measure of ‘abdominal 
obesity’ (as opposed to ‘central obesity’), though they also propose assessing this 
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using WC measures, and view the presence of elevated WC, together with any two of 
a suite of additional risk factors as sufficient and necessary for diagnosing MetS 
(International-Diabetes-Federation 2006). More recently, the US National Cholesterol 
Education Program – Third Adult Treatment Panel (NCEP ATP III) has suggested a 
simpler definition of MetS based on ‘any 3’ of a total of 5 possible risk factors (NCEP-
ATPIII 2002), although a subsequent update to the NCEP ATP III definition (suggested 
by the American Heart Association/National Heart, Lung, and Blood Institute Scientific 
statement (AHA/NHLBI) concludes that elevated WC should be one of the 5 possible 
risk factors rather than the most important/only required criterion (as proposed, for 
example, by the IDF) (Grundy 2008; Alberti et al. 2009). These disagreements aside, 
most of the definitions proposed have substantial similarities and are, in many 
respects, interchangeable (see Table 1.2, below). At the same time, there remains 
some merit in the NCEP ATP III definition given that it is perhaps both a more 
appropriate and practical tool for use across clinical and epidemiological contexts; not 
least because it does not require any dominant feature must be present, only that any 
three of the five features/symptoms/components are evident (Huang 2009). 
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Table 1.3 A summary of the different definitions and classifications of the metabolic 
syndrome (MetS) proposed since Reaven’s seminal hypothesis was published in 1988. 
 WHO 1998 EGIR 1999 IDF   2005  NCEP ATP III 
2001 
AHA/NHLBI 
2009  
Absolutely 
required  
Insulin resistance 
(Impaired glucose 
tolerance, impaired 
fasting glucose, 
type 2 diabetes) 
Hyperinsuline
mia (plasma 
insulin>75th 
percentile)   
Central obesity 
(defined as: 
WC≥94cm in 
males; ≥80 cm in 
females)  
None  None  
Clinical 
criteria 
(Insulin resistance 
or diabetes plus) 
Any two of the five 
characteristics 
below 
(Hyperinsuline
mia plus) Any 
two of the four 
characteristics 
below 
(Obesity plus) any 
two of the four 
characteristics 
below 
Any three of the 
five 
characteristics 
below 
Any three of 
the five 
characteristics 
below 
Obesity  WHR >0.90 in 
males, >0.85 in 
females or BMI>30 
kg/m2  
WC≥94cm in 
males, ≥80 
cm in females 
Required  WC>40 inches 
in males>35 
inches in 
females 
WC≥102cm 
(40 inches) in 
males, ≥88cm 
(35 inches) in 
females 
TG ≥150 mg/dl or 
HDL<35mg/dl in 
male, <39 mg/dl in 
female 
≥177 mg/dl or 
HDL <39mg/dl 
≥150 mg/dl or on 
treatment for 
elevated TG  
≥150 mg/dl or 
on treatment for 
elevated TG 
≥150 mg/dl 
(1.7 mmol/L) or 
on treatment 
for elevated 
TG 
HLD   <40 mg/dL in 
male, <50 mg/dL 
in female or on 
treatment for 
reduced HDL 
<40 mg/dL in 
male, <50 
mg/dL in female 
or on treatment 
for reduced 
HDL 
<40 mg/dL 
(1.03 mmol/L) 
in male, <50 
mg/dL (1.3 
mmol/L) in 
female or on 
treatment for 
reduced HDL 
Blood 
pressure  
≥140/90 mmHg ≥140/90 
mmHg or on 
antihypertensi
ve treatment  
>130 mmHg 
systolic blood 
pressure, or >85 
mmHg diastolic 
blood pressure, or 
on 
antihypertensive 
treatment 
>130 mmHg 
systolic blood 
pressure, or >85 
mmHg diastolic 
blood pressure, 
or on 
antihypertensive 
treatment 
≥130 mmHg 
systolic blood 
pressure, or 
≥85 mmHg 
diastolic blood 
pressure, or on 
antihypertensiv
e treatment  
Glucose  Required  Required Fasting 
glucose≥100mg/d
l  
Fasting 
glucose≥100mg
/dl or on 
treatment for 
elevated 
glucose  
Fasting 
glucose≥100m
g/dl or on 
treatment for 
elevated 
glucose 
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To a great extent, central obesity rather than generalized obesity has been 
found to be associated with an increased risk of cardiovascular disease (Janssen, 
Katzmarzyk and Ross 2004; Zhu et al. 2002). This is because increased visceral 
adipose tissue is associated with metabolic abnormalities, including reduced insulin 
sensitivity, glucose intolerance, and adverse lipid profiles – all of which are known risk 
factors for cardiovascular disease and diabetes (Björntorp 1996). Central obesity can 
be quite simply assessed using waist circumference (WC), which has been suggested 
to be superior to “waist to hip ratio” (WHR) and “body mass index” (BMI) in predicting 
metabolic and cardiovascular diseases (simply because BMI is a measurement that 
does not distinguish between the proportion of weight due to fat or muscle;(WHO 
2011). Nevertheless, subjects with lower height are prone to having more abdominal 
fat compared to taller subjects of the same WC, which may reflect the importance of 
height as an indicator of health (Park and Kim 2012). Indeed, short stature has been 
associated with obesity, diabetes, and heart disease primarily because it is a marker of 
the embodiment of challenging socioeconomic conditions and health hazards in early 
life (Perelman 2014).  
Following closely after obesity (and, particularly, central obesity), insulin 
resistance is widely considered to be the single most important contributor to MetS, 
and both obesity and insulin resistance are themselves associated with a range of 
different contributory sociodemographic characteristics (most notably: age; sex; and 
poverty). Accordingly, the management of MetS is primarily linked to the management 
of the modifiable risk factors associated with these three sociodemographic factors 
(e.g. an atherogenic diet, physical inactivity, and obesity), and has focused (as has so 
much of health improvement interventions, to-date) on promoting a ‘healthy lifestyle’ 
(Grundy 2005). The momentum behind these interventions has been epidemiological 
evidence suggesting that, in addition to a two-fold increase in the risk of CVD, and a 
3.5-5.0 fold risk of developing type 2 diabetes, patients diagnosed with MetS are also 
subject to an increased risk of: fatty liver; polycystic ovary syndrome; asthma; 
cholesterol gallstones, and (importantly, given the focus of the present thesis) sleep 
disturbance (Grundy et al. 2004). 
1.4 Sleep and MetS  
Changes in sleeping patterns have been increasingly recognised in recent 
years, with most surveys reporting that respondents now sleep only 6.8 hours on 
average compared to 9 hours a century ago (Sharma and Kavuru 2010). To put this in 
perspective, more than 30% of US adults aged 30-64 years recently reported having 
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less than 6 hours of sleep per night (Knutson and Van Cauter 2008). However, what is 
remarkable about the definitions of ‘short’ and ‘long’ sleep duration is that no 
standardised cut-off point for either have yet been established/agreed. Instead, the 
majority of studies have defined short sleep as ≤ 5hrs per night, ≤ 6hrs, or < 7hrs, 
while long sleep duration was defined predominantly as >8hrs or ≥ 9 hrs per night 
(Cappuccio et al. 2010).   
This apparent reduction in sleep duration has been accompanied by a number 
of substantial metabolic and endocrinological changes, namely elevated body mass 
index (BMI) and obesity, and insulin resistance (Grandner et al. 2014; Jennings, 
Muldoon and Hall 2007). Sleep loss (i.e. sleeping less than required) has also been 
found to have a strong impact on appetite-regulating hormones (particularly leptin, 
ghrelin, and orexin), leading to increased appetite and food intake (Markwald et al. 
2013). Poor sleep quality is strongly associated with reduced levels of leptin (an 
appetite suppressor hormone), elevated levels of ghrelin (a hormone that increases 
appetite and controls body weight), and elevated levels of orexin (a hormone that 
controls hunger and the sleep-wakefulness cycle). At the same time, simply as a 
consequence of the fatigue and sleepiness associated with shortened, poorer quality 
sleep, this may in turn cause reduced activity and energy expenditure which further 
contribute to incipient obesity (Knutson and Van Cauter 2008). 
Decreased glucose tolerance and increased insulin resistance has also been 
found to be associated with sleep loss due, in part, to increased levels of growth 
hormone and cortisol (hormones involved in glucose regulation), which then lead to an 
increased risk of diabetes. Sleep loss may likewise trigger elevated blood pressure 
due to increased activity of the sympathetic nervous system; and to elevated cortisol 
levels resulting from disturbances to the hypothalamic-pituitary-adrenal axis (which 
results in a reduction in the clearance rate of free cortisol, and thereby a build-up of 
circulating cortisol levels; (Bjorvatn et al. 2007). Yet another consequence of sleep 
loss is an increase in both cholesterol and low density lipoprotein (LDL) levels in the 
blood stream; phenomena that may be explained by increased appetite and food 
intake (as explained earlier), and/or by increased stress levels and reduced physical 
activity levels resulting from daytime fatigue (Gangwisch et al. 2010).  
Overall then, the relation between sleep loss and metabolic dysregulation is 
both complex and straightforward, involving well-established hormonal pathways, 
sympathetic stimulation (as discussed above), and inflammation (Sharma and Kavuru 
2010). Acute sleep loss has been found to be related to changes in immunological 
responses, and to an increase in pro-inflammatory cytokines. The presence of 
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cytokines (small proteins that are important in cell-cell signalling) is itself associated 
with insulin resistance and diabetes (Knutson and Van Cauter 2008).  
1.5 Challenges of self-reported data 
With the interest in assessing the relationship between sleep and MetS, only few 
large scale epidemiological studies have the capacity to collect direct measurements 
of anthropometric, physiological and objective biological measurements; instead, 
mostly they rely on self-reported data (Yoong et al. 2013; Engstrom et al. 2003) which 
tend to be easier and cheaper to collect. However, like all data, self-reports are not 
immune from random and systematic sources of errors (Huerta et al. 2009; Molenaar 
et al. 2007; Oksanen et al. 2010); and because each participant is intimately involved 
in generating (i.e. accurately remembering and accurately reporting) these forms of 
data, the risk of systematic bias is heightened. This is because variation in 
sociodemographic, economic, health and lifestyle characteristics – characteristics that 
are often central to the aims of large scale population-based epidemiological studies – 
can determine both the value of self-reported measures, but also the accuracy with 
which these values are/can be reported. (Goldman et al. 2003; Huerta et al. 2009; 
Molenaar et al. 2007).  
For anthropometric and physiological parameters, ostensibly ‘valid’ measures of 
these need to be measured directly so that their values can be compared to the self-
reports of these offered by the same participants – an approach that is central to 
previous validation studies which have compared self-reported data with more 
objective referent data from a range of alternative sources, including medical records 
and clinical investigations, as well as direct measurements (Goldman et al. 2003; 
Robinson et al. 1997). However, few such studies have access to data from nationally 
representative samples, and many based these on small samples that only included or 
excluded ethnic minorities, or populations from a limited geographical area (Goldman 
et al. 2003; Thawornchaisit et al. 2013; Vargas et al. 1997; Pastorino et al. 2014; 
Leikauf and Federman 2009; Margolis et al. 2008). 
1.6 Why study the relationship between sleep and Metabolic 
Syndrome?  
One of the key reasons why this study has chosen to focus on the speculative 
relationship(s) between sleep and MetS in adults is the possibility that such 
relationships might offer novel insights into the prevention and/or treatment of 
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associated clinical disease (and their associated risks). However, the underlying 
theoretical hypothesis (that sleep and MetS are functionally related), remains an area 
that remains hotly contested, and one that lacks substantial scientific attention. This 
field would therefore benefit greatly from capitalising on the growing number of large 
and powerful epidemiological datasets available, and the innovative analytical 
techniques that have recently been developed to generate aetiological knowledge from 
these (i.e. knowledge based on causal inference developed from the analysis of 
observational datasets). Considering the steady increase in obesity and apparent 
changes to human sleeping patterns; therefore, it is clearly important to expand both 
the volume and scope of research in this area. 
Although there can be little doubt that researchers have gained a firm grasp on 
a number of important dimensions and characteristics of sleep (most notably those 
related to sleep duration and quality), and have found MetS to be an important 
theoretical/prognostic concept for developing our understanding of chronic 
cardiometabolic disease, there remains considerable uncertainty (and a substantial 
lack of consensus) regarding: which sleep characteristics (if any) might be (the most) 
important determinants/causes of MetS; and how best one might operationalise MetS 
in order to explore its relationship(s) with sleep. Given the growing evidence of strong 
(cross-sectional and longitudinal) relationships between specific aspects of sleep 
(particularly, but not exclusively: sleep duration, sleep disturbance/quality, and 
obstructive sleep apnoea) and specific components of/contributors to MetS (notably, 
though not exclusively: obesity; glucose intolerance/insulin resistance; 
hyperlipidaemia; and hypertension), this is an area that warrants additional, and 
carefully considered, large-scale research – research that requires (and stands to 
benefit from) thoughtful epidemiological analyses and methodological innovation. 
1.7 Study design  
In epidemiological research, experimental and observational analytical studies 
are the two main approaches used to assess whether an exposure (in this instance 
MetS or sleep) might be associated with a particular outcome (in this instance sleep, 
or MetS (Eisenmann 2003). However, although experimental studies are said to 
occupy the highest grade of evidence based on research design (whereas, in fact, 
systematic reviews and meta-analyses of experimental studies trump these), it is not 
always true, feasible or efficient to conduct such studies (Rothman 2014), not least 
when the resources concerned might be better spent elsewhere (such as on areas of 
enquiry in which the evidence base from cheaper, observational studies is more 
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persuasive). For these reasons – and not least because it was not considered feasible 
or ethically defensible to conduct a trial involving interventions that exacerbate MetS or 
sleep-related problems in order to assess their effects on one another, but also 
because there are few proven interventions for addressing either MetS (as a whole, 
rather than separate symptoms/components thereof) or sleep without recourse to 
pharmacological formulations that may, themselves affect both sleep and MetS – an 
observational approach was adopted as most pragmatic for the present thesis’ 
evaluation of the relationship between MetS and sleep.   
The advantages of observational studies are that: they are relatively 
inexpensive, quick and easy to conduct; multiple outcomes can often be studied within 
data collected on a single occasion (hence data collection is only required once); and 
they are useful for both evaluating and generating hypotheses relevant to the aetiology 
of disease. However, these kinds of studies do not provide sufficient understanding of 
the mechanisms underlying any relationship between the exposure(s) and outcome(s) 
examined to infer causality, simply because they cannot differentiate between cause 
and association, and cannot identify the direction in which any association might 
operate. Another important limitation of observational studies is the possible influence 
of any confounding factors that may create, strengthen and (occasionally) attenuate an 
apparent relationship between exposure and outcome (Mann 2003). 
However, applying a causal path approach (such as using theoretical causal 
path diagrams in the form of directed acyclic graph, or DAG, to identify potential 
confounders and likely mediators) can help to minimise some of these limitations 
associated with observational studies. Such an approach allows data to be analysed in 
a temporal fashion set against a theoretical chronological sequence, on the basis of 
which variables (exposure, outcome, and covariates) precede or follow after one 
another.  
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1.8 Summary and conclusion  
This chapter successfully provided background information on sleep and 
metabolic syndrome and described the importance of this topic. Following this 
background, the aim is to generate an improved understanding of the available 
evidence regarding the speculative relationship between sleep and the metabolic 
syndrome (MetS). This aim will be operationalised using the following key question 
KQ1: “What methodological and empirical insights might be drawn from previous 
studies examining the relationship between sleep and the metabolic syndrome (MetS) 
to inform: the focus and conduct of future research; and our understanding of the 
evidence base regarding ‘unfavourable’ sleep as a possible cause and a possible 
consequence of MetS?” 
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Chapter 2 Systematic review of previous studies examining the 
relationship between sleep and MetS  
The present Chapter sets out to explore what might be learnt from the methods 
used, and findings generated, from previous empirical studies exploring the (possibility 
of a) relationship between the metabolic syndrome (MetS) and sleep.   
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2.1 Introduction  
Much has been written from both a theoretical and a conceptual basis, regarding 
the possible role that sleep might play in metabolic homeostasis and energy balance, 
and there is growing evidence from experimental studies that artificially shortened or 
disturbed sleep has immediate (i.e. acute) effects on glucose metabolism, appetite and 
satiety (Mullington et al. 2009). There is therefore much speculation regarding the 
potential role that ‘unfavourable’ or ‘less than ideal’ sleep might have either in the 
initiation of MetS (i.e. as the ‘cause of the cause’, be that insulin resistance as 
proposed by Reaven in 1988, or some other physiological change) or the facilitation of 
the impact these postulated physiological changes have on the subsequent 
development of the symptoms/components of MetS (i.e. central obesity; high blood 
pressure; dyslipidaemia; and diabetes). This is supported by studies demonstrating a 
steady decline in the duration and quality of sleep and an increase in the diagnosis of 
sleep disorders (Knutson et al. 2007), both occurring over the same period in which 
the obesity epidemic has emerged, and the prevalence of type 2 diabetes has been 
steadily increasing (and occurring at younger and younger ages; (Spiegel et al. 2009).  
However, most empirical studies exploring the possibility of an association 
between sleep and MetS have focussed either on clinical conditions with sleep-related 
effects (such as obstructive sleep apnoea, OSA – a condition that is strongly 
associated with obesity and hypertension) or on individual symptoms/components of 
MetS (i.e. obesity, high blood pressure, dyslipidaemia and diabetes). While conditions 
such as OSA occur while individuals are asleep, it is arguable whether they fairly 
constitute ‘sleep-related characteristics’, since they primarily reflect the impact of 
endogenous physiological and anatomical factors on sleep rather than issues arising 
out of sleep per se. And while studies examining the relationship between sleep and 
individual symptoms/components of MetS appear to offer substantial evidence of a link 
between (short, long and poorer quality) sleep and both obesity and 
hyperglycaemia/diabetes, few of these studies use the longitudinally collected data 
required (i.e. from three or more time points) to provide evidence of directionality – i.e. 
evidence that changes in sleep precede changes in obesity and/or glycaemic control; 
or vice versa. Moreover, the present thesis was unable to find any reviews of such 
studies that have critically appraised the potential methodological and analytical flaws 
involved (not least the possibility of reverse causality, in which the association 
between obesity/hyperglycaemia and sleep reflects the impact of the former on the 
latter). The present thesis has also failed to find any studies examining the long-term 
impact of shortened/disrupted (or improved) sleep on MetS-related 
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symptoms/components, beyond those examining its immediate, or short-term effects 
(as described earlier). Yet, even these studies would not provide unequivocal evidence 
of an association (or relationship) between sleep and MetS (i.e. the specific 
combination of symptoms/components intended to capture something ‘greater than the 
sum of its parts’ by way of indicating the possibility of a single preceding cause or 
trigger, such as the development of insulin resistance earlier in life). There is therefore 
a pressing need to further examine the relationship between sleep and MetS in order 
to evaluate what evidence might be available to support the suggestions that the 
classification of MetS: conveys additional information (i.e. information that information 
on each of its components, alone, cannot convey); and might have a very particular 
association (or simply an enhanced, or indeed attenuated, association) with sleep – 
associations that might help to assess the potential role of sleep in the development of 
MetS (and thereby each component of MetS), and the subsequent impact of MetS 
(and each component of MetS) on sleep. 
2.2 Aim and objectives 
 The key aim of this chapter was therefore to re-evaluate the evidence provided 
by previous studies examining the relationship between MetS and sleep by:  
(i) conducting a systematic search to identify any empirical studies examining 
the association between a formal classification of MetS (as opposed to any 
one, or other combinations, of its constituent symptoms/components) and 
sleep-related characteristics; 
(ii) identifying any studies conducted in the UK  
(iii) identifying any studies using cross-sectional, longitudinal and/experimental 
designs capable of generating evidence of association, directionality and 
causality, respectively; 
(iv) assessing the likely external validity of any such studies (both in terms of 
the range of geographical locations in which these have been conducted 
and the participant recruitment/sampling strategies used); 
(v) describing the range of definitions and measurements used to 
conceptualise and operationalise MetS and different sleep-related 
characteristics; 
(vi) critically appraising the statistical techniques used and the analytical 
models on which these are applied;  
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(vii) comparing any effect estimates generated from studies using comparable 
measures and comparable analytical techniques; and (in as much as this is 
possible) 
(viii) generating combined estimates of any association between different sleep-
related characteristics and MetS, using meta-analytical techniques. 
In this way, the present Chapter sought to address the following key question as 
established at the outset of this thesis: 
 
KQ1: “What methodological and empirical insights might be drawn from previous 
studies examining the relationship between sleep and the metabolic syndrome (MetS) 
to inform: the focus and conduct of future research; and our understanding of the 
evidence base regarding ‘unfavourable’ sleep as a possible cause and a possible 
consequence of MetS?” 
2.3 Methods 
2.3.1 Search strategy  
A systematic search was performed in Medline with the aim of finding original 
articles describing studies that had examined the association between sleep and 
MetS. 
2.3.1.1 Search terms  
1. Sleep  
The search terms selected to capture sleep-related studies included those relevant 
to both sleep-specific characteristics (e.g. duration and latency) and sleep-specific 
disorders (e.g. obstructive sleep apnoea and narcolepsy), and used all available 
synonyms thereof, namely: 
apnoea; central sleep apnoea treatment; central sleep apnoea; dyssomnia; 
hypersomnia;  hypopnoea syndrome; insomnia; nightmare; obstructive sleep 
apnoea; parasomnias; sleep-related breathing disorders; sleep apnoea; sleep; 
sleep time; sleep duration; sleep hours; sleep quantity; sleep quality; sleep 
disorder; sleep disorders; sleep disordered; sleep length; sleep disturbance; 
sleeplessness; sleepiness; sleep efficiency; sleep latency; sleep problem; 
sleep disturbance; sleep difficulties; sleep terror; sleep deprivation; time in bed; 
time spent asleep; time spent sleeping; time sleeping; and time asleep.  
18 
 
These search terms for ‘sleep’ were then combined using the Boolean operator ‘OR’; 
and were added to those relevant to the ‘metabolic syndrome’ using the operator 
‘AND’ (see below).  
2. Metabolic syndrome  
To identify articles describing studies that specifically addressed the metabolic 
syndrome (as opposed to the individual components thereof), the search terms used 
drew on Medical Subject Headings (MeSH) drawn from Medline’s MeSH directory. 
These MeSH terms included:  
insulin resistance syndrome x; syndrome x, metabolic; syndrome x, insulin 
resistance; metabolic x syndrome; syndrome, metabolic x; x syndrome, 
metabolic; dysmetabolic syndrome x; syndrome x, dysmetabolic; reaven 
syndrome x; syndrome x, reaven; metabolic cardiovascular syndrome; 
cardiovascular syndrome, metabolic; cardiovascular syndromes, metabolic; 
syndrome, metabolic cardiovascular 
These MeSH terms were then combined with the search terms for ‘sleep’ using the 
operator ‘AND’.  
2.3.2 Filters and limits  
Initially, no restrictions (i.e. filters or limits) were applied to the search in order to 
ensure that all available studies might be included and available for subsequent 
screening. However, during the application of the review’s exclusion criteria, Medline 
filters and limits based on human studies and adults 19yrs and older, were used to 
facilitate the exclusion of studies from the original list of those screened as eligible for 
consideration.  
2.3.3 Inclusion and exclusion criteria  
Given that an important aim of the systematic review was to synthesise the 
findings of any published articles describing primary empirical studies (focussing on 
articles which set out to assess the relationship between sleep-related characteristics, 
and/or sleep complications, and a classification of MetS in adults), these design-, 
topic- and participant-specific criteria constituted the principal ‘inclusion’ criteria 
relevant to the search undertaken. On this basis, articles identified in the preliminary 
Medline searches were excluded if they described animal studies (since the aim was 
to investigate the relationship between Sleep and MetS among human beings), or 
studies focussing on children or adolescents (since the burden of sleep- and MetS-
related problems is likely to be different, and higher, in adults when compared with 
children; (Crespo et al. 2007). Likewise, all studies that assessed the relation between 
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sleep and only one component of MetS (such as high blood pressure or central obesity 
alone, rather than a classification of MetS based on at least three of these) were 
excluded. The rationale for this was the review’s aim to assess whether the special 
cardiometabolic features considered central to the conceptualisation of MetS itself – 
i.e. as a ‘syndrome’ identified by the presence of more than one [indeed, often three or 
more] key metabolic and cardiovascular components; see Chapter 1: Introduction, for 
a more detailed summary of the proposed meaning and utility of MetS per se as 
originally conceptualised and subsequently operationalised – displayed any 
aetiologically insightful associations with sleep-related characteristics. And although 
the search strategy sought to include not only sleep-related characteristics and sleep-
related disorders, studies focussing exclusively on one common disorder considered 
by many to be sleep-specific (obstructive sleep apnoea; OSA) were excluded on the 
grounds that this complex disorder, though defined as a condition occurring 
only/primarily whilst asleep, is more likely to reflect the impact of respiratory and 
cardiovascular on sleep rather than as a function of sleep itself. This is also the reason 
why, after identifying and critically appraising a small number of experimental (n=9) 
and longitudinal (n=3) studies captured by the literature search (see Appendix 6.2 and 
6.3), it was decided to exclude these from the present Chapter and focus exclusively 
on studies adopting a cross-sectional design, this was also true for the small number 
of studies (n=3) adopting a quasi-cohort design, all of which used analyses of change 
that are likely to have been particularly susceptible to regression to the mean (Tu and 
Gilthorpe 2007) and none of which actually offer the evidence of directionality they 
claim (see Appendix 6.2). Likewise, the majority of experimental studies identified in 
the present Chapter’s search focussed exclusively on OSA and used interventions 
(such as continuous positive airway pressure “CPAP”) in participants with OSA to 
assess its subsequent effect on MetS. Indeed, the few experimental studies that 
targeted MetS to assess the effect thereof on sleep, all used weight loss alone as the 
intervention rather than more holistic interventions targeting all of the putative 
components of MetS simultaneously (i.e. central obesity, high blood pressure, 
dyslipidaemia and diabetes; see Appendix 6.3). As such, there were both pragmatic 
and substantive scientific reasons for limiting the focus of the present review to only 
those studies adopting a cross-sectional design. Finally, since the data required for 
both the synthesis and methodological critique envisaged in the present Chapter 
required articles describing primary empirical analyses of the association between 
MetS and sleep that could be carefully (and critically) examined, those published in 
languages other than English, and those that comprised ‘letters’, ‘comments’, ‘case 
reports’, ‘meeting abstracts’, or ‘narrative reviews’ were also excluded (the latter 
because these were unlikely to contain sufficient information on such analyses.  
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2.3.4 Data extraction  
Full-text copies of all of the articles meeting the inclusion criteria were close-
read for data extraction and critical appraisal purposes. Data were extracted and 
tabulated using a predesigned collection proforma covering the following information:  
Study citation and key characteristics – this included: first (two if only two) author(s) 
name(s); date of publication; country in which study took place; and sample size at 
recruitment; and duration;  
Participant characteristics – this included: details of the context/study through which 
recruitment occurred; any explicit inclusion and exclusion criteria; and the sex and age 
distribution of recruited participants;   
The definition and measurement of exposure(s)/intervention(s), outcome(s) and 
measured covariates –  for MetS, this included the classification used and any (self-
reported and/or direct) measurement techniques used for each of the constituent MetS 
components; for sleep-related characteristics, this included the objective and/or 
subjective tools used (e.g. actigraphy and/or polysomnography; vs. Pittsburgh Sleep 
Quality Index [PSQI] or the use of ‘custom sleep item sets’, respectively); and for any 
available/measured covariates, this included simply a list of these, collated from 
wherever these were mentioned in the article; and 
Analytical modelling – for each analytical model examining the association between 
MetS itself1 and sleep-relevant1 characteristics, this included: the statistical techniques 
used (e.g. Poisson regression, logistic regression), the format of the exposure and 
outcome variables (i.e. whether continuous, categorical-binary or categorical-
polytomous); the reported inclusion criteria and prevalence of MetS and the specific 
sleep characteristic examined in any indicator and referent categories; the unadjusted2 
effect estimates of the association between MetS and the specific sleep characteristic 
examined; a list of the covariates included in any adjustment sets used to generate 
adjusted effect estimates between MetS and the specific sleep characteristic 
examined; and the effect estimates for each of these adjusted analytical models.  
Note: 1Where any of the articles examined either: components of MetS separately (or combinations of 
MetS components that did not relate to a formal definition of MetS), and/or examined characteristics 
related to characteristics relevant though not considered, for the purposes of this review, specific to sleep 
(such as shift work patterns or OSA), then a note was made that these analyses had been undertaken, 
but no further details of these were summarised. 
 2Where the article did not report unadjusted associations between MetS and any given sleep 
characteristic, but where the article did report the data required to calculate these, the results of these 
calculations were included in the tables of extracted effect estimates. 
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2.3.5 Critical appraisal of analysis  
The critical appraisal of the analyses included in each of the studies reviewed 
was informed by causal path diagrams (in the form of directed acyclic graphs; DAGs). 
Causal path diagrams were used to conceptualize any likely/plausible relationships 
between exposure, outcome and all available/measured covariates, from which those 
variables acting as potential confounders could then be identified (and for which 
adjustment might then be expected to have been undertaken; (Hernán et al. 2002). 
Directed acyclic graphs (DAG), are useful graphical tools in observational (and 
some experimental) epidemiological studies that aim to assess the possibility of a 
causal link between exposures, outcomes and other measured (‘manifest’) and 
unmeasured (‘latent’) variables – so called ‘causal inference’ analyses (Fleischer and 
Roux 2008). Based on a priori knowledge about the exposure and outcome of interest, 
any other variables available to/measured by the study are called covariates. DAGs 
use arrows (so-called ‘arcs’) between variables (so-called ‘nodes’) to denote putative 
causal effects, and by clarifying which of the variables are causes of both the exposure 
and the outcome, can determine which are necessary to control for in order to adjust 
for potential confounding (VanderWeele and Robins 2007).  
However, from a causal inference perspective, covariates can actually have 
three different roles within DAGs: they can be: (potential) confounders; (likely) 
mediators, or competing exposures. As described earlier, a confounder is a variable 
that is a likely/plausible cause of both the exposure and the outcome, and is not 
situated on the causal path between exposure and outcome. A mediator is a variable 
that is a likely/plausible cause of the outcome but for which the exposure is a 
likely/plausible cause – so that mediators sit on the causal path between exposure and 
outcome. In contrast, a competing exposure is a variable that is not causally related to 
the exposure but is a likely/plausible cause of the outcome (or, more specifically, a 
cause of variance in the outcome). The following diagram (Figure 2.1) illustrates 
covariates roles in a simple DAG. 
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Figure 2.1 A stylised directed acyclic graph, demonstrating the distinction between a 
confounder, a mediator and a competing exposure. 
 
In multivariable statistical models, only covariates that fit the formal definition of 
a confounder need to be adjusted for (Pourhoseingholi, Baghestani and Vahedi 2012). 
Conversely, adjusting for mediators may yield flawed results, while adjusting for 
competing exposures may not introduce bias but may not always improve precision at 
the cost of degrees of freedom (Tu and Greenwood 2012) 
2.4 Results and Discussion 
2.4.1 Search Results  
Figure 2.2 summarises the total numbers of articles generated using each of 
the two sets of search terms (i.e. those for ‘sleep’ and those for ‘metabolic syndrome’), 
both separately combined (n=507). The results of applying each of the exclusion 
criteria on these n=507 articles have been summarised in Figure 2.3. Once articles on 
‘non-humans’, and those on children and adolescents had been excluded using the 
relevant Medline filters, only n=238 articles remained. The titles and abstracts (where 
these were available) of these n=238 papers were carefully examined and a further 
n=132 articles were excluded on the basis that they were irrelevant, assessed the 
relation between sleep and only one component of MetS or they were of different 
language. For each of the remaining n=106 articles, the full-text article was repeatedly 
close-read to ensure that their content/focus (as classified using only their title and, 
where available, their abstract) actually met the review’s inclusion criteria; a process 
that led to the exclusion of a further n=26 articles. The remaining n=80 articles, were 
filtered by the type of the study, a process that led to identifying n=9 intervention 
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studies which were all about OSA, n=6 studies about Syndrome Z (the interaction of 
OSA with MetS), and n=65 observational studies. A final round of assessment, result 
in further excluding n=44 observational studies that met the review’s exclusion criteria. 
Leaving a total of n=21 articles (containing reports of empirical, cross-sectional 
studies) that did not meet the review’s exclusion criteria (and therefore form the basis 
of the methodological critique and synthesis of results provided below). 
  
Sleep synonyms 
combined by OR 
n=18,6361 
Metabolic Syndrome 
MeSH terms 
n=19,989 
Combined Sleep  
AND  
Metabolic syndrome 
 n=507 
Figure.2.2 Search results for sleep alone, MetS alone and combined  
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Intervention studies (OSA) 
n=9  
Syndrome Z (OSA & 
MetS) n=6 
Observational 
studies  
n= 65 
Articles identified through 
database searching 
n=507 
Further assessment 
n=80 
Title and abstract evaluation 
n=238  
 Single component of MetS or 
irrelevant n=119  
Different language n=13 
Full evaluation 
n=106 Further exclusion: 
Not matching including criteria 
n=26 
Cohort n=4 (OSA n=1, quasi-cohort design n=3)  
Case-control n=5 (OSA) 
 Cross-sectional n=35 (OSA n=28, shift work n=4, and 
no results reported n=3) 
Articles excluded by search 
limited to human and adults 
studies; 
Children and adolescents=259 
Animal studies=10 
 
Cross-sectional studies for data 
synthesis   
n=21 
Figure 2.3 Results of applying each of the exclusion criteria. 
25 
 
2.4.2 Studies and participants characteristics  
As described in the Methods section of the present Chapter (see above), three 
separate sets of data were extracted from each of the n=21 articles included in this 
review, and these have been summarised in: Table 2.1 (key study and participant 
characteristics); Tables 2.2 and 2.3 (the definition and measurement of exposures and 
outcomes, and any available covariates); and Table 2.4 (the analytical models each 
study used to examine the association between MetS and sleep-specific 
characteristics). While all of these articles described cross-sectional studies that had 
been conducted between 2006 and 2014, n=2 had been conducted by the same 
research group (Hall et al. 2008; Hall et al. 2012), and two pairs of studies appeared to 
have used the same datasets (Thomas et al. 2006) and (Arora et al. 2011) using 
baseline data from the Guangzhou Biobank Cohort Study, as described by (Jiang et al. 
2006); (Roopa et al. 2010) and (Krishnan et al. 2012) using data from what appeared 
to be the same n=358 participants from the Chennai Urban Rural Epidemiology 
Study). However, on closer inspection it was clear that the studies by Hall et al. (2008; 
2012) had been conducted on different datasets (comprising data from the Adult 
Health and Behaviour Project Registry, and the SWAN Sleep Study, respectively), 
while those conducted by Thomas et al. (2006) and Arora et al. (2011) focussed on 
different sleep characteristics (snoring and sleep duration, respectively). This left only 
the studies by Roopa et al. (2010) and Krishnan et al. (2012), both of which examined 
similar sleep characteristics and classifications of MetS (though specifying these 
differently as exposure or outcome), and were flagged as being unlikely to offer 
evidence independent of one another.  
Most of the studies summarised in Table 2.1 had been conducted in Asia (n=11) 
or North America (n=8), with just two based in Europe (n=2), neither of which had 
been conducted in the UK. All but n=1 of the studies (Hall et al. 2012) included both 
male and female participants (though only n=1 stratified their analyses by gender), and 
the original numbers of participants recruited into each of these studies ranged from 
just n=98 to almost 300 times as many (n=29,333), and while most studies (n=9) were 
based on fewer than n=1,000 participants, n=7 recruited between n=1,000 and 10,000; 
and a sizeable proportion (n=5; around a quarter) recruited between n=10,000 and 
n=30,000 participants. As such this range of sample sizes offers a good basis from 
which it might be possible to evaluate the possible role of publication bias, provided 
similar measures and analyses are available for sufficient numbers of small, medium 
and large-scale studies (see below). In as far as could be determined (from the details 
provided in each of the articles), most of these studies (n=16) drew on secondary 
sources of data generated (at least in part) through health care delivery or in the 
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course of past/ongoing studies, while only n=5 were based on primary studies. The 
disproportionate number of studies based on secondary data sources presents both 
strengths and weaknesses to the evidence base these provide regarding the 
association/relationship between MetS and sleep: these sources often provide data on 
far larger samples of participants than are feasible to recruited in dedicated primary 
studies, and when these data include measures collected from previous surveys of the 
same participants they can offer far more (and more accurate) data on potential 
confounders; however, a substantial downside to the use of secondary data sources is 
that the participant sampling frame used, and the choice/measurement of variables 
(that are then available for inclusion in subsequent, secondary analyses) is not 
determined by the particular needs of any subsequent/secondary analyses. The latter 
might, for example, impose participant inclusion and exclusion criteria that might limit 
the external validity of any secondary analyses (not simply to any specific target 
population, but also to those populations at different risk from the conditions 
examined); and in the context of the present review, this might also have influenced 
the quality and detail provided on particular components of MetS or on the sleep-
related characteristics examined. Certainly, there was substantial variation in the 
sampling frames (and the inclusion/exclusion criteria) used by the n=21 studies 
summarised in Table 2.1; although for the most part these samples appear to have 
focussed on otherwise healthy participants rather than those at particular risk of MetS 
or unfavourable sleep (or an association between the two; as might have been the 
case had any of the studies only examined overweight or obese participants, or those 
with a history of sleep disorders). In this respect, the n=21 studies are therefore likely 
to offer a reasonable basis upon which to examine the association between MetS and 
sleep in otherwise healthy adult participants. 
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Table 2.1 key study and participant characteristics mentioned in (and extracted from) n=21 cross-sectional studies containing empirical analyses 
of the relationship between MetS and sleep; together with any measured sleep characteristics, and any those measured variables relevant to the 
classification of MetS. 
Citation Sample size Data source 
Period(s) of data 
collection  
Inclusion criteria Exclusion criteria 
Age (limits; 
range or 
mean [SD]) 
Sex distribution 
(Mesas et al. 2014) 
 
Spain 
 
n=10,342 Secondary: Nutrition 
and Cardiovascular 
Risk in Spain Study 
(ENRICA) 
2008-2010 As for ENRICA 
study (≥18yrs); 
additional inclusion 
criteria not reported 
As for ENRICA study: 
no specific criteria 
≥18yrs M: n=5,509 
F: n=4,833 
(Ohkuma et al. 2014) 
 
Japan  
n=4,402  Secondary: Fukuoka 
Diabetes Registry 
(FDR) 
2008-2010 As for FDR: 
Diabetic patients; 
additional inclusion 
criteria not reported 
As for FDR: patients 
with drug-induced 
diabetes or undergoing 
steroid treatment; 
undergoing renal 
replacement therapy; 
with serious diseases 
other than diabetes 
(such as advanced 
malignancies and 
decompensated liver 
cirrhosis); unable to 
visit diabetologists 
regularly; with type 1 
diabetes; who had 
already eaten breakfast 
≥20yrs  M: n=2,494  
F: n=1,908 
(Saleh and Janssen 
2014) 
 
USA 
 
n=1,371 Secondary: National 
Health and Nutrition 
Examination Survey 
(NHANES) 
2003-2004 and  
2005-2006 
Non-pregnant adult 
NHANES 
participants without 
chronic disease 
examined in the 
‘morning 
fasting subsample’ 
NHANES participants: 
missing one or more 
components of MetS; 
who did not have valid 
accelerometer 
data for the sedentary 
time and/or sleep 
duration measures; with 
missing one or more of 
the covariates 
20-≥60yrs M: n=770  
F: n=601 
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(Hung et al. 2013)  
 
Taiwan 
  
n=3,435 Secondary: database 
of the Prevention 
Health Centre of 
National Cheng Kung 
University Hospital  
2002-2006 Participants who 
received a health 
examination 
As for the main study: 
participants who self-
reported depression, 
anxiety, or other 
psychiatric disorders; 
with serum creatinine 
>132.6 mmol/l;  
who had serum 
aspartate 
aminotransferase (AST) 
or alanine 
aminotransferase 
(ALT) levels more than 
twice the normal upper 
limit; with a history of 
cancers, OSA, thyroid 
diseases, 
cerebrovascular 
diseases and chronic 
pain 
47.2yrs  
(SD: 11.8) 
M: n=2,208 
F: n=1227 
(Chaput et al. 2013b) 
 
Canada 
 
n=810 Secondary: the 
Quebec Family Study 
Phase 2 (1989-
1994) and  
Phase 3 (1995-
2001) 
As for the Quebec 
Family Study: 
participants 
displaying a BMI ≥ 
32 kg/m2 
As for the Quebec 
Family study: no 
specific criteria 
18-65yrs  M: n=349  
F: n=461 
(Lee et al. 2013) 
 
South Korea 
  
n=301 Primary: Primary 
care clinic of either 
Korea University 
Guro Hospital, Korea 
University Ansan 
Hospital or Seoul 
Veterans Hospital 
2007 Accepted to 
participate  
Patients: who had a 
past/present medical 
history of heart disease, 
kidney disease, 
asthma, lung disease, 
severe liver disease, 
other endocrine disease 
(except diabetes, 
obesity and 
dyslipidemia), familial 
dyslipidemia and history 
50.8yrs 
(SD:13.1) 
M: n=187 
F: n=114 
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of cancer, stroke or 
other atheromatous 
vascular disease; 
Participants who used 
drugs that could have a 
potential effect on blood 
pressure, blood sugar 
and lipid levels, or body 
weight (except anti-
hypertensive 
drugs and anti-diabetic 
drugs); Shift-workers, 
airline pilots and 
pregnant or breast-
feeding women 
(Stefani et al. 2013) 
 
South Korea 
 
n=24,511 Secondary: 
participants from the 
survey and health 
examination of the 
Korea National 
Health and Nutrition 
Survey (KNHANS); 
phases 2–5 
Phase 2 (2001); 
phase 3 (2005); 
phase 4 ( 2007–
2009); and phase 5 
(2010)  
As for the KNHNS: 
civilian 
noninstitutionalized 
Individuals >1yr for 
the Health and 
nutrition survey; 
>10yrs for the 
health behaviour 
and examination 
survey  
KNHANES participants: 
younger than 20 years 
old or older than 79 
years old; with missing 
sleep duration data; 
who had not fasted for 
at least 8hrs before 
blood sampling; who 
reported a diagnosis of 
stroke, myocardial 
infarction, angina, renal 
failure, liver cirrhosis, 
and/or any cancers; 
who were females and 
reported being pregnant 
at the time of the survey 
20-79yrs M: n=9,997  
F: n=14,514  
(Yoo and Franke 2013) 
 
USA 
n=106 Primary: in 
conjunction with the 
annual medical 
evaluation of the 
Sworn law 
Not reported  Accepted to 
participate 
Participants with 
incomplete answers  
42.3yrs 
(SD:8.4) 
M: not reported 
F: not reported  
30 
 
enforcement officers 
of the Iowa 
Department 
of Public Safety 
(Krishnan et al. 2012) 
 
India 
n=358  Secondary: Large 
cross-sectional study 
on population from 
Chennai city 
Not reported  Participants with a 
family history of 
hypothyroidism 
Not reported  20-76yrs M: n=190 
F: n=168 
(Kazman et al. 2012) 
 
USA 
n=248 Primary: Community 
based study targeting 
African American 
population 
Not reported Self-identified 
African American  
Participants who were 
pregnant or taking 
steroid medications 
44yrs  
(SD:11.5) 
M: n=97 
F: n=151 
(McCanlies et al. 2012) 
 
USA 
n=98  Secondary: The 
Buffalo Cardio-
Metabolic 
Occupational Police 
Stress study 
(BCOPS)  
1999 Sworn police officer 
and willing to 
participate in the 
study 
As for BCOPS  study: 
had history of 
mastectomy, removal of 
lymph nodes, 
Raynaud's syndrome, 
diabetes with insulin 
pump, kidney dialysis, 
use of blood thinners, 
high doses of aspirin, 
any other heart 
condition or circulatory 
disorder, history of 
heart attack, stroke, 
bypass surgery, carotid 
artery endarterectomy, 
transient ischemic 
attack, or physician-
diagnosed CHD 
39.61yrs  
(SD: 7.39) 
M: n=59 
F: n=39 
(Wu et al. 2012) 
 
Taiwan 
 
n=7,100 Secondary: data from 
a health examination 
centre in National 
Cheng Kung 
University Hospital in 
Taiwan  
2006-2009 Accepted to 
participate 
Participants: aged 
<20yrs; with a history of 
one or more cerebral 
vascular events, 
coronary artery 
disease, and/or thyroid 
44.7yrs  
(SD: 11.8) 
M: n=4,298 
F: n=2,802 
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dysfunction; using 
sleeping pills, 
antihypertensive drugs, 
hypoglycemic and/or 
lipid lowering agents.  
(Hall et al. 2012) 
 
USA 
 
n=340  Secondary: Study of 
Women's Health 
Across the Nation 
(SWAN) sleep study  
2003-2005 Women (only) in 
their ‘midlife’ 
As for the SWAN sleep 
study: using 
menopausal hormone 
replacement therapy, 
chemotherapy, 
radiation therapy, or 
oral corticosteroids;  
on regular night 
shiftwork; consuming 
>4 alcoholic drinks/day; 
who were 
noncompliance with 
Core SWAN 
procedures 
46-57yrs M: n=N/A 
F: n=340 
(Arora et al. 2011) 
 
China 
n=29,333 Secondary: 
Guangzhou Biobank 
Cohort Study (GBCS) 
2003-2004 50 years and older 
ambulatory 
permanent 
Guangzhou 
resident 
As for GBCS: receiving 
chemotherapy or 
radiotherapy for cancer, 
or dialysis for renal 
failure   
50-96yrs M: n=8.094 
F: n=21,239 
(Kobayashi et al. 2011) 
 
Japan 
n=44,452 
Analysis sample 
n=27,792 
 
Primary: patients 
seen in the annual 
health checkup 
program at the 
Centre for Preventive 
Medicine at St. 
Luke’s International 
Hospital 
2008 Accepted to 
participate 
Not reported  44.8yrs 
(SD:12.8) 
M: n=22,004 
F: n=22,448 
(Roopa et al. 2010)  
 
India 
 
n=358 Secondary: Chennai 
Urban Rural 
Epidemiology Study 
(CURES) phase 3 
2003-2004 Accepted to 
participate 
As for CURES study: 
no specific criteria 
 
20–76yrs M: n=190 
F: n=168 
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(Hall et al. 2008) 
 
USA 
 
n=1,214 Secondary: the 
University of 
Pittsburgh’s Adult 
Health and Behaviour 
registry (AHAB) 
Not reported Midlife adults 30-
54yrs 
As for AHAB: who had 
clinical history of 
atherosclerotic 
cardiovascular disease, 
chronic kidney, liver 
disease and/or cancer; 
with neurologic 
disorders, 
schizophrenia, and/or 
other psychotic ill-
nesses; using insulin, 
glucocorticoids, and/or 
antiarrhythmic, 
psychotropic and 
pregnant women  
30-54yrs M: n=568 
F: n=646 
(Choi et al. 2008)  
 
South Korea 
 
n=4,222 Secondary: Korean 
National Health and 
Nutrition Survey 
(KNHNS) 
2001 As for the KNHNS: 
civilian 
noninstitutionalized 
Individuals >1yr for 
the Health and 
nutrition survey; 
>10yrs for the 
health behaviour 
and examination 
survey  
KNHNS Participants: 
aged <20yrs; lacking 
fasting time data or who 
did not fast for required 
period of time; without 
sleep duration data; 
taking medications to 
treat the 
metabolic syndrome 
44.1yrs 
(SD:0.4) 
M: n=1,822  
F: n=2,400  
(Santos, Ebrahim and 
Barros 2007) 
 
Portugal 
 
n=2,164 Primary: Community 
based study targeting 
non-institutionalized 
adults inhabitants of 
Porto, Portugal 
1999-2003 Accepted to 
participate 
Participants who scored 
less than 24 on the 
mini-mental state 
examination scale for 
the evaluation of 
cognitive impairment 
18-92yrs M: n=832 
F: n=1,332  
(Jennings et al. 2007) 
 
USA 
  
n=210 Secondary: the 
University of 
Pittsburgh’s Adult 
Health and Behaviour 
registry (AHAB) 
Not reported Midlife adults 30-
54yrs 
As for AHAB: who had 
clinical history of 
atherosclerotic 
cardiovascular disease, 
chronic kidney, liver 
45.8yrs  
(SD: 6.0) 
M: n=120 
F: n=90 
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disease and/or cancer; 
with neurologic 
disorders, 
schizophrenia, and/or 
other psychotic ill-
nesses; using insulin, 
glucocorticoids, and/or 
antiarrhythmic, 
psychotropic and 
pregnant women 
(Thomas et al. 2006) 
 
China 
 
n=10,413 
Analysis sample 
n=8325 
Secondary: 
Guangzhou Biobank 
Cohort Study (GBCS) 
2003-2004 50 years and older 
ambulatory 
permanent 
Guangzhou 
resident 
As for GBCS: receiving 
chemotherapy or 
radiotherapy for cancer, 
or dialysis for renal 
failure   
50-85yrs M: n=2530 
F: n=5,795 
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2.4.3 Definition and measurement of exposures, outcomes and 
covariates  
All but two of the studies operationalised MetS as the outcome variable, with one 
(or more) sleep-specific characteristics as the exposure (see Table 2.2); and all 
operationalised MetS using established classifications: most (n=9) using classifications 
based on the NCEP ATP III criteria (2002); n=6 based on the AHA/NHLBI criteria 
(Eckel, Grundy and Zimmet 2005); n=5 on the ‘harmonised’ criteria (Alberti et al. 
2009); and n=1 on criteria proposed by the Japan Society for the Study of Obesity 
[JASSO] criteria (Matsuzawa 2005). All based their classification of MetS on direct 
measures (rather than self-reports) of  MetS components (i.e. central obesity, high 
blood pressure, dyslipidaemia and diabetes). In contrast, only two of the studies used 
objective measures of sleep (n=1 using actigraphy; n=1 using polysomnography), and 
of the remainder just over half (n=10) used established self-reported sleep and/or 
activity instruments (n=6 using the PSQI. (Buysse et al. 1989); n=2 using the modified 
STOP [Snoring, Tiredness during daytime, Observed apnoea, and high blood 
Pressure] questionnaire, (Chung et al. 2008); and n=1 each the Stanford 7-day 
Physical Activity Recall Scale, (Sallis et al. 1985), and the International Physical 
Activity Questionnaire (Hagströmer, Oja and Sjöström 2006); with n=9 using ‘custom 
sleep item sets’ (i.e. sleep-related questions developed and/or selected specifically for 
that study; see Table 2.2).  
The diversity of different instruments used, and the large number of studies 
using custom sleep item sets, may prove a significant challenge to any attempt to 
synthesise findings from more than a handful of these studies. This is likely to be 
compounded by the range of different sleep-related characteristics examined. Indeed, 
although the commonest sleep characteristic examined (sleep duration) was used by 
n=15 (71.4%) of the studies (for n=11 of which sleep duration was the only 
characteristic examined), only n=5 examined sleep quality (all of whom used the Total 
PSQI score), only n=4 independent studies examined snoring or ‘sleep-related 
breathing difficulty’ (the two Chennai studies using the same instrument; two separate 
studies using different interpretations of the same instrument; and one study using a 
custom item), and only n=1 independent study examined: sleep latency; sleep 
fragmentation; sleep efficiency; sleep medication use; daytime sleepiness (examined 
by both of the Chennai studies); and two measures derived from polysomnography 
(Non-REM Beta waves [a measure of wakefulness], and apnoea-hypopnoea index 
[AHI] events). As such, no single study examined more than n=4 sleep-related 
characteristics, and most (n=14) only studied one (of which, as reported earlier, most 
only studied sleep duration). These studies therefore offer evidence of the association 
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between MetS and sleep that is likely to be strongest for sleep duration (and, possibly, 
sleep quality) with much sparser information on other sleep characteristics (and most 
of this from just one study). 
Finally, the vast majority of studies provided (at least some) information on a 
range of available/measured covariates (see table 2.2), for which they offered a 
varying degree of information on the mean value/prevalence observed both for study 
participants as a whole and those disaggregated according to MetS and/or sleep-
related categories. In all but two instances these data (and data on each component of 
MetS and each sleep-related characteristic examined) appear to have been collected 
simultaneously. And while there tended to be more detail provided that was relevant to 
the time period for which many of the self-reports (and direct measures) of sleep might 
refer, and any time interval between the measurement of MetS and sleep, there was 
little consistently reported detail on the when and how each covariate was measured 
(and rarely sufficient to assess, with any degree of certainty the likely temporal 
sequence in which each of the social and/or biological characteristics examined by 
these covariates had occurred). This uncertainty is likely to pose additional challenges 
to any attempts to generate plausible causal path diagrams from which to identify 
covariates likely to have acted as confounders, mediators or competing exposures in 
any relationship between MetS and sleep (as described in some detail, below). 
Nonetheless, to assist in this process, all of the ‘available/measured’ covariates 
(i.e. covariates mentioned in any section of the articles reviewed, indicating that the 
primary and/or secondary sources of data on which the study was based had provided 
data on these) were harmonised across studies and categorised into nine conceptual 
groups, each intended to represent clusters of similarly defined/measured variables 
capturing characteristics or phenomena considered likely to have been emerged or 
established/determined at similar time points during the each participant’s lifecourse. 
These six categories (and the harmonised covariates considered relevant to each) 
have been summarised in Table 2.3, together with categories labelled ‘Sleep’, ‘Current 
anthropometric status’ and ‘Current clinical status’ which contain variables relevant to 
the exposures and outcomes examined by the n=21 different studies (taken from 
Table 2.2).
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Table 2.2 Definition and measurement of exposures/interventions and outcomes, and any available covariates mentioned in (and extracted from) n=21 
cross-sectional studies containing empirical analyses of the relationship between MetS and sleep; together with any measured sleep characteristics, 
and any those measured variables relevant to the classification of MetS. 
Citation Outcome 
variable 
specified 
Exposure 
variable 
specified 
 
Measurement of 
sleep 
characteristics 
(direct measure or 
self-report) 
Classification of 
MetS used 
Measurement of 
MetS components 
(direct measure or 
self-report) 
Available covariates Interval between 
measurement of 
covariates, 
outcome and 
exposure  
Sleep assessment 
period 
Mesas et al.  
2014  
 
Spain 
 
MetS Sleep-related 
 
Sleep latency; sleep 
fragmentation; sleep 
medication  
 
Custom sleep item set 
 
(self-reported) 
Harmonized  Weight; height; waist 
circumference; blood 
pressure; and fasting 
haematological analysis 
 
(directly measured) 
Age; sex; education; 
occupation; smoking; 
alcohol; coffee; energy 
intake; physical activity; 
diagnosed mental/physical 
illness; TV time; 
antihypertensive 
medication; lipid-lowering 
medication 
No interval Habitual 
Ohkuma et 
al.  
2014 
 
Japan  
MetS Sleep-related  
 
Sleep duration  
 
Custom sleep item set 
 
(self-reported) 
Harmonized  Weight; height; waist 
circumference; blood 
pressure; and fasting 
haematological analysis 
 
(directly measured) 
Age; sex; early/late onset 
diabetes; energy intake; 
smoking; alcohol; exercise; 
symptomatic mental illness; 
antidiabetic medication 
No interval Habitual 
Saleh and 
Janssen  
2014 
 
USA 
 
MetS Sleep-related  Sleep duration 
 
Actigraphy 
 
(directly measured)  
 
Harmonized  Waist circumference; 
blood pressure; and 
fasting haematological 
analysis 
 
(directly measured) 
 
Age; sex; ethnicity; 
education; socioeconomic 
status; smoking; alcohol; 
caffeine; screen time; 
sedentary time; physical 
activity 
No interval 7 days ahead from 
collecting data 
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Hung et al.  
2013  
 
Taiwan 
  
Sleep-related MetS 
 
Sleep quality  
 
PSQI 
 
(self-reported) 
AHA/NHLBI for 
Asian populations 
Weight; height; waist 
circumference; blood 
pressure; and fasting 
haematological analysis 
 
(directly measured) 
 
Age; sex; exercise; alcohol; 
smoking; creatinine levels 
No interval Past month  
Chaput et 
al.  
2013 
 
Canada 
 
MetS Sleep-related Sleep duration  
 
Custom sleep item set 
 
(self-reported)  
  
 
AHA/NHLBI Weight; height; waist 
circumference; blood 
pressure; and fasting 
haematological analysis 
 
(directly measured) 
Age; sex; smoking; 
education; income; coffee; 
menopausal status; energy 
intake; alcohol; physical 
activity 
No interval On average 
Lee et al.  
2013 
 
South 
Korea 
  
MetS Sleep-related Sleep duration; sleep 
quality; sleep-related 
breathing disorder  
 
PSQI 
 
(self-reported) 
NCEP ATPIII 
(modified using 
Korean definition 
of abdominal 
obesity)  
Weight; height; waist 
circumference; blood 
pressure; and fasting 
haematological analysis 
 
(directly measured) 
Sex; age; education; 
occupation; income; 
smoking; alcohol; exercise; 
stress; 
diagnosed/symptomatic 
mental illness 
No interval Past month  
Stefani et 
al.  
2013 
 
South 
Korea 
 
MetS Sleep-related Sleep duration  
 
Custom sleep item set 
 
(self-reported) 
Harmonized  Weight; height; waist 
circumference; blood 
pressure; and fasting 
haematological analysis 
 
(directly measured) 
Age; sex; income; 
occupation; education; 
smoking; alcohol; physical 
activity; BMI; energy intake 
No interval On average 
Yoo and 
Franke  
2013 
 
USA 
MetS Sleep-related  Sleep duration; sleep 
quality  
 
PSQI 
 
(self-reported)  
AHA/NHLBI 
(modified for use 
with BMI) 
Weight; height; blood 
pressure; and fasting 
haematological analysis 
 
(directly measured) 
Age; sex; smoking; physical 
activity; stress; 
diagnosed/symptomatic 
mental illness 
No interval Past month 
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Krishnan et 
al.  
2012 
 
India 
Sleep-related MetS Snoring; daytime 
sleepiness  
 
Modified STOP 
questionnaire 
 
(self-reported) 
 
NCEP ATP III 
(modified using 
Asia Pacific waist 
measurement)  
Weight; height; waist 
circumference; blood 
pressure; and fasting 
haematological analysis 
 
(directly measured) 
Age; sex; family history of 
hyperthyroidism; physical 
activity; smoking; alcohol 
No interval On average 
Kazman et 
al.  
2012  
 
USA 
MetS Sleep-related Sleep duration; sleep 
quality; difficulty 
breathing; snoring  
 
PSQI 
 
(self-reported) 
AHA/NHLBI Weight; height; waist 
circumference; blood 
pressure; and fasting 
haematological analysis 
 
(directly measured) 
Age; sex No interval Past month 
McCanlies 
et al.  
2012 
 
USA 
Mets Sleep-related Sleep duration; OSA  
 
PSQI; Sleep Apnoea 
Survey 
 
(self-reported) 
NCEP ATP III Weight; height; waist 
circumference; blood 
pressure; and fasting 
haematological analysis 
 
(directly measured) 
Age; sex; education; 
smoking; marital status; 
race/ethnicity; physical 
activity; occupation 
No interval Past month or past 
week 
 
 
Wu et al.  
2012  
 
Taiwan 
 
Mets Sleep-related Sleep duration  
 
Custom sleep item set 
 
(self-reported) 
NCEP ATP III Weight; height; waist 
circumference; blood 
pressure; and fasting 
haematological analysis 
 
(directly measured) 
Age; sex; education; family 
history of diabetes; family 
history of hypertension; 
smoking; alcohol; exercise; 
BMI  
No interval On average 
Hall et al.  
2012 
 
USA 
 
MetS Sleep-related Sleep duration; sleep 
efficiency; relative 
NREM Beta; AHI 
events  
 
PSQI and 
polysomnography 
 
(self-reported and 
NCEP ATP III Waist circumference; 
blood pressure; and 
fasting haematological 
analysis 
 
(directly measured) 
Age; race/ethnicity; 
menopausal status; 
education; marital status; 
diagnosed/symptomatic 
mental illness; symptomatic 
physical illness; health 
compliance; current 
medication; smoking; 
alcohol; exercise 
Exposure (sleep-
related) measured 
3.6mo after outcome 
and covariates 
Past month for 
subjective sleep-
related 
3 nights ahead for 
objective sleep-
related 
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directly measured) 
Arora et al.  
2011  
 
China 
MetS Sleep-related Sleep duration  
 
Custom sleep item set 
 
(self-reported)   
Harmonized  Weight; height; waist 
circumference; blood 
pressure; and fasting 
haematological analysis 
 
(directly measured) 
Age; sex; smoking; alcohol; 
physical activity; education; 
diagnosed/symptomatic 
mental and physical illness; 
use of hypnotics 
No interval Per day 
Kobayashi 
et al.  
2011 
 
Japan 
MetS Sleep-related Sleep duration  
 
Custom sleep item set 
 
(self-reported)  
 
JASSO 
 
Weight; height; waist 
circumference; blood 
pressure; and fasting 
haematological analysis 
 
(directly measured) 
Age; sex; alcohol; smoking; 
pre-existing physical and 
mental illness; 
diagnosed/symptomatic 
mental and physical illness; 
current medication; physical 
activity 
No interval On average 
 
Roopa et al.  
2010  
 
India 
 
MetS Sleep-related Snoring; daytime 
sleepiness  
 
Modified STOP 
questionnaire 
 
(self-reported)  
NCEP ATP III 
(modified using 
Asia Pacific waist 
measurement) 
Weight; height; waist 
circumference; blood 
pressure; and fasting 
haematological analysis 
 
(directly measured) 
Age; sex; physical activity; 
smoking; alcohol  
 
No interval On average 
Hall et al.  
2008  
 
USA 
 
MetS Sleep-related Sleep duration 
 
Stanford 7-day 
Physical Activity 
Recall Scale 
 
(self-reported)  
AHA/NHLBI Weight; height; waist 
circumference; blood 
pressure; and fasting 
haematological analysis 
 
(directly measured) 
Age; sex; race/ethnicity; 
education; smoking; 
alcohol; physical activity; 
blood lipid levels; 
symptomatic mental illness 
No interval Past week  
Choi et al.  
2008  
 
MetS Sleep-related Sleep duration  
 
Custom sleep item set 
NCEP ATP III 
(modified using 
Asia Pacific waist 
Weight; height; waist 
circumference; blood 
pressure; and fasting 
Age; sex; family history of 
hypertension; family history 
of diabetes; residential 
No interval On average 
40 
 
South 
Korea 
 
 
(self-reported)  
measurement)  haematological analysis 
 
(directly measured) 
area; education; income; 
alcohol; smoking; exercise; 
BMI 
Santos et 
al.  
2007 
 
Portugal 
 
MetS Sleep-related  Sleep duration  
 
Custom sleep item set 
 
(self-reported)  
 
 
NCEP ATP III Weight; height; waist 
circumference; blood 
pressure; and fasting 
haematological analysis 
 
(directly measured) 
Age; marital status; 
education; occupation; 
physical activity; exercise; 
smoking; alcohol 
No interval Per day  
Jennings et 
al.  
2006 
 
USA 
  
MetS Sleep-related  Sleep quality  
 
PSQI 
 
(self-reported) 
AHA/NHLBI Weight; height; waist 
circumference; blood 
pressure; and fasting 
haematological analysis 
 
(directly measured) 
Age; sex; race/ethnicity; 
diagnosed/symptomatic 
mental illness; smoking; 
alcohol; education; 
antihypertensive medication 
No interval Past month 
Thomas et 
al.  
2006  
 
China 
 
MetS Sleep-related Snoring  
 
Custom sleep item set 
 
(self-reported)  
 
NCEP ATP III 
(modified using 
Asia Pacific waist 
measurement) 
Weight; height; waist 
circumference; blood 
pressure; and fasting 
haematological analysis 
 
(directly measured) 
Age; sex; waist to hip ratio; 
occupation; education; 
exercise; smoking; alcohol; 
blood pressure; blood lipid 
levels; blood glucose levels 
No interval Past month 
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Table 2.3 A summary of the ‘available covariates’ mentioned in (and extracted from) n=21 cross-sectional studies containing empirical analyses 
of the relationship between MetS and sleep; together with any measured sleep characteristics, and any those measured variables relevant to 
the classification of MetS. 
Covariate classification Covariates included in adjustment sets 
Family clinical history Family history of hyperthyroidism; family history of hypertension; family history of diabetes 
Sociodemographic Age; sex; race/ethnicity; marital status 
Socioeconomic Education; occupation; income; residential area;  
Clinical history Pre-existing/diagnosed physical and mental illness; early/late onset diabetes; early/late menopausal onset; height 
Current lifestyle Smoking; alcohol; coffee/caffeine; energy intake; physical activity/exercise; sedentary time; screen/TV time; health compliance  
Current clinical status Blood pressure/hypertension; glucose levels/diabetes; blood lipid levels; symptomatic mental and physical illness; creatinine levels; 
stress 
Current medication Psychotropic, hypnotic and sleep-affecting drugs; antidiabetic medication; antihypertensive medication; lipid-lowering medication; 
current medication 
Current anthropometric 
status 
Weight; BMI; waist circumference; waist-to-hip ratio 
Sleep Sleep duration; sleep latency; sleep fragmentation; sleep efficiency; sleep medication; snoring; OSA/sleep-related breathing 
disorder; sleep quality; Non-REM Beta; AHI events; daytime sleepiness; insomnia 
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2.4.4 Analytical models used and reported effect estimates  
The statistical techniques, covariate adjustment sets and effect estimates 
reported for each of the models used by the n=21 cross-sectional studies included in 
the present review have been summarised in Table 2.4. As mentioned earlier (see 
Table 2.2), all but two of these models operationalised sleep-related characteristics as 
exposures, with MetS as the outcome. One of the studies used only Poisson 
regression analyses (with MetS categorised as a binary outcome variable), while 
another used both linear and logistic regression analyses (with the PSQI Total Score 
operationalised as both a continuous and binary outcome variable). All of the 
remaining studies used (only) logistic regression analyses, with binary outcome 
variables based on either the presence/absence of MetS (as defined and classified 
according to the criteria chosen by each study); or the presence/absence of a 
specified sleep characteristic (such as snoring or daytime sleepiness). While the 
referent category used for the latter was usually unambiguous (i.e. the absence of or 
specified referent to the category examined), the referent category used for MetS was 
not clearly described by any of the n=21 studies reviewed. As such, it was not at all 
clear whether the referent category comprised participants who lacked: any of the 
relevant MetS components; or only those combinations of MetS components 
necessary to achieve the classification of MetS used.  
 All of the studies contained models that were adjusted for covariates, most 
reporting a series of models employing just one (n=7), two (n=8) or three (n=3) 
different adjustment sets, with only n=1 study each employing four, six and seven 
different adjustment sets, respectively. In contrast, only around half of the studies 
(n=9) reported effect estimates for unadjusted models, although some of the 
remainder reported stratified prevalences (of MetS by the specific sleep characteristic 
examined, or vice versa) from which it was possible to calculate unadjusted effect 
estimates (see Table 2.4). In the main, the adjustment sets used included different 
combinations of the various categories of covariates identified amongst the ‘available 
covariates’ summarised in Table 2.3 (see earlier) – i.e. family clinical history; 
sociodemographic characteristics; socioeconomic status; clinical history; current 
medication; current lifestyle*; current anthropometric status*; presence of MetS-related 
components (‘current clinical status’);* and sleep characteristics* (those indicated with 
an asterisk* representing what are likely to be measures contemporaneous with the 
cross-sectional measures of sleep and MetS).  
On the basis of the models summarised in Table 2.4, there appears strong 
prima facie evidence that MetS was associated with less favourable sleep across a 
wide range of sleep-related characteristics, both before and after adjustment for 
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covariates. This was particularly evident amongst the n=15 studies examining sleep 
duration (many of which found that both short and long sleep duration was associated 
with an increased likelihood of MetS), the n=5 that examined sleep quality (many of 
which reported that MetS was associated with an increased  risk of ‘poor’ sleep 
quality), and the n=4 independent analyses that examined snoring or ‘sleep-related 
breathing difficulty’ (all of which reported an increased risk of snoring associated with 
MetS). There was also some evidence that MetS was associated with many of the 
other sleep-related characteristics (each of which were only examined by one of the 
n=21 studies reviewed), and in particular that: habitual sleep latency, poor sleep 
efficiency, sleep medication use, Non-REM Beta and AHI events (though not sleep 
fragmentation and daytime sleepiness) were all associated with an increased risk of 
MetS. At face value, these findings appear to support the presence of an association 
between MetS and a wide range of sleep-related characteristics. However, the 
somewhat equivocal findings (particularly the absence of associations between MetS, 
short/prolonged sleep duration, poor sleep quality and snoring in some of n=4-15 
studies examining these; and the absence of an association between MetS, sleep 
fragmentation and daytime sleepiness in the two independent studies examining 
these) suggests that the evidence may be less than secure, or that differences in 
sampling, measurement and analysis, together with publication bias, may have 
influenced the evidence these studies provide. 
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Table 2.4 Analytical models examining the association between MetS and sleep-specific characteristics mentioned in (and extracted from) 
n=21 cross-sectional studies containing empirical analyses of the relationship between MetS and sleep; together with any measured sleep 
characteristics, and any those measured variables relevant to the classification of MetS. 
Citation  Statistical 
test(s) used 
Outcome/dependent 
variable; prevalence of 
indicator; and  
(referent category)  
Exposure/independent 
variable; prevalence of 
indicator; and  
(referent category) 
Covariate adjustment sets Unadjusted and adjusted effect 
estimates 
Mesas et al.  
2014  
 
Spain  
Logistic 
regression 
MetS  
(Yes: 22.2%; No[ref]) 
 
MetS referent category 
comprised: Not clear (not 
identified as MetS) 
1. Sleep latency 
 (Habitual 14.8%; Not habitual 
[ref]) 
 
2. Sleep fragmentation 
(Habitual 15.9%; Not habitual 
[ref]) 
 
3. Sleep medication 
(Habitual 6.9%; Not habitual 
[ref]) 
 
M0: Unadjusted (not reported) 
M1: Sex; age; education; occupation 
M2: M1+smoking; alcohol; coffee 
M3: M2+diagnosed mental/physical 
illness; diabetes 
M4: M3+sleep duration  
M5: M4+energy intake 
M6: M5+physical activity; TV time  
M7: M6+antihypertensive medication; 
lipid-lowering medication 
1. Sleep latency 
M0: Not reported – calculated: 
       OR:1.55 (95%CI:1.37,1.75) 
M1: OR1.31 (95%CI:1.12,1.53) 
M2: OR:1.28 (95%CI:1.09,1.49) 
M3: OR:1.25 (95%CI:1.06,1.47) 
M4: OR:1.23 (95%CI:1.04,1.46) 
M5: OR:1.23 (95%CI:1.04,1.46) 
M6: OR:1.20 (95%CI:1.01,1.42) 
M7: OR:1.16 (95%CI:0.97,1.39) 
 
2. Sleep fragmentation 
M0: Not reported – calculated: 
       OR:2.76 (95%CI:2.44,3,12) 
M1: OR:1.15 (95%CI:0.99,1.33) 
M2: OR:1.15 (95%CI:0.99,1.33) 
M3: OR:1.16 (95%CI:0.99,1.36) 
M4: OR:1.14 (95%CI:0.97,1.35) 
M5: OR:1.15 (95%CI:0.97,1.35) 
M6: OR:1.13 (95%CI:0.96,1.33) 
M7: OR:1.09 (95%CI:0.92,1.30) 
 
3. Sleep medication  
M0: Not reported – calculated: 
       OR:2.07 (95%CI:1.76,2.43) 
M1: OR:1.27 (95%CI:1.04,1.54) 
M2: OR:1.23 (95%CI:1.01,1.50) 
M3: OR:1.16 (95%CI:0.93,1.45) 
M4: OR:1.15 (95%CI:0.92,1.44) 
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M5: OR:1.15 (95%CI:0.92,1.44) 
M6: OR:1.11 (95%CI:0.88,1.39) 
M7: OR:1.02 (95%CI:0.81,1.29)  
Ohkuma et al.  
2014 
 
Japan  
Logistic 
regression 
MetS  
(Yes: %Not reported – 
calculated 54.3%; No[ref])  
 
MetS referent category 
comprised: Not clear (not 
identified as MetS) 
 
(Separate analyses 
conducted on: elevated 
waist circumference; high 
blood pressure; raised 
blood triglycerides; and 
reduced HDL cholesterol) 
 
1. Sleep duration 
(<5.5hrs:14.2%; 5.5-
6.4hrs:25.0%; 6.5-7.4hrs [ref]; 
7.5-8.4hrs:23.5%; 
≥8.5hrs:9.5%) 
M0: Unadjusted (not reported) 
M1: Age; sex; early/late onset diabetes; 
energy intake; smoking; alcohol; 
exercise; symptomatic mental illness; 
antidiabetic medication 
1.1 Sleep duration <5.5hrs 
M0: Not reported – calculated: 
       OR:1.64 (95%CI:1.34,1.99) 
M1: OR:1.71 (95%CI:1.39,2.11) 
 
1.2 Sleep duration 5.5-6.4hrs 
M0: Not reported – calculated: 
       OR:1.04 (95%CI:0.88,1.23) 
M1: OR:1.03 (95%CI:0.87,1.22) 
 
1.3 Sleep duration 7.5-8.4hrs 
M0: Not reported – calculated: 
       OR:1.04 (95%CI:0.88,1.23) 
M1: OR:1.09 (95%CI:0.92,1.29) 
 
1.4 Sleep duration ≥8.5hrs 
M0: Not reported – calculated: 
       OR:1.74 (95%CI:1.38,2.20) 
M1: OR:1.48 (95%CI:1.17,1.88)  
 
Saleh and 
Janssen  
Logistic 
regression 
MetS  
(Yes: 37.4%; No[ref]) 
1. Sleep duration  
(quartiles: 3.0-7.2hrs:34.1%; 
M0: Unadjusted 
M1: Age; ethnicity; screen time 
1.1 Sleep duration <7.2hrs 
M0:  OR:0.86 (95%CI:0.60,1.23) 
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2014 
 
USA 
 
 
MetS referent category 
comprised: Not clear (not 
identified as MetS) 
 
(Separate analyses 
conducted on: elevated 
waist circumference; high 
blood pressure; raised 
blood triglycerides; 
elevated plasma glucose; 
and reduced HDL 
cholesterol) 
 
7.2-8.6hrs [ref]; 8.6-
9.7hrs:35.6%; 9.7-
11.8hrs:39.8%) 
 
M2: Age; education; physical activity; 
sedentary time 
M1: OR:0.90 (95%CI:0.62,1.32) 
M2: OR:0.91 (95%CI:0.62,1.33) 
 
1.2 Sleep duration 8.6-9.7hrs 
M0:  OR:0.93 (95%CI:0.65,1.33) 
M1: OR:0.89 (95%CI:0.61,1.30) 
M2: OR:0.89 (95%CI:0.61,1.29) 
 
1.3 Sleep duration >9.7hrs 
M0:  OR:1.12 (95%CI:0.78,1.60) 
M1: OR:0.97 (95%CI:0.67,1.41) 
M2: OR:0.95 (95%CI:0.66,1.39) 
 
Hung et al.  
2013  
 
Taiwan 
  
Linear 
regression and 
logistic 
regression 
Sleep quality  
(PSQI Total Score 
continuous: per unit; PSQI 
Total Score categorical:  
>5 (56.1%); ≤5[ref]) 
1.MetS 
(Yes: 26.2%; No[ref]) 
 
MetS referent category 
comprised: not identified with 
MetS 
 
(Separate analyses 
conducted on: central obesity; 
hyperglycaemia; high blood 
pressure; and reduced HDL 
cholesterol) 
 
1. Linear regression: 
M0: Unadjusted (not reported) 
M1: Age; sex; sleep duration 
M2: M1+snoring; alcohol; smoking; 
exercise; creatinine levels  
 
2. Logistic regression: 
M0: Unadjusted (not reported) 
M1: Age; sex; sleep duration; snoring; 
alcohol; smoking; exercise; creatinine 
levels 
1. Sleep quality PSQI Total Score 
per unit 
M0: Not reported  
M1: β: 0.96 (95%CI:0.76,1.16) 
M2: β: 0.87 (95%CI:0.66,1.07) 
 
2. Poor sleep quality PSQI score >5 
M0: Not reported – calculated: 
       OR:1.51 (95%CI:1.29,1.76) 
M1: OR:1.48 (95%CI:1.25,1.74) 
 
Chaput et al.  
2013 
 
Canada 
 
Logistic 
regression  
MetS  
(Yes:24.6%; No[ref]) 
 
MetS referent category 
comprised: Not clear (not 
identified as MetS) 
 
1. Sleep duration 
(≤6hrs:11.1%; 7-8hrs [ref]; 
≥9hrs:18.4%) 
  
 
M0: Unadjusted 
M1: age; sex; smoking; education; 
income; alcohol; coffee; menopausal 
status 
M2: M2+energy intake; physical activity 
1.1 Sleep duration ≤6hrs 
M0: OR:2.02 (95%CI:1.32,3.23) 
M1: OR:1.80 (95%CI:1.15,2.98) 
M2: OR:1.76 (95%CI:1.08–2.84) 
 
1.2 Sleep duration ≥9hrs 
M0: OR:1.46 (95%CI:0.95,2.14) 
M1: OR:1.43 (95%CI:0.91-2.09) 
M2: OR:1.35 (95%CI:0.83-1.99) 
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Lee et al.  
2013 
 
South Korea 
  
Logistic 
regression 
MetS  
(Yes: 35.2%; No[ref]) 
 
MetS referent category 
comprised: Not clear  
MetS categorised based 
on number of risk factors 
0, ≥1, ≥2, and ≥3  
 
1. Sleep duration 
(<5.5hrs:16.9%; 5.5-
6.49hrs:32.6%; 6.5-
7.49hrs[ref]; 7.5-
8.49hrs:14.3%; ≥8.5hrs:4.3%) 
 
2. Sleep quality 
(PSQI Total Score>5: 41.9%; 
≤5[ref]) 
 
3. Sleep-related breathing 
disorder  
(Low risk [ref]; High risk: 
34.2%) 
 
M0: Unadjusted 
M1: Sex; age; education; occupation; 
income; smoking; alcohol; exercise; 
stress; diagnosed/symptomatic mental 
illness; sleep duration (for PSQI and 
SRBD); PSQI Total Score (for duration 
and SRBD); SRDB (for duration and 
PSQI) 
1.1 Sleep duration <5.5hrs  
M0: OR:6.35 (95%CI:3.01,13.40) 
M1: OR:4.89 (95%CI:1.90,12.58) 
 
1.2 Sleep duration 5.5-6.49hrs  
M0: OR:1.40 (95%CI:0.74,2.64) 
M1: OR:1.26 (95%CI:0.59,2.67) 
 
1.3 Sleep duration 7.5-8.49hrs 
M0: OR:1.09 (95%CI:0.48,2.50) 
M1: OR:1.27 (95%CI:0.50,3.26) 
 
1.4 Sleep duration  ≥ 8.5hrs 
M0: OR:5.08 (95%CI:1.51,17.06) 
M1: OR:5.98 (95%CI:1.41,25.41) 
 
2. Poor sleep quality PSQI Total 
Score >5 
M0: OR:3.71 (95%CI:2.26,6.10) 
M1: OR:3.83 (95%CI:1.91,7.65) 
 
3. Sleep-related breathing disorder: 
M0: OR:1.98 (95%CI:1.21,3.24) 
M1: OR:1.92 (95%CI:1.04,3.54) 
 
Stefani et al.  
2013 
 
South Korea 
 
Logistic 
regression 
MetS  
(Yes: 25%; No[ref])  
 
MetS referent category 
comprised: Not clear (not 
identified as MetS) 
 
1. Sleep duration 
(≤5hrs:13.6%; 6hrs:25.7%; 
7hrs [ref]; 8hrs:23.4%; 
≥9hrs:7.5%) 
M0: Unadjusted 
M1: age; sex 
M2: M1+ education; occupation; 
physical activity; smoking; alcohol 
M3: M2+BMI 
1.1 Sleep duration ≤5 hrs 
M0: OR:1.74 (95%CI:1.59,1,91) 
M1: OR:1.06 (95%CI:0.96,1.17) 
M2: OR:1.04 (95%CI:0.94,1.14) 
M3: OR:1.00 (95%CI:0.90,1.11) 
 
1.2 Sleep duration 6hrs 
M0: OR:1.10 (95%CI:1.01,1.19) 
M1: OR:1.01 (95%CI:0.93,1.10) 
M2: OR:1.00 (95%CI:0.92,1.09) 
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M3: OR:0.95 (95%CI:0.87,1.05) 
 
1.3 Sleep duration 8hrs 
M0: OR:1.04 (95%CI:0.96,1.13) 
M1: OR:1.02 (95%CI:0.94,1.12) 
M2: OR:1.01 (95%CI:0.92,1.10) 
M3: OR:1.06 (95%CI:0.96,1.17) 
 
1.4 Sleep duration ≥9hrs 
M0: OR:1.32 (95%CI:1.17,1.48) 
M1: OR:1.14 (95%CI:1.00,1.29) 
M2: OR:1.10 (95%CI:0.97,1.25) 
M3: OR:1.31 (95%CI:1.14,1.51)  
Yoo and 
Franke  
2013 
 
USA 
Logistic 
regression 
MetS  
(Yes: 33.0%; No[ref]) 
 
MetS referent category 
comprised: Not clear (not 
identified as MetS) 
 
(Separate analyses 
conducted on: obesity; 
hypertension; glucose 
intolerance; raised blood 
triglycerides; and reduced 
HDL cholesterol) 
 
1. Sleep duration 
(≤6hrs:30.2%; >6<8hrs [ref]; 
≥8hrs:19.8%)) 
 
2. Sleep quality  
((PSQI Total Score>5: 26.8%; 
≤5[ref]) 
 
M0: Unadjusted (not reported) 
M1: Age; sex; smoking; physical activity 
M2: M1+ diagnosed/symptomatic 
mental illness 
1.1 Sleep duration ≤6hrs  
M0: Not reported – calculated: 
       OR:1.40 (95%CI:0.53,3.71) 
M1: OR:1.94 (95%CI:0.65,5.82) 
M2: OR:2.30 (95%CI:0.71,7.50) 
 
1.2 Sleep duration ≥8hrs 
M0: Not reported – calculated: 
       OR:4.10 (95%CI:1.41,11.92) 
M1: OR:3.62 (95%CI:1.14,11.52) 
M2: OR:4.89 (95%CI:1.32,18.13) 
 
2. Poor sleep quality PSQI Total 
Score >5 
M0: Not reported – calculated: 
       OR:1.02 (95%CI:0.44,2.37) 
M1: OR:1.56 (95%CI:0.61,4.03)  
M2: OR:2.25 (95%CI:0.70,7.19)  
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Krishnan et al. 
2012 
 
India 
Logistic 
regression 
1. Snoring  
(Yes: 40.0%; No[ref]) 
 
2. Daytime sleepiness  
(Yes: 59.0%; No[ref]) 
 
MetS  
(Yes: %Not reported; No[ref]) 
 
MetS referent category 
comprised: Not clear (not 
identified as MetS) 
 
 
M0: Unadjusted 
M1: age 
M2: age; sex 
M3: M2+family history of 
hyperthyroidism 
M4: M3+physical activity 
M5: M4+smoking 
M6: M5+alcohol 
1. Snoring 
M0: OR:2.56 (95%CI:1.64,4.00) 
M1: OR:2.21 (95%CI:1.38,3.54) 
M2: OR:2.07 (95%CI:1.28,3.36) 
M3: OR:2.03 (95%CI:1.25,3.30) 
M4: OR:2.21 (95%CI:1.28,3.83) 
M5: OR:2.21 (95%CI:1.27,3.83) 
M6: OR:2.19 (95%CI:1.26,3.80) 
 
2. Daytime sleepiness 
M0: OR:1.44 (95%CI:0.92,2.26) 
M1: OR:1.31 (95%CI:0.81,2.10) 
M2: OR:1.33 (95%CI:0.83,2.15) 
M3: OR:1.29 (95%CI:0.80,2.09) 
M4: OR:1.27 (95%CI:0.74,2.19) 
M5: OR:1.27 (95%CI:0.74,2.19) 
M6: OR:1.23 (95%CI:0.71.2.12) 
 
Kazman et al.  
2012  
 
USA 
Logistic 
regression 
MetS  
(Yes: 39.0%; No[ref]) 
 
MetS referent category 
comprised: Not clear (not 
identified as MetS) 
 
1. Sleep duration 
(≤6hrs:54.0%; 6-9hrs [ref]; 
≥9hrs:8.0%) 
 
2. Sleep quality  
(PSQI Total Score>5 (49.0%); 
≤5 [ref]) 
 
3. Difficulty breathing  
(≥once per week: 19.0%; 
<once per week [ref]) 
 
4. Snoring  
(≥once per week: 26.0%; 
<once per week [ref]) 
 
M0: Unadjusted (not reported) 
M1: Age; sex  
1.1 Sleep duration ≤6hrs 
M0: Stratified prevalences not 
available to permit calculation  
M1: OR:0.99 (95%CI:0.33,3.00) 
 
1.2 Sleep duration ≥9hrs 
M0: Stratified prevalences not 
available to permit calculation  
M1: OR:0.99 (95%CI:0.33,3.00) 
 
2. Poor sleep quality PSQI Total 
Score >5  
M0:  Stratified prevalences not 
available to permit calculation  
M1: OR:0.67 (95%CI:0.37,1.21) 
 
3. Difficulty breathing ≥once per 
week 
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M0:  Stratified prevalences not 
available to permit calculation  
M1: OR:1.15 (95%CI:0.57,2.30) 
 
4. Snoring ≥once per week 
M0:  Stratified prevalences not 
available to permit calculation  
M1: OR:2.57 (95%CI:1.40,4.71) 
 
McCanlies et 
al.  
2012 
 
USA 
Poisson 
regression 
Mets  
(Yes: 14.0%; No[ref]) 
 
MetS referent category 
comprised: Not clear (not 
identified as MetS) 
 
1. Sleep duration 
(<6hrs:28.6%; ≥6hrs [ref]) 
 
2. OSA  
(Ever: %Not reported; 
Never[ref])  
M0: Unadjusted 
M1: Age 
M2: Age; sex 
M3: M2+education; smoking  
1. Sleep duration <6hrs  
M0: PR:2.50 (95%CI:0.97,6.47) 
M1: PR:2.52 (95%CI:0.98,6.49) 
M2: PR:2.42 (95%CI:0.95,6.12) 
M3: PR:2.29 (95%CI:0.81,6.49) 
 
2. OSA – Not reported 
M0: Stratified prevalences not 
available to permit calculation   
M1: Not reported 
M2: Not reported 
M3: Not reported 
 
Wu et al.  
2012  
 
Taiwan 
 
Logistic 
regression 
MetS  
(Yes: %Not reported – 
calculated for males 
17.8%, and females 9.8%; 
No[ref])  
 
 
MetS referent category 
comprised: Not clear  
MetS are categorised 
based on number of risk 
factors 0, 1 or 2, and 3 or 
more  
 
1. Sleep duration 
(<6hrs:24.6%; 6-8hrs [ref]; 
>8hrs:3.4%) 
M0: Unadjusted (not reported) 
M1: Age; education; BMI; smoking; 
alcohol; exercise  
1.1.1 Sleep duration <6hrs - Males 
M0: Not reported – calculated: 
       OR:1.31 (95%CI:1.14,1.50) 
M1: OR:1.28 (95%CI:1.01,1.63) 
 
1.1.2 Sleep duration <6hrs - 
Females 
M0: Not reported – calculated: 
       OR:1.36 (95%CI:1.04,1.77) 
M1: OR:1.04 (95%CI:0.72,1.51) 
 
1.2.1 Sleep duration >8hrs - Males 
M0: Not reported – calculated: 
       OR:1.21 (95%CI:0.87,1.67) 
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M1: OR:1.43 (95%CI:0.82,2.48) 
 
1.2.2 Sleep duration >8hrs - 
Females 
M0: Not reported – calculated: 
       OR:1.01 (95%CI:0.50,2.04) 
M1: OR:0.90 (95%CI:0.32,2.51) 
  
Hall et al.  
2012 
 
USA 
 
Logistic 
regression 
MetS  
(Yes: 30.9%; No[ref]) 
 
MetS referent category 
comprised: Not clear (not 
identified as MetS) 
 
1. Sleep duration  
(per additional hr of sleep)  
 
2. Poor sleep efficiency  
(per percentage) 
 
3. Relative NREM Beta  
(per unit) 
 
4. AHI events  
(events per hr) 
 
(No raw prevalence reported) 
M0: Unadjusted (not reported) 
M1: race/ethnicity; menopausal status; 
education; marital status; health 
compliance; current medication; 
smoking; alcohol; exercise.  
M2: M1+BMI 
1. Sleep duration per hr  
M0:  Stratified prevalences not 
available to permit calculation 
M1: OR:0.89 (95%CI:0.69,1.15) 
M2: OR:0.93 (95%CI:0.71-1.22) 
 
2. Poor sleep efficiency per percent 
M0:  Stratified prevalences not 
available to permit calculation  
M1: OR:1.38 (95%CI:1.05,1.83) 
M2: OR:1.40 (95%CI:1.04,1.89) 
 
3. Relative NREM Beta per unit 
M0:  Stratified prevalences not 
available to permit calculation  
M1: OR:1.45 (95%CI:1.10,1.91) 
M2: OR:1.45 (95%CI:1.08,1.95) 
 
4. AHI events per hr 
M0:  Stratified prevalences not 
available to permit calculation  
M1: OR:1.87 (95%CI:1.40,2.51) 
M2: OR:1.73 (95%CI:1.26,2.37) 
 
Arora et al.  
2011  
 
China 
Logistic 
regression 
MetS  
(Yes: 28.0%; No[ref]) 
 
MetS referent category 
1. Sleep duration 
(<6hrs:13.5%; 6<7hrs:24.4%; 
7<8hrs [ref]; 8<9hrs:23.5%; 
≥9hrs:8.8%) 
M0: Unadjusted 
M1: Age; sex 
M2: M1+education; smoking; physical 
activity; diagnosed mental illness; sleep 
1.1 Sleep duration <6hrs 
M0: OR:1.14 (95%CI:1.05,1.24) 
M1: OR:0.98 (95%CI:0.90,1.06) 
M2: OR:0.97 (95%CI:0.88,1.06) 
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comprised: Not clear (not 
identified as MetS) 
 
  fragmentation; use of hypnotics; 
daytime sleepiness; alcohol; snoring 
 
1.2 Sleep duration 6<7hrs 
M0: OR:1.10 (95%CI:1.03,1.18) 
M1: OR:1.02 (95%CI:0.95,1.09) 
M2: OR:1.00 (95%CI:0.93,1.08)  
 
1.3 Sleep duration 8-9hrs 
M0: OR:1.14 (95%CI:1.06,1.22) 
M1: OR:1.16 (95%CI:1.08,1.25) 
M2: OR:1.16 (95%CI:1.08,1.25)  
 
1.4 Sleep duration ≥9hrs 
M0: OR:1.18 (95%CI:1.07,1.30) 
M1: OR:1.22 (95%CI:1.11,1.35) 
M2: OR:1.21 (95%CI:1.10,1.34)   
 
Kobayashi et 
al.  
2011 
 
Japan 
Logistic 
regression 
MetS  
(Yes: 8.7%; No[ref]) 
 
MetS referent category 
comprised: Not clear (not 
identified as MetS) 
 
1. Sleep duration  
(<6hrs: 26.2%; 6-
6.99hrs:40.9%; 7-
7.99hrs:24.2%; ≥8hrs[ref]) 
 
M0: Unadjusted (not reported) 
M1: Age; sex; alcohol; pre-existing 
physical and mental illness; physical 
activity 
1.1 Sleep duration <6hrs 
M0: Not reported – calculated: 
       OR:0.79 (95%CI:0.68,0.92) 
M1: OR:1.42 (95%CI:1.20,1.68) 
 
1.2 Sleep duration 6-6.99 hrs 
M0: Not reported – calculated: 
       OR:0.71 (95%CI:0.61,0.82) 
M1: OR:1.12 (95%CI:0.95,1.31) 
 
1.3 Sleep duration 7-7.99hrs 
M0: Not reported – calculated: 
       OR:0.79 (95%CI:0.68,0.92) 
M1: OR:1.02 (95%CI:0.86,1.20) 
 
Roopa et al.  
2010  
 
India 
 
Logistic 
regression 
MetS  
(Yes: 34.6% No[ref]) 
 
MetS referent category 
comprised: Not clear (not 
1. Snoring  
(Snores: 40.0%; Does not 
snore[ref]) 
 
2. Daytime sleepiness 
M0: Unadjusted 
M1: Age 
M2: Age; sex  
M3: M2+physical activity 
M4: M3+smoking  
1. Snoring 
M0: OR:2.56 (95%CI:1.64,4.00) 
M1: OR:2.25 (95%CI:1.40,3.59) 
M2: OR:2.11 (95%CI:1.30,3.41)  
M3: OR:2.27 (95%CI:1.31,3.93)  
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identified as MetS) 
 
(Yes:%Not reported; No[ref]) 
 
M5: M4+alcohol  M4: OR:2.27 (95%CI:1.31,3.93)  
M5: OR:2.25 (95%CI:1.30,3.91) 
 
2. Daytime sleepiness 
M0:  Stratified prevalences not 
available to permit calculation 
M1: Not reported 
M2: Not reported  
M3: Not reported  
M4: Not reported  
M5: Not reported 
 
Hall et al.  
2008  
 
USA 
 
Logistic 
regression 
MetS  
(Yes: 22.3%; No[ref]) 
 
MetS referent category 
comprised: Not clear (not 
identified as MetS) 
 
(Separate analyses 
conducted on: central 
obesity; blood glucose 
levels; hypertension; 
raised blood triglycerides; 
and reduced HDL 
cholesterol) 
 
1. Sleep duration 
(<6hrs:15.4%; 6<7hrs:33.1%; 
7-8hrs [ref]; >8hrs:8.2%) 
M0: Unadjusted (not reported) 
M1: Age; sex; race/ethnicity; education; 
smoking; physical activity; blood lipid 
levels; symptomatic mental illness 
1.1 Sleep duration <6hrs 
M0:  Stratified prevalences not 
available to permit calculation  
M1: OR:1.83 (95%CI:1.19,2.80) 
 
1.2 Sleep duration 6<7hrs 
M0:  Stratified prevalences not 
available to permit calculation  
M1: OR:1.48 (95%CI:1.05,2.10) 
 
1.3 Sleep duration <6hrs 
M0:  Stratified prevalences not 
available to permit calculation  
M1: OR:1.81 (95%CI:1.04,3.15) 
Choi et al.  
2008  
 
South Korea 
 
Logistic 
regression 
MetS  
(Yes: %Not reported; 
No[ref])  
 
MetS referent category 
comprised: Not clear  
MetS are categorised 
based on number of risk 
factors 0, ≥1, ≥2, ≥ 3, ≥4 
1. Sleep duration 
(≤5hrs:%Not reported; 
6hrs:%Not reported; 7hrs[ref]; 
8hrs:%Not reported; 
≥9hrs:%Not reported) 
 
M0: Unadjusted 
M1: Age; sex; family history of 
hypertension; family history of diabetes 
M2: M1+residential area; education; 
income; alcohol; smoking; exercise  
M3: M2+BMI 
1.1 Sleep duration ≤5hrs 
M0: OR:1.74 (95%CI:1.33,2.26) 
M1: OR:1.23 (95%CI:0.92,1.64) 
M2: OR:1.15 (95%CI:0.85,1.55) 
M3: OR:1.17 (95%CI:0.87,1.59) 
 
1.2 Sleep duration 6hrs 
M0: OR:1.27 (95%CI:1.04,1.56) 
M1: OR:1.13 (95%CI:0.91,1.40) 
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and 5  
 
M2: OR:1.11 (95%CI:1.01,1.57) 
M3: OR:1.07 (95%CI:0.85,1.34) 
 
1.3 Sleep duration 8hrs 
M0: OR:1.27 (95%CI:1.01,1.63) 
M1: OR:1.28 (95%CI:1.00,1.64) 
M2: OR:1.26 (95%CI:1.01,1.57) 
M3: OR:1.32 (95%CI:1.01,1.73) 
 
1.4 Sleep duration ≥9hrs 
M0: OR:1.55 (95%CI:1.15,2.07) 
M1: OR:1.47 (95%CI:1.08,2.00) 
M2: OR:1.46 (95%CI:1.07,1.98) 
M3: OR:1.69 (95%CI:1.17,2.45)  
 
Santos et al.  
2007 
 
Portugal 
 
Logistic 
regression 
MetS  
(Yes: %Not reported; 
No[ref])  
 
MetS referent category 
comprised: Not clear (not 
identified as MetS) 
 
1. Sleep duration 
(≤6hrs:%Not reported; 
7hrs:%Not reported; 
8hrs:%Not reported; 
≥9hrs[ref]) 
 
 
M0: Unadjusted (not reported) 
M1: age; education 
M2: M1+smoking; alcohol 
1.1.1 Sleep duration ≤6hrs - Males 
M0: Stratified prevalences not 
available to permit calculation 
M1: OR:0.99 (95%CI:0.51,1.85) 
M2: OR:0.91 (95%CI:0.47,1.76) 
 
1.1.2 Sleep duration ≤6hrs - 
Females 
M0: Stratified prevalences not 
available to permit calculation 
M1: OR:0.45 (95%CI:0.27,0.74) 
M2: OR:0.46 (95%CI:0.28,0.75) 
  
1.2.1 Sleep duration 7hrs - Males 
M0: Stratified prevalences not 
available to permit calculation  
M1: OR:0.74 (95%CI:0.45,1.23)  
M2: OR:0.65 (95%CI:0.38,1.11) 
 
1.2.2 Sleep duration 7hrs - Females 
M0: Stratified prevalences not 
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available to permit calculation   
M1: OR:0.50 (95%CI:0.33,0.75) 
M2: OR:0.50 (95%CI:0.33,0.76) 
 
1.3.1 Sleep duration 8hrs - Males 
M0: Stratified prevalences not 
available to permit calculation 
M1: OR:0.78 (95%CI:0.48,1.26)  
M2: OR:0.73 (95%CI:0.44,1.21) 
 
1.3.2 Sleep duration 8hrs - Females 
M0: Stratified prevalences not 
available to permit calculation 
M1: OR:0.60 (95%CI:0.45,0.84)   
M2: OR:0.58 (95%CI:0.41,0.84)  
 
Jennings et 
al.  
2006 
 
USA 
  
Logistic 
regression 
MetS  
(Yes: 20.0%; No[ref]) 
 
MetS referent category 
comprised: Not clear (not 
identified as MetS) 
 
(Separate analyses 
conducted on: obesity; fat 
percentage; waist 
circumference; 
hypertension; blood 
glucose levels; insulin 
resistance; raised blood 
triglycerides; and reduced 
HDL cholesterol) 
 
1. Sleep quality  
(PSQI Total Score >5: 30.0%; 
≤5[ref]) 
M0: Unadjusted (not reported) 
M1: Age; sex 
M2: M1+smoking; alcohol; education 
 
1. Poor sleep quality PSQI Total 
Score >5 
M0:  Stratified prevalences not 
available to permit calculation  
M1: OR:1.44 (95%CI:1.01,2.06) 
M2: Not reported 
 
Thomas et al.  
2006  
 
Logistic 
regression 
MetS  
(Yes: %Not reported – 
calculated 22.5%; No[ref])  
1. Snoring  
(Ever: 51.6%; Never[ref]) 
M0: Unadjusted (not reported) 
M1: Age; sex; waist to hip ratio; 
occupation; education; exercise; 
1. Snoring  
M0: Not reported – calculated: 
       OR:1.18 (95%CI:1.06,1.31) 
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China  
MetS referent category 
comprised: Not clear (not 
identified as MetS) 
 
(Separate analyses 
conducted on: 
hypertension; 
dyslipidaemia; central 
obesity; and diabetes) 
smoking; alcohol M1: OR:2.16 (95%CI:1.88,2.49) 
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2.4.5 The development of theoretical causal path diagrams to 
critically appraise the covariate adjustment sets used in 
multivariable statistical models 
To assess these possibilities, and to assist in the critical interpretation of effect 
estimates generated using models adjusting for very different sets of confounders, the 
present Chapter first sought to establish whether any of these adjustment sets might 
have: (i) excluded potential confounders (either because suitable covariates were not 
available/measured; or because the study in question had failed to adjust for an 
available/measured confounder); or (ii) adjusted for likely mediators (i.e. covariates 
falling on the causal path between exposure and outcome – either because these 
variables were misclassified as potential confounders or because the authors were 
unaware of the potential bias incurred by adjusting for mediators). This involved, 
drawing upon the complete list of the covariates that were available to/measured by 
any of the n=21  studies reviewed (see Table 2.3), and using this list (together with any 
‘exposure’ or ‘outcome’ variables) to generate a causal path diagram (in the form of a 
directed acyclic graph; DAG), based on a theoretical evaluation of the likely functional 
and temporal relationships between each of these variables. This theoretical model 
was intended to facilitate the identification of covariates acting as potential 
confounders, likely mediators or competing exposures in any relationship between 
MetS and sleep. DAGs help in this regard because they specify not only the temporal 
nature of a speculative causal path between an exposure (occurring at some time in 
the immediate, recent or distant past) and an outcome (occurring at some time 
thereafter), on which other variables (i.e. covariates) operate as: ‘potential 
confounders’ (i.e. have the potential to act as confounders) if the process, event or 
phenomenon to which they refer occurred before both the exposure and the outcome 
(in which case the variable concerned is a potential contributory cause of both); or 
‘likely mediators’ (i.e. have the potential to act as mediators) if the event or 
phenomenon to which they refer occurred after the exposure but before the outcome 
(in which case the variable concerned potentially falls on the ‘causal path’ between 
exposure and outcome).  
In this instance – i.e. when assessing the speculative causal relationships 
between MetS and sleep-related characteristics, and the relationships between these 
and any other variables included in the various covariate adjustment sets used by the 
n=21 cross-sectional studies examined in this review – it was necessary to develop a 
clear understanding of: what the ‘Metabolic Syndrome’ (MetS) was understood to 
mean by each/most of the studies reviewed; and what temporal and aetiological 
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processes are likely to lie behind its occurrence (and the manner in which it 
subsequently becomes evident in three or more of symptoms/components considered 
necessary to classify MetS: central obesity; dyslipidaemia; high blood pressure; and/or 
diabetes). Notwithstanding substantial disquiet and controversy regarding the validity 
and utility of MetS as an aetiological and clinical construct/phenomenon (Kahn et al. 
2005; Kahn 2008; Ahmadi et al. 2015; Scuteri et al. 2016) – and given that MetS has 
been conceptualised as a marker for insulin resistance initiated at some time in the 
past (Reaven 1988) while operationalised as the specific additive/interactive 
consequences (i.e. the subsequent symptomatic manifestation) of cardiometabolic 
comorbidity (e.g. (Scuteri et al. 2016) – this theory-driven approach assumed that 
where researchers explicitly set out to explore the relationship between MetS and 
sleep they intended to examine the potential role(s) that sleep might play either as a 
potential trigger for (and/or facilitator/cause/enhancer of of) symptomatic MetS or as a 
consequence of subsequent MetS-related symptoms (central obesity; dyslipidaemia; 
hypertension; and/or diabetes; or the cardiovascular consequences thereof, such as 
CHD and stroke). This assumption – together with careful consideration of how the 
data collection processes and measurement tools used by each of the n=21 cross-
sectional studies might have influenced the way in which the data available/collected 
(on sociodemographic, socioeconomic, lifestyle, anthropometric and clinical factors; as 
well as on sleep and the symptoms/components of MetS) might reflect related 
events/phenomena occurring over different time periods prior to data collection – is 
what guided the development of the DAG summarised in Figure 2.4, below.  
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Figure 2.4 A causal path diagram (in the form of a directed acyclic graph; DAG), 
summarising the theoretical relationships between the available/measured 
covariates, exposures and outcomes used by the n=21 cross-sectional studies 
included in the review. Variables have been grouped into temporally and 
functionally coherent categories, and three additional categories of 
unmeasured/unavailable (‘latent’) variables have been added to facilitate the 
specification and interpretation of the DAG. 
 
This DAG uses each of the categories of covariates, exposures and outcomes 
(as classified) in Table 2.3, together with three additional ‘latent categories’ (indicated 
in square parentheses; [ ]), which comprise groups of unmeasured variables that are 
intended to aid both the specification and interpretation of the DAG (particularly by 
indicating how measures of these variables, had they been available, might have 
contributed to the causal pathways summarised by the DAG):  
‘[MetS]’ – was intended to signify the speculative physiological event (be that insulin 
resistance, as originally proposed by Reaven, 1988; or something as yet 
unknown) postulated by the original MetS hypothesis as the common cause of 
the subsequent symptoms/components of MetS used by each of the studies 
examined in the present review to identify/classify MetS;  
‘[lifestyle history]’ – was intended to capture any aspects of earlier behaviours likely to 
have influenced the later development of both sleep-related factors and MetS-
related symptoms/components ; and  
‘[health endowment]’ – was intended to reflect the resilience/vulnerability afforded by 
an individual’s social and biological background, both intergenerationally and 
during early life (what some have called the ‘embodiment’ of dis/advantage; 
(Krieger and Davey Smith 2004; Krieger 2001; Lindau et al. 2003), and the 
subsequent importance of such resilience/vulnerability in the emergence of 
‘[MetS]’ (the speculative physiological event, whatever that might turn out to 
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be), subsequent lifestyle(s) and ultimately the symptoms/components of MetS 
itself.  
By attributing three categories of variables (‘[lifestyle history]’; ‘clinical history’; 
and ‘[MetS]’) to a common latent cause (‘[health endowment]’) the DAG acknowledges 
that each of these might operate as both potential causes and potential consequences 
of one another at various times in their development. Thereafter, the positioning of the 
four remaining categories of covariates within the DAG suggests that all but one of 
these operate as likely mediators (i.e. on the causal path between ‘[MetS]’ and 
‘Sleep’), though one category – ‘Current clinical status’ (a category created to contain 
contemporaneous measures of potentially labile physiological parameters, such as the 
cardiometabolic components used by most symptomatic classifications of MetS; i.e. 
blood glucose and lipid levels, and blood pressure) – was positioned after the outcome 
(sleep) to recognise the likelihood that the sorts of sleep measures collected by the 
n=21 studies included in the present review were likely to: capture sleep-related 
events/processes that had already occurred (whether the night/day before these were 
measured, or during the weeks preceding the cross-sectional survey point); and reflect 
the known susceptibility of cardiometabolic physiological parameters such as these to 
short term disruption following sleep disturbance (Knutson et al. 2007). And while it is 
debatable whether the temporal sequence of the remaining three categories of 
variables identified as mediators might operate as indicated within Figure 2.4 – i.e. 
with ‘Current medication’ determined by ‘Clinical history’ (amongst others), and 
thereafter influencing the more contemporaneously measured ‘Current lifestyle’ 
(which, in turn, might be likely to have determined ‘Current anthropometric status’) – 
the precise temporal sequence is irrelevant, since any appropriately specified 
adjustment sets based on this DAG would exclude variables in any of these three 
categories as likely mediators. 
As such, the DAG specified in Figure 2.4 proposes that: 
(i) the initiation of MetS (i.e. ‘[MetS]’) should be positioned before 
‘Sleep’ (since the events and processes necessary to establish 
MetS are likely to have occurred at some time prior to the period 
over which any cross-sectional assessment of sleep occurred; even 
where the measurement of sleep explicitly requested self-reports 
over days or weeks preceding measurement);  
(ii) several groups of variables are likely to act as confounders (since 
the processes and events that determined these were likely to have 
occurred prior to the initiation of ‘[MetS]’);  
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(iii) several other groups of variables are likely to act as mediators 
(since it seems plausible that the processes and events that 
determined these, as measured in the n=21 cross-sectional studies 
reviewed, would have occurred in the interval between the 
emergence of MetS symptoms and the measurement of sleep); and 
(iv) analyses exploring the relationship between sleep and the 
symptoms of MetS (i.e. some combination of the four or five 
components of MetS used by most classifications of MetS, namely: 
central obesity, high blood pressure, dyslipidaemia and diabetes) 
are likely to be challenging if, as suggested in Figure 2.4, ‘Current 
anthropometric status’ (a collection of variables that would contain 
obesity-related measures) and ‘Current medication’ were situated 
before ‘Sleep’, while ‘Sleep’ was situated before the ‘Current clinical 
status’ measures (comprising the non-anthropometric/non-
medication-based symptoms/components of MetS, namely: high 
blood pressure; dyslipidaemia; and diabetes). This temporal 
arrangement of obesity, medication, sleep and the remaining 
symptoms of MetS would seem likely provided: (a) obesity 
emerged/became established some time before the cross-sectional 
measurement of sleep; and (b) more/less favourable sleep had an 
acute impact on the cardiometabolic symptoms of MetS (blood 
pressure, blood glucose and lipid levels), as recent experimental 
studies involving shortened/disrupted sleep suggest (Knutson et al. 
2007).  
On this basis, given the methods used to measure/classify MetS in the 
n=21 studies reviewed (none of which had collected variables relevant to 
insulin resistance prior to the development of the anthropometric and 
cardiometabolic symptoms/components considered definitive of the 
subsequent symptomatic manifestation of MetS), the DAG summarised in 
Figure 2.4 suggests that none of the studies reviewed had access to/generated 
data on all of the variables required to examine the relationship between 
‘[MetS]’ and ‘Sleep’ (whether as a cause or a consequence thereof). This is 
simply because all of these studies operationalised MetS as the presence of 
symptomatic ‘cardiometabolic comorbidity’, and measured this cross-
sectionally alongside the assessment of (recent) sleep, and a range of recalled 
sociodemographic, health and lifestyle factors. 
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For this reason, however conceptually plausible Figure 2.4 might be, 
based as it is on Reaven’s (1988) original hypothesis (that insulin resistance, or 
some other physiological phenomenon, is what lies behind the emergence of 
MetS-related symptoms later in life), this does not offer a model from which it is 
easy to assess the adjustment sets used by the n=21 studies examined in the 
present review; first, because it is not clear whether any of these studies 
sought to assess the association between ‘[MetS]’ and ‘Sleep’ (although many 
appear to have intended to do so, using contemporaneous measures of MetS-
related symptoms/components as markers for the initiation of/susceptibility to 
‘[MetS]’ at some time in the past); and second, because many of these studies 
classified MetS using variables from more than one of the categories in Figure 
2.4, including two categories (‘Current medication’ and ‘Current anthropometric 
status’) considered to precede the contemporaneous measures of sleep and 
cardiometabolic symptoms/components of MetS (i.e. ‘Current clinical status’). It 
is therefore necessary to offer a simpler theoretical causal framework – one 
that focuses primarily on the variables that were actually measured 
by/available to the n=21 studies reviewed (rather than on any implicit/explicit 
intention these studies may have had to examine ‘[MetS]’). This, alternative 
framework  simply considers the likely sequence of cause and effect in a 
manner that reflects the variables collected by/available to the n=21 studies 
reviewed, and is therefore amenable for use in evaluating the different 
adjustment sets these studies used in their multivariable statistical analyses. 
This simplified approach posits four categories of measured/available 
variables (‘Family clinical history’, ‘Sociodemographic’, ‘Socioeconomic’ and 
‘Clinical history’) as potential confounders regardless of the causal paths 
between three others: ‘Current lifestyle’, ‘Sleep’ and ‘Current MetS’ (the latter 
comprising a new category created in recognition of the fact that all of the n=21 
studies used classifications of MetS that relied upon variables contained within 
the three original categories labelled ‘Current medication’, ‘Current 
anthropometric status’ and ‘Current clinical status’; see Table 2.3). 
Disregarding, for a moment, the likely temporal and functional sequence of 
these three categories of variables (‘Current lifestyle’, ‘Sleep’ and ‘Current 
MetS’) – i.e. the sequence proposed in Figure 2.3 which places ‘Sleep’ (as 
measured) after ‘Current medication’ and ‘Current anthropometric status’, but 
before ‘Current clinical status’) – there are only n=6 possible sequences in 
which these three new categories might be arranged: two with ‘Current MetS’, 
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‘Current lifestyle’ and ‘Sleep’ positioned first; two with each of these positioned 
second; and two with each of these positioned third (see Figure 2.5). 
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Figure 2.5 Simplified directed acyclic graphs (DAGs) summarising the six theoretical causal paths (1-6) between four categories of variables 
available to/measured by the n=21 cross-sectional studies reviewed (in which four categories of variables from Table 2.3 [‘Family clinical 
history’; ‘Sociodemographic’; ‘Socioeconomic’; and ‘Clinical history’] have been incorporated into the single category ‘Confounders’; and three 
categories of variables from Table 2.3 [‘Current medication’; ‘Current anthropometric status’; and ‘Current clinical status’] have been 
incorporated into the single category ‘Current MetS’). 
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2.4.6 The potential impact of unadjusted confounding and mediator 
adjustment on the association between MetS and sleep 
 Based on Figure 2.5, it is possible to identify: three possible models for the 
n=19 studies that considered ‘Sleep’ as the exposure and ‘Current MetS’ as the 
outcome (DAGs 1, 4 and 5); and three possible models for the n=2 studies that 
considered ‘Current MetS’ as the exposure and ‘Sleep’ as the outcome (DAGs 2, 3 
and 6). All of these models ignore the possibility that some of the variables used to 
assess specific symptoms/components of MetS might fall on either side of ‘Sleep’ (as 
suggested in Figure 2.4), and instead assume that the use of such 
variables/components in the classification of ‘Current MetS’ offers a temporally 
discrete assessment of MetS status that occurred after (as in DAGs 1, 4 and 5) or 
before (as in DAGs 2, 3 and 6) ‘Sleep’ as measured. Likewise, while all six possible 
models recognise the presence of ‘Confounders’, the variables considered relevant as 
confounders will not only comprise preceding sociodemographic and economic factors 
(which are known to influence the subsequent patterning of lifestyle, sleep and health), 
but also the pre-existing health conditions (including the onset of insulin resistance, or 
whatever physiological phenomenon might be responsible for initiating the onset of, or 
susceptibility to, the development of symptomatic MetS). Since none of the studies 
reviewed had collected/available data on these specific pre-existing health conditions 
– and used many of those variables they had measured/available (particularly 
prescribed antihypertensive or antidiabetic medication) to measure 
symptoms/components of MetS – the simplification of Figure 2.4 in the DAGs 
presented in Figure 2.5 implies that perhaps all of the analyses reported by the n=21 
studies reviewed are likely to suffer from (substantial) unadjusted confounding.  
 These points aside, it is nonetheless worth considering which of the DAGs in 
Figure 2.5 (i.e. in DAGs 1, 4 and 5; or 2, 3 and 6), might place the simplified groups of 
variables in the correct/most plausible temporal/causal sequence. More specifically, it 
is necessary to establish whether the variables contained in the category labelled 
‘Current lifestyle’ might act as potential confounders or likely mediators in any 
relationship between ‘Sleep’ and ‘Current MetS’. Given that cross-sectional measures 
of sleep, and of the anthropometric-, medication- and cardiometabolic symptom-
related components of MetS, are likely to reflect, at least in part, the consequences of 
established/preceding lifestyle characteristics, it might be argued that ‘Current lifestyle’ 
variables are likely to act as potential confounders. However, if the symptoms (or 
treatment) of MetS-related components affect (or lead to changes in) lifestyle, then it is 
plausible that lifestyle might (in part) reflect the impact of MetS symptoms and/or 
diagnosis thereof.  
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Certainly, it seems likely that lifestyle (as measured in the studies reviewed) 
was more fluid and therefore more ‘contemporaneous’ than MetS; and, as such, would 
better reflect characteristics emerging after the development of MetS. Thus, while 
‘Current lifestyle’ variables might act as either confounders or mediators in the 
relationship between ‘Current MetS’ (as the exposure) and ‘Sleep’ (as the outcome), 
the latter (i.e. acting as mediators) seems more likely. Indeed, it seems less likely that 
cross-sectionally measured sleep characteristics (many of which, as measured in the 
n=21 studies reviewed, appear to capture recent sleep-related experiences) will have 
preceded (m)any of the ‘Current lifestyle’ variables measured by these studies. For 
these reasons – and notwithstanding the point made earlier (see (iv), above) regarding 
the use of MetS-related criteria likely to have occurred either side of (cross-sectionally 
measured) ‘Sleep’ – the model that appears most plausible in Figure 2.5 is DAG 6, in 
which: ‘MetS’ precedes ‘Current lifestyle’ which, in turn, precedes ‘Sleep’. It is 
therefore surprising that only two of the n=21 studies reviewed actually operationalised 
MetS as the exposure and ‘Sleep’ as the outcome (Krishnan et al. 2012) and (Hung et 
al. 2013). Nonetheless, DAG 6 in Figure 2.5 remains pertinent (albeit from a 
parametric point of view) for evaluating any adjustment sets used by the remaining 
n=19 studies (i.e. those that operationalised ‘Sleep’ as the exposure and ‘Current 
MetS’ as the outcome), even if these imply the authors concerned had conceptualised 
the theoretical (i.e. non-parametric) relationships between these (and any covariates 
they had available/measured) somewhat differently.  
On this basis, Table 2.5 summarises an evaluation of any adjustment sets 
used by models reported by each of the n=21 studies; which contains separate 
columns for adjustment sets that contained only confounders (with a list of any 
available/measured confounders missing therein), and for adjustments sets that 
contained both confounders and mediators (with any components of sleep or MetS 
contained therein clearly identified).From Table 2.5 it is clear that all but one (Kazman 
et al. 2012) of the n=21 studies included at least one multivariable analytical model in 
which the adjustment set(s) used contained variables that were considered to be likely 
mediators. And while some of these studies also included alternative models 
containing no likely mediators (n=6 with one such model; n=2 with two; and n=1 with 
three), only n=2 of these alternative models included all of that study’s 
available/measured covariates considered to be potential confounders. As such, Table 
2.5 suggests that all but one of the multivariable analyses presented by the n=21 
studies reviewed suffered from either the inclusion of mediators and/or the omission of 
(available/measured) confounders. While the effect estimates these analyses provide 
need to be interpreted with caution, what is less clear from Table 2.5, is that few of 
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these studies had data available/measured on more than a handful of covariates 
considered likely to act as potential confounders. Indeed, as highlighted earlier, none 
of the n=21 studies reported data on the wide range of covariates available 
to/measured by one or more of the other studies. Instead, the available/measured 
covariates most commonly reported were those relating to current lifestyle (i.e. likely 
mediators) and current health (i.e. likely exposures/outcomes), with relatively few that 
were potential confounders (and most of these being sociodemographic or economic 
factors rather than those pertinent to a familial or personal history of health and 
lifestyle issues more directly relevant to MetS and sleep).  
Assuming that the inclusion of data on each of the covariates summarised in 
Table 2.3 by at least one of the n=21 studies reviewed indicates that these variables 
could have been available to/measured by many more of these studies, it appears that 
the principal reason why many (if not all) of the multivariable analyses these studies 
report are likely to have suffered from unadjusted confounding is because they failed 
to access/measure (some/many of) the covariates required to address this. In part this 
may reflect the absence of these variables in the secondary datasets used by the 
majority of studies reviewed (n=15/21); and in part the practical challenges of 
accessing/measuring data on covariates acting as potential confounders in studies 
adopting a cross-sectional design (many of which occurred many months or years 
prior to the assessment of sleep and MetS). However, it is also likely to reflect a lack of 
appreciation for the substantial role that unadjusted confounding might play in the 
effect estimates generated by these (and most other) cross-sectional studies.  
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Table 2.5 An assessment of the inclusion of available/measured (potential) confounders and likely mediators in each of adjustment sets 
used by multivariable statistical models reported by the n=21 studies examined in the present review. 
Citation  Available/measured covariates  
(from Table 2.2) 
Covariate adjustment sets 
(from Table 2.4) 
Adjustment for confounders  
(not mediators) 
 (missing potential confounders)1 
Adjustment for confounders 
(and likely mediators) 
 (included likely mediators) 
Mesas et al.  
2014  
 
Spain  
Age; sex; education; occupation; 
smoking; alcohol; coffee; energy intake; 
physical activity; diagnosed 
mental/physical illness; diabetes; TV 
time; antihypertensive medication; lipid-
lowering medication 
M0: Unadjusted (not reported) 
M1: Sex; age; education; occupation 
M2: M1+smoking; alcohol; coffee 
M3: M2+diagnosed mental/physical 
illness; diabetes 
M4: M3+sleep duration  
M5: M4+energy intake 
M6: M5+physical activity; TV time  
M7: M6+antihypertensive medication; 
lipid-lowering medication 
M1 (diagnosed mental/physical 
illness)   
 
M2 (smoking; alcohol; coffee) 
M3 (smoking; alcohol; coffee; 
diabetes*) 
M4 (smoking; alcohol; coffee; 
diabetes;* sleep duration) 
M5 (smoking; alcohol; coffee; 
diabetes;* sleep duration; energy 
intake) 
M6 (smoking; alcohol; coffee; 
diabetes;* sleep duration; energy 
intake; physical activity) 
M7 (smoking; alcohol; coffee; 
diabetes;* sleep duration; energy 
intake; physical activity; 
antihypertensive medication;* lipid-
lowering medication*) 
*Components of the outcome 
Ohkuma et al.  
2014 
 
Japan  
Age; sex; early/late onset diabetes; 
energy intake; smoking; alcohol; 
exercise; symptomatic mental illness; 
antidiabetic medication 
M0: Unadjusted (not reported) 
M1: Age; sex; early/late onset diabetes; 
energy intake; smoking; alcohol; 
exercise; symptomatic mental illness; 
antidiabetic medication 
 M1  (energy intake; smoking; 
alcohol; exercise; antidiabetic 
medication*) 
*Components of the outcome 
Saleh and 
Janssen  
2014 
 
USA 
 
Age; sex; ethnicity; education; 
socioeconomic status; smoking; 
alcohol; caffeine; screen time; 
sedentary time; physical activity 
M0: Unadjusted 
M1: Age; ethnicity; screen time 
M2: Age; education; physical activity; 
sedentary time 
 M1 (screen time) 
M2 (physical activity; sedentary 
time*) 
*Component of the exposure 
Hung et al.  
2013  
 
Age; sex; exercise; alcohol; smoking; 
creatinine levels 
1. Linear regression: 
M0: Unadjusted (not reported) 
M1: Age; sex; sleep duration 
 M1 (sleep duration*) 
M2 (sleep duration;* snoring;* 
alcohol; smoking; exercise; 
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Taiwan 
  
M2: M1+snoring; alcohol; smoking; 
exercise; creatinine levels  
 
2. Logistic regression: 
M0: Unadjusted (not reported) 
M1: Age; sex; sleep duration; snoring; 
alcohol; smoking; exercise; creatinine 
levels 
creatinine levels**) 
*Component of the outcome 
**Component of the exposure 
Chaput et al.  
2013 
 
Canada 
 
Age; sex; smoking; education; income; 
coffee; menopausal status; energy 
intake; alcohol; physical activity 
M0: Unadjusted 
M1: age; sex; smoking; education; 
income; alcohol; coffee; menopausal 
status 
M2: M2+energy intake; physical activity 
 M1 (smoking; alcohol; coffee) 
M2 (smoking; alcohol; coffee; 
energy intake; physical activity) 
Lee et al.  
2013 
 
South Korea 
  
Sex; age; education; occupation; 
income; smoking; alcohol; exercise; 
stress; diagnosed/symptomatic mental 
illness 
M0: Unadjusted 
M1: Sex; age; education; occupation; 
income; smoking; alcohol; exercise; 
stress; diagnosed/symptomatic mental 
illness; sleep duration (for PSQI and 
SRBD); PSQI Total Score (for duration 
and SRBD); SRDB (for duration and 
PSQI) 
 M1 (smoking; alcohol; exercise; 
stress; sleep duration [for PSQI and 
SRBD];* PSQI Total Score [for 
duration and SRBD];* SRDB [for 
duration and PSQI]*) 
*Component of the exposure 
Stefani et al.  
2013 
 
South Korea 
 
Age; sex; income; occupation; 
education; smoking; alcohol; physical 
activity; BMI; energy intake 
M0: Unadjusted 
M1: age; sex 
M2: M1+ education; occupation; 
physical activity; smoking; alcohol 
M3: M2+BMI 
M1 (income; occupation; education) 
 
M2 (physical activity; smoking; 
alcohol) 
M3 (physical activity; smoking; 
alcohol; BMI*) 
*Component of the outcome 
Yoo and 
Franke  
2013 
 
USA 
Age; sex; smoking; physical activity; 
stress; diagnosed/symptomatic mental 
illness 
M0: Unadjusted (not reported) 
M1: Age; sex; smoking; physical activity 
M2: M1+ diagnosed/symptomatic 
mental illness 
 M1 (smoking; physical activity) 
M2 (smoking; physical activity) 
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Krishnan et al. 
2012 
 
India 
Age; sex; family history of 
hyperthyroidism; physical activity; 
smoking; alcohol 
M0: Unadjusted 
M1: age 
M2: age; sex 
M3: M2+family history of 
hyperthyroidism 
M4: M3+physical activity 
M5: M4+smoking 
M6: M5+alcohol 
M1 (sex; family history of 
hyperthyroidism) 
M2 (family history of 
hyperthyroidism) 
M3 (no missing measured/available 
confounders) 
M4 (physical activity) 
M5 (physical activity; smoking) 
M6 (physical activity; smoking; 
alcohol) 
Kazman et al.  
2012  
 
USA 
Age; sex M0: Unadjusted (not reported) 
M1: Age; sex  
  
McCanlies et 
al.  
2012 
 
USA 
Age; sex; education; smoking; marital 
status; race/ethnicity; physical activity; 
occupation 
M0: Unadjusted 
M1: Age 
M2: Age; sex 
M3: M2+education; smoking  
M1 (sex; education; marital status; 
race/ethnicity) 
M2 (education; marital status; 
race/ethnicity) 
 
M3 (smoking) 
Wu et al.  
2012  
 
Taiwan 
 
Age; sex; education; family history of 
diabetes; family history of hypertension; 
smoking; alcohol; exercise; BMI  
M0: Unadjusted (not reported) 
M1: Age; education; BMI; smoking; 
alcohol; exercise  
 M1 (BMI;* smoking; alcohol; 
exercise) 
*Component of the outcome 
Hall et al.  
2012 
 
USA 
 
Age; race/ethnicity; menopausal status; 
education; marital status; 
diagnosed/symptomatic mental illness; 
symptomatic physical illness; health 
compliance; current medication; 
M0: Unadjusted (not reported) 
M1: race/ethnicity; menopausal status; 
education; marital status; health 
compliance; current medication; 
smoking; alcohol; exercise.  
 M1 (current medication;* smoking; 
alcohol; exercise).  
M2 (current medication;* smoking; 
alcohol; exercise; BMI*) 
*Component of the outcome and/or 
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smoking; alcohol; exercise M2: M1+BMI exposure 
Arora et al.  
2011  
 
China 
Age; sex; smoking; alcohol; physical 
activity; education; 
diagnosed/symptomatic mental and 
physical illness; use of hypnotics 
M0: Unadjusted 
M1: Age; sex 
M2: M1+education; smoking; physical 
activity; diagnosed mental illness; sleep 
fragmentation; use of hypnotics; 
daytime sleepiness; alcohol; snoring 
M1 (education; 
diagnosed/symptomatic mental and 
physical illness; use of hypnotics) 
 
M2 (smoking; physical activity; 
sleep fragmentation;* daytime 
sleepiness;* alcohol; snoring*) 
*Component of the exposure 
Kobayashi et 
al.  
2011 
 
Japan 
Age; sex; alcohol; smoking; pre-existing 
physical and mental illness; 
diagnosed/symptomatic mental and 
physical illness; current medication; 
physical activity 
M0: Unadjusted (not reported) 
M1: Age; sex; alcohol;  
diagnosed/symptomatic mental and 
physical illness; physical activity 
 M1 (alcohol; physical activity) 
Roopa et al.  
2010  
 
India 
 
Age; sex; physical activity; smoking; 
alcohol  
 
M0: Unadjusted 
M1: Age 
M2: Age; sex  
M3: M2+physical activity 
M4: M3+smoking  
M5: M4+alcohol  
M1 (sex) 
M2 (no missing measured/available 
confounders) 
M3 (physical activity) 
M4 (physical activity; smoking)  
M5 (physical activity; smoking; 
alcohol) 
Hall et al.  
2008  
 
USA 
 
Age; sex; race/ethnicity; education; 
smoking; alcohol; physical activity; 
blood lipid levels; symptomatic mental 
illness 
M0: Unadjusted (not reported) 
M1: Age; sex; race/ethnicity; education; 
smoking; physical activity; blood lipid 
levels; symptomatic mental illness 
 M1 (smoking; physical activity; 
blood lipid levels*) 
*Component of outcome 
Choi et al.  
2008  
 
South Korea 
 
Age; sex; family history of hypertension; 
family history of diabetes; residential 
area; education; income; alcohol; 
smoking; exercise; BMI 
M0: Unadjusted 
M1: Age; sex; family history of 
hypertension; family history of diabetes 
M2: M1+residential area; education; 
income; alcohol; smoking; exercise  
M3: M2+BMI 
M1 (residential area; education; 
income) 
M2 (alcohol; smoking; exercise)  
M3 (alcohol; smoking; exercise; 
BMI*) 
*Component of outcome 
Santos et al.  
2007 
 
Portugal 
 
Age; marital status; education; 
occupation; physical activity; exercise; 
smoking; alcohol 
M0: Unadjusted (not reported) 
M1: age; education 
M2: M1+smoking; alcohol 
M1 (marital status; occupation) 
 
M2 (smoking; alcohol) 
Jennings et 
al.  
Age; sex; race/ethnicity; 
diagnosed/symptomatic mental illness; 
M0: Unadjusted (not reported) 
M1: Age; sex 
M1 (race/ethnicity; 
diagnosed/symptomatic mental 
M2 (smoking; alcohol) 
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1
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o
t
e
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h
is assessment only considered those covariates that had been measured by/were available to the specific study concerned (see also 
Tables 2.2 and 2.3). 
 
2006 
 
USA 
  
smoking; alcohol; education; 
antihypertensive medication 
M2: M1+smoking; alcohol; education 
 
illness; education) 
 
Thomas et al.  
2006  
 
China 
Age; sex; waist to hip ratio; occupation; 
education; exercise; smoking; alcohol; 
blood pressure; blood lipid levels; blood 
glucose levels 
M0: Unadjusted (not reported) 
M1: Age; sex; waist to hip ratio; 
occupation; education; exercise; 
smoking; alcohol 
 M1 (waist to hip ratio;* exercise; 
smoking; alcohol) 
*Component of outcome 
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To assess the possible impact of unadjusted confounding and mediator-
adjustment on the effect estimates reported by the n=21 studies examined in the 
present review, studies using comparable exposures and outcomes were carefully 
identified (as described below). The intention was then to perform meta-analyses on 
effect estimates generated both prior to adjustment, and using models that had 
adjusted for potential confounders alone, or for potential confounders and likely 
mediators (as summarised in Table 2.5). Fortunately, all of the n=21 studies reviewed 
used classifications of MetS based on direct measures of MetS 
symptoms/components, and although a range of different MetS classifications were 
used, most of these appear broadly comparable (i.e. as measures of the presence of 
‘Current MetS’; all being based on three or more of: obesity; high blood pressure; 
dyslipidaemia; and/or diabetes). However, none of the studies presented sufficient 
detail on the specification of the MetS referent groups they used in their statistical 
analyses (i.e. whether these groups comprised participants who simply lacked 
sufficient symptoms/components of MetS to warrant a formal classification of MetS; or 
those displaying none of these symptoms/components) – an issue that may contribute 
considerable heterogeneity to the findings reported by the n=21 studies reviewed.  
Unfortunately, as described earlier (see 3.4.2, above), only three sleep 
characteristics (duration, quality and snoring/breathing difficulties) were used as 
exposure or outcome variables by more than one study, and only two of these 
characteristics (duration and quality) were measured using the same (or comparable) 
items/instruments in each of the studies examining these. To further complicate 
comparisons between these studies, one (McCanlies et al. 2012) used Poisson 
regression while the remainder all used logistic regression (albeit one of these also 
used linear regression; (Hung et al. 2013)). Likewise, while all of the studies examining 
sleep quality used the same instrument (PSQI), the same the cut-off point (good sleep 
quality ≤5 PSQI Total Score; poor sleep quality >5 PSQI Total Score) and the same 
referent category (poor sleep quality);  those examining sleep duration used a range of 
different: categories (n=5/14 studies using 5 categories; n=4/14 using either 4 or 3 
categories; and n=1 using ‘per additional hr of sleep’); cut-off points (one based on 
quartiles, the others pragmatic yet somewhat arbitrary); and referent categories (n=12 
studies using a normative category that ranged from 6-9hrs to 6.5-7.49hrs; n=2 studies 
using prolonged duration of ≥8hrs or ≥9hrs as the referent; and n=1 using ‘per 
additional hr of sleep’ above the average; see Table 2.4). The meta-analyses that 
follow therefore examine only those studies: using logistic regression analyses; 
reporting both unadjusted effect estimates (or the stratified prevalence data required to 
calculate these) and covariate-adjusted effect estimates in which comparable referent 
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and indicator categories were available. This involved excluding: (McCanlies et al. 
2012); which only reported the results of Poisson regression models; (Hall et al. 2008; 
Kazman et al. 2012; Santos, Ebrahim and Barros 2007; Jennings et al. 2007; Hall et 
al. 2012); none of which reported unadjusted effect estimates or the stratified 
prevalences required to calculate these; and (Kobayashi et al. 2011); since this was 
the only study remaining that had used prolonged sleep duration as the referent 
category. This left n=9 studies examining the relationship between sleep duration and 
MetS, and n=3 studies examining the relationship between (PSQI-defined) sleep 
quality and MetS (see Table 2.6). 
Amongst the n=9 studies included in Table 2.6, all of which reported the 
information on (unadjusted and adjusted) analyses of the relationship MetS and sleep, 
two reported these separately for male and female study participants (Wu et al. 2012), 
and each of the sex-specific models was therefore treated separately. Of the n=10 
separate sets of models: all provided effect estimates unadjusted for any covariates; 
n=3 adjusted for confounders alone; and n=7 adjusted for both confounders and 
mediators. Prior to adjustment, most of these models reported that MetS was 
associated with an increased odds of both the shortest and the longest sleep duration 
categories specified, although the odds were substantially higher in models reported 
by two of the smallest studies (Lee et al. 2013) and (Yoo and Franke 2013); which 
examined just n=301 and n=106 participants, respectively), suggesting the possibility 
of publication bias. In those three studies reporting models that had adjusted (only) for 
confounders, all displayed consistent attenuation of the effect estimates observed. In 
contrast, amongst the n=7 studies reporting models that had adjusted for (both) 
confounders and mediators, in some the effect sizes were attenuated while in others 
the effect sizes strengthened following adjustment. These findings appear to confirm 
that the relationship between MetS and sleep duration is susceptible to confounding; 
and, given that few of the studies included in the present review were able to adjust for 
more than a handful of available/measured confounders, it is likely that many (if not all) 
of the adjusted effect estimates they report suffer from unadjusted confounding. 
Meanwhile, the varied impact of adjusting for covariates considered likely mediators 
(i.e. those pertinent to ‘Current lifestyle’, as classified in Table 2.3) suggest that these 
models are affected by “suppression” a phenomenon of increased effect size due the 
introduction of a third variable to the model (Tu, Gunnell and Gilthorpe 2008).  
Unfortunately, none of the n=3 studies providing all of the necessary 
information on their unadjusted and covariate-adjusted analyses of the relationship 
between sleep quality and MetS, presented effect estimates adjusted for potential 
confounders alone, but all included models that had adjusted for both confounders and 
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mediators. The unadjusted models reported by two of these studies found that MetS 
was associated with a higher odds of poor quality sleep, while the third study found 
little evidence of any unadjusted association between MetS and sleep quality (see 
Table 2.6). Following adjustment for potential confounders and likely mediators, the 
reported odds strengthened for two of these studies and remained essentially 
unchanged for the third; such that all three studies reported that MetS was associated 
with a higher adjusted odds of poor sleep quality, again suggesting that covariates 
considered likely mediators were correctly identified as such in Figure 2.5 (DAGs 5 
and 6). 
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Table 2.6 Studies reporting effect estimates of the association between MetS and/or sleep duration (above) or sleep quality (below) from 
logistic regression models in which comparable measures and referent categories were used. Odds ratios (with 95% confidence intervals, 
in parentheses) are presented prior to covariate adjustment, and for any models adjusting for only potential confounders or for both 
potential confounders and likely mediators (the model chosen being that adjusting for the largest number of appropriate covariates; see 
Table 2.5). 
Study  Sex (n) Sleep duration 
(referent) 
Unadjusted (M0) 
OR (95%CI) 
Adjusted for confounders  
(model with most covariates) 
OR (95%CI) 
Adjusted for confounders and mediators 
(model with most covariates) 
OR (95%CI) 
Sleep duration 
Ohkuma et al.  
2014 
Japan  
Males and 
females  
(n=4,402) 
<5.5hrs 
5.5-6.4hrs 
(6.5-7.4hrs) 
7.5-8.4hrs 
 ≥8.5hrs        
 
1.64 (1.34,1.99) 
1.04 (0.88,1.23) 
1.00 
1.04 (0.88,1.23) 
1.74 (1.38,2.20) 
 1.71 (1.39,2.11) 
1.03 (0.87,1.22) 
1.00 
1.09 (0.92,1.29) 
1.48 (1.17,1.88)  
Saleh and 
Janssen  
2014 
USA 
Males and 
females 
(n=1,371) 
3.0-7.2hrs 
(7.2-8.6hrs) 
8.6-9.7hrs 
9.7-11.8hrs 
0.86 (0.60,1.23) 
1.00 
0.93 (0.65,1.33) 
1.12 (0.78,1.60) 
 0.91 (0.62,1.33) 
1.00 
0.89 (0.61,1.29) 
0.95 (0.66,1.39) 
Chaput et al.  
2013 
Canada 
 
Males and 
females 
(n=810) 
≤6hrs 
(7-8hrs) 
≥9hrs 
2.02 (1.32,3.23) 
1.00 
1.46 (0.95,2.14) 
 
 1.76 (1.08–2.84) 
1.00 
1.35 (0.83-1.99) 
 
Lee et al.  
2013 
South Korea 
  
Males and 
females 
(n=301) 
<5.5hrs 
5.5-6.49hrs 
(6.5-7.49hrs)  
7.5-8.49hrs 
≥8.5hrs 
6.35 (3.01,13.40) 
1.40 (0.74,2.64) 
1.00 
1.09 (0.48,2.50) 
5.08 (1.51,17.06) 
 
 4.89 (1.90,12.58) 
1.26 (0.59,2.67) 
1.00 
1.27 (0.50,3.26) 
5.98 (1.41,25.41) 
Stefani et al.  
2013 
South Korea 
 
Males and 
females 
(n=24,511) 
≤5hrs 
6hrs 
(7hrs) 
8hrs 
≥9hrs 
1.74 (1.59,1,91) 
1.10 (1.01,1.19) 
1.00 
1.04 (0.96,1.13) 
1.32 (1.17,1.48) 
 
1.06 (0.96,1.17) 
1.01 (0.93,1.10) 
1.00 
1.02 (0.94,1.12) 
1.14 (1.00,1.29) 
 
1.00 (0.90,1.11) 
0.95 (0.87,1.05) 
1.00 
1.06 (0.96,1.17) 
1.31 (1.14,1.51) 
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Yoo and 
Franke  
2013 
USA 
Males and 
females 
(n=106) 
≤6hrs 
(>6<8hrs)  
≥8hrs 
 
1.40 (0.53,3.71) 
1.00 
4.10 (1.41,11.92) 
 
 2.30 (0.71,7.50) 
1.00 
4.89 (1.32,18.13) 
Wu et al.  
2012 
Taiwan 
Males 
(n=4,298) 
<6hrs 
(6-8hrs) 
>8hrs 
1.31 (1.14,1.50) 
1.00 
1.21 (0.87,1.67) 
 1.28 (1.01,1.63) 
1.00 
1.43 (0.82,2.48) 
Females 
(n=2,802) 
<6hrs 
(6-8hrs) 
>8hrs 
1.36 (1.04,1.77) 
1.00 
1.01 (0.50,2.04) 
 
 1.04 (0.72,1.51) 
1.00 
0.90 (0.32,2.51) 
Arora et al.  
2011 
China 
Males and 
females 
(n=29,333) 
<6hrs 
6<7hrs 
(7<8hrs) 
8<9hrs 
≥9hrs 
1.14 (1.05,1.24) 
1.10 (1.03,1.18) 
1.00 
1.14 (1.06,1.22) 
1.18 (1.07,1.30) 
 
 0.98 (0.90,1.06) 
1.02 (0.95,1.09) 
1.00 
1.16 (1.08,1.25) 
1.22 (1.11,1.35) 
 
0.97 (0.88,1.06) 
1.00 (0.93,1.08)  
1.00 
1.16 (1.08,1.25)  
1.21 (1.10,1.34)   
 
Choi et al.  
2008 
South Korea 
 
Males and 
females 
(n=4,222) 
≤5hrs 
6hrs 
(7hrs) 
8hrs 
≥9hrs 
1.74 (1.33,2.26) 
1.27 (1.04,1.56) 
1.00 
1.27 (1.01,1.63) 
1.55 (1.15,2.07) 
 
1.23 (0.92,1.64) 
1.13 (0.91,1.40) 
1.00 
1.28 (1.00,1.64) 
1.47 (1.08,2.00) 
 
1.17 (0.87,1.59) 
1.07 (0.85,1.34) 
1.00 
1.32 (1.01,1.73) 
1.69 (1.17,2.45)  
 
Sleep quality 
Hung et al.  
2013  
Taiwan 
  
Males and 
females 
(n=3,435) 
Poor 
(Good) 
1.51 (1.29,1.76) 
1.00 
 1.48 (1.25,1.74) 
 
Lee et al.  
2013 
South Korea  
Males and 
females 
(n=301) 
Poor 
(Good) 
3.71 (2.26,6.10) 
1.00 
  3.83 (1.91,7.65) 
Yoo and 
Franke  
2013 
USA 
Males and 
females 
(n=106) 
Poor 
(Good) 
1.02 (0.44,2.37) 
1.00 
 
 
2.25 (0.70,7.19) 
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2.4.7 Meta-analyses of unadjusted and (confounder- and/or 
mediator-)adjusted analyses examining the association 
between MetS and sleep 
The conclusions drawn from the summaries provided in Table 2.6 were largely 
upheld by the formal meta-analyses summarised in Figure 2.6 and 2.7 for sleep 
duration and sleep quality, respectively. A total of six separate meta-analyses were 
possible using odds ratios reported for short and prolonged sleep duration from: 
unadjusted models (which were reported by all n=9 of the studies included in Table 
2.6); confounder (only)-adjusted models (which were reported by only n=3 of the 
studies); confounder and mediator-adjusted models (which were also reported by all 
n=9 of the studies).  
A comparison of the three meta-analyses conducted on results reported for 
short sleep duration (see Figure 2.6a) confirmed that the combined estimate 
generated from unadjusted models suggested that short sleep duration was 
associated with more than 1.5 times the odds of MetS (OR:1.52; 95%CI:1.26,1.83); 
and while this was substantially attenuated in models from the n=3 studies that 
adjusted for confounders alone (OR:1.03; 95%CI: 0.95,1.12), it strengthened again 
once mediators were included in the adjustment sets used (OR:1.24; 
95%CI:1.04,1.47). A similar pattern, though somewhat less pronounced, was observed 
in the three  meta-analyses conducted on results reported for prolonged sleep duration 
(see Figure 2.6b), in which the combined estimate generated from unadjusted models 
reported by all n=9 studies suggested that prolonged sleep duration was associated 
with 1.38 times the odds of MetS (OR:1.38; 95%CI:1.20;1.58), an association that was 
modestly attenuated following adjustment for confounders alone (OR:1.21; 
95%CI:1.11,1.32), but again strengthened close to the unadjusted association 
(OR:1.34; 95%CI:1.17,1.53) following adjustment for both confounders and mediators.  
Although none of the studies examining the association between sleep quality 
and MetS that were eligible for inclusion in Table 2.6 reported the results of models 
using adjustment sets containing only confounders, all n=3 of these studies reported 
the results of unadjusted models and models using adjustment sets containing both 
confounders and mediators (see Figure 2.7). Once again, formal meta-analyses of 
results from these two sets of models (unadjusted; and both confounder- and 
mediator-adjusted) confirm that the combined odds generated from unadjusted models 
(which suggested that poor sleep quality was associated with almost twice the odds of 
MetS; OR:1.86; 95%CI:0.95,3.363) strengthened substantially (to OR:2.20; 
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95%CI:1.10,4.37) when based on results from models that adjusted for both 
confounders and mediators – clear evidence of over-adjustment. 
As such, neither set of meta-analyses provide much in the way of reassurance 
that short or prolonged sleep duration, or poor sleep quality are actually associated 
with MetS. This is likely to be the result of suppression, since the associations 
observed were clearly attenuated following adjustment for the limited number of 
confounders available to/measured by the studies examined here; and are therefore 
likely to be susceptible to further attenuation were it possible to adjust for additional 
confounders (both latent/unmeasured confounders, and those that were 
available/measured by the studies reviewed, yet excluded from some of the 
adjustment set used; see Table 2.5). Likewise, the strengthened combined odds ratios 
generated following the inclusion of mediators in the covariate adjustment sets used, 
poses a real challenge to a more circumspect interpretation of the evidence examined 
by the present Chapter, since these strengthened odds ratios are likely to be 
interpreted by others (including unwitting journal reviewers and editors) as evidence 
that the association between sleep duration/quality and MetS is somehow 
‘independent of’ mediators falling on the causal path between sleep and MetS (and 
also, for those adjustment sets that included these, ‘independent of’ other sleep 
characteristics or individual components of MetS; see Table 2.5). Indeed, this may be 
what lies behind the evidence of publication bias contained in Figures 2.6 and 2.7, in 
which there is a marked tendency for those studies adding a greater ‘percentage 
weight’ to these meta-analyses to have reported odds ratios closer to the null (this is 
evident from the ‘percentage weight’ figures presented to the far right of each study-
specific OR and 95%CI in each of the meta-analysis plots; figures determined by the 
sample size, and hence statistical power, of each study). Taken together with the 
many methodological weaknesses and potential analytical biases identified in the n=21 
studies reviewed in the present Chapter, there remains considerable uncertainty as to 
whether there is any association between sleep and Mets except that generated 
through confounding, and/or through inappropriate adjustment for mediators. Fresh 
analyses of well-powered samples, avoiding each of these pitfalls, will be required to 
address this ongoing uncertainty. 
 
80 
 
Figure 2.6a Meta-analyses of odds ratios reported for studies examining the 
association between short sleep duration and MetS using models that were: 
unadjusted for any covariates (top); adjusted only for confounders (middle); and 
adjusted for both confounders and mediators (bottom) 
 
 
 
 
NOTE: Weights are from random effects analysis
Overall  (I-squared = 88.2%, p = 0.000)
Choi et al. 2008
Stefani et al. 2013
Arora et al. 2011
Wu et al.  2012 (females)
Wu et al.  2012 (males)
Ohkuma et al. 2014
Chaput et al. 2013
Lee et al. 2013
ID
Study
Yoo and Franke 2013
Saleh and Janssen 2014
1.52 (1.26, 1.83)
1.74 (1.33, 2.26)
1.74 (1.59, 1.91)
1.14 (1.05, 1.24)
1.36 (1.04, 1.77)
1.31 (1.14, 1.50)
1.64 (1.34, 1.99)
2.02 (1.32, 3.23)
6.35 (3.01, 13.40)
OR (95% CI)
1.40 (0.53, 3.71)
0.86 (0.60, 1.23)
100.00
11.09
13.90
13.98
11.08
13.33
12.35
7.79
4.29
Weight
%
2.88
9.32
  
1.05 14
Short sleep duration-unadjusted
NOTE: Weights are from random effects analysis
Overall  (I-squared = 35.7%, p = 0.211)
Study
Choi et al. 2008
Arora et al. 2011
ID
Stefani et al. 2013
1.03 (0.95, 1.12)
1.23 (0.92, 1.64)
0.98 (0.90, 1.06)
OR (95% CI)
1.06 (0.96, 1.17)
100.00
%
8.08
50.33
Weight
41.59
  
1.5 2
Short sleep duration-adjusted for confounders
NOTE: Weights are from random effects analysis
Overall  (I-squared = 79.6%, p = 0.000)
Wu et al.  2012 (males)
Choi et al. 2008
ID
Lee et al. 2013
Wu et al.  2012 (females)
Yoo and Franke 2013
Stefani et al. 2013
Study
Saleh and Janssen 2014
Chaput et al. 2013
Ohkuma et al. 2014
Arora et al. 2011
1.24 (1.04, 1.47)
1.28 (1.01, 1.63)
1.17 (0.87, 1.59)
OR (95% CI)
4.89 (1.90, 12.58)
1.04 (0.72, 1.51)
2.30 (0.71, 7.50)
1.00 (0.90, 1.11)
0.91 (0.62, 1.33)
1.76 (1.08, 2.84)
1.71 (1.39, 2.11)
0.97 (0.88, 1.06)
100.00
12.73
11.14
Weight
2.80
9.51
1.91
15.84
%
9.26
7.28
13.51
16.03
  
1.05 13
Short sleep duration-adjusted for confounders and mediators
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Figure 2.6b.Meta-analyses of odds ratios reported for studies examining the 
association between long sleep duration and MetS using models that were: unadjusted 
for any covariates (top); adjusted only for confounders (middle); and adjusted for both 
confounders and mediators (bottom) 
 
 
 
NOTE: Weights are from random effects analysis
Overall  (I-squared = 59.4%, p = 0.008)
ID
Wu et al.  2012 (females)
Stefani et al. 2013
Arora et al. 2011
Study
Ohkuma et al. 2014
Lee et al. 2013
Chaput et al. 2013
Yoo and Franke 2013
Wu et al.  2012 (males)
Saleh and Janssen 2014
Choi et al. 2008
1.38 (1.20, 1.58)
OR (95% CI)
1.01 (0.50, 2.04)
1.32 (1.17, 1.48)
1.18 (1.07, 1.30)
1.74 (1.38, 2.20)
5.08 (1.51, 17.06)
1.46 (0.95, 2.14)
4.10 (1.41, 11.92)
1.21 (0.87, 1.67)
1.12 (0.78, 1.60)
1.55 (1.15, 2.07)
100.00
Weight
3.33
20.14
21.10
%
14.12
1.23
7.78
1.57
10.21
9.10
11.42
  
1.05 17.5
Long sleep duration-unadjusted
NOTE: Weights are from random effects analysis
Overall  (I-squared = 16.3%, p = 0.303)
Study
Choi et al. 2008
ID
Stefani et al. 2013
Arora et al. 2011
1.21 (1.11, 1.32)
1.47 (1.08, 2.00)
OR (95% CI)
1.14 (1.00, 1.29)
1.22 (1.11, 1.35)
100.00
%
7.66
Weight
37.21
55.13
  
1.5 2 3
Long sleep duration-adjusted for confounders
NOTE: Weights are from random effects analysis
Overall  (I-squared = 45.4%, p = 0.058)
Saleh and Janssen 2014
Ohkuma et al. 2014
Chaput et al. 2013
Wu et al.  2012 (females)
Study
Yoo and Franke 2013
Wu et al.  2012 (males)
Choi et al. 2008
ID
Arora et al. 2011
Lee et al. 2013
Stefani et al. 2013
1.34 (1.17, 1.53)
0.95 (0.66, 1.39)
1.48 (1.17, 1.88)
1.35 (0.83, 1.99)
0.90 (0.32, 2.51)
4.89 (1.32, 18.13)
1.43 (0.82, 2.48)
1.69 (1.17, 2.45)
OR (95% CI)
1.21 (1.10, 1.34)
5.98 (1.41, 25.41)
1.31 (1.14, 1.51)
100.00
9.23
15.85
7.30
1.63
%
1.03
5.00
9.33
Weight
26.59
0.85
23.20
  
1.05 25.5
Long sleep duration-adjusted for confounders and mediators
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Figure 2.7 Meta-analyses of odds ratios reported for studies examining the 
association between poor sleep quality and MetS using models that were: unadjusted 
for any covariates (top); and adjusted for both confounders and mediators (bottom) 
 
 
  
NOTE: Weights are from random effects analysis
Overall  (I-squared = 84.2%, p = 0.002)
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Hung et al. 2013
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%
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2.5 Summary  
 The literature search conducted for the present review into the association 
between MetS and sleep, found little evidence generated from experimental studies 
(beyond those examining the use of CPAP-related, or weight-loss, interventions), and 
no robust longitudinal analyses of data collected from more than two time points 
(baseline and follow-up). Instead, the only evidence available on the association 
between MetS and sleep that had looked beyond the individual symptoms/components 
of MetS (such as the experimental studies examining weight loss) and beyond clinical 
sleep disorders (such as obstructive sleep apnoea), comes from cross-sectional 
studies.  
A total of n=21 such studies were identified, conducted between 2006 and 
2014, and predominantly in North America and Asia (with only two studies to-date in 
Europe, neither in the UK). Most of these studies (n=15/21) involved secondary 
analyses of data from past/ongoing studies, all but one of which included both male 
and female participants, and around half involving more than n=1,000 participants. For 
the most part the recruitment of participants involved excluding those with serious pre-
existing clinical conditions (including psychiatric diagnoses, cancers, and advanced 
cardiovascular disease), and few focussed exclusively on patients sampled from 
clinics providing treatment for these. As such, the samples of participants examined by 
these studies appear to offer a sound basis for extrapolation to the wider population of 
(ostensibly healthy) adults in each of the contexts where these studies were based. 
Although four different classifications of MetS were used by the studies 
reviewed, these were all broadly comparable (each requiring the presence of three or 
more measures of obesity, high blood pressure, dyslipidaemia and diabetes to 
establish the presence of MetS); and all of the studies based their use of these on 
direct measures of the four or five measures they used. In contrast, only n=2 of the 
studies used direct (objective) measures of sleep, the remainder using a wide range of 
established instruments and custom sleep item sets. There was also little consistency 
in the specific sleep-related characteristics examined, and although a sizeable number 
of studies (n=14) involved some measure of sleep duration, only n=6 measured sleep 
quality and only n=5 assessed snoring/sleep-disordered breathing, with many 
commonly recognised sleep characteristics (including: sleep latency; sleep 
fragmentation; sleep efficiency; sleep medication use; daytime sleepiness) examined 
in analyses on just a single dataset. Moreover, very few of the studies examined more 
than one or two sleep-related characteristics, which means it is not yet possible to 
compare whether any association between MetS and sleep depends upon the specific 
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characteristic of sleep examined, except from the results of individual studies (none of 
which examined a comprehensive list of sleep-related characteristics), or by 
comparing across studies that examined different participants, in different contexts, 
using different methods. 
 Even where substantial numbers of studies examined the same sleep 
characteristic (i.e. sleep duration; sleep quality; or snoring/sleep-disordered breathing), 
a lack of consistency in the instruments used to measure these characteristics, 
together with variation in the specification and number of response categories used 
(and in the analytical and reporting practices applied), makes comparisons across 
these studies challenging. As a result, the present review only found it possible to 
compare the association between MetS and sleep duration across n=9/14 studies, and 
between MetS and sleep quality across n=3/6 studies; while inconsistencies in 
measurement, analysis and reporting meant it was not possible to compare the 
association between MetS and snoring/sleep-disordered breathing between two or 
more of the n=5 studies reporting these. 
 Nonetheless, by comparing the associations between MetS and sleep duration 
across n=9 broadly comparable studies, and between MetS and sleep quality across 
n=3 studies with similar approaches to measurement and analysis, it was possible to 
generate substantial insight into the evidence such cross-sectional studies might offer. 
Both comparisons suggest that MetS is associated with a higher odds of less 
favourable sleep duration (i.e. short and prolonged sleep duration), and a higher odds 
of ‘poor’ sleep quality. However, the strongest associations were observed in studies 
with comparatively small samples sizes (n<500), which suggests the possibility of 
publication bias. Moreover, using a theoretical causal path diagram (developed using: 
a list of the covariates reported by all n=21 studies; and an assessment of how and 
when data on these variables, and on MetS- and sleep-related variables, were 
collected) it was possible to compare reported associations between MetS and these 
two sleep characteristics before and after adjustment for potential confounders (for 
n=3 of the studies examining sleep duration) and likely mediators (for all n=9 studies 
examining sleep duration and all n=3 studies examining sleep quality).  
These comparisons indicate that most of the unadjusted associations between 
MetS and sleep duration were substantially attenuated following adjustment for 
available/measured covariates considered potential confounders; while adjustment for 
both confounders and likely mediators attenuated the associations observed in some 
studies and strengthened these in others. Similar effects – involving attenuation 
following adjustment for confounders alone; and a mix of attenuated and strengthened 
associations following adjustment for confounders and mediators – were also evident 
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for many of the other sleep characteristics examined by individual studies. This 
suggests that many of the associations between MetS and a range of sleep-related 
characteristics might be susceptible to substantial confounding; and that the inclusion 
of likely mediators (in addition to potential confounders) in the covariate adjustment 
sets used, can introduce substantial bias.  
While the use of multivariable analyses to generate adjusted estimates of the 
association between MetS and sleep indicates that most of the studies recognised the 
potential impact of confounding (and the importance of addressing this through 
adjustment), none of the studies included in the present review reported data on all of 
the available/measured covariates mentioned by one or more of the other studies. At 
the same time, most of the covariate adjustment sets used by the studies reviewed 
included likely mediators as well as confounders, indicating that few (if any) of the 
studies recognised the potential for bias associated with inappropriate adjustment for 
mediators. For these reasons, it seems likely that many (if not all) of the confounder-
adjusted estimates (of the association between MetS and sleep) reported by these 
studies will suffer from unadjusted confounding – simply because the adjustment sets 
these used omitted covariates acting as confounders (i.e. those covariates that 
appeared feasible to collect given these were available to/measured by at least some 
of the other studies). For similar reasons, it seems likely that substantial care is 
required when interpreting the adjusted estimates reported by many of the cross-
sectional studies examining the association between MetS and sleep, to ensure that 
these do not suffer from bias as a result of the inclusion of likely mediators in their 
covariate adjustment sets. 
2.6 Conclusion 
 The present review suggests that, while there is some evidence of an 
association between MetS and sleep across a range of sleep-related characteristics, 
this evidence draws on a small (n=21) number of cross-sectional studies, some of 
which involve under-powered samples of participants, and many of which use methods 
that are prone to error and bias (not least in the analytical techniques they employ). 
None of these studies were conducted in the UK; and none provide evidence on more 
than four separate sleep characteristics; while variation in sampling, the variables 
available/measured, and the measurement and analysis techniques used, make it 
difficult to provide a comprehensive assessment of the relationship between MetS and 
sleep across the full range of sleep-related characteristics based on these n=21 
studies.  
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 To address these gaps (and flaws) in the evidence available to-date, a suitable 
dataset was sought that contained appropriate (and sufficient) information to support a 
de novo analysis using more robust methods. Such a dataset would ideally: have been 
conducted in the UK (given the absence of any such UK-based studies, to-date); 
contain data on a range of different sleep characteristics (and, in particular, not simply 
data on sleep duration and sleep quality); and have sufficient information on MetS-
related criteria as well as a broad range of potential confounders to permit suitably 
adjusted analyses of the potential relationship between MetS and sleep. 
2.7 Development of research aim and objectives 
2.7.1 Research aim  
This thesis sets out to explore, in greater detail, the epidemiological 
relationship(s) between MetS and sleep at the population level, and to provide clearer 
evidence of whether variation in MetS might predict changes in sleep patterns (or vice 
versa). As such, the present study aimed to identify a large-scale, nationally 
representative survey of UK adults in which suitable data (on sleep, MetS and 
potential confounders) were available.  
2.7.2 Objectives  
The overarching aim of the present thesis is to generate an improved 
understanding of the available evidence regarding the speculative relationship 
between sleep and the metabolic syndrome (MetS). This aim will be operationalised 
using three key questions (KQs):  
KQ2: “What UK-based datasets are available from which to examine the relationship 
between sleep and the metabolic syndrome (MetS) to inform: the focus and conduct of 
future research; and our understanding of the evidence base regarding ‘unfavourable’ 
sleep as a possible cause and a possible consequence of MetS?”  
KQ3: “To what extent might self-reported items relevant to identifying MetS in large 
datasets offer sufficiently valid measures of MetS symptoms/components to provide a 
basis upon which to generate a ‘self-reported’ classification of MetS suitable for use in 
population-based analyses where direct measures of MetS components are not 
available/feasible?”   
and  
KQ4: “What methodological and aetiological insights into the association between 
sleep and MetS might be generated from analyses of such data?” 
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Each of these three questions have been addressed in successive Chapters of 
the present thesis, using a range of different methods, including: KQ2 – a search for a 
suitable dataset containing sufficient/appropriate variables (Chapter 3); KQ3 - the 
development of self-reported measures of MetS-related symptoms/components, and 
comparing them to their direct/objective measures; and KQ4 - novel analyses of a 
contemporary secondary dataset, addressing the flaws identified in the systematic 
review (Chapter 2), and using the self-reported classification of MetS (Chapter 4).  
The analytical Chapters are then followed by the concluding Chapter to the present 
thesis, which rehearses the key findings from the preceding Chapters, and synthesises 
what might be learnt by comparing the results of these (and from an assessment their 
limitations) to generate key recommendations for future research building on the 
foundation prepared by the present thesis. 
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Chapter 3 Data sources and analytical methods  
The present Chapter identifies a suitable dataset for use in the present study and 
introduces the methods used in the following (results) Chapter (Chapter 4). It provides 
further insight into the dataset selected for analysis within the thesis including a 
description of the study design and sample used; the variables available, and their 
definitions; data management; and the various statistical methods applied in the 
analyses that follow.  
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3.1 Introduction  
Given the important statistical advantages (in terms of power) associated with 
studies examining large scale datasets, the present thesis established at an early 
stage the need to identify a suitable secondary dataset containing information on MetS 
and sleep, as well as a suitable range of covariates likely to act as potential 
confounders. The (secondary) analysis of data from existing datasets – i.e. those that 
have been collected for different (or, indeed, for generic) research purposes – is a 
common strategy in epidemiology since it has several advantages over the collection 
and analysis of primary data. Secondary datasets tend to be available/accessible at 
much lower cost to the researcher than the collection of primary data; and they often 
contain high quality data, benefitting (as they often do) from collaborations between 
multidisciplinary teams of experts across a range of different fields, who are able to 
advise on the most appropriate validated instruments to use. Many such studies also 
go through several rounds of developmental ‘pilot’ phases in which every step of data 
collection, collation and preparation is scrutinised, practised and evaluated. 
Nonetheless, such datasets all too often fail to collect all of the necessary data 
required to address very specific research questions, and researchers using these 
datasets rarely have any influence over what data have been collected or how. 
Similarly, researchers analysing secondary data are usually unaware of key details 
affecting the quality and validity of the data collected, simply because they are rarely 
involved in the process of designing and administering the measurement tools and 
surveys used (Cheng and Phillips 2014; Miller and Brewer 2003). It is therefore 
important, when conducting secondary analyses, to take great care when selecting an 
existing dataset to ensure that this has sufficient data on relevant variables of interest 
to address the question(s) in hand.  
After a dedicated search for contemporaneous datasets offering large-scale 
samples with information on MetS, sleep and a comprehensive range of potential 
confounders (see Table 3.1), the present thesis settled on the United Kingdom 
Household Longitudinal Study (UKHLS). 
  
90 
 
Table 3.1 Contemporary UK cohort studies that include data on sleep in their 
secondary datasets. 
Name of the study  Sample size and age Area  Number of sleep 
characteristics 
The United Kingdom 
Household Longitudinal 
Study (UKHLS) 
50,994 (+10yrs) Britain  (7)Sleep duration, sleep 
latency, sleep 
fragmentation, sleep 
disturbance due to 
cough/snore, sleep 
medication use, 
daytime sleepiness and 
sleep quality.  
The Hertfordshire 
Cohort Study 
3,000 (+4yrs) Hertfordshire (1)Trouble with sleep 
National Survey of 
Health and 
Development 
5,362 (-57yrs) England, Scotland and 
Wales 
 
(1)Trouble with sleep 
1970 British Cohort 
Study 
17,000 (-33yrs) England, Scotland and 
Wales 
(2)Sleeping difficulty 
and Sleep latency 
Southampton Women's 
Survey 
12,583 women (+26yrs) Southampton (1)Sleep duration  
Avon Longitudinal Study 
of Parents and Children 
14,000 pregnant 
women, the children 
arising from the 
pregnancy, and their 
partners 
Avon (1)Trouble with sleep 
 
The UKHLS displayed many of the key prerequisites of the ‘ideal’ secondary 
dataset sought for use in the present thesis: it is based on a nationally representative 
sample of households recruited throughout the United Kingdom, including samples 
drawn from England, Scotland, Wales and Northern Ireland; and it has used a 
longitudinal approach, with regular surveys of each household and each household 
member (aged ten and above), thus far involving around n=40,000 households. The 
UKHLS has also succeeded in generating data across a wide spectrum of sleep- and 
MetS-relevant variables as a result of its multi-topic focus, supported with substantial, 
sustained funding from consecutive governments (and a number of government 
departments), as well as from the UK’s Economic and Social Research Council 
(ESRC).  
The UKHLS aims include generating – at community, individual and household 
level – high quality longitudinal data on: social and demographic factors, education, , 
income,  and health; as well as collecting objectively/directly measured health data on 
a large sub-sample of adult participants (through a dedicated ‘Nurse Health 
Assessment’; NHA). Together, these data are intended to help better understand both 
short and long-term changes in each of these social characteristics, and to help 
design/evaluate policy interventions capable of enhancing the wellbeing of the UK 
population (Knies 2014). 
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Choosing the UKHLS dataset over other surveys was made on the basis that it 
offered contemporary data from a large, nationally representative, multi-topic 
longitudinal survey of UK adults in which components of MetS, sleep characteristics, 
and a range of potential confounders have been recorded. None of the alternative 
datasets identified were capable of addressing each of these issues so 
comprehensively (see Table 3.1) 
3.2 The United Kingdom Household Longitudinal Study 
(UKHLS) 
The UKHLS datasets contain anonymised data that are available in the public 
domain through the UK Data Service, and permitted for use by, amongst others, 
University-based researchers. However, since any study involving human participants 
warrants ethical scrutiny, the UKHLS was designed and undertaken in line with the 
Institute for Social and Economic Research’s (ISER) internal Code of Ethics and the  
Research Ethics Framework of the principal funder (the Economic and Social 
Research Council; ESRC). This Code and Framework led the UKHLS to obtain formal 
ethical approval for each successive Wave of the study from the University of Essex 
Ethics Committee and the National Research Ethics Service. All prospective UKHLS 
participants were required to provide informed consent; verbal consent being 
considered adequate for participation in the questionnaire surveys, and for all direct 
measurements including blood pressure and anthropometric measurements; while 
written consent was required for any invasive procedures such as the collection of 
blood samples.  
3.2.1 The UKHLS sample design  
The UKHLS comprises a number of different sample components. Amongst 
these, the present thesis drew data primarily from the so-called “general population 
sample”, comprising household members drawn from a representative sample of UK 
households. To achieve representativeness, the UKHLS general population sample 
was stratified across addresses selected by postcode in England, Wales and Scotland 
with households in each strata selected at random. Households from Northern Ireland 
(NI) drew on a systematically un-clustered random sample of household addresses 
selected from the NI Land and Property Services Agency’s list of domestic addresses. 
Together these samples generated a total of n=49,915 addresses. However, the study 
only managed to recruit households at n=30,169 addresses so that the subsequent 
interviews were conducted on n=50,994 individuals (i.e. on average just over five 
adults in every three households) during the first Wave (“Wave 1”) of the study. , and 
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these respondents make up the original sample of participants recruited into the 
UKHLS. 
3.2.2 Main survey and Nurse Health Assessment 
In 2009 the first UKHLS main survey (‘Wave 1’) began, with data collection 
lasting for approximately two years. Subsequent Waves have then taken place at 
approximately two year intervals, interdigitating with the preceding Wave, such that 
Wave 1 took place from January 2009 to January 2011, while Wave 2 took place from 
January 2010 to January 2012 and so on (Knies 2014).  
In 2010-2012 the UKHLS augmented the Wave 2 main survey with a home 
visit-based ‘nurse health assessment’ (NHA) which involved a detailed examination of 
a subsample of study participants to provide direct (objective) measures that might be 
used in the assessment of chronic disease, and for exploring a range of biosocial 
determinants/components of human health (McFall 2013). These NHA visits took 
place five months after the completion of the main survey during Wave 2 and extended 
over 24 months so that these were still underway as the main survey was being 
completed during Wave 3. In Wave 2 only adult respondents who had completed the 
main survey, and were not pregnant, and not physically or mentally ill were eligible to 
participate.  
The NHA Wave 2 NHA subsample comprised n=15,646 adults (aged 16yrs and 
over) each of whom received a home visit from a trained registered research nurse at 
which the following direct measures were taken: weight, height, percentage body fat, 
waist circumference, blood pressure, grip strength, and lung function. All of these 
participants were also eligible to provide a non-fasting blood sample with the exception 
of those: with clotting or bleeding disorders; taking anticoagulant drugs; who had ever 
had a fit or convulsion; suffering from hepatitis B or C, or who were HIV positive; and 
who were not willing to give written consent for this procedure. Of the blood samples 
collected from this ‘sample within the subsample’ n=13,258 adults were subsequently 
subjected to laboratory screening for selected biomarkers, including: cholesterol 
levels; glycated haemoglobin (HbA1c); high sensitivity C - reactive protein and 
fibrinogen; haemoglobin and ferritin; and others relevant to liver and kidney function 
(Benzeval 2014).  
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Figure 3.1 Wave 1, Wave 2 and Nurse Health Assessment temporal sequence 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.3 The UKHLS data collection and processing  
Prior to each wave, a small pilot study and ‘dress rehearsal’ were conducted, 
which involved a run-through of all proposed data instruments. The collection of data 
within each selected household comprised an interview involving a range of different 
types of questionnaires: 
1. A household questionnaire (one per household);  
2. A face-to-face questionnaire using Computer Aided Personal Interview (CAPI); 
and  
3. A proxy questionnaire for individuals who were not available at the time data 
were collected and who gave their permission for information to be given by a 
nominated ‘proxy respondent’ on their behalf.  
Two self-administered questionnaires were also left with households for completion 
and subsequent return by post: 
4. Adult self-completion questionnaire (one per eligible adult aged 16yrs and over); 
and  
5. Young Person self-completion questionnaire (one per eligible youth aged under 
16yrs). 
The main adult questionnaire delivered face-to-face was organised in ‘modules’ 
(such as these containing items on social, educational or health-related issues). Some 
of these modules (and all of the items they contained) were repeated in every 
subsequent main adult questionnaire; while others were modified or repeated in their 
entirety only at intervals of 2-3 subsequent Waves. This pattern of topic-focussed data 
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collection reflected both the resources available to administer long(er) questionnaires, 
and constraints related to the burden of data collection placed upon participants (and 
the importance of retaining participants from one Wave to the next, given the UKHLS’ 
longitudinal design). 
 Following the fieldwork, data underwent detailed quality control to ensure that 
answers matched the pre-defined questionnaire item specifications. This was followed 
by editing, error reporting and coding of any free text information generated by open-
ended questions. Data from paper documents (including the Adult and Young Person 
self-completed questionnaires) were then entered into the dataset, and a range of 
different codes were applied to the dataset to record different reasons for 
‘missingness’ (i.e. the type, and reason for, any absent valid responses, such as: 
missing by error or considered implausible; a question not being applicable whether to 
the respondent concerned or as a result of their answers to previous questions – so-
called ‘routing’; participant refused to answer; or participants didn’t know the answer). 
Finally, all of the resulting variables were clearly labelled as either ‘original’ (i.e. the 
direct responses to items in the relevant questionnaire) or ‘derived’ (variables that 
were computed or determined from the direct responses given to one or more of the 
‘original’ variables).  
Data from each successive Wave are released in separate files, each containing 
information on the source (i.e., the household interview, the adult interview, and the 
youth interview). In each of these files, individual participants are pseudo-anonymised 
using a unique personal identifier that remains unchanged in any Wave in which they 
participate, facilitating the linkage of data provided by the same participants in each 
successive Wave. 
3.3 Study design and samples 
To generate datasets relevant to the topic of interest to the present thesis, data 
from Wave 1, Wave 2 and the Wave 2 NHA were used. Data from these waves were 
merged into wide format files using the unique participant identifier to link data for the 
same participant from each of these three (original UKHLS) datasets.   
Data from Wave 1 were particularly relevant to exploring the association 
between MetS and sleep because the questionnaire used in this Wave included data 
on participants’ self-reported weight and height; self-reported clinical diagnoses of high 
blood pressure and diabetes; and self-reported sleep characteristics. In contrast, data 
from Wave 2 and Wave 2 NHA did not contain data on self-reported height and weight, 
nor on self-reported sleep. However, because the questionnaires used and direct 
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measures recorded in these UKHLS datasets contained self-reported clinical 
diagnoses of high blood pressure and diabetes (Wave 2) and direct measures of 
height, weight, waist circumference, blood pressure and HbA1c levels (the latter from 
subsequent laboratory analyses of non-fasting blood samples), together with lists of all 
prescribed medication (including antihypertensive and antidiabetic medication), these 
datasets provided the data necessary to assess the level of agreement between self-
reported and direct measures of two of the three key components of MetS (high blood 
pressure and diabetes). Figure 3.2 demonstrates the way in which each of the three 
UKHLS datasets (Wave 1, Wave 2 and Wave 2 NHA) were used in the present thesis 
– Wave 1 also providing the self-reported weight and height data used to estimate 
‘self-reported’ waist circumference; an estimate that could then be compared to direct 
measures of waist circumference recorded during the NHA.  
  
 
 Wave 1 
Self-reported health 
measures 
 
Height 
Weight 
Diabetes 
High blood pressure 
 
Self-reported sleep 
characteristics 
Sleep duration, latency, 
fragmentation, 
coughing/snoring, sleep 
medication, daytime 
sleepiness and sleep 
quality  
 
Wave 1 
Wave 2 
Wave 2 
 
(Nurse health assessment) 
+ (blood sample) 
Self-reported health 
measures  
Height 
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Blood pressure 
HbA1c  
Figure 3.2 The structure of the present study using UKHLS Wave 1, Wave 2, and 
Wave 2 Nurse Health Assessment datasets 
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3.4 Study variables and definitions  
3.4.1 Sleep characteristics  
In Wave 1 of the UKHLS the Adult Self-completion Questionnaire contained 
seven items which sought information on different sleep-related characteristics. These 
questions and their response categories mimic those questions contained in the 
Pittsburgh Sleep Quality Index (PSQI); (Buysse et al. 1989) and the Jenkins Sleep 
Questionnaire (JSQ); (Jenkins et al. 1988) – two of the most commonly used validated 
sleep questionnaires. However, because there is no validated scoring system for the 
UKHLS sleep questionnaire, each sleep characteristic needed to be considered 
separately. 
  The UKHLS sleep-related items asked participants to report their sleep during 
the month preceding the Wave 1 interview, including self-reports of: sleep duration 
(actual hours of sleep at night); sleep latency (cannot get to sleep within 30 minutes); 
sleep fragmentation (trouble sleeping due to waking up in the middle of the night or 
early in the morning); coughing/snoring (trouble sleeping due to coughing or snoring 
loudly); sleep medication use (medicine [prescribed or ‘over the counter’] to help 
participants sleep); daytime sleepiness (trouble staying awake while driving, eating 
meals, or engaging in social activity), and sleep quality (overall sleep quality). 
Sleep duration responses were recorded as hours and minutes, whereas all 
but one of the remaining sleep variables (the exception being sleep quality) were 
recorded in five categories: “Not during the past month”; “Less than once a week”; 
“Once or twice a week”; “Three or more times a week”; and “More than once most 
nights”. Sleep quality responses were recorded in four categories as: “very good”; 
“fairly good”; “fairly bad”; and “very bad”.  
For use in the present thesis, data on sleep duration were categorised into: 
short sleep duration (<6 hrs), mid-length sleep duration (≥6-8 hrs) and long sleep 
duration (>8hrs). This categorisation of sleep duration was made on the basis of the U-
shaped association between sleep duration and adverse health consequences 
(Ohkuma et al. 2014); and because previous studies have found that MetS may be 
associated with both short sleep duration (≤6hrs) and long sleep duration (≥9hrs; as 
compared to 7-8 hrs; (Chaput et al. 2013b). 
All of the sleep variables (latency, fragmentation, loud coughing/soring, 
medication, daytime sleepiness and sleep quality) were dichotomised based upon the 
presence or absence of the sleep-related condition – which for all of the sleep 
characteristics except sleep quality, resulted in dichotomisation close to the median 
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value with: 0=“Not during the past month” and 1= “At some time during the past 
month” (comprising: “Less than once a week”, “Once or twice a week”, “Three or more 
times a week”, or “More than once most nights”). While the sleep quality variable was 
dichotomised to: 0=“very good”; and 1= “fairly good”, “fairly bad”, or “very bad”. 
3.4.2 The classification of ‘Metabolic Syndrome’ (MetS) 
Although, as described in the introductory Chapter to the present thesis (see: 
Chapter 1: Introduction), a wide range of definitions and classifications of MetS have 
been proposed, most of these generally agree that the syndrome should be 
recognised as present if three or more of five key components are present, namely: 
obesity (particularly central obesity); insulin resistance or symptoms of poor glucose 
regulation; high blood pressure; and dyslipidaemia (comprising elevated TG and/or low 
HDL levels). While some definitions place greater emphasis on (central) obesity or 
insulin resistance as pre-requisites for MetS (i.e. requiring one or other to be present 
together with two or more of the remainder), other definitions define MetS simply as 
the presence of any 3 of the 5 possible components. 
 Of the various definitions for MetS, the NCPI-ATP III (Executive Summary of 
The Third Report of The National Cholesterol Education Program (NCEP) Expert 
Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults 
(Adult Treatment Panel III)  2001) is considered to be one of the most useful, simply 
because it is known to be the easiest to apply in both epidemiological and clinical 
settings. Importantly, it does not base its definition on any preconceived concept 
regarding the cause of MetS (i.e. whether this be central obesity or insulin resistance), 
and as a result does not require any particular component of MetS to be present; 
instead being defined simply as the presence of any three components of MetS (Eckel, 
Grundy and Zimmet 2005; Huang 2009). It is for this reason that the NCPI-ATP III was 
chosen as the formal classification of MetS examined in the present thesis. 
Within its classificatory framework, the NCPI-ATP III defines each component 
of MetS as follows: 
1. Elevated waist circumference ≥ 102 cm for men and ≥ 88 cm for women 
2. Poor glucose regulation involving either fasting glucose ≥ 110 mg/dl, 
and/or antidiabetic medication 
3. High blood pressure involving either systolic ≥ 130 and/or diastolic ≥ 85 
mm Hg, and/or antihypertensive medication  
4. Dyslipidaemia involving raised blood triglycerides ≥ 150 mg/dl and/or 
relevant medication 
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5. Dyslipidaemia involving reduced HDL-C < 40 mg/dl in males and < 50 
mg/dl in females and/or relevant medication   
Unfortunately, because the UKHLS provided no data on dyslipidaemia 
(whether by self-report or from fasting blood samples), the data available for use in the 
present thesis required the use of a modification of the NCPI-ATP III classification, in 
which MetS was simply defined as the presence of three risk factors: elevated waist 
circumference , high blood pressure and diabetes. Furthermore, since the present 
thesis was interested in exploring the potential utility of self-reported MetS components 
(and assessing the validity of these by comparing them to direct measures thereof), a 
further modification applied in the present thesis involved the use of cut-offs for all 
three components (elevated waist circumference, high blood pressure and diabetes) 
based on those proposed by the UK NHS (through the UK’s National Institute for 
Clinical Excellence; NICE – the body charged with establishing clinical guidelines and 
standards for use within the NHS, and therefore the thresholds of each of these 
components that would lead to formal clinical diagnoses as reported by UKHLS 
participants who had received any such diagnosis).  
For this reason, the present thesis defined each component of MetS as follow: 
Table 3.2 Definition of MetS using data available within current UKHLS datasets  
Risk factor  Defining level  
Waist 
circumference  
 
Men  ≥ 102cm 
Women  ≥ 88cm 
Blood pressure  ≥140/90 mmHg and/or prescribed antihypertensive medication 
Diabetes  HbA1c ≥ 48 mmol/mol and/or prescribed antidiabetic medication 
Based on these cut-offs of these three components of MetS, two separate 
variables could be generated from UKHLS data generated by questionnaire (i.e. Wave 
1 and Wave 2) or from direct measures (i.e. recorded in the Wave 2 NHA): self-
reported MetS and directly measured MetS. 
3.4.3 Directly measured MetS components and classification 
3.4.3.1 Directly measured waist circumference 
All NHA participants were eligible to receive direct measurements of their waist 
circumference unless they were pregnant, in a wheelchair, or had a 
colostomy/ileostomy (McFall 2013). Waist circumference was measured twice at the 
midpoint between the lower rib and the top of the hips using a tape measure with an 
insertion buckle at one end. Measurements were recorded to the nearest millimetre. 
An elevated waist circumference variable was generated and defined as: WC ≥ 102cm 
for males, WC ≥ 88cm for females. 
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3.4.3.2 Directly measured high blood pressure  
Blood pressure measurements were made using a validated portable blood 
pressure monitor (Omron HEM 907). The NHA research nurse took three 
measurements from the right arm with participants sitting in a comfortable position with 
their feet on a flat floor, and having been able to relax for 5 minutes before the first 
reading was taken. The research nurse recorded whether participants had eaten, 
drunk alcohol, smoked or been physically active during 30 minutes preceding these 
measurements (McFall 2013).  
The nurses were also tasked with checking and recording any prescribed 
antihypertensive medications used by each participant – a classification based on 
prescriptions for any drugs prescribed for the treatment of hypertension.  
In line with NICE hypertension guidelines (NICE 2011a), the lower reading of the 
last two systolic and diastolic measurements for each participant was used to classify 
high blood pressure if these reached or exceeded a BP of ≥140/90 mmHg (i.e. the 
level recommended for the diagnosis of stage 1 hypertension); and this, together with 
any prescribed antihypertensive medication formed the basis for classifying high blood 
pressure amongst UKHLS participants in the present thesis 
3.4.3.3 Directly measured indicators of diabetes 
Among the biomarkers that were subsequently analysed within the non-fasting 
blood samples collected during the NHA was glycated haemoglobin (HbA1c). This 
offers a measure of the proportion of haemoglobin that are bound to glucose, and as 
such can be used as a marker for undiagnosed or poorly managed diabetes during the 
8-12 weeks preceding the blood sample.  
As for antihypertensive medication, the NHA research nurse recorded whether 
each participant had been prescribed antidiabetic medication – a classification based 
on prescriptions for insulin, metformin, or any other drugs prescribed for the treatment 
of diabetes.  
In line with NICE guidelines (NICE 2011b) for the diagnosis of diabetes using 
HbA1c, a cut-off point of HbA1c ≥ 48 mmol/mol was used to classify the presence of 
diabetes; and this, together with any prescribed antidiabetic medication formed the 
basis for classifying diabetes amongst UKHLS participants in the present thesis.  
3.4.3.4 Directly measured MetS classification  
As described earlier, directly measured MetS was classified as the presence of all 
three directly measured risk factors: elevated waist circumference; high blood 
pressure; and diabetes. 
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3.4.4 Self-reported MetS components and classification 
3.4.4.1 Self-reported waist circumference  
As mentioned previously, survey participants were not asked to report their 
waist circumference for the Wave 1 or Wave 2 questionnaires. Instead, participants 
were only asked to report their body weight and height with the following question in 
Wave 1 alone: “I would like to ask you about your height and weight, how tall are you 
without shoes? And what is your current weight without clothes?”. Height could be 
reported in either feet and inches or metres and centimetres, the former being 
converted to metric units in a unified, derived variable. Similarly weight could be 
reported in either stones and pounds or kilograms, and reports given in imperial units 
were again metricised and used to generate a unified derived variable in kilogrammes.  
Using these self-reported data on weight and height, the present study sought 
to estimate ‘self-reported’ measures of waist circumference. This involved using NHA-
derived direct measures of waist circumference, weight and height to generate linear 
regression models (stratified for age and sex) that fitted waist circumference as a 
function of body mass index (BMI: weight in kg  [height in metres]2). This approach 
had previously been used and validated by (Bozeman et al. 2012), who recommended 
its use in the absence of direct waist circumference measurements.  
As mentioned earlier (see also Figure 3.2, above), direct measurements were 
available in the Wave 2 NHA dataset, which recruited n=15,646 participants. However, 
after excluding missing observations for: waist circumference; weight and height 
(hence BMI); sex; age; and data from participants on whom there were problems with 
waist circumference measurement, the sample available for analysis comprised 
n=14,669 participants. On these data the following equation was used to summarise 
the relationship between waist circumference BMI and age, as:  
Estimated waist circumference= a + b1 BMI + b2 Age + e  
To assess the fit of this model, residuals were plotted against the fitted values (see 
Figure 3.3) and this revealed a well-fitted model, since the residuals showed no 
pattern and were randomly scattered around the horizontal line. 
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Figure 3.3 Residual plot to assess the goodness fit of estimated waist circumference. 
 
Six additional models were also developed (three for males, one each for those aged 
<40yrs, 40-<60yrs and ≥60yrs; and three for females, one each for those aged <40yrs, 
40-<60yrs and ≥60yrs). The results obtained for each of these models have been 
presented in Table 3.3 
Table 3.3 Coefficients (intercepts/constants and slopes) generated from regressions 
of (directly measured) waist circumference on (directly measured) BMI and age for 
n=14,669 participants in the UKHLS NHA, conducted separately for male and female 
UKHLS participants.  
 Males Females  
 Coefficient  95% CI Coefficient 95% CI 
 Age <40yrs 
Constant  23.1 21.6, 24.5 26.7 25.3, 28.1 
BMI 2.40 2.34, 2.45 1.99 1.95, 2.03 
age 0.204 0.169, 0.239 0.160 0.125, 0.196 
 Age 40-<60yrs 
Constant  26.4 24.1, 28.7 26.5 24.4, 28.6 
BMI 2.35 2.30, 2.40 2.06 2.02, 2.09 
age 0.144 0.106, 0.183 0.109 0.071, 0.147 
 Age ≥60yrs 
Constant  29.1 26.2, 31.9 31.4 28.4, 34.3 
BMI 2.41 2.36, 2.46 2.05 2.00, 2.10 
age 0.0765 0.044, 0.109 0.0430 0.008, 0.079 
 
To estimate ‘self-reports’ of waist circumference, self-reported data on weight and 
height from Wave 1 of the UKHLS were first used to generated self-reported BMI, and 
then waist circumference, using the age- and sex- specific coefficients summarised in 
Table 3.3. Finally, these estimated ‘self-reports’ of waist circumference were used to 
generate a derived variable denoting ‘elevated (self-reported) waist circumference’ 
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defined as WC ≥ 102cm for males and WC ≥ 88cm for females (based on the cut-off 
values proposed by NICE). 
To assess the level of error involved in the estimation of waist circumference, the 
same equations were applied to predict an estimated (direct measure of) waist 
circumference using the direct measures of BMI collected in Wave 2 NHA (i.e. the data 
that had been used to generate the coefficients summarised in Table 3.3). These 
estimates of (directly measured) waist circumference were then compared to the 
original direct measures of waist circumference, after classifying both the estimates 
and the original measurements as ‘elevated’ or ‘not elevated’ using the same NICE-
proposed cut-offs (i.e. WC ≥ 102cm for males, WC ≥ 88cm for females). 
A comparison of these two classifications of elevated waist circumference (one 
estimated, the other ‘original’) found that the estimated values had: a sensitivity of 
82.5%; a specificity of 89.0%; a positive predictive value of 85.6%; a negative 
predictive value of 86.5%; overall agreement of 86.10%; and a Cohen’s kappa value of 
0.72. These comparisons suggest that (notwithstanding that these were derived from 
the same direct measures of BMI and age) the estimated ‘direct measures’ of elevated 
waist circumference offered good evidence of validity for directly measured ‘elevated 
waist circumference’ – evidence that the estimation approach used was broadly robust 
(though not, necessarily, that this would be similarly robust for estimates based on 
self-reported BMI; as will be discussed later in the present thesis). 
3.4.4.2 Self-reported high blood pressure 
Items generating data on self-reported clinical diagnoses of high blood pressure were 
available in both the Wave 1 and Wave 2 questionnaire. In Wave 1 (through the CAPI) 
participants were asked “Has a doctor or other health professional ever told you that 
you have any of the conditions listed on this card?” for which the sixteenth condition 
listed was “High blood pressure”. A subsequent question then asked: “Do you still 
have high blood pressure?”. In Wave 2 participants were asked “Since [the date on 
which the Wave 1 main adult questionnaire was completed] has a doctor or other 
health professional newly diagnosed you as having any of the following conditions?” 
(one of which was, again, ‘high blood pressure’). A subsequent question then asked 
“do you still have [newly diagnosed health condition]”.   
Subsequently, for the analyses conducted using Wave 2 data, self-reports of clinical 
diagnoses of high blood pressure was identified as ‘still’ at Wave 1 or ‘still’ at Wave 2, 
while for the analyses conducted using Wave 1 data, self-reported measure of high 
blood was identified as ‘still’ at Wave 1 alone.  
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3.4.4.3 Self-reported diabetes 
 Items generating self-reported clinical diagnosis of diabetes were also available 
in both the Wave 1 and Wave 2 questionnaires. In the Wave 1 questionnaires 
participants were asked “Has a doctor or other health professional ever told you that 
you have any of the conditions listed on this card?” for which the fourteenth condition 
listed was “Diabetes”. A subsequent questions then asked: “Do you still have 
diabetes?” and “What age were you when you were first told you had diabetes?”. In 
Wave 2 participants were asked “Since [the date on which the Wave 1 main adult 
questionnaire was completed] has a doctor or other health professional newly 
diagnosed you as having any of the following conditions?” (for which, again, one of the 
conditions listed was ‘diabetes’). A subsequent question then asked “do you still have 
[newly diagnosed health condition]”.  
Subsequently, for the analyses conducted using Wave 2 data, self-reported diabetes 
was identified as ‘still’ at Wave 1 (and diagnosed at ≥ 20yrs to ensure that this variable 
was more likely to capture Type 2 [i.e. late onset] diabetes rather than Type 1 [i.e. 
early onset] diabetes) or ‘still’ at Wave 2 alone. On the other hand, for the analyses 
conducted using Wave 1 data, self-reported diabetes was identified as ‘still’ at Wave 1 
alone (and a diagnosis made at age ≥20yrs). 
3.4.4.4 Self-reported MetS classification  
Self-reported MetS classification was identified as the presence of all three 
self-reported risk factors together:  elevated estimated ‘self-reported’ waist 
circumference (WC ≥ 102cm for males, WC ≥ 88cm for females); self-reported clinical 
diagnosis of high blood pressure; and self-reported clinical diagnosis of diabetes. 
3.4.5 Covariates 
Based on the narrative review that had been undertaken during the initiation of the 
present thesis (Appendix 6.1) and on the systematic review conducted in the previous 
Chapter (Chapter 2: A Systematic review of previous studies examining the 
relationship between sleep and MetS), a subset of relevant covariates were selected 
for consideration as potential confounders, possible mediators and/or competing 
exposures. However, because the secondary data source chosen for the present 
thesis’ analyses restricted the specific variables that had been measured/were 
available to those collected by the UKHLS, the covariates chosen were in large part 
determined by what the UKHLS datasets could provide. In another words, while there 
was no alteration or modification to the overarching research questions posed by the 
present thesis, the analyses conducted needed to be adaptable to the availability of 
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variables within the UKHLS datasets (and these were therefore somewhat constrained 
by what variables had already been collected, and in what form these variables had 
been measured). 
Among the variables considered to be likely to be associated with both sleep and 
MetS (and which had been measured/were available within the UKHLS dataset) were 
a range of sociodemographic, health, lifestyle and behavioural characteristics collected 
by the questionnaires used in either Wave 1 and/or Wave 2. These were: 
 Sex (male; female) 
 Age (>30 years old; 30-39 years; 40-49 years; 50-59 years; 60 years or 
older) – derived from ‘age group’ variable: 13 categories 
 Marital/cohabitation status (single; cohabiting; separated and divorced; 
widowed) – ‘derived from legal marital status’ variable: 10 categories  
 Educational attainment, presented as the current highest qualification 
achieved (higher degree; other degree; A-level; GCSE; other qualification; 
no qualifications). 
 Occupation (management and professional; intermediate; small employers 
and own account; lower supervisory and technical; semi-routine; routine 
and never worked long time; unemployed; retired; student) – derived from 
‘current job defined’ based on the five category version of the National 
Statistics Socio-economic Classification (NS-SEC; (Chandola and 
Jenkinson 2000) . 
 Parenthood (not responsible for any child; responsible for one or more 
child) – derived from ‘number of children aged under 18 responsible for’: 8 
categories. 
 Household structure (empty nesters; dwelling-sharing childless adults; 
partnered with child; partnered with children; large family majority with 
overcrowding; single parent household; extended family, majority with 
overcrowding) – after (Fowler et al. 2014). 
 Physical health (a continuous scale with a range of 0 “low functioning” to 
100 “high functioning” based on the SF-12; (Gandek et al. 1998). 
 Mental health (a continuous scale with a range of 0 “low functioning” to 100 
“high functioning” based on the SF-12; (Gandek et al. 1998). 
 Number of servings of fruit/vegetables per day (1; 2; 3; 4; 5; 6; and more 
than 6). Derived from ‘number of servings of fruit/vegetables per day’: 17 
categories.  
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 Sport activity (0; 1-2; 3-4; 5-6; ≥7) – derived from ‘sport activity ranking 
scale’ from 0 to 10, with 0 being 'doing no sport at all' and 10 being 'very 
active'. 
 Smoking (never smoked; quit smoking; smokes less than 10 cigarettes per 
day; smokes 10-20 cigarette per day; smoke more than 20 cigarette per 
day) – derived from ‘usual number of cigarettes smoked per day’, ‘ever 
smoked cigarettes’ and ‘current smoking’ variables.   
 Alcohol consumption (almost every day; five or six days a week; three or 
four days a week; once or twice a week; once or twice a month; once every 
couple of months; once or twice a year; not at all in the last 12 months) – 
derived from ‘alcohol drinking frequency during the last 12 months’: 9 
categories. 
 Time difference in days between Wave 2 NHA interview and Wave 2 main 
survey; calculated by subtracting Wave 2 NHA date from Wave 2 main 
survey interview date.  
 Time difference in days between Wave 2 NHA and Wave 1 main survey; 
calculated by subtracting Wave 2 nurse health interview date from Wave 1 
main survey interview date. 
 Some activities that were believed to affect the NHA blood pressure 
measurements including: eating, smoking, drinking alcohol, and doing 
vigorous exercise in the 30 minutes preceding blood pressure 
measurement (not mentioned, mentioned)  
 Units used to self-report weight (stones, kilograms) 
 Units used to self-report height (feet and inches, meters and centimetres) 
 Participant-based assessment of the accuracy of self-reported weight (fairly 
sure, estimate) 
 Participant-reported time when last weighed (a scale ranging from ‘last 
week’ to ‘more than five years ago’). 
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3.5 Data transformation  
For analytical reasons such as improving results interpretation; easier 
comparison and/or discussion, some variables required transformation as recoded; or 
derived new variables. Examples of how some of the variables were transformed in 
this fashion are listed below: 
1. Merging categories 
Some categorical variables were recoded into fewer categories by combining 
some categories. An example of this is the marital/cohabitation status variable 
where the original responses were reduced to fewer categories by combining 
some categories (Table 3.4). 
Table 3.4 An example for recoded categorical variable into fewer categories by 
combinding some categories. 
Original variable   Re-categorised variable  
De facto marital status Frequency  Cohabiting status  Frequency  
Refusal 3 Missing 16 
Don't know 13   
Single and never married/in civil partner 11,917 Single 11,917 
Married 25,726 Cohabit 31,485 
In a registered same-sex civil partners 90 Separated or 
Divorced   
4,291 
Separated but legally married 1,148 Widowed  2,988 
Divorced 3,132   
Widowed 2,984   
Separated from civil partner 11   
A former civil partner 1   
A surviving civil partner 4   
Living as couple 5,668   
Total 50,697 Total 50,697 
 
2. Replace values with different values from another variable 
This method was applied to reduce invalid responses primarily when one of the 
categories within a given variable indicated that this was ‘inapplicable’ (either 
because the question had been asked in previous wave of the UKHLS; or 
because the answer had already been provided by another, preceding question). 
The true values for these ‘inapplicable’ observations were traced and replaced 
using either the earlier variable from the same UKHLS Wave or a similar variable 
collected at a preceding Wave (in the present thesis this was only feasible for 
107 
 
some ‘inapplicable’ data in the NHA and/or Wave 2 datasets, for which 
preceding datasets were available).  
One example of this is the ‘occupation’ variable, where ‘inapplicable’ data among 
the Five Class NS-SEC responses were replaced with another categories from 
other variables, as summarised in Table 3.5 (below) 
Table 3.5 An example for recoded categorical variable by replacing values with 
different values from another categorical variable 
Wave 1 Current job: Five Class 
NS-SEC 
Wave 1 current economic 
activity  
New employment variable  
Category  Frequency  Category  Frequency  
Missing 220 
 
 
 
 
 
Unemployed or family care 
or unpaid family business 
or doing something else  
Missing  
592 
Inapplicable 
 
 
22,517 
Management & 
professional  11,072 
Intermediate  
3,697 
Small employers & 
own account 2,694 
Management and 
professional 
11,270 
Retired  Lower supervisory & 
technical  2,073 
Intermediate 3,838 
Full time student or 
government training 
scheme  
Semi-routine, routine 
& never worked or 
long term 
unemployed   
9,196 
Small employers 
and own account 
2,774 
Unemployed  
7,399 
Lower supervisory 
and technical 
2,123 
Long-time sick or disabled  Retired  
10,108 
Semi-routine, 
routine and never 
worked long time 
7,955 
Student  
3,866 
Total  50,697   50,697 
 
3. Categorising continuous variables  
Some continuous variables needed to be categorised to ensure these were more 
meaningful (i.e. easier to apply and interpret), or to facilitate comparison 
between ostensibly distinct groups. For example, as we have already seen, 
sleep duration was categorised into three categories from a continuous variable 
(sleep duration in hours and minutes) in order to identify and compare 
participants reporting short sleep, mid-length sleep and long sleep duration (see 
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Table 3.6, below) 
 
Table 3.6 An example for recoded continuous variable to categorical variable 
Wave 1 sleep duration as 
continuous hours of sleep  
Wave 1 recoded sleep 
duration into categories  
Freq. 
Sleep duration in hours as a 
continuous scale  
Missing  12,556 
<6 hrs  4,659 
≥6-8 hrs 28,538 
> 8 hrs  4,944 
Total 50,697 
 
4. Dichotomizing categorical variables  
This method was applied to generate binary variables from categorical variables 
with more than two categories (so-called polytomous categorical variables). An 
example of this involved generating a binary variable for ‘number of children 
adult is responsible for’, where 0 reflected a participant who was responsible for 
no children, and 1 where the adult was responsible for one or more children (see 
Table 3.7, below). 
Table 3.7 An example for recoded categorical variable to dichotomous variable 
Wave 2 number of children aged 
under18 an adult responsible for 
New binary variable  
Number of children  Freq. Number of children  Frequency  
Proxy  3,882 Proxy   3,882 
0 40,622 0  (no child)  40,622 
1 4,449 
2 3,856 1 (one or more)  10,093 
3 1,320 
4 348   
5 88   
6 20   
7 8   
8 2   
9 2   
Total 54,597  54,597 
 
5. Recoding continuous variables to a string  
In UKHLS datasets dates were coded with separate variables for the interview 
day, the month of interview and the year of interview. It was therefore necessary 
to transform these into a single (string) variable in order to calculate the 
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‘difference in time interval’ for NHA, Wave 1 and Wave 2 data collection events. 
The procedure used in this instance is summarised in Table 3.8 (below) 
Table 3.8 An example for recoded date continuous variables to a string variable 
Health assessment or Wave 2 or Wave 3 
interview date 
New string variable  
Date interview with respondent was 
started as date of day   
A string of the date as 
“DMY” 
D: Day 
M: Month 
Y: Year 
Date interview with respondent was 
started as month    
Date interview with respondent was 
started as year  
3.6 Identifying study samples 
Each Wave of the UKHLS used self-administered and/or interviewer-administered 
questionnaires to collect a range of self-reported variables (sociodemographic, 
socioeconomic and health) from study participants and their households. In addition, 
the second Wave of the study used a questionnaire containing additional items on 
contemporaneous diet and lifestyle factors, and was followed by a dedicated “Nurse 
Health Assessment” (NHA) during which direct anthropometric, and physiological 
measurements and blood analyses (together with a list of all prescribed and over-the-
counter medication taken) were recorded for a subsample of n=13,258 UKHLS 
participants. Given that the aims of the present study included comparing self-reports 
and direct measures of each component of MetS, and all three components combined 
(the formal classification of MetS adopted in the present study); and examining both 
objective (directly measured) and subjective (self-reported) assessments of the three 
key components of MetS (central obesity, diabetes and hypertension), the samples of 
UKHLS participants examined in the present thesis comprised those with data on self-
reported sleep and either: 
Sample 1: both self-reported and directly measured data on each MetS 
component (for which data should have been available for most 
of those participants included in the UKHLS NHA); or  
Sample 2: only self-reported data on MetS components (for which data 
should have been available for all UKHLS participants).  
The first of these samples (for which data on both sources of each component of MetS 
were potentially available) was constrained by the smaller number of UKHLS 
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participants selected for inclusion in the NHA; while the second of these samples (for 
which only data on self-reported components of MetS were required) potentially 
included all participants in Wave 1 of the UKHLS.   
Since data from both self-reported and directly measured components of MetS 
were required for the analyses conducted in the present thesis, and since the self-
reported sleep data necessary for inclusion in these analyses were available only for 
participants included at Wave 1 of the UKHLS (see section 3.3), both of the samples 
examined drew on participants providing data in either both Wave 2 and its associated 
NHA (i.e. the smaller first sample) or Wave 1 alone (i.e. the larger second sample). As 
such, the two samples examined can be summarised as follows:  
Sample 1:  Only those adult participants who were eligible for inclusion in the Wave 
2 NHA who had complete data on: all seven self-reported sleep 
characteristics (recorded in Wave 1); self-reported MetS components 
(waist circumference estimated from self-reported weight and height in 
Wave 1; and self-reported clinical diagnoses of diabetes and 
hypertension recorded in Wave 2); directly measured MetS components 
(recorded during the NHA); and relevant self-reported covariates 
(sociodemographic and lifestyle from data recorded in Wave 2).  
Sample 2:  Only those adult participants providing data in Wave 1 who had 
complete data on: all seven self-reported sleep characteristics; self-
reported MetS components; and relevant self-reported covariates 
(excluding data on lifestyle which were only recorded in the Wave 2 
questionnaires).  
 Figures 3.4 and 3.5 summarise how each of the two sample was generated from the 
data available from Wave 1, Wave 2 and the NHA of the UKHLS. The identification of 
suitable samples for analyses involved removing any adult participants who lacked 
complete data on sleep characteristics, self-reported and directly measured MetS 
components (and MetS itself), or on the sociodemographic, economic, health and 
lifestyle variables. Table 3.9 summarises the distribution of all self-reported sleep 
characteristics, self-reported and directly measured components of MetS (and MetS 
itself, classified as a combination of all three) and all potential confounders including 
diet and lifestyle variables among Sample 1. Table 3.10 summarises the distribution of 
all self-reported sleep characteristics, self-reported MetS, directly measured 
components of MetS (and MetS itself, classified as a combination of all three) and all 
potential confounders among Sample 2. 
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Figure 3.4 A summary of the steps taken to generate Sample 1 using UKHLS 
participants who had completed data on sleep characteristics, directly measured MetS 
components, self-reported measures of MetS and relevant covariates. 
 
  
9, 485 participants who participated in the 
UKHLS Wave1, Wave 2, NHA and blood 
samples  
4, 202 participants who had missing data on 
any sleep characteristics and/or directly 
measured MetS components and/or self-
reported MetS components and/or relevant 
self-reported covariates 
5, 283 participants who had complete data on: 
all seven self-reported sleep characteristics; 
directly measured MetS components, self-
reported MetS components; and relevant self-
reported covariates  
Yes 
No 
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Figure 3.5 A summary of the steps taken to generate Sample 2 using UKHLS 
participants who had completed data on self-reported measures of MetS and sleep 
 
 
50,994 participants who participated in the 
UKHLS Wave1 only  
21,558 participants who had missing data on 
any sleep characteristics and/or self-reported 
MetS components and/or relevant self-
reported covariates 
29,436 participants who had complete data on: 
all seven self-reported sleep characteristics, self-
reported MetS components; and relevant self-
reported covariates  
Yes 
No 
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Table 3.9 Variation in the distribution of: sociodemographic and lifestyle characteristics; self-reported and directly measured MetS components 
(and combinations thereof); and self-reported sleep characteristics, for all adult (≥16yrs) participated in Wave 1, Wave 2 and NHA of the UKHLS 
(n=9,485) and complete data on all self-reported and directly measured variables (Sample 1; n=5,283). All variables have been categorised with 
the distribution across categories summarised as frequencies (n) with percentages in parentheses (%). 
 
 
UKHLS Wave 1 
participants 
n=9,485 
Sample 1 
n=5,283 
Sociodemographic characteristics    
Covariates            n (%)        n (%) 
Sex 
Missing        0   (0.0)        0   (0.0) 
Male 4,171 (44.0) 2,387 (45.2) 
Female 5,314 (56.0) 2,896 (54.8) 
Age 
Missing         0   (0.0)        0   (0.0) 
Below 30 years old     943   (9.9)    543 (10.3) 
30-39 years old  1,310 (13.8)    794 (15.0) 
40-49 years old  1,921 (20.2) 1,154 (21.8) 
50-59 years old  1,838 (19.4) 1,107 (20.9) 
60years or older  3,473 (36.6) 1,685 (32.0) 
Marital/cohabitation status 
Missing         0   (0.0)        0   (0.0) 
Single 1,282 (13.5)    689 (13.0) 
Cohabited  6,502 (68.5) 3,841 (72.7) 
Separated and Divorced      997 (10.5)    507   (9.6) 
Widowed     704   (7.4)    246   (4.7) 
Educational attainment 
Missing          9   (0.1)        0   (0.0) 
Degree 2,123 (22.4) 1,332 (25.2) 
Other higher degree  1,290 (13.6)    777 (14.7) 
 
A-level  1,709 (18.0) 1,001 (19.0) 
 
GCSE 1,845 (19.4) 1,080 (20.4) 
 
Other qualification 1,104 (11.6)    538 (10.2) 
 
No qualification 1,405 (14.8)    555 (10.5) 
Employment status 
Missing       77   (0.8)        0   (0.0) 
Management and professional  2,205 (23.2) 1,485 (28.1) 
Intermediate     719   (7.6)    460   (8.7) 
Small employers and own account    514   (5.4)    284   (5.4) 
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Lower supervisory and technical     398   (4.2)    252   (4.8) 
Semi-routine, routine and never worked 
long-term  
1,608 (16.9) 
   850 (16.1) 
Unemployed     915   (9.6)    510   (9.6) 
Retired  2,815 (29.7) 1,284 (24.3) 
Student     234   (2.5)    158   (3.0) 
Household structure1 
Missing         4   (0.0)        0   (0.0) 
Empty nesters  5,680 (59.9) 3,139 (59.5) 
Dwelling sharing childless adults  1,137 (12.0)    550 (10.4) 
Partnered with child  1,241 (13.1)    779 (14.8) 
Partnered with children     593   (6.2)    355   (6.7) 
Large family, majority with overcrowding     347   (3.7)    208   (3.9) 
Single parent household     310   (3.3)    164   (3.1) 
Extended family, majority with 
overcrowding  
   173   (1.8)      84   (1.6) 
Daily number of servings of  
fruit and vegetables consumed 
Missing       70   (0.7)        0   (0.0) 
1    732   (7.7)    383   (7.2) 
2 2,013 (21.2) 1,079 (20.4) 
3 2,407 (25.4) 1,370 (25.9) 
4 1,823 (19.2) 1,054 (20.0) 
5 1,631 (17.2)    939 (17.8) 
6 and more     809   (8.5)    458   (8.7) 
Sport activity ranking 
Missing         4   (0.0)        0   (0.0) 
no sport at all 2,460 (25.9) 1,145 (21.7) 
1-2 1,724 (18.2)    979 (18.5) 
3-4 1,836 (19.4) 1,076 (20.4) 
5-6 1,820 (19.2) 1,069 (20.2) 
7-very active 1,641 (17.3) 1,014 (19.2) 
Smoking status 
Missing        7   (0.1)        0   (0.0) 
Never smoke 3,771 (39.8) 2,134 (40.4) 
Quit smoking 3,854 (40.6) 2,216 (41.9) 
Smoke less than 10 cig/day    556   (5.9)    305   (5.8) 
Smoke 10-20 cig/day 1,136 (12.0)    559 (10.6) 
Smoke more than 20 cig/day    161   (1.7)      69   (1.3) 
Alcohol consumption during the last 12 Missing    985 (10.4)        0   (0.0) 
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months almost every day    811   (8.5)    502   (9.5) 
five or six days a week    530   (5.6)    348   (6.6) 
three or four days a week 1,356 (14.3)    892 (16.9) 
once or twice a week 2,418 (25.5) 1,550 (29.3) 
once or twice a month 1,260 (13.3)    777 (14.7) 
once every couple of months    745   (7.8)    475   (9.0) 
once or twice a year    740   (7.8)    402   (7.6) 
not at all in the last 12 months    640   (6.7)    337   (6.4) 
Self-reported sleep characteristics     
Sleep duration  
(“…hours of actual sleep did you usually get 
at night during the last month?”) 
Missing 1,303 (13.7)        0   (0.0) 
<6 hrs  1,010 (10.6)    582 (11.0) 
6-8 hrs 6,318 (66.6) 4,159 (78.7) 
>8 hrs     854   (9.0)    542 (10.3) 
Sleep latency  Missing  1,640 (17.3)        0   (0.0) 
(“…trouble sleeping because you cannot  Not during the past month 3,156 (33.3) 2,210 (41.8) 
get to sleep within 30 minutes?”) During the past month  4,689 (49.4) 3,073 (58.2) 
Sleep fragmentation Missing  1,394 (14.7)        0   (0.0) 
(“…trouble sleeping because you wake up  Not during the past month 1,472 (15.5) 1,049 (19.9) 
in the middle of the night or early in the 
morning?”) 
During the past month 6,619 (69.8) 4,234 (80.2) 
Coughing/snoring loudly Missing  2,324 (24.5)        0   (0.0) 
(“…trouble sleeping because you cough or Not during the past month 4,367 (46.0) 3,291 (62.3) 
snore loudly?”) During the past month 2,794 (29.5) 1,992 (37.7) 
Sleep medication  Missing  1,054 (11.1)        0   (0.0) 
(“…taken medicine [prescribed or over-the- Not during the past month 7,029 (74.1) 4,475 (84.7) 
counter] to help you sleep?”) Presence of the event  1,402 (14.8)    808 (15.3) 
Daytime sleepiness Missing  1,067 (11.3)        0   (0.0) 
(“…had trouble staying awake while driving,  Not during the past month 7,184 (75.7) 4,531 (85.8) 
eating meals, or engaging in social 
activity?”) 
During the past month 1,234 (13.0)    752 (14.2) 
Sleep quality Missing     986 (10.4)        0   (0.0) 
(“During the past month how would you rate  Good quality  2,050 (21.6) 1,332 (25.2) 
your sleep quality overall?”) Poor quality  6,449 (68.0) 3,951 (74.8) 
Metabolic Syndrome (MetS)   
Self-reported MetS components Missing     516   (5.4)        0   (0.0) 
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Elevated waist circumference (EWC) 1,826 (19.2) 1,101 (20.8) 
 
High blood pressure (HBP)    672   (7.1)    350   (6.6) 
 
Diabetes (DM)    128   (1.3)      57   (1.1) 
 
EWC and HBP    645   (6.8)    322   (6.1) 
 
EWC and DM    172   (1.8)      73   (1.4) 
 
HBP and DM      90   (0.9)      34   (0.6) 
 
EWC and HBP and DM    181   (1.9)      93   (1.8) 
 
None  5,255 (55.4) 3,253 (61.6) 
Directly measured MetS components Missing  1,076 (10.9)        0   (0.0) 
Elevated waist circumference (EWC) 2,347 (23.7) 1,453 (27.5) 
High blood pressure (HBP)    704   (7.1)    386   (7.3) 
Diabetes (DM)      61   (0.6)      23   (0.4) 
EWC and HBP 1,064 (10.7)    606 (11.5) 
EWC and DM    163   (1.7)      93   (1.8) 
HBP and DM      84   (0.8)      39   (0.7) 
EWC and HBP and DM    269   (2.7)    132   (2.5) 
None  4,137 (41.8) 2,551 (48.3) 
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Table 3.10 Variation in the distribution of: sociodemographic; self-reported measured MetS components (and combinations thereof); and self-
reported sleep characteristics, for all adult (≥16yrs) participated in Wave 1 (n=50,994) and complete data on all self-reported measured variables 
(Sample 2; n=29,436). All variables have been categorised with the distribution across categories summarised as frequencies (n) with percentages 
in parentheses (%). 
 
 
UKHLS Wave 1 
participants 
n=50,994 
Sample 2 
n=29,436 
Sociodemographic characteristics    
Covariates            n (%)          n (%) 
Sex 
Missing          0          0   (0.0) 
Male 23,208 (45.5) 13,673 (46.5) 
Female 27,786 (54.5) 15,763 (53.5) 
Age 
Missing           0   (0.0)          0   (0.0) 
Below 30 years old  11,543 (22.6)   7,085 (24.1) 
30-39 years old    9,317 (18.3)   5,784 (19.6) 
40-49 years old    9,707 (19.0)   5,855 (20.0) 
50-59 years old    7,683 (15.1)   4,430 (15.0) 
60years or older  12,744 (25.0)   6,282 (21.3) 
Marital/cohabitation status 
Missing         17   (0.1)          0   (0.0) 
Single 12,009 (23.5)   6,972 (23.7) 
Cohabited  31,642 (62.0) 18,849 (64.0) 
Separated and Divorced     4,319   (8.5)   2,373   (8.1) 
Widowed    3,007   (5.9)   1,242   (4.2) 
Educational attainment 
Missing          92   (0.2)          0   (0.0) 
Degree 10,954 (21.5)   7,428 (25.2) 
Other higher degree    5,537 (10.9)   3,559 (12.1) 
 
A-level    9,591 (18.8)   6,011 (20.4) 
 
GCSE 10,526 (20.6)   6,201 (21.1) 
 
Other qualification   5,225 (10.2)   2,677   (9.1) 
 
No qualification   9,069 (17.8)   3,560 (12.1) 
Employment status 
Missing       593   (1.2)          0   (0.0) 
Management and professional  11,121 (21.8)   7,731 (26.3) 
Intermediate    3,713   (7.3)   2,451   (8.3) 
Small employers and own account   2,709   (5.3)   1,588   (5.4) 
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Lower supervisory and technical    2,080   (4.1)   1,345   (4.6) 
Semi-routine, routine and never worked 
long-term  
  9,257 (18.1)   5,050 (17.2) 
Unemployed    7,448 (14.6)   3,875 (13.2) 
Retired  10,171 (20.0)   4,994 (17.0) 
Student    3,902   (7.6)   2,402   (8.2) 
Household structure1 
Missing         65   (0.1)          0   (0.0) 
Empty nesters  24,710 (48.5) 14,302 (48.6) 
Dwelling sharing childless adults    8,240 (16.2)   4,530 (15.4) 
Partnered with child    7,465 (14.6)   4,745 (16.1) 
Partnered with children    3,175   (6.2)   1,998   (6.8) 
Large family, majority with overcrowding    3,369   (6.6)   1,709   (5.8) 
Single parent household    2,181   (4.3)   1,262   (4.3) 
Extended family, majority with 
overcrowding  
  1,789   (3.5)      890   (3.0) 
Self-reported sleep characteristics     
Sleep duration  
(“…hours of actual sleep did you usually get 
at night during the last month?”) 
Missing 12,620 (24.8)          0   (0.0) 
<6 hrs    4,716   (9.2)   3,223 (11.0) 
6-8 hrs 28,684 (56.2) 22,344 (75.9) 
>8 hrs    4,974   (9.8)   3,869 (13.1) 
Sleep latency  Missing  13,893 (27.2)          0   (0.0) 
(“…trouble sleeping because you cannot  Not during the past month 15,228 (29.9) 12,489 (42.4) 
get to sleep within 30 minutes?”) During the past month  21,873 (42.9) 16,947 (57.6) 
Sleep fragmentation Missing  13,230 (25.9)          0   (0.0) 
(“…trouble sleeping because you wake up  Not during the past month   8,538 (16.8)   7,272 (24.7) 
in the middle of the night or early in the 
morning?”) 
During the past month 29,226 (57.3) 22,164 (75.3) 
Coughing/snoring loudly Missing  16,997 (33.3)          0   (0.0) 
(“…trouble sleeping because you cough or Not during the past month 21,378 (41.9) 18,823 (64.0) 
snore loudly?”) During the past month 12,619 (24.8) 10,613 (36.0) 
Sleep medication  Missing  11,215 (22.0)          0   (0.0) 
(“…taken medicine [prescribed or over-the- Not during the past month 32,827 (64.4) 24,777 (84.2) 
counter] to help you sleep?”) Presence of the event    6,952 (13.6)   4,659 (15.8) 
Daytime sleepiness Missing  11,269 (22.1)          0   (0.0) 
(“…had trouble staying awake while driving,  Not during the past month 33,469 (65.6) 24,808 (84.3) 
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eating meals, or engaging in social 
activity?”) 
During the past month   6,256 (12.3)   4,628 (15.7) 
Sleep quality Missing  10,773 (21.1)          0   (0.0) 
(“During the past month how would you rate  Good quality    9,954 (19.5)   7,566 (25.7) 
your sleep quality overall?”) Poor quality  30,267 (59.4) 21,870 (74.3) 
Metabolic Syndrome (MetS)   
Self-reported MetS components Missing    6,763 (13.3)          0   (0.0) 
 
Elevated waist circumference (EWC)   8,489 (16.7)   5,611 (19.1) 
 
High blood pressure (HBP)   2,672   (5.2)   1,514   (5.1) 
 
Diabetes (DM)      574   (1.1)      325   (1.1) 
 
EWC and HBP   2,510   (4.9)   1,415   (4.8) 
 
EWC and DM      704   (1.4)      370   (1.3) 
 
HBP and DM      423   (0.8)      217   (0.7) 
 
EWC and HBP and DM      726   (1.4)      393   (1.3) 
 
None  28,133 (55.2) 19,591 (66.5) 
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3.7 Implications of missing data 
Missing data can be a substantial problem in epidemiological studies involving 
human participants. Despite researchers’ best efforts, missing data arise due to 
respondents refusing or forgetting/being unable to answer questions, or due to 
participants withdrawing/dropping out of the study. It may also occur where 
researchers forget to include questions/items at relevant points within the data 
collection tools, or simply due to errors in data collection, collation and/or transcription 
(Raghunathan 2004; Brick and Kalton 1996). 
Missing data are important because analysing datasets with missing 
observations can lead to a number of problems, ranging from reduced statistical power 
(and hence increased random error), to unrepresentative and biased estimates 
(Sterne et al. 2009; Brick and Kalton 1996). The variety and extent of the impact 
depends on a combination of the proportion of the sample affected, and the reason(s) 
why the data are missing. Missing data are typically categorised as being either 
missing completely at random (MCAR), missing at random (MAR), or missing not at 
random (MNAR); (Kim and Curry 1977). Data are MCAR when there is no systematic 
reason for the missingness such that the group with complete data are an unbiased 
subsample of the total dataset. For MCAR data, the only concern is therefore the loss 
of statistical power. Data are MAR when it is more likely to be missing in certain 
groups (e.g. men from more deprived socioeconomic circumstances) or for certain 
reasons which have been observed. MAR data may produce biased estimates unless 
the uneven pattern of missingness can be accounted for. Data are MNAR when it is 
more likely to be missing in certain groups or for certain reasons which have not been 
observed. MNAR data may produce biased estimates, for which there are currently no 
clear or effective solutions (Pigott 2001; Rubin 1976; Kim and Curry 1977).  
The nature of the missingness, i.e. whether the data are MCAR, MAR or 
MNAR, determines the most appropriate method of handling and analysing the data. 
Unfortunately, it can be difficult to distinguish between these types, and MNAR can 
never be formally excluded (since it depends on data which, by definition, have not 
been collected; (Pigott 2001). Several methods are available for handling missing 
data. By far the most common approach is list wise deletion, also known as complete 
case analysis, yet epidemiologists are increasingly using a more sophisticated 
approach known as multiple imputation (MI). 
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3.7.1 Complete case analysis 
A complete case analysis involves the exclusion of all participants where data 
are missing for any of the variables under examination (Saunders et al. 2006). The 
advantage of this method is its simplicity, since no further data manipulation is 
required before analysis. For that reason, most statistical packages, including Stata 
(the statistical software used in the present thesis) will conduct a complete case 
analysis for most procedures (such as logistic regression) by default, and without 
warning (Pigott 2001).  
Complete-case analyses are appropriate where only a few cases are missing 
and the sample size is sufficiently large, since there is likely to be a limited impact on 
the statistical power, and the remaining sample (i.e. after the exclusion the small 
proportion of participants with missing data) is likely to still be broadly representative of 
the population (Schafer and Graham 2002; Saunders et al. 2006; Kim and Curry 
1977). Conversely, when there are large amounts of missing data, complete-case 
analyses are prone to inferential bias (since the sample may not be representative of 
the population) and to increased random error (Pigott 2001).  
To resolve bias resulting from data that are MAR a more sophisticated 
approach is required, such as inverse-probability weighting or multiple imputation, the 
latter of which can also increase the statistical power. 
3.7.2 Multiple imputation  
Multiple imputation (MI) is a computational technique for analysing data with 
missing values, which aims to minimise bias and maximise precision. Like traditional, 
or 'single imputation', missing values for individual variables are predicted from other 
observed variables. These predicted (imputed) values are used to replace missing 
values and create a new imputed dataset. Direct analysis of these singly imputed data 
would produce less biased estimates than the incomplete data, but with greatly inflated 
precision; since there is no accounting for the uncertainty of the prediction. To account 
for this, multiple imputation repeats the process several times, with each imputed 
dataset taking different values from the distribution of predicted values, such that as a 
group they reflect the uncertainty of the estimate. Each imputed dataset is then 
analysed individually (although this process is typically automated) and the results 
pooled to incorporate the uncertainty between datasets (Wayman 2003; Sterne et al. 
2009) (Figure 3.6). 
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Incomplete 
dataset  
Multiple imputed 
dataset  
Analyses of each 
dataset  
Final results  
Imputation Analysis Pooling 
Figure 3.6 Diagrammatic representation of multiple imputation. Figure adapted from 
Missing Data and Multiple Imputation in Clinical Epidemiology Research (Pedersen et al. 
2017) 
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Multiple Imputation for Multivariate Data 
Multivariate missing data can occur when there are missing values in more 
than one variable in the dataset. In this scenario, the predictors required for the 
imputation themselves have missing values; predicting these may in turn be 
dependent on other variables with missing values. This is further complicated by the 
range of potential variable types, e.g. continuous, binary, nominal and ordinal (Van 
Buuren and Oudshoorn 1999; Van Buuren et al. 2006). In general, two approaches are 
employed to address the challenge of imputing multivariate missing data, these are 
joint modelling (JM) MI and fully conditional specification (FCS) MI - also known as MI 
by chained equations (MICE) (Kropko et al. 2014; Van Buuren 2007).  
In JM MI, a single predictive model is applied for all multivariate missing data. 
This typically includes a set of correlated complete predictor variables as well as the 
incomplete variables to be imputed; in this case the same model is applied for both 
imputation and analysis afterwards. One benefit of this approach is it is not too 
computationally demanding. However, this method has some drawbacks, especially in 
the presence of a mix of variable types (e.g. binary, categorical or continuous), where 
the results are prone to bias (Van Buuren 2007; Kropko et al. 2014).  
FCS on the other hand permits each variable to be predicted by its own model. The 
immediate benefit is that this allows the correct parameterisation of variables taking 
different forms, e.g. linear variables with linear regression, binary with logistic 
regression, nominal with multinomial logit regression, and ordinal with ordered logit 
regression (Van Buuren et al. 2006; Van Buuren 2007; Kropko et al. 2014). 
Computationally, however, this approach is particularly demanding - since it involves 
iteratively repeating each model (hence 'chained') with ever improving estimates until 
the values stabilise.   
MI model specification  
As with all predictive models, specification of the multiple imputation model is 
important to avoid inaccurately imputed values and biased results. This can be 
achieved through applying different principles.  
 To maximise the chances that the data are MAR nor MNAR, the imputation 
model should draw on as much observed information as possible. However, 
including more than 15 to 25 variables can create problems with 
multicollinearity (Van Buuren, Boshuizen and Knook 1999). 
 The imputation model should include all the variables that will be included in 
the analysis model, including the outcome variable (Moons et al. 2006). 
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 All variables that help with predicting missing values - including those that 
are not essential for the analysis (so-called 'auxiliary variables') should be 
included in the imputation model. (Hsu et al. 2006). 
 As with the analytical model, any relevant and necessary interaction terms 
and non-linear transformations should be included in the imputation model 
(White, Royston and Wood 2011). 
 Since the distribution of imputed estimates tend to be normally distributed, 
non-normal continuous variables should be transformed to an approximate 
normal distribution before the imputation. Prior to conducting the analyses, 
these imputed values can be easily transformed back to their original scale 
(White, Royston and Wood 2011). 
 
Unfortunately, the substantial number of UKHLS participants with missing data in 
Wave 1, 2 and the NHA, and the large number of variables under examination, made it 
impractical to perform multiple imputation with any of the data in the present thesis. It 
was hoped that a sensitivity analysis could at least be performed to compare the 
observed data to those generated using multiple imputation. MICE was therefore 
attempted on the models described in Chapter 4, but Stata IC 14.2 was unable to even 
store the required number of estimates for chaining to be performed. Even when 
selecting a reduced variable set, the computational demand was so high as to make 
the approach entirely impractical in the context of the UKHLS given current computing 
power. While the computational demand could have been reduced using a simpler 
multivariate imputation method, such as JM, the mix of variable types (binary, ordinal, 
and nominal) makes this equally unhelpful. It was therefore decided that all analyses 
would rely on a complete-case analysis. To evaluate the risk of bias, and the 
plausibility of the MCAR assumption, the present thesis focussed carefully on 
examining the differences between the included and excluded cases (as described in 
detail within the ‘results’ chapter, Chapter 4). Only modest signs of predictable 
missingness were generally identified, suggesting that any resultant bias should be 
small. No method can of course discount the possibility of MNAR, and the inability to 
perform a confirmatory MI analysis means that the specific effects estimates (and the 
generalisability of these to the UKHLS population, and to other populations) should be 
viewed with caution.  
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3.8 Statistical methods and data analysis 
3.8.1 Analysis approach 
As introduced earlier (see Chapter 1: Introduction), the analytical designs 
adopted in the present thesis were informed by causal path diagrams in the form of 
DAGs (see also Chapter 2 section 2.3.5). 
3.8.2 Statistical software  
All analyses were performed using Stata software. However, in order to deal 
with the large dataset, and to allow merging data from more than one Wave of the 
UKHLS, Stata/SE was used in preference to Stata/IC (the latter only capable of 
managing moderate-sized datasets). For this reason, a single-user Stata/SE (version 
13; StataCrop 2013) was purchased and installed on the University desktop C-drive 
(StataCrop 2013). 
3.8.3 Descriptive analyses  
In order to summarise the distribution of variables amongst each of the 
(incomplete- and complete-data) samples of UKHLS participants examined in the 
present thesis, descriptive analyses were extensively used. In these analyses, 
continuous variables were summarised by calculating the mean and standard 
deviation (SD); while categorical variables were summarised as frequencies with 
percentages in parentheses (%)  
3.8.4 Accuracy analysis  
Before relying on ‘self-reported’ data as plausible measures of each of the 
three MetS components (and for classifying MetS based thereon), the present thesis 
considered it important – and (given the availability of directly measured data from a 
substantial subsample of participants in the Wave 2 NHA) meaningful – to evaluate the 
extent to which these (self-reported) data might accurately reflect (and/or deviate from) 
the results obtained from direct measures thereof. For this reason, a range of different 
measures of accuracy were chosen for use in the analysis summarised in Chapter 4 
(Part I) (How reliable are self-reported indicators of elevated waist circumference, 
diabetes and high blood pressure and classifications of MetS based thereon?) to 
assess whether the two sources of MetS data (self-reports vs. directly measured) 
agree to a sufficient degree to warrant further use in the analyses summarised in the 
same Chapter. The measures of agreement used were: sensitivity; specificity; positive 
and negative predictive values (PPV and NPV); total agreement; and Cohen’s kappa 
statistic.  
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3.8.4.1 Sensitivity, Specificity, PPV and NPV 
Sensitivity is defined as the ability of a measurement to correctly identify true 
positives. In the present thesis it represents the proportion of those participants who 
tested positive for each component/classification of directly measured MetS that was 
correctly identified by self-reported measures thereof. Specificity is defined as the 
ability of a measurement to correctly identify true negatives. In the present thesis, this 
is the proportion of those participants who tested negative for each 
component/classification of directly measured MetS that was correctly identified by 
self-reported measures thereof (Peacock and Peacock 2011; Lalkhen and McCluskey 
2008).  
PPV is the proportion of those who actually have the condition (i.e. who are 
‘positive’ according to direct measures) among those whose self-reports are ‘positive’ 
(where ‘positive’ means the presence of a component/classification of MetS). Likewise, 
NPV is the proportion of those who actually do not have the condition (i.e. who are 
‘negative’ according to direct measures) among those whose self-reports are 
‘negative’ (where ‘negative’ means the absence of a component/classification of MetS; 
(Peacock and Peacock 2011; Lalkhen and McCluskey 2008). 
In general, a measure with high sensitivity will correctly identify individuals with 
the condition, and a test with high specificity will correctly identify individuals who do 
not have the condition. However, in practice, measures are unlikely to have both high 
sensitivity and high specificity (Peacock and Peacock 2011). Alternatively, a good test 
can have high sensitivity and low specificity or low sensitivity and high specificity, in 
this case all false positives (‘negative’ according to direct measures but ‘positive’ 
according to self-reports) will be identified as free of the condition (Lalkhen and 
McCluskey 2008). 
3.8.4.2 Overall agreement and kappa statistics 
The overall agreement is calculated as the proportion of cases for which different 
measures agree (in respect of both ‘present’ or ‘absent’ conditions) – the different 
measures in this instance being those based on self-reports of MetS components and 
a classification of MetS itself based on these; and those based on direct measures of 
MetS components and a classification of MetS itself based on these. However, the 
notion of ‘overall agreement’ tends to be misleading since it ignores the possibility of 
agreement simply by chance. It is therefore recommended that overall agreement and 
Cohen’s kappa are used together (Peacock and Peacock 2011), since Cohen’s kappa 
is an agreement-related parameter that assesses the extent of agreement between 
different measures that takes into account the likelihood of agreement simply by 
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chance (Peacock and Peacock 2011; Campbell, Machin and Walters 2010; Viera and 
Garrett 2005). Interpreting different values of Cohen’s kappa tends to be based on 
somewhat arbitrary criteria, such as that suggested by (Viera and Garrett 2005); for 
instance Kappa <0 is considered to indicate poor agreement which is less than chance 
agreement, 0.01-0.20 slight agreement; 0.21-0.40 fair agreement; 0.41-0.60 moderate 
agreement; 0.61-0.80 substantial agreement; and 0.81-0.99 almost perfect agreement.  
3.8.5 Regression analysis  
Regression involves fitting a model comprising a dependent variable (the 
‘outcome’) and the independent variable (‘exposure’), with the form of regression used 
(be this linear or logistic) dependent on the form in which the exposure and outcome 
variables are available/measured (Chap 2003). 
In the present study logistic regression analysis was applied in Chapter 4. 
Logistic regression models are applied when the dependent variable is categorical 
(and more usually, dichotomous) such as diseased Yes/No. It is used when the aim of 
the analyses is to assess whether an event or condition occurred or not. Logistic 
regression uses logarithmic transformation to allow a linear relationship to be predicted 
(using the maximum likelihood statistic). The regression coefficients produced can 
then be presented in the form of odds ratios (ORs) – the ratio of the odds that an 
event/condition occurred to the odds that it did not (Chap 2003) . The OR can vary 
from 0 to infinity, with a value of 1.00 being the null value (i.e. those ‘exposed’ having 
no different odds of the outcome to those who were not ‘exposed’). An OR of <1 can 
be interpreted as those with the ‘exposure’ being associated with a lower odds of 
having the outcome; while an OR>1 can be interpreted as those with the ‘exposure’ 
being associated with a higher odds of having the outcome.  
In the subsequent analysis/results chapter (i.e. Chapter 4), univariable logistic 
regression models were initially applied to generate unadjusted ORs with their 
respective 95% confidence intervals (CI). These were then followed by models 
including covariate adjustment sets (of variables considered potential confounders) to 
generate (confounder-) adjusted ORs, again with their respective 95%Cis (Chap 
2003). 
When the dependent (outcome) variable was polytomous (i.e. had more than two 
categories with no natural order amongst them), multinomial logistic regression was 
used. Multinomial logistic regression is an extension of logistic regression that breaks 
the regression into a series of binary regressions and compares each group to a base 
group comprising the referent category for the dependant variable (Dobson and 
Barnett 2008). Estimates generated using multinomial logistic regression can be 
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expressed as relative risk ratios (RRR) with their 95% (CI), where each category can 
be interpreted in a similar way to the OR with reference to the base category.  
3.9 Summary and conclusion 
The present Chapter successfully identified both a suitable dataset for assessing 
the relationship between sleep and MetS in a contemporary UK-based population (the 
UKHLS), and one that also offered suitable items for generating ‘self-reported’ 
measures of each of the MetS components (elevated waist circumference [estimated 
from self-reported height and weight), diabetes and high blood pressure) and a 
classification of MetS based thereon. This Chapter also successfully identified suitable 
items within the UKHLS datasets that offered ‘direct’ measures of each of the MetS 
components (elevated waist circumference, diabetes and high blood pressure) and a 
classification of MetS based thereon. Finally, this Chapter successfully identified two 
different samples with data on: self-reported sleep characteristics and either self-
reported and directly measured MetS (Sample 1); or only self-reported measures of 
MetS (Sample 2) suitable for analysis in the subsequent chapter (Chapter 4). The 
source, forma, manipulation and analysis of these data are also described in some 
detail, as is consideration of the potential impact of high rates of missingness for data 
pertaining to both Sample 1 and 2,  
Looking ahead to the next chapter (Chapter 4), this contains empirical analyses 
that aim to address many of the shortcomings identified in Chapter 2: (A Systematic 
review of previous studies examining the relationship between sleep and MetS), by 
analysing the association between MetS and no fewer than seven different sleep-
related characteristics, using self-reported and directly measured data from a single, 
large contemporary study – the UK Household Longitudinal Study (UKHLS); analyses 
in which covariate adjustment was carefully specified with reference to a DAG. As 
such, Chapter 4 provides the first study to examine the association between MetS and 
sleep in the UK. It is also the first such study to use causal path diagrams (in the form 
of directed acyclic graphs; DAGs) to identify which of the variables available within the 
UKHLS might be necessary to include as potential confounders in any covariate 
adjustment sets. However, before proceeding to these analyses, Chapter 4 (Part I) 
examines the potential utility of developing and using self-reported data to generate 
valid measures of MetS components (and a classification of MetS itself, based 
thereon) – data that are likely to extend the scope and statistical power of future 
studies examining the association between MetS and sleep to those datasets (like the 
UKHLS) where there are large(r) samples of participants with (self-reported) data on 
the symptoms/components of MetS. As such, Chapter 4 will establish whether the 
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limited evidence generated by the n=21 studies examined in the review (Chapter 2), 
might be extended to include the wealth of data available within existing cross-
sectional datasets containing relevant self-reported data on sleep and on variables 
offering valid indicators of MetS-related symptoms/components. 
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Chapter 4 Results 
The present Chapter draws on the analysis of previous cross-sectional studies 
exploring the association between MetS and sleep (Chapter 2: A systematic review of 
cross-sectional studies examining the association between MetS and sleep) in which 
none of these studies were found to have been conducted in the UK or to have used 
self-reports of any MetS components (nor classifications of MetS based on self-
reported MetS components). To this end, one of the aims of Chapter 3 (Data Sources 
and Analytical Methods) was to identify any suitable items in the UKHLS datasets 
which might offer a suitable basis for generating ‘self-reported’ measures of each of 
the MetS components (elevated waist circumference, diabetes and high blood 
pressure) for which direct measures were known to have been collected during the 
UKHLS Nurse Health Assessment (NHA). Chapter 3 identified two items in the main 
questionnaire used in Wave 1 (the UKHLS Wave in which self-reported sleep data 
were collected for the first time) capable of identifying participants who 
recalled/reported that they had been told “by a doctor or other health professional” that 
they had “high blood pressure” and/or “diabetes”. However, no comparable items on 
elevated waist circumference or dyslipidaemia were found, although items requesting 
self-reports of height and weight were available in the Wave 1 questionnaire (the only 
Wave to-date in which these items have been included), and by using these together 
with direct measures of height, weight and waist circumference, Chapter 3 generated 
suitable equations (stratified by age and sex) with which to estimate waist 
circumference from self-reports of height and weight, and therefore generate estimates 
of ‘self-reported’ waist circumference.  
In the present Chapter, Part 1 takes the development and evaluation of these self-
reports and direct measures of the three key components of MetS (and a classification 
of MetS itself based on the presence of all three) one step further, by comparing these 
different measures to assess the potential validity and utility of self-reported MetS. As 
such, under Part 2, the present Chapter draws on (and seeks to address) each of the 
methodological limitations of the previous studies examined in Chapter 2; and on the 
development (and evaluation) of self-reported indicators of three key MetS 
components. The findings generated from each of these preceding Chapters are then 
brought to bear on data collected from the UK Household Longitudinal Study (UKHLS), 
to generate a more comprehensive understanding of the evidence provided by 
previous cross-sectional analyses of the relationship between MetS and sleep.  
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Part I 
4.1 How reliable are self-reported indicators of elevated waist 
circumference, diabetes and high blood pressure and 
classifications of MetS based thereon? 
4.1.1 Aim and objectives 
 The key aim of this Part of the present Chapter was to evaluate the potential 
utility of self-reported indicators as measures of three key components of MetS 
(elevated waist circumference, high blood pressure and diabetes; and a classification 
of MetS based on a combination of all three of these components) by: 
using analyses of sensitivity, specificity, positive predictive value, negative predictive 
value, overall agreement and Cohen’s kappa () to evaluate the validity of self-
reported MetS components (and a classification of MetS based on a combination of all 
three components) as compared to direct measures thereof; 
As such, Part I of the present Chapter sought to address the following key question as 
established at the outset of this thesis:  
KQ3: “To what extent might self-reported items relevant to identifying MetS in large 
datasets offer sufficiently valid measures of MetS symptoms/components to provide a 
basis upon which to generate a ‘self-reported’ classification of MetS suitable for use in 
population-based analyses where direct measures of MetS components are not 
available/feasible?”   
4.1.2 Methods 
The present Chapter (Part I) drew on Sample 1 (see Chapter 3) of the UKHLS 
comprising participants who had data on both self-reported and directly measured 
MetS components; and data on all relevant sociodemographic, economic, health, 
lifestyle and sleep parameters – data that had been collected primarily by 
questionnaire, or during the Nurse Health Assessment, in Wave 2; while relying on 
self-reports of sleep and self-reports of height and weight (which, as described in 
Chapter 3:, were necessary to generate estimates of self-reported waist 
circumference) from items that had only been included in UKHLS questionnaires at 
Wave 1. 
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4.1.2.1 Self-reported indicators of MetS components the classification of 
MetS (itself) based thereon 
Four different self-reported indicators were identified within the UKHLS 
questionnaires for which Part I of the present Chapter was able to assess their 
agreement with direct measurements thereof:  
1. ‘Elevated waist circumference’ (EWC) based on estimates of reported waist 
circumference (WC) generated from self-reports of height and weight (as 
described in Chapter 3), with cut-offs for elevated WC based on those 
proposed by the NCPI-ATP III MetS definition: WC ≥ 102cm for males; WC ≥ 
88cm for females. 
2. Self-reports of clinically diagnosed high blood pressure, generated by items 
available in both Wave 1 and Wave 2 UKHLS questionnaires (“Has a doctor or 
other health professional ever told you that you have… high blood pressure” 
and “Do you still have high blood pressure?”).  
3. Self-reports of clinically diagnosed diabetes, generated by the same bank of 
questions as that for high blood pressure (see 2, above). 
4. A classification of ‘self-reported MetS’ based on a combination of all three (self-
reported) components of MetS (i.e. 1-3, above). 
More detail on why these indicators were considered a suitable basis for generating 
self-reported measures of these three key MetS components is provided in Chapter 3 
(section 3.4.4) 
4.1.2.2 Directly measured MetS components and the classification of 
MetS (itself) based thereon  
Four different sets of direct measurements were identified from those collected 
during the UKHLS NHA as suitable for use as ‘direct measures’ of the same three 
components of MetS, and the combination of all three. These measurements form the 
basis upon which the present Chapter examined the potential validity of self-reports 
described earlier (see 4.3.2, above): 
1. ‘Elevated waist circumference’ (EWC) based on direct measurements of waist 
circumference (WC) undertaken as part of the suite of anthropometric 
measurements collected during the NHA, with cut-offs for elevated WC again 
based on those proposed by the NCPI-ATP III MetS definition: WC ≥ 102cm for 
males, WC ≥ 88cm for females. 
2.  ‘High blood pressure’ (HBP) based on direct measurements of systolic and 
diastolic blood pressure, classified as ‘high’ BP according to the diagnostic cut-
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offs (BP ≥140/90 mmHg) recommended by the UK’s National Institute of 
Clinical Excellence (NICE; and thereby the same criteria as those underpinning 
the clinical diagnosis of high blood pressure in the UK NHS, on which valid 
self-reports of a clinical diagnosis of HBP would have been based) and/or the 
inclusion of antihypertensive medication in the records of all prescribed 
medication made during the NHA. 
3. Diabetes based on the analysis of non-fasting blood samples (collected during 
the NHA) for HbA1c, again using the cut-off recommended by the UK’s NICE 
(HbA1c ≥ 48 mmol/mol) as sufficient for the diagnosis of diabetes (and 
therefore one of the criteria underpinning the clinical diagnosis of diabetes in 
the UK NHS, on which valid self-reports of diabetes diagnosis would have been 
based), and/or the inclusion of antidiabetic medication in the records of all 
prescribed medication made during the NHA. 
4. MetS classification based on a combination of all three directly measured 
components of MetS (as described in 1-3, above). 
Once again, more details on the direct measurements involved in collecting data on 
each of these components of MetS is provided in Chapter 3 (section 3.4.3)  
4.1.3 Statistical analysis plan 
Preliminary descriptive analyses were performed to describe the distribution of 
self-reported and directly measured MetS components (and MetS itself) amongst 
Sample 1 (as described earlier) and to compare these distributions with those 
observed amongst UKHLS participants examined in Wave 1, Wave 2 and/or the NHA 
(i.e. all participants recruited by the UKHLS up to and including the NHA). These 
descriptive analyses were summarised as frequencies with percentages in 
parentheses (%), or as mean values with standard deviations in parentheses (SD).  
Further details of the descriptive analytical techniques chosen for use in the present 
Chapter have been provided in Chapter 3 (section 3.8.3).  
To assess the extent to which self-reported measures of the three key MetS 
components (and the classification of MetS itself based on a combination of these) 
differ from those directly measured, a range of different tests (many designed for use 
in diagnostic tests) were applied. These comprised tests of sensitivity, specificity, 
positive and negative predictive values (PPV and NPV), total agreement and tests 
using the Cohen’s kappa statistics. More details of these analyses have been 
described earlier in Chapter 3 (section 3.8.4). 
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4.1.4 Results 
4.1.4.1  The distribution of self-reported and directly measured MetS 
components amongst Sample 1 
Table 4.1 summarises the distribution of self-reported and directly measured 
MetS components (and MetS itself, classified as a combination of all three) of UKHLS 
participants in the NHA who also participated in the Wave 1 and Wave 2 main surveys 
(n=9,485), and those participants with complete data on self-reported and direct  
measures (n=5,283). 
Considering first the missingness rate among the main sample, it can be seen 
that this was low (1.2%-1.7%) for self-reports and direct measures that were only 
collected from participants selected for inclusion in the NHA, while it was slightly 
higher (8.3%) for direct measures that required blood analysis. These levels of 
missingness result in a substantial fall in the numbers of participants with complete 
data on all variables available for analysis (a reduction in the sample available of 
55.7%).  
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Table 4.1 The distribution of self-reported and directly measured MetS components 
(and MetS itself) amongst participated in Wave 1, Wave 2 and NHA of the UKHLS 
(n=9,485) and the complete dataset (n=5,283) 
 UKHLS NHA 
participants 
n=9,485 
Complete 
Sample 1 
n=5,283 
Components of MetS     
Elevated waist circumference    
SR- WC Missing           0   (0.0) 0   (0.0) 
Not elevated WC    6,647 (70.1) 3,694 (69.9) 
Elevated WC    2,838 (29.9) 1,589 (30.1) 
Directly measured WC Missing       115   (1.2) 0   (0.0) 
Not elevated WC    5,084 (53.6) 2,999 (56.8) 
Elevated WC   4,286 (45.2) 2,284 (43.2) 
High blood pressure    
SR-BP  Missing      157   (1.6) 0   (0.0) 
Not HBP   7,679 (81.0) 4,484 (84.9) 
HBP   1,649 (17.4) 799 (15.1) 
Directly measured BP Missing      152   (1.6) 0   (0.0) 
Not HBP   6,981 (73.6) 4,120 (78.0) 
HBP   2,352 (24.8) 1,163 (22.0) 
Diabetes     
SR-diabetes  Missing      124   (1.3) 0   (0.0) 
Not diabetic   8,761 (92.4) 5,026 (95.1) 
Diabetic       600   (6.3) 257   (4.9) 
Directly measured 
Hba1c 
Missing      800   (8.4) 0   (0.0) 
Not diabetic   8,086 (85.3) 4,996 (94.6) 
Diabetic       599   (6.3) 287   (5.4) 
MetS classification     
SR-MetS Missing       159   (1.7) 0   (0.0) 
Not MetS   9,145 (96.4) 5,190 (97.2) 
MetS      181   (1.9) 93   (1.8) 
Directly measured 
MetS  
Missing  1,030   (10.9) 0   (0.0) 
Not MetS   8,186 (86.3) 5,151 (97.5) 
MetS  269   (2.8) 132   (2.5) 
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4.1.4.2 Analyses of agreement between self-reported and directly 
measured MetS (and classifications of MetS based thereon) 
The sensitivity and specificity, positive predictive values (PPVs), negative 
predictive values (NPVs), agreement and Cohen’s kappa statistics were calculated to 
determine the extent that self-reported measures of MetS, and its individual 
components, were in agreement the directly observed measures. These are 
summarised in Table 4.2. Sensitivities ranged from 46.2% to 75.3% and while 
specificities ranged from 96.8% to 99.4%. The self-reported indicator of diabetes was 
more likely to identify direct diagnoses of diabetes (i.e. based on HbA1c and 
prescribed medication) than any of the other self-reported MetS component measures 
(or MetS itself). Of those who reported that a clinician had told them they had diabetes, 
75.3% were identified as having diabetes from their HbA1c levels and/or medication 
records. This was followed by elevated waist circumference; among those whose self-
reported height and weight indicated they had elevated waist circumference, 61.6% 
were so classified from direct measurement. In contrast, self-reported high blood 
pressure (HBP) displayed lower sensitivity for directly measured HBP; only 57.4% who 
reported a clinical diagnosis had a correspondingly high blood pressure measurement 
and/or were using antihypertensive medication. Similarly for the presence of MetS, 
classification using self-reported information displayed only 46.2% sensitivity 
compared with classification based on direct measures. 
In general, much higher levels of specificity were observed between self-
reported and directly measured MetS components (and the classification of MetS 
involving a combination of all three). This suggests that self-reported measures were 
more capable of identifying participants who were free of MetS and each of its 
components, although this conclusion is prone to the effects of prevalence on the 
measurement of both sensitivity and specificity (Brenner and Gefeller 1997). To 
provide an example, 99.2% of participants considered free of diabetes (based on 
direct measurements of HbA1c and medication), and 99.4% considered free of MetS 
(based on direct measurements) were correctly identified using self-reported 
measures.  
Meanwhile the positive predictive values (PPVs) calculated for these analyses 
(which, in this instance, indicates the proportion of participants with self-reported MetS 
components [or the classification of MetS based on these] that actually display this 
component/classification based on directly measured MetS components) found that 
only 65.6% classified as having (self-reported) MetS were classified as such based on 
directly measured MetS components. However the PPVs were calculated for each of 
the three separate MetS components were higher than this level. And, as for the 
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higher levels of specificity described earlier, the negative predictive values (NPVs) 
calculated were substantially higher than the PPVs (ranging from 76.2%-98.6%; see 
Table 4.2), with NPVs as high as 98.6% for self-reported vs. directly measured 
diabetes and MetS itself. 
Finally, the analyses and calculations summarised in Table 4.2 also indicate 
that the overall agreement (the proportion of cases for which self-reported and directly 
measured data agree, regardless of the presence or absence of MetS components or 
MetS itself) was reasonable, ranging from 79.92% to 98.05% with the highest level of 
overall agreement achieved for the classification of MetS itself. Nonetheless, the 
Cohen’s kappa statistics generated to evaluate levels of agreement between self-
reported and directly measured MetS components (and the classification of MetS itself 
based on these) suggested that the level of agreement ranged from 0.53 ‘moderate’ to 
0.78 ‘substantial’, with the highest values of Cohen’s kappa for diabetes, followed by 
high blood pressure, MetS and then elevated waist circumference. 
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Table 4.2 A summary of the sensitivity, specificity, PPV, NPV, overall agreement and Cohen’s kappa statistic () calculated for comparisons 
between MetS components (and the classification of MetS itself based on a combination of all three) derived from self-reported indicators or by 
direct measurement. 
SR-Measures  
Sensitivity 
% (95%CI) 
Specificity 
% (95%CI) 
PPV 
% (95%CI) 
NPV 
% (95%CI) 
Overall 
agreement 
%  
Kappa 
  
      
      
SR-EWC 61.6 (59.5,63.6) 93.9 (93.0,94.7) 88.5 (86.8,90.0) 76.2 (74.8,77.6) 79.92 0.57 
SR-HBP 57.4 (54.5,60.3) 96.8 (96.2, 97.3) 83.6 (80.9, 86.1) 89.0 (88.0,89.9) 88.15 0.61 
SR-DM 75.3 (69.8, 80.1) 99.2 (98.9, 99.4) 84.0 (79.0, 88.3) 98.6 (98.2, 98.9) 97.88 0.78 
SR-MetS   46.2 (37.5, 55.1) 99.4 (99.1, 99.6) 65.6 (55.0, 75.1) 98.6 (98.3, 98.9) 98.05 0.53 
SR-EWC: elevated waist circumference estimated from self-reports of height and weight (as described in Chapter 3: Data Sources and Analytical Methods); SR-HBP: self-reported 
clinical diagnoses of high blood pressure; SR-DM: self-reported clinical diagnoses of diabetes mellitus; and SR-MetS: the metabolic syndrome classification based on the presence 
of SR-EWC, SRHBP and SR-DM combined
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4.1.5 Discussion 
Limitations 
The findings presented in Part I of the present Chapter are prone to three 
substantive limitations, namely: the absence of data on waist circumference generated 
directly by self-report (rather than by estimation); the substantial time period(s) 
between the measurement of the self-reported and direct measures of MetS 
components (and classification of MetS itself based thereon) examined; and the 
inherent risk of ‘false positives’ and ‘false negatives’ in both self-reports and direct 
measures of MetS components (and the classification of MetS based on these). In the 
absence of an item (or items) on waist circumference in any of the UKHLS 
questionnaires providing data for the present Chapter, self-reported waist 
circumference had to be estimated from the only two self-reported anthropometric 
characteristics available: height and weight, items on which were only included in the 
Wave 1 questionnaire. As described in Chapter 3 the approach adopted to estimate 
‘self-reports’ of waist circumference (from self-reports of height and weight) used 
equations based on the relationship between direct measures of height, weight and 
waist circumference (collected from participants in the NHA) and then applied these 
equations to self-reports of height and weight for all participants providing data on 
these in responses to the Wave 1 questionnaire. This approach to estimation is fraught 
with potentially erroneous assumptions, the most important of which are that: (i) the 
relationship between height, weight and waist circumference is similar regardless of 
whether these are self-reported or directly measured; (ii) the relationship between 
height, weight and waist circumference can be used to predict waist circumference 
with a sufficient degree of accuracy (using height and weight alone) to permit the 
accurate classification of individuals displaying elevated waist circumference (i.e. 
displaying this key component of MetS); and (iii) there is no systematic variation in the 
relationship between these three variables amongst individuals with different heights 
and/or weights, or those with different sociodemographic or economic characteristics. 
In the absence of self-reported data on waist circumference it is not possible to assess 
whether the first of these issues (see (i), above) poses a substantive concern, but it is 
an issue that warrants serious consideration given contemporary social preference for 
tallness and slimness, which result in the differential over-reporting of height and the 
under-reporting of weight in most high-income settings (Yoong et al. 2013; Dekkers et 
al. 2008). As for the second (i.e. (ii), above), a comparison of elevated waist 
circumference based either on direct measures of waist circumference or on estimates 
of directly measured waist circumference (the latter using direct measures of height 
and weight to estimate ‘measured’ waist circumference using the equation describing 
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the relationship between direct measures of height, weight and waist circumference) 
found overall agreement of 86.10% (see Chapter 3). This suggests that a similar level 
of precision is likely to be possible when using self-reported height and weight to 
estimate ‘self-reported’ waist circumference. Indeed, given the three potential 
weaknesses of this approach and the fact that the self-reports of height and weight 
used to estimate self-reported waist circumference were collected (in Wave 1 of the 
UKHLS) around 18 months before the direct measurements of waist circumference 
were taken (during the UKHLS NHA, shortly after Wave 2), it is frankly surprising that 
estimated ‘self-reports’ of elevated waist circumference achieved such high levels of 
sensitivity (61.6%), specificity (93.9%), PPV (88.5%), NPV (76.2%) and overall 
agreement (79.9%; see Table 4.2, above). And since there is a some evidence to 
suggest that many people (particularly those who are overweight and/or have large 
waist circumferences) may find it very difficult to measure their waist circumference – 
or even to find the midpoint between the lower border of the ribs and the upper border 
of the pelvis where most auxologists recommend the measurement be taken (Cullum 
et al. 2004; Dekkers et al. 2008) – it may even be that estimates of waist 
circumference generated using self-reports of height and weight are no worse than 
self-reported waist circumference.  
Meanwhile, an additional consequence of the lack of items generating self-
reports of waist circumference in any of the UKHLS questionnaires – and the inclusion 
of items requesting self-reports of height and weight only in the questionnaire used in 
Wave 1 (items have not, to-date, re-appeared in any of the questionnaires used in 
subsequent Waves) – is that the data used to estimate ‘self-reported’ waist 
circumference were collected around 18 months before the direct measures of waist 
circumference were recorded at the NHA. This compares to an interval of only around 
5 months between the self-reports of (clinical diagnoses of) high blood pressure and 
diabetes collected during Wave 2, and the direct measures of these two components 
of MetS during the NHA. Neither of these intervals are ideal for analyses assessing the 
potential validity of two different measures of the same characteristics, not least when 
all three components of MetS examined in the present Chapter are susceptible to 
change over time (not least as a result of an increasing tendency for weight gain, rising 
blood pressure and an increased risk diabetes with age). In fact, an important marker 
of quality applied to the critical appraisal of studies comparing two diagnostic tests is 
that there should be no interval between the applications of each (Bossuyt et al. 2015). 
In both instances the time interval between the collection of self-reports and direct 
measures, be that 5 or 18 months, will have introduced the possibility that (some) 
participants experience a change in one (or more) of the MetS components examined, 
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and will have reduced the apparent validity of all three self-reported measures. 
Unfortunately, there is little that can be done to address this issue in the present thesis 
given its reliance on data from the UKHLS, chosen specifically because it offered a 
contemporary survey of both self-reports and direct measures of MetS components 
(as well as data on a comprehensive list of n=7 sleep characteristics) for a large 
sample of adults designed to be representative of the UK population. Nonetheless, this 
inherent weakness in the likely comparability of self-reported and direct measures of 
MetS components is nonetheless reassuring if, as seems likely, this weakness is in 
part responsible for what might otherwise appear relatively modest levels of sensitivity, 
specificity, PPV, NPV and overall agreement observed. 
Setting aside such reassurances, the additional possibility that self-reports of 
elevated waist circumference, high blood pressure and/or diabetes were more (or less) 
susceptible to ‘false positives’ and/or ‘false negatives’ than direct measures thereof, 
might appear to pose a serious limitation of the present Chapter’s findings. ‘False 
positives’ would occur where, for example, erroneous self-reports or direct 
measurements for individuals who did not display elevated waist circumference, high 
blood pressure and/or diabetes led these individuals to be classified as having (one or 
more) of these components of MetS. Likewise, ‘false negatives’ would occur when 
erroneous data led individuals who had (one or more of) these MetS components to be 
classified as free of these. Estimates of waist circumference based on self-reports of 
height and weight would be particularly prone to ‘false negatives’ given the tendency 
for under-reporting body weight (Dekkers et al. 2008). Likewise, the high prevalence of 
undiagnosed blood pressure and diabetes – together with substantial variation in 
‘health literacy’ amongst individuals with different sociodemographic characteristics, 
economic circumstances and lifestyles (Halladay et al. 2016) – would also tend to 
make self-reports of these MetS components susceptible to ‘false negatives’, 
particularly amongst individuals with modest ‘health literacy’. At the same time, direct 
measures of waist circumference, high blood pressure and diabetes can also be 
susceptible to ‘false negatives’ and ‘false positives’, and under the measurement 
protocols used by the UKHLS NHA (which did not require participants to be fasted, 
rested or abstain from smoking prior to measurement) it seems likely that more ‘false 
positives’ than ‘false negatives’ are likely to have occurred simply because eating, 
activity and smoking (along with the likely stress of measurement/examination), are 
likely to have led to a rise in blood pressure, blood glucose levels and even, perhaps, 
waist circumference. As such, the higher risk of ‘false positives’ amongst direct 
measures of the three MetS components examined in the present Chapter (and of 
‘false negatives’ amongst self-reports of these components, as discussed above), 
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would have contributed to the somewhat different prevalences of self-reported vs. 
directly measured MetS components summarised in Table 4.1; and would also have 
attenuated all of the measures used to compare these two different measures of MetS 
components summarised in Table 4.2. However, whilst this differential susceptibility to 
‘false negatives’/‘false positives’ might undermine the validity of both self-reports and 
direct measures of MetS components at the individual level, the self-reports developed 
for use in the present thesis (and compared to direct measures thereof in the present 
Chapter) might still prove useful for the analysis of the potential causes and 
consequences of these MetS components (and a classification of MetS based 
thereon) at the population level – such as the analyses exploring their relationship(s) 
with self-reported sleep as described in the next Part of this Chapter: (Re-evaluating 
the association between self-reported sleep and MetS). For each separate component 
of MetS, this might well be the case provided the risk of ‘false negative/positive’ values 
was unaffected by those factors being investigated as potential causes or 
consequences (in this instance, sleep), or by other variables that, in turn, influence or 
are influenced by these (i.e., here, variables acting as confounders in the relationship 
between MetS and sleep). However, for this to be true for the classification of ‘MetS 
itself’ (based as this is, in the present thesis, on a combination of all three MetS 
components), any differential risk of ‘false negatives’ vs. ‘false positives’ amongst the 
constituent components of MetS might not only undermine the precision of a MetS 
classification based thereon, and introduce further bias to population-based analyses 
of its relationship with speculative causes and/or consequences. Unfortunately, given 
the data available within the UKHLS, it is not possible to assess the differential impact 
of what seems likely to be a higher risk of ‘false negatives’ amongst self-reported 
components of MetS and a higher risk of ‘false positives’ amongst direct measures of 
these components. Instead, the best the present Chapter can provide is some (limited) 
reassurance that self-reports of all three MetS components (and the classification of 
MetS itself based on these) appear to offer reasonable-to-good levels of sensitivity, 
specificity, PPV, NPV and overall agreement for direct measures thereof. 
Methodological considerations 
Notwithstanding these three key limitations, and the limited degree to which Part 
I of the present Chapter was able to avoid, address or even ameliorate these, this 
Chapter (Part I) was nonetheless designed to avoid a number of flaws evident in many 
previous studies examining the validity of self-reported MetS components (and related 
anatomical or physiological characteristics). For example, many such studies have 
only studied male or female participants (e.g. (Margolis et al. 2008; Engstrom et al. 
2003; Colditz et al. 1986); others focussed exclusively on specific populations 
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(including minority ethnic groups, specific age groups or those living in particular 
geographical contexts: (Leikauf and Federman 2009; Kriegsman et al. 1996; de 
Menezes, Oliveira and de Sousa Fischer 2014; Martin et al. 2000). In contrast, the 
data used in Part I of the present Chapter was only limited to participants recruited by 
the UKHLS (in a sample designed to be broadly representative of the UK’s 
sociodemographically diverse populations). And while the items used to collect self-
reports of high blood pressure and diabetes in the UKHLS questionnaires specifically 
asked whether these had “ever” been diagnosed by a “doctor or other health 
professional”, many other studies used items that did not include these important 
features (de Menezes, Oliveira and de Sousa Fischer 2014; Vargas et al. 1997; Okura 
et al. 2004; Molenaar et al. 2007; Bowlin et al. 1996; Huerta et al. 2009). Finally, the 
availability of data generated using measurements undertaken by the UKHLS itself 
(rather than secondary data sourced from medical records or clinician-derived data), is 
likely to have offered much more reliable (and accurate) information on the three MetS 
components than that used by/available to many of the previous studies examining the 
validity of self-reports vs. medical/clinical records (Oksanen et al. 2010; Martin et al. 
2000; Robinson et al. 1997; Okura et al. 2004) (Kehoe et al. 1994; Kriegsman et al. 
1996). 
The potential utility of self-reported MetS components 
Since the principal aim of Part I of the present Chapter was to assess the extent 
to which it might be possible to rely upon self-reports of three key components of MetS 
(elevated waist circumference, high blood pressure and diabetes; and thereafter on a 
classification of MetS based thereon) to examine their association with seven self-
reported sleep characteristics (analyses that are summarised in Part 2 of this 
Chapter), it is reasonable to conclude that Part I of this Chapter largely succeeded in 
achieving this aim. Notwithstanding a number of inherent limitations in the availability 
and measurement of self-reported indicators of MetS-relevant components (as 
detailed extensively above), comparisons between self-reports and direct measures of 
three key MetS components (and a classification of MetS itself based thereon) suggest 
that MetS still had considerable potential utility, not least as a result of their high 
specificity (ranging from 93.4%-99.4%) and high negative predictive values (NPVs; 
ranging from 76.2%-98.6%; see Table 4.2). Indeed, although self-reports of the three 
MetS components (and the classification of MetS itself based thereon) had lower 
sensitivity (ranging from just 46.2% to 75.3%) and lower positive predictive values 
(PPVs; ranging from 65.6% to 88.5%), they still displayed moderate-to-strong overall 
agreement with direct measures (overall agreement between the two ranging from 
79.9% to 98.0%) and associated values of Cohen’s kappa (a coefficient generally 
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considered to offer a better assessment of agreement since it takes into account the 
possibility of agreement simply by chance;(Landis and Koch 1977) that ranged from 
0.50 (considered ‘moderate’ and ‘fair-to-good’ evidence of agreement by Landis and 
Koch, 1977; and Fleiss 1981, respectively) to 0.79 (considered ‘substantial’ by Landis 
and Koch, 1977; and as ‘excellent’ by Fleiss, 1981)  
Clearly, self-reports of some MetS components offer more valid measures of 
directly measurements than others: self-reports of diabetes offering greater levels of 
agreement with direct measures than did self-reports of high blood pressure; and self-
reports of high blood offering more valid measures of (directly measured) high blood 
pressure than the estimated ‘self-reports’ of elevated waist circumference did for direct 
measurements thereof. This is likely to reflect the fact that conditions with clearer 
symptoms (including those more proactively targeted by public health screening 
programmes – such as hypertension), and those requiring regular/continuous 
monitoring and follow-up (with changes to lifestyle, medication and daily routines – 
such as diabetes) are more likely to be better remembered and better reported 
(Leikauf and Federman 2009; Goldman et al. 2003). Indeed, Goldman et al. (Goldman 
et al. 2003) found that self-reported hypertension (49.4%) displayed lower sensitivity 
than self-reported diabetes (85.2%); likewise El Fakiri et al. (El Fakiri, Bruijnzeels and 
Hoes 2007) reported moderate levels of agreement between self-reports and direct 
measures of hypertension (Cohen’s kappa=0.63) and substantial agreement between 
self-reports and direct measures of diabetes (Cohen’s kappa=0.84). Far fewer studies 
have attempted to validate self-reports of waist circumference, all of which found 
substantial underestimation by both males and females (Spencer, Roddam and Key 
2004; Rimm et al. 1990; Hall and Young 1988; Han and Lean 1998). One of these 
studies (Han and Lean 1998), sought to validate self-reports of elevated waist 
circumference (defined as: >1020mm in men; and >880mm in women) and found that 
these had a sensitivity of 35.3% and 44.9% and a specificity of 98.5% and 90.7% for 
males and females, respectively – levels that are broadly comparable with what the 
present Chapter found using estimated ‘self-reports’ of elevated waist circumference.  
And, while self-reports of all three MetS components (and the use of these to 
classify MetS itself) may offer better measures of their absence than their presence 
(as indicated by their higher specificity and NPVs than their sensitivity and PPVs) – 
and while the differential validity of each component appears to reduce the validity of 
‘self-reported’ MetS itself (i.e. MetS based on self-reports of MetS components) – 
these self-reports still attain remarkable levels of agreement with the direct measures 
they were intended to replace (not least since these direct measures were recorded 5-
18 months after the self-reports collected in Waves 1 and 2 of the UKHLS). As such it 
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seems likely that self-reported measures of MetS may have substantial utility, not least 
for population-based epidemiological studies (where often only the collection of data 
using self- or interviewer-administered surveys is feasible).  
Clearly, there is still much to learn about the validity of self-reported MetS 
components (and classifications of MetS itself based thereon), and how these might 
be strengthened by innovations in questionnaire content, delivery and design. 
Although these are beyond the scope of the present thesis, the priorities for further 
research in this area (including the development of more reliable/valid items for 
inclusion in survey questionnaires) will be discussed in further detail in the final 
Discussion Chapter of this thesis. In the meantime it is worth evaluating the potential 
utility of self-reported MetS components (and the classification of MetS itself based on 
these) by comparing the findings these generate with those generated using directly 
measured MetS components in analyses exploring the association between MetS and 
sleep in the next Part of this Chapter (Part 2). 
4.1.6 Summary and conclusion  
The analyses conducted in Part I of the present Chapter confirm that self-reports 
of all three of the MetS components examined (i.e. those for which suitable items were 
identified in the UKHLS questionnaires to generate, or estimate, self-reported 
measures of these: elevated waist circumference; high blood pressure; and diabetes) 
had a lower prevalence amongst UKHLS participants than that observed from direct 
measures thereof. And since the classification of MetS adopted in the present thesis 
(comprising the presence of all three of these MetS components) was generated from 
data on each constituent component of MetS, it is not surprising that the prevalence of 
self-reported MetS was also lower than that observed when using MetS classified 
using direct measures of each MetS component. 
These differences in prevalence (together with the substantive time intervals 
between the collection of self-reports and direct measures of MetS in the UKHLS; and 
the need to use self-reported height and weight to estimate ‘self-reports’ of waist 
circumference, because items to generate the latter were not included in UKHLS 
questionnaires) contributed to lower levels of sensitivity, specificity, positive predictive 
value, negative predictive value, overall agreement and Cohen’s kappa than might 
otherwise have been achieved for these self-reports of MetS components (and the 
classification of MetS itself based thereon). Indeed, given the limitations of the data 
available within the UKHLS, it is surprising (and somewhat reassuring) that agreement 
between these two sources of data remained substantial (particularly when assessed 
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using Cohen’s kappa to address the risk of chance agreement between MetS 
components categorised simply as binary variables: present vs. absent). 
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Part II 
4.2 Re-evaluating the association between self-reported sleep 
and MetS  
The empirical evidence providing the principal motivation for the present thesis 
comprised a range of observational studies reporting ostensibly clear associations 
between less favourable sleep and poor health (Kaur, Sharma and Singh 2015) – 
studies in which inter alia self-reports of (both long and short) sleep duration and poor 
sleep quality were associated with a variety of health-related problems. In particular, 
such studies have found that short (≤6hrs) and prolonged (≥9hrs) sleep duration are 
both associated with an increased risk of insulin resistance, hyperglycaemia, obesity, 
dyslipidaemia and/or cardiovascular disease (Lee et al. 2013; Barone and Menna-
Barreto 2011; Mesas et al. 2014). Meanwhile, self-reports of poor sleep quality have 
been found to be associated with both insulin resistance and obesity, even after 
adjustment for sleep duration (Kazman et al. 2012; Hung et al. 2013). 
 Given that many of these cardiometabolic factors are characteristic of the so-
called ‘Metabolic Syndrome’ (MetS) – a cluster of risk factors for coronary heart 
disease that comprise: (central) obesity, hyperglycaemia, hypertension, elevated 
levels of triglycerides and lower levels of high-density lipoprotein cholesterol (Alberti et 
al. 2009) – there has been growing interest in the possibility that unfavourable sleep 
might represent an important cause of MetS (as suggested by associations between 
sleep duration, sleep quality and various classifications of MetS ) (Xi et al. 2014; 
Ohkuma et al. 2014; Lee et al. 2013; Hung et al. 2013; Arora et al. 2011) However, 
there is growing evidence that unfavourable sleep could be both a cause and a 
consequence of MetS, since a number of studies have reported an increased 
prevalence of sleep disorders amongst individuals with poor glycaemic control (Hung 
et al. 2013; Barone and Menna-Barreto 2011).  
 The findings of these studies are certainly intriguing, yet it is clear from Chapter 
2 that the bulk of the evidence they provide stems from observational analyses of 
cross-sectional datasets, while the few experimental studies focussed primarily on 
obstructive sleep apnoea (or, occasionally, obesity) and therefore offer limited insight 
into other (non-clinical) sleep characteristics. Although a small number of studies were 
identified that claimed to adopt longitudinal designs, none of these had data collected 
at more than two time points and all adopted analytical strategies that were particularly 
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susceptible to bias from regression to the mean. What evidence there is thus relies on 
cross-sectional data that are ill-equipped to provide evidence of directionality and 
causality (i.e. whether less favourable sleep might precede MetS, whether MetS might 
precede less favourable sleep, or both). At the same time, none of these cross-
sectional studies have examined more than a few characteristics of sleep (most 
focussing on sleep duration (Ohkuma et al. 2014; Chaput et al. 2013b; Stefani et al. 
2013; Wu et al. 2012; Arora et al. 2011), with fewer examining sleep latency, sleep 
fragmentation/maintenance or snoring (Mesas et al. 2014; Lee et al. 2013; Chedraui et 
al. 2013)). Indeed, even those studies that measured sleep using multi-item quasi-
psychometric instruments (such as the Pittsburgh Sleep Quality Index), examined 
each of the separate sleep characteristics measured by the different items these 
instruments contain (Hung et al. 2013; Jennings et al. 2007) – a substantial oversight 
given the important insights such analyses might have offered. 
Additional flaws in the design, sampling and analysis of previous cross-
sectional studies include the small, clinic-based samples employed - which are 
susceptible to inadequate statistical power, and are likely to have limited external 
validity (Chaput et al. 2013b; Yoo and Franke 2013; McCanlies et al. 2012; Roopa et 
al. 2010) - and a lack of consensus on the referent group used. Some studies used 
referent groups comprised of participants that lacked any components of MetS or any 
unfavourable sleep characteristics while others used referent groups that only lacked 
the specific component(s) of MetS or unfavourable sleep that were being examined. 
These differences are likely to result in very different effect estimates of the 
association between MetS and sleep. Many studies also fail to report the rationale for 
the inclusion (or exclusion) of specific covariates within the adjustment sets used in 
their multivariable statistical analyses. Many of these analyses will therefore be at risk 
of under-adjustment confounding (by failing to measure and adjust for potential 
confounders) and/or inappropriate adjustment for mediators (covariates falling on the 
causal path between MetS and sleep).  
These analytical concerns were mapped out in some detail in Chapter 2, where 
a series of six possible causal path diagrams were presented (in the form of directed 
acyclic graphs; DAGs) using a list of all the covariates measured by the cross-
sectional studies reviewed (see Figure 2.4, on page 59). It is worth reproducing a 
simplification of this figure in the present Chapter (see Figure 4.1, overleaf) to revisit 
why the present thesis proposes that only one of these DAGs can reflect the temporal 
sequence of MetS, sleep and other covariates when collected by previous cross-
sectional studies. Without repeating the arguments, it is nonetheless instructive to 
remind that the most plausible model - based on what is known about the time taken 
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for these characteristics to develop, and when/how these were measured - is Model 
4.1.6, in which: sociodemographic factors precede the initiation/development of MetS 
which, then, precedes contemporaneous lifestyle factors which, finally, precede self-
reported sleep. This is therefore the model adopted for the current analyses, which 
assume (for cross-sectional analyses of the relationship between MetS and sleep) 
that: sociodemographic factors are the only potential confounders that require 
adjustment; and that contemporaneous lifestyle factors are likely to act as mediators in 
any relationship between MetS and sleep and should not therefore be included in the 
adjustment set for any multivariable analyses thereof).
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Figure 4.1 Simplified directed acyclic graphs (DAGs) summarising the six theoretical causal paths (4.1.1-4.1.6) between cross-sectionally 
measured data on: contemporaneous lifestyle factors, sleep and MetS. Adapted from Figure 2.5 in Chapter 2 (A systematic review of cross-
sectional studies examining the association between MetS and sleep). 
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4.2.1 Aim and objectives 
 The key aim of Part II of this chapter was to re-evaluate the association 
between MetS and self-reported sleep by examining any variation in this association 
related to:  
(ix) the use of different referent groups (specifically: individuals without all three 
of the key components of MetS available within the UKHLS; and individuals 
without the specific key component[s] used for each classification of MetS 
examined in (ii), above);  
(x) the use of objective (direct measurements) and subjective (self-reports) of 
each of the three components of MetS examined; and  
(xi) the inclusion of lifestyle variables in the adjustment sets used to control for 
potential confounding when evaluating the (confounder adjusted) 
association between sleep and MetS. 
(xii) different characteristics of self-reported sleep (specifically: sleep duration, 
latency, disturbance, coughing/snoring, medication, quality and daytime 
sleepiness);  
different classifications of MetS (based on one, two or all of three key 
components available within the UKHLS: central obesity; hypertension; and 
diabetes);  
A final aim of Part II of the present Chapter was to: 
(xiii) apply the use of self-reported MetS components (and combinations of MetS 
components) to a large, population based sample designed to be 
representative of the UK population and thereby demonstrate: not only their 
potential utility for analysing the association between different 
components/combinations of MetS and sleep in large-scale epidemiological 
surveys; but also what evidence these surveys might offer regarding the 
association between MetS and sleep (not least in the UK, where there have 
been no such studies to-date). 
As such, Part II of the present Chapter sought to address the following key 
questions as established at the outset of this thesis: 
KQ4: “What methodological and aetiological insights into the association between 
sleep and MetS might be generated from analyses of large dataset?” 
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4.2.2 Methods 
4.2.2.1 Study design and sample 
 The data on which this Chapter’s (Part II) analyses were based originate from 
the UKHLS Sample 1 and Sample 2 (see Chapter 3). As such, the two samples 
examined were identified as follows:  
Sample 1:  Only those adult participants who were eligible for inclusion in the Wave 
2 NHA who had complete data on: all seven self-reported sleep 
characteristics (recorded in Wave 1); self-reported MetS components 
(central obesity from data recorded in Wave 1; diabetes and 
hypertension recorded in Wave 2); directly measured MetS components 
(recorded during the NHA); and relevant self-reported covariates 
(sociodemographic and lifestyle from data recorded in Wave 2).  
Sample 2:  Only adult participants providing data in Wave 1 who had complete data 
on: all seven self-reported sleep characteristics; self-reported MetS 
components; and relevant self-reported covariates (excluding data on 
lifestyle which were only recorded in the Wave 2 questionnaires).  
4.2.2.2 Self-reported sleep characteristics  
Wave 1 of the UKHLS included seven items relevant to sleep in its ‘Adult Self-
completion Questionnaire'. These generated data on seven sleep characteristics 
during the month preceding the survey: sleep duration (“hours of actual sleep”); sleep 
latency (“cannot get to sleep within 30 minutes”); sleep quality (“sleep quality overall”); 
sleep fragmentation (“wake up in the middle of the night or early in the morning”); 
coughing/snoring (“cough or snore loudly”); sleep medication use (“medicine 
[prescribed or ‘over the counter’] to help you sleep”); and daytime sleepiness (“trouble 
staying awake while driving, eating meals, or engaging in social activity”).  
Data on sleep duration were categorised into <6 hrs, ≥6-8, and >8hrs, and 
sleep quality was dichotomised as (“Very good” vs. “Fairly good” “Fairly bad” and “Very 
bad”). The remaining sleep variables (the items for which all used frequency-related 
response options) were dichotomised to binary variables with “Not during the past 
month” and “At some time during the past month” (comprising: “Less than once a 
week”, “Once or twice a week”, “Three or more times a week” and “More than once 
most nights”) as the two resulting categories. More detail on the measurement and 
categorisation of these sleep variables is provided in Chapter 3 (section 3.4.1). 
4.2.2.3 Metabolic syndrome components and classification 
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Since one aim of the present Chapter (Part II) was to examine the association 
between sleep and different components/combinations of MetS (based on one, two or 
all of three of the key components available within the UKHLS), it was necessary to 
establish suitable definitions for each of these components and for the classification of 
‘MetS itself’ based on combinations of these. Based on the review of MetS 
classifications used by previous studies examining the association between sleep and 
MetS (see Chapter 2), the empirical analyses conducted in this thesis focussed on a 
formal classification of MetS (and the definitions of each component of MetS used 
therein) as defined by the NCPI-ATP III (see also Chapter 3). However, because the 
UKHLS did not provide data on two of the components of MetS relevant to 
dyslipidaemia (triglycerides and HDL cholesterol) that are included in the definition of 
MetS proposed by the NCPII-ATP III, the analyses in this thesis have focussed on just 
three components: elevated waist circumference (as a marker for central obesity); high 
blood pressure; and diabetes. The NCPI-ATP III definition defines each of these 
components as follows:  
Central obesity:  waist circumference ≥ 102 cm for men and ≥ 88 cm for women;  
Diabetes:  fasting serum glucose ≥ 100 mg/dL, and/or the use of 
antidiabetic medication; and  
High blood pressure: systolic blood pressure ≥ 130 mm Hg, or diastolic blood pressure 
≥ 85 mm Hg , and/or the use of antihypertensive medication 
(Huang 2009). 
For Sample 1 (for whom data were available on both directly measured and 
self-reported MetS components), data from the NHA alone were used to identify 
participants with central obesity, high blood pressure and prescribed medication for 
blood pressure (see also Chapter 3). The assessment of diabetes relied upon HbA1c 
measurements and prescribed antidiabetic medication rather than on fasting serum 
glucose levels, since fasting blood samples were not collected during the UKHLS 
NHA). Equivalent self-reported measures of each of these MetS components (for use 
in analyses involving both Sample 1 and Sample 2) were generated from: self-reports 
of height and weight  (collected in Wave 1, and used to estimate waist circumference, 
as described in Chapter 3); and self-reported clinical diagnoses of “high blood 
pressure” and “diabetes” (described in greater detail in Chapter 3). 
The analyses that follow compare the association between sleep and the 
presence of: each MetS component alone; each pair of MetS components; and all 
three components together – the latter comprising the classification of ‘MetS itself‘ 
examined in the present Chapter (based on the NCPII-ATP III definition). As such, 
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‘directly measured MetS (itself)’ was defined as the presence of: central obesity 
(directly measured WC ≥ 102cm for males, WC ≥ 88cm for females); high blood 
pressure (BP ≥140/90 mmHg and/or on prescribed medication for blood pressure); 
and diabetes (HbA1c ≥ 48 mmol/mol and/or prescribed antidiabetic medication). In 
contrast, ‘self-reported MetS’ was defined as: the presence of central obesity 
(estimated WC ≥ 102cm for males, WC ≥ 88cm for females – where WC was 
estimated from self-reports of height and weight); and self-reports of clinically 
diagnosed high blood pressure and of clinically diagnosed diabetes.  
More details on the definition of directly measured and self-reported MetS 
components, and on the classification of ‘MetS itself’ used (based on the NCPI-ATP III 
definition) is described in Chapter 3 (see section 3.4.2)  
4.2.2.4 Covariates 
Following the theoretical DAGs that were generated from previous cross-
sectional studies of the association between MetS and sleep (see Chapter 2), the 
Wave 1 and Wave 2 UKHLS questionnaires were carefully examined to identify items 
capable of providing relevant data for analysis.  
These comprised a range of sociodemographic variables (age; sex; marital 
status/cohabition; educational attainment, employment status; and household 
composition), and a number of contemporaneous lifestyle variables (habitual fruit and 
vegetable consumption [as a marker for diet]; smoking status; alcohol consumption; 
and participation in sport). Further detail on the questionnaire items used to generate 
each of these variables can be found in Chapter 3. 
4.2.3 Statistical analysis  
1. Descriptive analyses 
Descriptive analyses were undertaken to summarise the distribution of the 
exposure and outcome variables, and each of the available covariates, for both: the 
original UKHLS and NHA samples; and the two analytical samples with complete data 
for all relevant variables (i.e. Samples 1 and 2). Summaries of each variable were 
presented as frequencies (n) with percentages (%) in parentheses.  
2. Unadjusted and adjusted analyses of the association 
between sleep and MetS 
A series of (unadjusted and adjusted) logistic regression models were used to 
establish whether any variation in the association between (different characteristics of) 
sleep and (different combinations of) MetS components was related to: the use of 
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different referent groups; the use of directly measured vs. self-reported components of 
MetS; and the inclusion of contemporaneous lifestyle variables in any adjustment sets 
used.  
Sample 1: 
Two sets of models were used to examine UKHLS participants in the first sample 
(Sample 1 – for which data were available on both directly measured and self-reported 
components of MetS, and data on contemporaneous lifestyle variables); one set using 
directly measured components of MetS, and the other using self-reported components 
of MetS. Both sets examined the association between different MetS component 
combinations (i.e. one, two or all three) and each of the available sleep characteristics, 
using both referent groups (those who did not display any components of MetS and 
those who did not display the particular MetS component or combination being 
examined). These were evaluated without adjustment for other covariates, adjusted for 
sociodemographic factors alone, and adjusted for both sociodemographic and 
contemporaneous lifestyle factors. 
Sample 2: 
A single set of models was then used to examine UKHLS participants in the 
second sample (Sample 2 – which included a larger proportion of UKLHS participants, 
but lacked data on directly measured components of MetS, and data on 
contemporaneous lifestyle variables). As before, these models examined the 
association between different MetS component combinations (i.e. one, two or all three) 
and each sleep characteristic, using both referent groups (those who did not display 
any components of MetS and those who did not display the particular component or 
combination being examined). These were evaluated before and after adjustment for 
sociodemographic factors, but not for both sociodemographic and contemporaneous 
lifestyle factors, since no data were available on the latter. These three sets of logistic 
regression models (n=16 models in all) have been summarised in Table 4.3. (See also 
Appendix; Tables 6.9 - 6.25)  
.
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Table 4.3 Summary of the statistical models used to examine whether any variation in the relationship between (different characteristics of) sleep 
and (different combinations of) MetS components was associated with: the use of different referent groups; the use of directly measured vs. self-
reported components of MetS; and the inclusion of contemporaneous lifestyle variables in any adjustment sets used. 
Figure  Sample Measurement of MetS components Referent group used Adjustment for 
sociodemographic variables 
Adjustment for 
lifestyle variables 
4.2 
Sample 1 
(n=5,283) 
Directly measured Participants do not display any components of MetS No No 
4.3 
Sample 1 
(n=5,283) 
Directly measured Participants do not display any components of MetS Yes No 
4.4 
Sample 1 
(n=5,283) 
Directly measured Participants do not display any components of MetS Yes Yes 
4.5 
Sample 1 
(n=5,283) 
Directly measured 
Participants do not display the particular combination of MetS components 
being examined 
No No 
4.6 
Sample 1 
(n=5,283) 
Directly measured 
Participants do not display the particular combination of MetS components 
being examined 
Yes No 
4.7 
Sample 1 
(n=5,283) 
Directly measured 
Participants do not display the particular combination of MetS components 
being examined  
Yes Yes 
4.8 
Sample 1 
(n=5,283) 
Self-reported Participants do not display any components of MetS No No 
4.9 
Sample 1 
(n=5,283) 
Self-reported Participants do not display any components of MetS Yes No 
4.10 
Sample 1 
(n=5,283) 
Self-reported Participants do not display any components of MetS Yes Yes 
4.11 
Sample 1 
(n=5,283) 
Self-reported 
Participants do not display the particular combination of MetS components 
being examined 
No No 
4.12 
Sample 1 
(n=5,283) 
Self-reported 
Participants do not display the particular combination of MetS components 
being examined 
Yes No 
4.13 
Sample 1 
(n=5,283) 
Self-reported 
Participants do not display the particular combination of MetS components 
being examined  
Yes Yes 
4.14 
Sample 2 
(n=29,436) 
Self-reported Participants do not display any components of MetS No Not available 
4.15 
Sample 2 
(n=29,436) 
Self-reported Participants do not display any components of MetS Yes Not available 
4.16 
Sample 2 
(n=29,436) 
Self-reported 
Participants do not display the particular combination of MetS components 
being examined 
No Not available 
4.17 
Sample 2 
(n=29,436) 
Self-reported 
Participants do not display the particular combination of MetS components 
being examined  
Yes Not available 
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4.2.4 Sample 1 Results 
4.2.4.1 Descriptive analyses 
Table 4.4 summarises the distribution of sociodemographic and lifestyle 
variables, self-reported and directly measured MetS components, and seven self-
reported sleep characteristics UKHLS participants who had participated in all Waves 
up until the NHA (i.e. the main sample; n=9,485); and those participants with complete 
data on all self-reported and directly measured variables; and all self-reported 
variables (i.e. Sample 1; n=5,283).  
Considering first the missingness among the main sample, it can be seen that 
the rate of missingness was negligible (0.0%-0.8%) for most of the sociodemographic 
and health variables collected in the Wave 2 questionnaire, except for alcohol 
consumption (10.4%), and the self-reported sleep characteristics (10.4%-24.5%) 
collected only in Wave 1 using the adult self-completion questionnaire. Looking at the 
missingness rate among the self-reported and directly measured components of MetS, 
it can be seen that it was low (5.4%) for self-reports, but moderate (10.4%) for direct 
measures that were collected from participants selected for inclusion in the NHA and 
who had provided blood sample.  
These levels of missingness result in a moderate fall in the numbers of 
participants with complete data on all variables available for analysis in Sample 1 (a 
fall of n=9,485 to n=5,283 participants). The exclusion of such a substantial number of 
participants from the analytical sample (Sample 1) is likely to constrain the external 
validity of these analyses (i.e. the generalisability of the results that might be affected 
by biased sub-sample selection and small sample sizes) if the reduction in sample size 
was accompanied by changes in the distribution of key variables. To assess this 
possibility it is worth comparing the distribution of these variables in the main sample 
with that observed in Sample 1. By examining the distribution of all variables, it is clear 
that both samples  had a very similar distribution. In particular, around 55% of 
participants in both samples were female, aged 60yrs or more (30%). Participants in 
both samples were also less likely to be single (13%) and more likely to be 
married/cohabiting (73%); and were less likely to have no educational qualifications 
(11%) and more likely to be in ‘management or professional’ employment (28%).  
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Table 4.4 Variation in the distribution of: sociodemographic and lifestyle characteristics; self-reported and directly measured MetS components 
(and combinations thereof); and self-reported sleep characteristics, for all adult (≥16yrs) participated in Wave 1, Wave 2 and NHA of the UKHLS 
(n=9,485) and complete data on all self-reported and directly measured variables (Sample 1; n=5,283). All variables have been categorised with 
the distribution across categories summarised as frequencies (n) with percentages in parentheses (%). 
 
 
UKHLS Wave 1, 
Wave 2 and 
NHA 
participants 
n=9,485 
Sample 1 
n=5,283 
Sociodemographic characteristics    
Covariates            n (%)        n (%) 
Sex 
Missing        0   (0.0)        0   (0.0) 
Male 4,171 (44.0) 2,387 (45.2) 
Female 5,314 (56.0) 2,896 (54.8) 
Age 
Missing         0   (0.0)        0   (0.0) 
Below 30 years old     943   (9.9)    543 (10.3) 
30-39 years old  1,310 (13.8)    794 (15.0) 
40-49 years old  1,921 (20.2) 1,154 (21.8) 
50-59 years old  1,838 (19.4) 1,107 (20.9) 
60years or older  3,473 (36.6) 1,685 (32.0) 
Marital/cohabitation status 
Missing         0   (0.0)        0   (0.0) 
Single 1,282 (13.5)    689 (13.0) 
Cohabited  6,502 (68.5) 3,841 (72.7) 
Separated and Divorced      997 (10.5)    507   (9.6) 
Widowed     704   (7.4)    246   (4.7) 
Educational attainment 
Missing          9   (0.1)        0   (0.0) 
Degree 2,123 (22.4) 1,332 (25.2) 
Other higher degree  1,290 (13.6)    777 (14.7) 
 
A-level  1,709 (18.0) 1,001 (19.0) 
 
GCSE 1,845 (19.4) 1,080 (20.4) 
 
Other qualification 1,104 (11.6)    538 (10.2) 
 
No qualification 1,405 (14.8)    555 (10.5) 
Employment status 
Missing       77   (0.8)        0   (0.0) 
Management and professional  2,205 (23.2) 1,485 (28.1) 
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Intermediate     719   (7.6)    460   (8.7) 
Small employers and own account    514   (5.4)    284   (5.4) 
Lower supervisory and technical     398   (4.2)    252   (4.8) 
Semi-routine, routine and never worked 
long-term  
1,608 (16.9) 
   850 (16.1) 
Unemployed     915   (9.6)    510   (9.6) 
Retired  2,815 (29.7) 1,284 (24.3) 
Student     234   (2.5)    158   (3.0) 
Household structure1 
Missing         4   (0.0)        0   (0.0) 
Empty nesters  5,680 (59.9) 3,139 (59.5) 
Dwelling sharing childless adults  1,137 (12.0)    550 (10.4) 
Partnered with child  1,241 (13.1)    779 (14.8) 
Partnered with children     593   (6.2)    355   (6.7) 
Large family, majority with overcrowding     347   (3.7)    208   (3.9) 
Single parent household     310   (3.3)    164   (3.1) 
Extended family, majority with 
overcrowding  
   173   (1.8)      84   (1.6) 
Daily number of servings of  
fruit and vegetables consumed 
Missing       70   (0.7)        0   (0.0) 
1    732   (7.7)    383   (7.2) 
2 2,013 (21.2) 1,079 (20.4) 
3 2,407 (25.4) 1,370 (25.9) 
4 1,823 (19.2) 1,054 (20.0) 
5 1,631 (17.2)    939 (17.8) 
6 and more     809   (8.5)    458   (8.7) 
Sport activity ranking 
Missing         4   (0.0)        0   (0.0) 
no sport at all 2,460 (25.9) 1,145 (21.7) 
1-2 1,724 (18.2)    979 (18.5) 
3-4 1,836 (19.4) 1,076 (20.4) 
5-6 1,820 (19.2) 1,069 (20.2) 
7-very active 1,641 (17.3) 1,014 (19.2) 
Smoking status 
Missing        7   (0.1)        0   (0.0) 
Never smoke 3,771 (39.8) 2,134 (40.4) 
Quit smoking 3,854 (40.6) 2,216 (41.9) 
Smoke less than 10 cig/day    556   (5.9)    305   (5.8) 
Smoke 10-20 cig/day 1,136 (12.0)    559 (10.6) 
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Smoke more than 20 cig/day    161   (1.7)      69   (1.3) 
Alcohol consumption during the last 12 
months 
Missing    985 (10.4)        0   (0.0) 
almost every day    811   (8.5)    502   (9.5) 
five or six days a week    530   (5.6)    348   (6.6) 
three or four days a week 1,356 (14.3)    892 (16.9) 
once or twice a week 2,418 (25.5) 1,550 (29.3) 
once or twice a month 1,260 (13.3)    777 (14.7) 
once every couple of months    745   (7.8)    475   (9.0) 
once or twice a year    740   (7.8)    402   (7.6) 
not at all in the last 12 months    640   (6.7)    337   (6.4) 
Self-reported sleep characteristics     
Sleep duration  
(“…hours of actual sleep did you usually get 
at night during the last month?”) 
Missing 1,303 (13.7)        0   (0.0) 
<6 hrs  1,010 (10.6)    582 (11.0) 
6-8 hrs 6,318 (66.6) 4,159 (78.7) 
>8 hrs     854   (9.0)    542 (10.3) 
Sleep latency  Missing  1,640 (17.3)        0   (0.0) 
(“…trouble sleeping because you cannot  Not during the past month 3,156 (33.3) 2,210 (41.8) 
get to sleep within 30 minutes?”) During the past month  4,689 (49.4) 3,073 (58.2) 
Sleep fragmentation Missing  1,394 (14.7)        0   (0.0) 
(“…trouble sleeping because you wake up  Not during the past month 1,472 (15.5) 1,049 (19.9) 
in the middle of the night or early in the 
morning?”) 
During the past month 6,619 (69.8) 4,234 (80.2) 
Coughing/snoring loudly Missing  2,324 (24.5)        0   (0.0) 
(“…trouble sleeping because you cough or Not during the past month 4,367 (46.0) 3,291 (62.3) 
snore loudly?”) During the past month 2,794 (29.5) 1,992 (37.7) 
Sleep medication  Missing  1,054 (11.1)        0   (0.0) 
(“…taken medicine [prescribed or over-the- Not during the past month 7,029 (74.1) 4,475 (84.7) 
counter] to help you sleep?”) Presence of the event  1,402 (14.8)    808 (15.3) 
Daytime sleepiness Missing  1,067 (11.3)        0   (0.0) 
(“…had trouble staying awake while driving,  Not during the past month 7,184 (75.7) 4,531 (85.8) 
eating meals, or engaging in social 
activity?”) 
During the past month 1,234 (13.0)    752 (14.2) 
Sleep quality Missing     986 (10.4)        0   (0.0) 
(“During the past month how would you rate  Good quality  2,050 (21.6) 1,332 (25.2) 
your sleep quality overall?”) Poor quality  6,449 (68.0) 3,951 (74.8) 
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Metabolic Syndrome (MetS)   
Self-reported MetS components Missing     516   (5.4)        0   (0.0) 
 
Elevated waist circumference (EWC) 1,826 (19.2) 1,101 (20.8) 
 
High blood pressure (HBP)    672   (7.1)    350   (6.6) 
 
Diabetes (DM)    128   (1.3)      57   (1.1) 
 
EWC and HBP    645   (6.8)    322   (6.1) 
 
EWC and DM    172   (1.8)      73   (1.4) 
 
HBP and DM      90   (0.9)      34   (0.6) 
 
EWC and HBP and DM    181   (1.9)      93   (1.8) 
 
None  5,255 (55.4) 3,253 (61.6) 
Directly measured MetS components Missing  1,076 (10.9)        0   (0.0) 
Elevated waist circumference (EWC) 2,347 (23.7) 1,453 (27.5) 
High blood pressure (HBP)    704   (7.1)    386   (7.3) 
Diabetes (DM)      61   (0.6)      23   (0.4) 
EWC and HBP 1,064 (10.7)    606 (11.5) 
EWC and DM    163   (1.7)      93   (1.8) 
HBP and DM      84   (0.8)      39   (0.7) 
EWC and HBP and DM    269   (2.7)    132   (2.5) 
None  4,137 (41.8) 2,551 (48.3) 
1Household structure as classified by (Fowler et al. 2014) 
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4.2.4.2 Potential analytical determinants of variation in the association 
between sleep and MetS 
Figures 4.2-4-13 summarise the results of logistic regression analyses 
examining the relationship between each MetS component, combination of MetS 
components, and the seven self-reported sleep characteristics available from 
participants in the UKHLS NHA (see also Table 4.3 for a full list of these). Figures 4.2-
4.7 use directly measured MetS components, while Figures 4.8-4.13 use self-reported 
data as measures of each MetS component. The first three of each set of Figures (i.e. 
Figures 4.2-4.4 and 4.8-4.10) use those participants who did not display any of the 
three MetS components as the referent group; while the second three of each set of 
Figures (i.e. Figures 4.5-4.7 and 4.11-4.13) use those participants who did not display 
the particular component (or combination of components) being examined as the 
referent. Finally, in each set of three Figures, the models summarised in the first (i.e. 
Figures 4.2, 4.5, 4.8 and 4.11) are unadjusted for any potential confounders, while the 
second (i.e. Figures 4.3, 4.6, 4.9 and 4.12) and third (i.e. Figures 4.4, 4.7, 4.10 and 
4.13) summarise models adjusted for sociodemographic (age, sex, 
marital/cohabitation status, educational attainment and household composition) and 
contemporaneous lifestyle (diet, smoking status, alcohol consumption and sport 
participation) factors, respectively. 
To address each of the key questions posed by the present Chapter (Part II) it 
is necessary to read within and across these 12 Figures in order to assess whether 
any variation in the relationship between (different characteristics of) sleep and 
(different combinations of) MetS components was associated with: the use of different 
referent groups; the use of directly measured vs. self-reported components of MetS; 
and the inclusion of sociodemographic and contemporaneous lifestyle variables in any 
adjustment sets used. To facilitate this process, it is worth considering, first, the likely 
impact of the three methodological issues on the analysis of MetS itself (which, in the 
present study, was defined as a combination of all three available components of 
MetS; i.e. elevated waist circumference and high blood pressure and diabetes): (i) the 
use of different referent groups; (ii) the use of directly measured vs. self-reported 
components of MetS; and (iii) the adjustment for potential (sociodemographic) 
confounders and possible (lifestyle) mediators 
.
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Figure 4.2 Logistic regression analyses of the relationship between different directly measured components (and combinations of components) of 
MetS and seven self-reported sleep characteristics, amongst n=5,283 participants included in the UKHLS NHA, before adjustment for 
sociodemographic and contemporaneous lifestyle variables. The referent group comprised participants who did not display any of the three 
components of MetS examined (elevated waist circumference, diabetes and high blood pressure). Results are given as relative risk ratios for sleep 
duration (RRRs; for multinomial logistic analyses) or odds ratios for sleep latency, sleep fragmentation, cough/snore loudly, sleep medication, 
daytime sleepiness and sleep quality (ORs; for binary logistic regression analyses), with 95% confidence intervals (95%CI) in parentheses. 
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Figure 4.3 Logistic regression analyses of the relationship between different directly measured components (and combinations of components) of 
MetS and seven self-reported sleep characteristics, amongst n=5,283 participants included in the UKHLS NHA, after adjustment for 
sociodemographic variables. The referent group comprised participants who did not display any of the three components of MetS examined 
(elevated waist circumference, diabetes and high blood pressure). Results are given as relative risk ratios for sleep duration (RRRs; for 
multinomial logistic analyses) or odds ratios for sleep latency, sleep fragmentation, cough/snore loudly, sleep medication, daytime sleepiness and 
sleep quality (ORs; for binary logistic regression analyses), with 95% confidence intervals (95%CI) in parentheses. 
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Figure 4.4 Logistic regression analyses of the relationship between different directly measured components (and combinations of components) of 
MetS and seven self-reported sleep characteristics, amongst n=5,283 participants included in the UKHLS NHA, after adjustment for 
sociodemographic and contemporaneous lifestyle variables. The referent group comprised participants who did not display any of the three 
components of MetS examined (elevated waist circumference, diabetes and high blood pressure). Results are given as relative risk ratios for sleep 
duration (RRRs; for multinomial logistic analyses) or odds ratios for sleep latency, sleep fragmentation, cough/snore loudly, sleep medication, 
daytime sleepiness and sleep quality (ORs; for binary logistic regression analyses), with 95% confidence intervals (95%CI) in parentheses. 
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Figure 4.5 Logistic regression analyses of the relationship between different directly measured components (and combinations of components) of 
MetS and seven self-reported sleep characteristics, amongst n=5,283 participants included in the UKHLS NHA, before adjustment for 
sociodemographic and contemporaneous lifestyle variables. The referent group comprised participants who do not display the particular 
component (or combination of components) of MetS being examined (but may have displayed none, one or all of the others). Results are given as 
relative risk ratios for sleep duration (RRRs; for multinomial logistic analyses) or odds ratios for sleep latency, sleep fragmentation, cough/snore 
loudly, sleep medication, daytime sleepiness and sleep quality (ORs; for binary logistic regression analyses), with 95% confidence intervals 
(95%CI) in parentheses. 
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Figure 4.6 Logistic regression analyses of the relationship between different directly measured components (and combinations of components) of MetS 
and seven self-reported sleep characteristics, amongst n=5,283 participants included in the UKHLS NHA, after adjustment for sociodemographic 
variables. The referent group comprised participants who do not display the particular component (or combination of components) of MetS being 
examined (but may have displayed none, one or all of the others). Results are given as relative risk ratios for sleep duration (RRRs; for multinomial 
logistic analyses) or odds ratios for sleep latency, sleep fragmentation, cough/snore loudly, sleep medication, daytime sleepiness and sleep quality (ORs; 
for binary logistic regression analyses), with 95% confidence intervals (95%CI) in parentheses. 
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Figure 4.7 Logistic regression analyses of the relationship between different directly measured components (and combinations of components) of 
MetS and seven self-reported sleep characteristics, amongst n=5,283 participants included in the UKHLS NHA, after adjustment for 
sociodemographic and contemporaneous lifestyle variables. The referent group comprised participants who do not display the particular component 
(or combination of components) of MetS being examined (but may have displayed none, one or all of the others). Results are given as relative risk 
ratios for sleep duration (RRRs; for multinomial logistic analyses) or odds ratios for sleep latency, sleep fragmentation, cough/snore loudly, sleep 
medication, daytime sleepiness and sleep quality (ORs; for binary logistic regression analyses), with 95% confidence intervals (95%CI) in 
parentheses. 
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Figure 4.8 Logistic regression analyses of the relationship between different self-reported components (and combinations of components) of MetS 
and seven self-reported sleep characteristics, amongst n=5,283 participants included in the UKHLS NHA, before adjustment for sociodemographic 
and contemporaneous lifestyle variables. The referent group comprised participants who did not display any of the three components of MetS 
examined (elevated waist circumference, diabetes and high blood pressure). Results are given as relative risk ratios for sleep duration (RRRs; for 
multinomial logistic analyses) or odds ratios for sleep latency, sleep fragmentation, cough/snore loudly, sleep medication, daytime sleepiness and 
sleep quality (ORs; for binary logistic regression analyses), with 95% confidence intervals (95%CI) in parentheses. 
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Figure 4.9 Logistic regression analyses of the relationship between different self-reported components (and combinations of components) of MetS 
and seven self-reported sleep characteristics, amongst n=5,283 participants included in the UKHLS NHA, after adjustment for sociodemographic 
variables. The referent group comprised participants who did not display any of the three components of MetS examined (elevated waist 
circumference, diabetes and high blood pressure). Results are given as relative risk ratios for sleep duration (RRRs; for multinomial logistic 
analyses) or odds ratios for sleep latency, sleep fragmentation, cough/snore loudly, sleep medication, daytime sleepiness and sleep quality (ORs; 
for binary logistic regression analyses), with 95% confidence intervals (95%CI) in parentheses.  
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Figure 4.10 Logistic regression analyses of the relationship between different self-reported components (and combinations of components) of 
MetS and seven self-reported sleep characteristics, amongst n=5,283 participants included in the UKHLS NHA, after adjustment for 
sociodemographic and contemporaneous lifestyle variables. The referent group comprised participants who did not display any of the three 
components of MetS examined (elevated waist circumference, diabetes and high blood pressure). Results are given as relative risk ratios for sleep 
duration (RRRs; for multinomial logistic analyses) or odds ratios for sleep latency, sleep fragmentation, cough/snore loudly, sleep medication, 
daytime sleepiness and sleep quality (ORs; for binary logistic regression analyses), with 95% confidence intervals (95%CI) in parentheses. 
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Figure 4.11 Logistic regression analyses of the relationship between different self-reported components (and combinations of components) of 
MetS and seven self-reported sleep characteristics, amongst n=5,283 participants included in the UKHLS NHA, before adjustment for 
sociodemographic and contemporaneous lifestyle variables. The referent group comprised participants who do not display the particular component 
(or combination of components) of MetS being examined (but may have displayed none, one or all of the others). Results are given as relative risk 
ratios for sleep duration (RRRs; for multinomial logistic analyses) or odds ratios for sleep latency, sleep fragmentation, cough/snore loudly, sleep 
medication, daytime sleepiness and sleep quality (ORs; for binary logistic regression analyses), with 95% confidence intervals (95%CI) in 
parentheses. 
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Figure 4.12 Logistic regression analyses of the relationship between different self-reported components (and combinations of components) of 
MetS and seven self-reported sleep characteristics, amongst n=5,283 participants included in the UKHLS NHA, after adjustment for 
sociodemographic variables. The referent group comprised participants who do not display the particular component (or combination of 
components) of MetS being examined (but may have displayed none, one or all of the others). Results are given as relative risk ratios for sleep 
duration (RRRs; for multinomial logistic analyses) or odds ratios for sleep latency, sleep fragmentation, cough/snore loudly, sleep medication, 
daytime sleepiness and sleep quality (ORs; for binary logistic regression analyses), with 95% confidence intervals (95%CI) in parentheses.  
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Figure 4.13 Logistic regression analyses of the relationship between different self-reported components (and combinations of components) of 
MetS and seven self-reported sleep characteristics, amongst n=5,283 participants included in the UKHLS NHA, after adjustment for 
sociodemographic and contemporaneous lifestyle variables. The referent group comprised participants who do not display the particular component 
(or combination of components) of MetS being examined (but may have displayed none, one or all of the others). Results are given as relative risk 
ratios for sleep duration (RRRs; for multinomial logistic analyses) or odds ratios for sleep latency, sleep fragmentation, cough/snore loudly, sleep 
medication, daytime sleepiness and sleep quality (ORs; for binary logistic regression analyses), with 95% confidence intervals (95%CI) in 
parentheses.  
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4.2.4.3 Methodological factors influencing analyses of the association 
between MetS and sleep  
4.2.4.3.1 The impact of different referent groups on the associations between 
MetS and sleep  
Assuming that directly measured components of MetS offer the most accurate 
basis upon which to classify MetS (as a combination of elevated waist circumference, 
high blood pressure and diabetes), and based solely on comparisons between the 
unadjusted models summarised in Figures 4.2 (using participants that did not display 
any of the three MetS components as the referent) and 4.5 (using, as the referent for 
MetS itself, participants displaying fewer than all three of the MetS components), it is 
clear that both Figures reveal very similar relationships between MetS and the seven 
self-reported sleep characteristics. MetS was associated with a higher risk of short 
sleep duration (≤6hrs), loud coughing/snoring, sleep medication use and poor sleep 
quality in both sets of analyses.  
Both sets of analyses also revealed that MetS was consistently associated with 
an elevated risk of sleep fragmentation and daytime sleepiness, and with a lower risk 
of prolonged sleep (≥8hrs). However, a comparison of these two sets of models 
indicates that the inclusion of participants who might have had one or two (though not 
all three) components of MetS in Figure 4.5 substantially attenuated the associations 
observed in Figure 4.2 (where the referent group included only healthy participants – 
i.e. participants who did not display any components of MetS).  
For example, using a healthy referent group, the unadjusted association 
between MetS and short sleep duration was stronger (RRR:2.60; 95%CI:1.64,4.13; 
Figure 4.2) than when using a referent group that included participants displaying one 
or two MetS components (RRR:1.88; 95%CI:1.20,2.94; Figure 4.5); likewise, the odds 
of loud coughing/snoring (OR:2.04; 95%CI:1.44,2.90), using sleep medication 
(OR:2.01; 95%CI:1.32,3.08), and poor quality sleep (OR:1.62; 95%CI:1.03,2.57), were 
all higher when assessed using a healthy referent group than when the referent group 
included some participants displaying one or two components of MetS 
(coughing/snoring OR:1.57; 95%CI:1.11,2.22; sleep medication OR:1.65; 
95%CI:1.09,2.50; poor sleep quality OR:1.61; 95%CI:1.02,2.54). 
Indeed, looking further afield than MetS itself to individual components of MetS 
(and different pairs of these), and including those analyses using self-reported MetS, a 
consistent pattern of effect attenuation is evident when comparing models using 
participants that do not display any components of MetS vs. those in which the 
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referent group includes some participants displaying one, two and/or (for those models 
examining just one or two components) all three components of MetS (i.e. MetS itself 
as classified in the present Chapter). These comparisons indicate that the referent 
group used influences the strength of any association between MetS and sleep; a 
finding that may not be surprising given the increased risk of less favourable sleep 
observed for many of the three components (and combinations of components) of 
MetS, as will be examined in greater detail later. 
4.2.4.3.2 The impact of using directly measured vs. self-reported MetS on the 
association between MetS and sleep 
Given the attenuation of effect size observed when using referent groups 
containing some vs. no participants displaying (one or more) MetS components, the 
comparisons that follow focus on models using healthy referent groups (i.e. referent 
groups comprising participants who displayed no components of MetS; Figures 4.2 
and 4.8). These offer a comparison of unadjusted models examining the association 
between MetS and sleep where MetS was based on either: directly measured 
components (i.e. using measurements of waist circumference, blood pressure, HbA1c 
and diabetic medication undertaken during the UKHLS NHA; Figure 4.2); or self-
reported indicators thereof (i.e. using self-reported height and weight to estimate waist 
circumference, and self-reported clinical diagnoses of high blood pressure and 
diabetes; Figure 4.8). In this instance there was a tendency for the associations 
between MetS and sleep to be stronger where MetS was based on self-reported 
indicators of each MetS component (i.e. Figure 4.8) than where the MetS had been 
directly measured (i.e. Figure 4.2). 
In particular, the unadjusted associations between directly measured MetS and 
short sleep duration (<6hrs; RRR:2.60; 95%CI:1.64,4.14), sleep medication (OR:2.01; 
95%CI:1.32,3.08), and poor sleep quality (OR:1.62; 95%CI:1.03,2.57) were all lower 
than those observed between self-reported MetS and sleep (short duration RRR:3.41; 
95%CI:2.06,5.63; medication OR:2.67; 95%CI:1.69,4.21; poor quality OR:1.84; 
95%CI:1.05,3.22). However, this was not the case for loud coughing/snoring (directly 
measured MetS OR:2.04; 95%CI:1.44,2.90; self-reported MetS OR:1.75; 
95%CI:1.16,2.65) and closer examination of the remaining sleep characteristics 
(prolonged sleep >8hrs; latency; fragmentation and daytime sleepiness – none of 
which had strong associations with MetS indicates that some (latency and 
fragmentation) had very similar effect estimates with both directly measured and self-
reported MetS, while others displayed either an attenuation of risk when using self-
reported MetS (daytime sleepiness) or an attenuated risk when using directly 
measured MetS (prolonged sleep).  
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Looking elsewhere in Figures 4.2 and 4.8 across associations between 
separate (and different combinations of) MetS components, a similar pattern is 
evident: some effect estimates appear unaffected, some were attenuated and some 
were strengthened when using directly measured vs. self-reported indicators of MetS 
components. These findings mirror the conclusions drawn in Part I of the present 
Chapter, suggesting that self-reported indicators of MetS components (and 
classifications of MetS itself, based thereon) are broadly comparable to those provided 
by direct measurements thereof. The potential value of self-reported indicators of MetS 
components will be assessed in greater detail later (see 4.2.6.2, below), where these 
have been used to explore the association between MetS and sleep amongst a much 
larger number of UKHLS participants than those included in the NHA.  
4.2.4.3.3 The impact of adjusting for potential (sociodemographic) confounders 
and possible (lifestyle) mediators on the association between MetS 
and sleep 
Assuming that models using directly measured components of MetS and 
referent groups containing (only) healthy participants are likely to offer the most 
accurate assessment of any relationship(s) between MetS components (and 
combinations of MetS components) and sleep, the final methodological issue 
examined in Part II of this Chapter of the thesis (the impact of adjustment for 
sociodemographic and contemporaneous lifestyle factors) will once again focus on 
analyses of MetS itself (i.e. elevated waist circumference and diabetes and high blood 
pressure) as summarised in Figures 4.2-4.4. Figure 4.2 includes the results of models 
examining the unadjusted association between MetS and sleep, while in Figures 4.3 
and 4.4 these models have been adjusted for a range of sociodemographic factors or 
for both sociodemographic and contemporaneous lifestyle factors, respectively.  
In all three Figures MetS was associated with a increased risk of short sleep 
duration (<6hrs), loud coughing/snoring, sleep medication use, and poor sleep quality. 
However, the effect estimates of the first three sleep characteristics were all 
attenuated following adjustment for sociodemographic and lifestyle factors 
(unadjusted: short duration RRR:2.60; 95%CI:1.64,4.13; coughing/snoring OR:2.04; 
95%CI:1.44;2.90; medication OR:2.01; 95%CI:1.32,3.08; sociodemographic adjusted: 
short duration RRR:1.72; 95%CI:1.05,2.80; coughing/snoring OR:1.62; 
95%CI:1.12,2.35; medication OR:1.83; 95%CI:1.18,2.85; sociodemographic and 
lifestyle adjusted: short duration OR:1.41; 95%CI:0.86,2.31; coughing/snoring 
OR:1.52; 95%CI:1.04,2.22; medication OR:1.65; 95%CI:1.05,2.58).  
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Indeed the association between MetS and short sleep duration was no longer 
statistically significant after adjustment for both sociodemographic and lifestyle factors. 
In contrast, the odds of poor quality sleep (OR:1.62; 95%CI:1.03,2.57) strengthened 
following adjustment for sociodemographic factors (OR:2.21; 1.38,3.55) and were then 
only partially attenuated following (additional) adjustment for contemporaneous 
lifestyle factors (OR:2.01; 95%CI:1.25,3.23). Likewise, MetS was only modestly 
associated with an increased odds of daytime sleepiness before adjustment (OR:1.43; 
95%CI:0.92,2.23) but this association strengthened following adjustment for 
sociodemographic factors (OR:2.01; 95%CI:1.31,3.36) only to become somewhat 
attenuated following additional adjustment for contemporaneous lifestyle factors 
(OR:1.83; 95%CI:1.13,2.94).  
Broadly similar patterns were evident in the trends observed between MetS 
and the three remaining sleep characteristics (prolonged sleep duration, >8hrs; sleep 
latency; and sleep fragmentation), for each of which the associations observed were 
attenuated following adjustment for sociodemographic factors, but either strengthened 
slightly (prolonged duration and latency) or remained largely unaffected 
(fragmentation) following adjustment for contemporaneous lifestyle factors. These 
patterns were also evident in the associations observed for different MetS components 
(and different combinations of MetS components) in Figures 4.2, 4.3 and 4.4 – and for 
models using self-reported indicators of MetS components in Figures 4.8, 4.9 and 4.10 
– suggesting that, in most instances, adjustment for potential confounders (i.e. 
sociodemographic factors) and possible mediators (i.e. contemporaneous lifestyle 
factors) attenuated the association between MetS components and sleep. However, 
for two sleep characteristics (sleep quality and daytime sleepiness) their unadjusted 
associations with MetS were strengthened following adjustment for sociodemographic 
factors, and were only then somewhat attenuated following subsequent (additional) 
adjustment for lifestyle factors.  
These findings indicate that sociodemographic and lifestyle factors play a 
different role in the relationship between MetS and different characteristics of sleep. 
For some (notably: short duration, loud coughing and medication), where adjustment 
resulted in the attenuation of effect estimates, it is likely that sociodemographic and 
contemporaneous lifestyle factors act as confounders in the association between MetS 
and sleep. For others (notably: poor quality and daytime sleepiness), the role of 
sociodemographic and contemporaneous lifestyle factors is less clear, and it may be 
that (at least some of these) factors may play a more important role as competing 
exposures which are unaffected by MetS yet influence the likelihood or accuracy of 
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reporting poor sleep quality and/or daytime sleepiness. This is an issue that will be 
discussed in more detail later in this Chapter. 
4.2.4.4 Variation in the association between MetS and sleep amongst 
different components (and combinations of MetS components) 
and different sleep characteristics 
Having established that the use of referent groups comprising participants 
displaying some vs. no components of MetS influenced the strength of the 
associations between MetS and sleep – and that these associations were also 
influenced both by the use of directly measured vs. self-reported indicators of MetS 
components, and by adjustment for sociodemographic and contemporaneous lifestyle 
factors (see above) – all that remains is to assess whether these associations depend 
upon the specific MetS components used (or combinations of these), and/or on the 
specific self-reported sleep characteristics examined. Assuming that models using 
healthy referent groups, directly measured components of MetS, and analyses 
adjusted for potential confounders (i.e. sociodemographic factors) and/or possible 
mediators (i.e. contemporaneous lifestyle factors) offer the most valid insights into the 
associations between different components of MetS (and combinations thereof) and 
different sleep characteristics, what follows focusses primarily on Figures 4.3 and 4.4, 
with Figures 4.6 and 4.7 offering an indication of how different MetS components (and 
different  combinations of these) fare when used to explore the association between 
MetS and sleep when the referent group includes some participants displaying other 
components (or combinations of components) of MetS. 
4.2.4.4.1 Does the association between MetS and sleep depend upon the 
specific MetS components (or combination of MetS components) 
used? 
Both sets of models summarised in Figures 4.3 and 4.4 display a similar 
pattern of associations between different MetS components (and combinations of 
MetS components) and the seven different self-reported sleep characteristics. As 
discussed previously, in both Figures MetS itself (i.e. the presence of elevated waist 
circumference and high blood pressure and diabetes) was associated with a higher 
odds of: loud coughing/snoring; sleep medication; poor sleep quality; and daytime 
sleepiness; while in Figure 4.3 MetS itself was also associated with a higher risk of 
short sleep duration (<6hrs). None of the other MetS components (or combinations of 
MetS components) displayed significant associations with as many different sleep 
characteristics, though elevated waist circumference alone was associated with four 
sleep characteristics (short duration, coughing/snoring, medication and daytime 
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sleepiness) in Figure 4.3 and with all but one of these (not daytime sleepiness) in 
Figure 4.4.  
Indeed, a larger number of sleep characteristics displayed significant 
associations with elevated waist circumference alone, or in combination with diabetes 
(4 sleep characteristics in Figure 4.3, and 3 sleep characteristics in Figure 4.4) or high 
blood pressure (3 sleep characteristics in Figure 4.3, and 2 sleep characteristics in 
Figure 4.4) than that observed for high blood pressure alone (just 1 sleep 
characteristic in both Figure 4.3 and 4.4), diabetes alone (none in either Table) or both 
combined (just 1 sleep characteristic in both Figure 4.3 and 4.4). This appears to 
suggest that elevated waist circumference alone was the single most important 
component of MetS in terms of its association with sleep; and since MetS itself (i.e. 
elevated waist circumference and high blood pressure and diabetes) was only 
associated with one additional sleep characteristic (sleep quality) than elevated waist 
circumference alone in either Figure 4.3 or 4.4, it appears as if the contribution of 
diabetes and high blood pressure to these associations is relatively minor.  
However, it is important to emphasise that there was substantial variation in the 
number of participants displaying only one component of MetS (or only one 
combination of two or three MetS components) – only n=23/5,283 (0.4%) participants 
displaying diabetes alone, and only n=39/5,283 (0.7%) participants displaying diabetes 
and high blood pressure alone, for example. While many more were associated with 
the 1,453/5,283 (27.5%) participants displaying elevated waist circumference alone, 
and the 132/5,283 (2.5%) participants with MetS itself (i.e. all three components of 
MetS). 
A very different picture emerges from the models summarised in Figures 4.6 
and 4.7, in which the referent groups used comprise all participants with any 
combination of MetS components other than that being examined. In contrast to the 
models in Figures 4.3 and 4.4, in which the effect estimates indicate the risk of less 
favourable sleep amongst participants displaying a given (combination of) MetS 
component(s) as compared to those participants displaying none, the models in 
Figures 4.6 and 4.7 offer a clearer indication of whether participants displaying a given 
(combination) of MetS component(s) have a different risk of less favourable sleep than 
all other participants in the sample examined (which, in this instance, comprise those 
who took part in the UKHLS NHA). In this instance, a combination of elevated waist 
circumference and diabetes displayed strong associations with the highest number of 
sleep characteristics (4: short duration, coughing/snoring, medication and daytime 
sleepiness) while MetS itself was only associated with 2 (daytime sleepiness and 
sleep quality), the same number of characteristics as that achieved by elevated waist 
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circumference alone (though, in this instance, the sleep characteristics concerned 
were short duration and coughing/snoring). 
Indeed, high blood pressure alone and diabetes alone were not associated with 
any of the 7 sleep variables; and combinations of elevated waist circumference and 
high blood pressure, and of high blood pressure and diabetes, were only associated 
with a higher risk of one sleep characteristic each (coughing/snoring and medication, 
respectively). The interpretation of these very different patterns amongst each 
component, and combination of components, of MetS is that each poses a different 
(and somewhat) distinct risks to different characteristics of sleep over and above those 
posed by other MetS components (and combinations thereof) and this may be 
explained by latent confounding of one risk factor to another. The potential aetiological 
and clinical utility of these findings will be considered in greater detail in the Discussion 
section of the present Chapter (see 4.2.6 below).  
4.2.4.4.2 Does the association between MetS and sleep depend upon the 
specific sleep characteristics examined? 
As mentioned in the preceding section, there was not only substantial variation 
in the associations observed between different components of MetS (and 
combinations thereof) and self-reported sleep characteristics, but there was also 
substantial variation in the sleep characteristics most frequently associated with one or 
more (combination of) MetS components. From Figures 4.3 and 4.4 it is clear that 
sleep medication was more often associated with different (combinations of) MetS 
components than any other sleep characteristic. The next characteristic most 
commonly associated with MetS was coughing/snoring, followed by short duration and 
daytime sleepiness, and sleep quality. Indeed, three sleep characteristics (prolonged 
duration, >8hrs; latency and fragmentation) displayed no significant associations with 
any (combinations of) MetS characteristics. 
Far fewer of the components/combinations of MetS were associated with self-
reported sleep characteristics when the referent group used contained some 
participants displaying one or more components of MetS (see Figures 4.6 and 4.7). 
Most striking amongst these was the fall in the number of associations between 
components/combinations of MetS and the use of sleep medication (which fell from 
n=6/7 in Figures 4.3 and 4.4, to just n=2/7 in Figure 4.6 and n=1/7 in Figure 4.7). The 
components/combinations of MetS most affected by this decline in associations with 
sleep were elevated waist circumference alone and those combinations of MetS 
components that included this MetS component (i.e. elevated waist circumference 
and: high blood pressure; and both high blood pressure and diabetes – MetS itself). 
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These findings further confirm the important role that elevated waist circumference is 
likely to play in the associations observed between different components/combinations 
of MetS and sleep, since the inclusion of (some) participants with elevated waist 
circumference in the referent group used in these analyses (i.e. the models 
summarised in Figures 4.6 and 4.7) will have diluted any difference in sleep between 
these participants and those with the particular MetS component/combination being 
studied. These findings also confirm the likely importance of sleep medication 
(whether prescribed or over-the-counter, as specified in the UKHLS questionnaire) as 
a marker of poor sleep associated with a wide range of MetS 
components/combinations, since when participants with these were included in the 
referent group the association between the component/combination being examined 
and self-reported sleep medication use was substantially attenuated. 
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4.2.5 Sample 2 Results  
4.2.5.1 Descriptive analysis  
Table 4.5 summarises the distribution of sociodemographic and lifestyle 
variables, self-reported and directly measured MetS components, and seven self-
reported sleep characteristics of UKHLS participants in Wave 1 (n=50,994), and those 
of these participants with complete data on all self-reported variables from Wave 1 
alone (i.e. Sample 2; n=29,436). Looking first at those variables exhibiting the highest 
rates of missingness amongst Wave 1 participants, it is clear that: rates of 
missingness were low (≤1.2%) for the sociodemographic variables generated by items 
in the main adult questionnaire used in Wave 1; were higher (at 13.3%) for self-
reported MetS components; and were much more pronounced (at 21.1%-33.3%) for 
self-reported sleep characteristics collected using the adult self-completion 
questionnaire in Wave 1.  
These levels of missingness result in a substantial fall in the numbers of 
participants with complete data on all variables available for analysis in Sample 2 
(n=29,436, 57.7% of the n=50,994 participants in Wave 1). The exclusion of such a 
large number of participants from the analytical sample (i.e. Sample 2) is likely to 
constrain the external validity of these analyses if the reduction in sample size was 
accompanied by changes in the distribution of key variables. To assess this possibility 
it is worth comparing the distribution of these variables in Sample 2 with that observed 
in the complete sample of participants in Wave 1. By examining the distribution of 
sociodemographic variables (which had only modest rates of missingness), it is clear 
that participants in Sample 2 were similar to participants in Wave 1 overall. In 
particular, a greater proportion of Sample 2 participants were female (54%), aged 
<30yrs (24%). Participants were also less likely to be single (24%) and more likely 
to be married/cohabiting (64%); and were less likely to have no educational 
qualifications (12%) and more likely to be in ‘management or professional’ 
employment (26%). These results suggest that the analyses based on Sample 2 are 
likely to be broadly representative of the UKHLS sample as a whole, not least given 
that the sampling frame used was, itself, designed to be representative of the UK 
population as a whole. 
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Table 4.5 Variation in the distribution of: sociodemographic; self-reported MetS components (and combinations thereof); and self-reported sleep 
characteristics, for all adult (≥16yrs) participated in Wave 1 (n=50,994) and complete data on all self-reported measured variables (Sample 2; 
n=29,436). All variables have been categorised with the distribution across categories summarised as frequencies (n) with percentages in 
parentheses (%). 
 
 
UKHLS Wave 1 
participants 
n=50,994 
Sample 2 
n=29,436 
Sociodemographic characteristics    
Covariates            n (%)          n (%) 
Sex 
Missing          0          0   (0.0) 
Male 23,208 (45.5) 13,673 (46.5) 
Female 27,786 (54.5) 15,763 (53.5) 
Age 
Missing           0   (0.0)          0   (0.0) 
Below 30 years old  11,543 (22.6)   7,085 (24.1) 
30-39 years old    9,317 (18.3)   5,784 (19.6) 
40-49 years old    9,707 (19.0)   5,855 (20.0) 
50-59 years old    7,683 (15.1)   4,430 (15.0) 
60years or older  12,744 (25.0)   6,282 (21.3) 
Marital/cohabitation status 
Missing         17   (0.1)          0   (0.0) 
Single 12,009 (23.5)   6,972 (23.7) 
Cohabited  31,642 (62.0) 18,849 (64.0) 
Separated and Divorced     4,319   (8.5)   2,373   (8.1) 
Widowed    3,007   (5.9)   1,242   (4.2) 
Educational attainment 
Missing          92   (0.2)          0   (0.0) 
Degree 10,954 (21.5)   7,428 (25.2) 
Other higher degree    5,537 (10.9)   3,559 (12.1) 
 
A-level    9,591 (18.8)   6,011 (20.4) 
 
GCSE 10,526 (20.6)   6,201 (21.1) 
 
Other qualification   5,225 (10.2)   2,677   (9.1) 
 
No qualification   9,069 (17.8)   3,560 (12.1) 
Employment status 
Missing       593   (1.2)          0   (0.0) 
Management and professional  11,121 (21.8)   7,731 (26.3) 
Intermediate    3,713   (7.3)   2,451   (8.3) 
Small employers and own account   2,709   (5.3)   1,588   (5.4) 
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Lower supervisory and technical    2,080   (4.1)   1,345   (4.6) 
Semi-routine, routine and never worked 
long-term  
  9,257 (18.1)   5,050 (17.2) 
Unemployed    7,448 (14.6)   3,875 (13.2) 
Retired  10,171 (20.0)   4,994 (17.0) 
Student    3,902   (7.6)   2,402   (8.2) 
Household structure1 
Missing         65   (0.1)          0   (0.0) 
Empty nesters  24,710 (48.5) 14,302 (48.6) 
Dwelling sharing childless adults    8,240 (16.2)   4,530 (15.4) 
Partnered with child    7,465 (14.6)   4,745 (16.1) 
Partnered with children    3,175   (6.2)   1,998   (6.8) 
Large family, majority with overcrowding    3,369   (6.6)   1,709   (5.8) 
Single parent household    2,181   (4.3)   1,262   (4.3) 
Extended family, majority with 
overcrowding  
  1,789   (3.5)      890   (3.0) 
Self-reported sleep characteristics     
Sleep duration  
(“…hours of actual sleep did you usually get 
at night during the last month?”) 
Missing 12,620 (24.8)          0   (0.0) 
<6 hrs    4,716   (9.2)   3,223 (11.0) 
6-8 hrs 28,684 (56.2) 22,344 (75.9) 
>8 hrs    4,974   (9.8)   3,869 (13.1) 
Sleep latency  Missing  13,893 (27.2)          0   (0.0) 
(“…trouble sleeping because you cannot  Not during the past month 15,228 (29.9) 12,489 (42.4) 
get to sleep within 30 minutes?”) During the past month  21,873 (42.9) 16,947 (57.6) 
Sleep fragmentation Missing  13,230 (25.9)          0   (0.0) 
(“…trouble sleeping because you wake up  Not during the past month   8,538 (16.8)   7,272 (24.7) 
in the middle of the night or early in the 
morning?”) 
During the past month 29,226 (57.3) 22,164 (75.3) 
Coughing/snoring loudly Missing  16,997 (33.3)          0   (0.0) 
(“…trouble sleeping because you cough or Not during the past month 21,378 (41.9) 18,823 (64.0) 
snore loudly?”) During the past month 12,619 (24.8) 10,613 (36.0) 
Sleep medication  Missing  11,215 (22.0)          0   (0.0) 
(“…taken medicine [prescribed or over-the- Not during the past month 32,827 (64.4) 24,777 (84.2) 
counter] to help you sleep?”) Presence of the event    6,952 (13.6)   4,659 (15.8) 
Daytime sleepiness Missing  11,269 (22.1)          0   (0.0) 
(“…had trouble staying awake while driving,  Not during the past month 33,469 (65.6) 24,808 (84.3) 
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eating meals, or engaging in social 
activity?”) 
During the past month   6,256 (12.3)   4,628 (15.7) 
Sleep quality Missing  10,773 (21.1)          0   (0.0) 
(“During the past month how would you rate  Good quality    9,954 (19.5)   7,566 (25.7) 
your sleep quality overall?”) Poor quality  30,267 (59.4) 21,870 (74.3) 
Metabolic Syndrome (MetS)   
Self-reported MetS components Missing    6,763 (13.3)          0   (0.0) 
 
Elevated waist circumference (EWC)   8,489 (16.7)   5,611 (19.1) 
 
High blood pressure (HBP)   2,672   (5.2)   1,514   (5.1) 
 
Diabetes (DM)      574   (1.1)      325   (1.1) 
 
EWC and HBP   2,510   (4.9)   1,415   (4.8) 
 
EWC and DM      704   (1.4)      370   (1.3) 
 
HBP and DM      423   (0.8)      217   (0.7) 
 
EWC and HBP and DM      726   (1.4)      393   (1.3) 
 
None  28,133 (55.2) 19,591 (66.5) 
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4.2.5.2 Population-based assessment of the association between (self-
reported) MetS and (self-reported) sleep characteristics amongst 
a representative sample of adults from the UK  
Having established that self-reported indicators could provide reasonably valid 
measures of the three key components of MetS examined in the present thesis (see 
Part I of the present Chapter); and having demonstrated in Part II of the present 
Chapter that these self-reported measures of MetS displayed very similar relationships 
with self-reported sleep to those observed for directly measured MetS components, 
the final aim of Part II of the present Chapter was to assess the potential utility of self-
reported MetS components in larger, population-based studies of any associations 
between MetS and sleep. To demonstrate this potential, the present Part repeated the 
analyses of self-reported MetS and self-reported sleep conducted on the n=5,283 
participants in the UKHLS NHA (for whom data on both self-reported and directly 
measured components of MetS were available) on the far larger number of UKHLS 
participants (n=29,436) providing only data on self-reported MetS in Wave 1 (Figures 
4.14, 4.15, 4.16 and 4.17). Once again, these models generated very similar findings 
to those observed in the smaller (NHA) sample (of n=5,283), MetS itself being 
associated with elevated risks of no fewer than n=6/7 self-reported sleep 
characteristics (including sleep fragmentation), even after adjustment for 
sociodemographic confounding (Figure 4.15): short duration (RRR:2.32; 
95%CI:1.80,2.99); fragmentation (OR:1.44; 95%CI:1.09,1.92); loud coughing/snoring 
(OR: 2.53; 95%CI:2.05,3.12); medication (OR:2.25; 95%CI:1.79-2.84); daytime 
sleepiness (OR:1.59; 95%CI:1.21,2.11); quality (OR:1.53;95%CI:1.20,1.94). In part, 
the larger number of self-reported sleep characteristics associated with MetS here 
simply reflects the greater statistical power of the larger number of participants 
involved (i.e. those included in Sample 2; n=29,436); in part, these reflect the absence 
of lifestyle factors in the adjustment sets used in these analyses (since items on 
lifestyle factors were not included in the UKHLS questionnaires used in Wave 1). As 
such, the effect estimates presented in Figure 4.15 are also likely to reflect the impact 
of unadjusted confounding (for lifestyle factors and any other latent confounders), and 
are unlikely to be as strong as they appear. Nonetheless, since the sociodemographic 
characteristics of participants in Sample 2 were very similar to those in Wave 1 as a 
whole (see Table 4.5), and since the latter were selected with the intention of 
generating a representative sample of the UK population, the results summarised in 
Table 4.15 offer the first comprehensive assessment of the association between MetS 
and sleep in the UK population. This assessment indicates that a variety of MetS 
components, and combinations thereof, display strong associations with a number of 
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self-reported sleep characteristics, and suggest that MetS is associated with an 
elevated risk of less favourable sleep outcomes. 
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Figure 4.14 Logistic regression analyses of the relationship between different self-reported measured components (and combinations of components) of MetS 
and seven self-reported sleep characteristics, amongst n=29,436 participants included in Wave 1 of the UKHLS, before adjustment for sociodemographic and 
contemporaneous lifestyle variables. The referent group comprised participants who did not display any of the three components of MetS examined (elevated 
waist circumference, diabetes and high blood pressure). Results are given as relative risk ratios for sleep duration (RRRs; for multinomial logistic analyses) or 
odds ratios for sleep latency, sleep fragmentation, cough/snore loudly, sleep medication, daytime sleepiness and sleep quality (ORs; for binary logistic regression 
analyses), with 95% confidence intervals (95%CI) in parentheses.  
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Figure 4.15 Logistic regression analyses of the relationship between different self-reported measured components (and combinations of components) of MetS 
and seven self-reported sleep characteristics, amongst n=29,436 participants included in Wave 1 of the UKHLS, after adjustment for sociodemographic variables. 
The referent group comprised participants who did not display any of the three components of MetS examined (elevated waist circumference, diabetes and high 
blood pressure). Results are given as relative risk ratios for sleep duration (RRRs; for multinomial logistic analyses) or odds ratios for sleep latency, sleep 
fragmentation, cough/snore loudly, sleep medication, daytime sleepiness and sleep quality (ORs; for binary logistic regression analyses), with 95% confidence 
intervals (95%CI) in parentheses.  
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Figure 4.16 Logistic regression analyses of the relationship between different self-reported measured components (and combinations of components) of MetS 
and seven self-reported sleep characteristics, amongst n=29,436 participants included in Wave 1 of the UKHLS, before adjustment for sociodemographic and 
contemporaneous lifestyle variables. The referent group comprised participants who do not display the particular component (or combination of components) of 
MetS being examined (but may have displayed none, one or all of the others). Results are given as relative risk ratios for sleep duration (RRRs; for multinomial 
logistic analyses) or odds ratios for sleep latency, sleep fragmentation, cough/snore loudly, sleep medication, daytime sleepiness and sleep quality (ORs; for 
binary logistic regression analyses), with 95% confidence intervals (95%CI) in parentheses. 
  
WC
BP
DM
WC&BP
WC&DM
DM&BP
MetS
WC
BP
DM
WC&BP
WC&DM
DM&BP
MetS
1 1.05 1.1 1.15 .95 1 1.05 .6 .8 1 1.2 1.4 1 1.5 2 2.5
1 1.5 2 2.5 3 1 1.5 2 2.5 3 .5 1 1.5 .5 1 1.5
Sleep duration <6hrs Sleep duration >8hrs Sleep latency Sleep fragmentation
Cough/snour loudly Sleep medication Daytime sleepiness Sleep quality
192 
 
Figure 4.17 Logistic regression analyses of the relationship between different self-reported measured components (and combinations of components) of MetS 
and seven self-reported sleep characteristics, amongst n=29,436 participants included in Wave 1 of the UKHLS, after adjustment for sociodemographic lifestyle 
variables. The referent group comprised participants who do not display the particular component (or combination of components) of MetS being examined (but 
may have displayed none, one or all of the others). Results are given as relative risk ratios for sleep duration (RRRs; for multinomial logistic analyses) or odds 
ratios for sleep latency, sleep fragmentation, cough/snore loudly, sleep medication, daytime sleepiness and sleep quality (ORs; for binary logistic regression 
analyses), with 95% confidence intervals (95%CI) in parentheses. 
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4.2.6 Discussion 
Limitations 
The data presented in Part II of this Chapter are limited in a number of key respects, 
including the absence of data on dyslipidaemia; the specific cut-off values used for each 
component of MetS; the absence of data on self-reported waist circumference; the different 
sociodemographic characteristics of participants in Sample 1 and Wave 1; the limited 
numbers of participants with complete data (together with the fact that it proved 
impracticable to perform multiple imputation; see Chapter 3); and the limited prevalence of 
some components of MetS (and for some MetS component combinations). 
The collection of non-fasting blood samples during the NHA meant that these could 
not provide reliable measures of blood lipid values. Since the assessment of dyslipidaemia 
remains challenging (and highly contested; see, for example (Ridker 2014)) without such 
samples – not least in non-clinical populations with access to over-the-counter lipid lowering 
medicine and supplements (Danavi, Memon and Phan 2015; Qato et al. 2016) –robust data 
on dyslipidaemia were not available for UKHLS participants in the NHA. At the same time, 
the development of reliable self-assessment tools for collecting self-reported data on 
dyslipidaemia remains elusive (Tolonen et al. 2014), and none of the items included in any 
of the Wave 1 and Wave 2 UKHLS questionnaires generated data on plausible (let alone 
valid) self-reported indicators of blood lipid levels. For these reasons the present thesis was 
unable to include this important component of MetS (whether directly measured or self-
reported) in its analysis of the association between MetS and sleep in the UKHLS. 
However, it was able to include all three of the other key components of MetS considered 
relevant to the classification of MetS itself (i.e. elevated waist circumference, high blood 
pressure and diabetes). Since most of the classifications of MetS itself used in previous 
studies exploring the association between MetS and sleep require the presence of at least 
three separate MetS components, the classification of MetS itself adopted in the present 
thesis (and used in the analyses presented in Part II of the present Chapter), would have 
identified a substantial proportion of those UKHLS participants with MetS as recognised by 
most of these classifications – i.e. UKHLS participants exhibiting a combination of elevated 
waist circumference and high blood pressure and diabetes.  
Nonetheless, since the classification of MetS itself used in Part II of the present 
Chapter may have excluded a number of UKHLS participants with dyslipidaemia together 
with any two of the other three MetS components, these participants would have been 
included in the referent group for those analyses (i.e. those summarised in: Figures 4.5, 4.6 
and 4.7; Figures 4.11, 4.12 and 4.13; and Figures 4.16 and 4.17, where the referent group 
included participants who did not display the particular component (or combination of 
components) of MetS being examined. This would also have been the case for those 
analyses using referent groups comprising ostensibly healthy participants who did not 
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display any of the three MetS components available (i.e. those analyses summarised in 
Figures 4.2, 4.3 and 4.4; Figures 4.8, 4.9 and 4.10; and Figures 4.14 and 4.15), simply 
because some of these (‘healthy’) participants may have actually displayed dyslipidaemia. 
However, unless the distribution of dyslipidaemia varied substantially across those groups 
of participants displaying three, two, one or none of the three other MetS components, the 
lack of data on dyslipidaemia should not have had a substantial impact on the direction or 
strength of associations observed between different MetS components (or different 
combinations of MetS components) and sleep. Unfortunately limited contemporary data are 
available on the distribution of these four MetS components (elevated waist circumference, 
high blood pressure, diabetes and dyslipidaemia) for samples or populations representative 
of the UK population. For this reason the impact of a lack of data on dyslipidaemia on the 
findings of Part II of the present Chapter’s analyses remains unclear. 
While the absence of data on dyslipidaemia may limit the specificity of any 
associations observed between other components/combinations of MetS and sleep, and 
may limit any comparison with previous studies in which data on dyslipidaemia were 
available (and were included in the analysis of any association between MetS and sleep), a 
further challenge to the comparability of the analyses conducted in Part II of the present 
Chapter with those from previous studies is the somewhat different cut-off points used to 
classify ‘high’ blood pressure and a ‘diagnosis’ of diabetes. These differences stem from the 
present thesis’ interest in developing, evaluating and analysing self-reported indicators of 
MetS components to facilitate their use in larger population based samples than might 
otherwise be possible given the constraints of collecting direct measurements of MetS 
components from large numbers of participants. Indeed, these constraints are clearly 
evident from the decision to select only a small proportion of UKHLS participants for 
inclusion in the NHA, on whom direct measurements of MetS components (and other 
physiological and anthropometric characteristics) were then collected – a decision 
determined in part by the costs involved, and in part by participation-related concerns 
(McFall 2013).  
For the purposes of the present thesis, which aimed to develop valid self-reported 
measures of MetS, it was necessary to examine the items available within the UKHLS 
questionnaires that might plausibly measure each component of MetS. As mentioned 
earlier, no suitable items were found on which a plausible self-report of dyslipidaemia might 
be based, and since the NHA itself did not provide suitable blood samples to generate direct 
measures of this component of MetS, a decision was taken to exclude consideration of 
dyslipidaemia as a component of MetS in the present thesis. However, the adult main 
UKHLS questionnaires did contain self-reported clinical diagnoses of both “high blood 
pressure” and “diabetes”, and to establish relevant, directly measured referents for these 
two (self-reports of) clinical diagnoses, it was necessary to determine the clinical definitions 
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that were likely to have been used by the clinicians responsible (i.e. by the clinicians who 
had first told participants that they had “high blood pressure” and/or “diabetes”). Since these 
definitions are currently provided by the UK’s National Institute for Clinical Excellence (NICE 
2011a; NICE 2011b), the most valid comparisons available between a “self-reported clinical 
diagnosis” of both “high blood pressure” and “diabetes” were those relevant to the specific 
definitions of these that would have been used by the clinicians concerned (see also 
Chapter 3 – in which the rationale for the choice of cut-offs used is presented in more 
detail). These definitions differ somewhat to those recommended by the NCPI-ATP III 
(Huang 2009). In particular, the definition of “high blood pressure” recommended by the 
NCPI-ATP III is >130 mmHg systolic or >85 mmHg diastolic, while NICE recommend that a 
Stage 1 formal diagnosis of “high blood pressure” is when blood pressure ≥140/90 mmHg. 
Likewise, the NCPI-ATP III recommend that “diabetes” be determined by fasting glucose 
≥100 mg/dl, while NICE recognise three diagnostic tests of diabetes – fasting blood glucose 
levels ≥ 7.0 mmol/l, blood glucose levels ≥ 11.1 mmol/l following a standard oral glucose 
tolerance test, and/or HbA1c levels ≥ 48 mmol/mol – and since the UKHLS NHA only 
provided data on HbA1c the present thesis had to rely on these data alone in order to 
determine the presence of diabetes. Elsewhere, since antihypertensive and diabetic 
medication are also recognised as valid measures of “high blood pressure” and “diabetes” 
by the NCPI-ATP III, the detailed records of these collected from UKHLS participants during 
the NHA allowed this information to be applied in an identical fashion to that recognised by 
the NCPI-ATP III. It is therefore only in the modest differences in cut-off values for blood 
pressure and in the use of HbA1c values rather than that recommended by the NCPI-ATP 
III. While these differences are likely to have resulted in slightly more UKHLS participants 
identified as displaying these two components of MetS, and might thereby have altered both 
the magnitude and/or precision of any association(s) between these and sleep observed, it 
is unlikely that these differences would have been sufficient to substantially accentuate or 
attenuate the associations observed. 
As for the assessment of elevated waist circumference, the cut-offs used for these 
were precisely as defined by the NCPI-ATP III, and the only differences in the classification 
of directly measured data on this component of MetS stem from the different measurement 
protocols used by the NHA and those recommended by the NCPI-ATP III. There were, 
however, no items requesting self-reports of waist circumference in any of the UKHLS 
questionnaires. Indeed, the only anthropometric variables for which self-reports were 
collected were height and weight. It was therefore necessary to assess the possibility of 
generating a reliable estimate of waist circumference based on self-reports of height and 
weight alone. The approach used to generate these estimates has been described in some 
detail in Chapter 3, and comparisons of these with the direct measurements of waist 
circumference collected during the NHA have been described in substantial detail in Part I 
of the present Chapter – comparisons suggesting that self-reported estimates of ‘elevated 
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waist circumference’ derived from self-reported height and weight displayed comparable 
levels of sensitivity, specificity and predictive value to those observed for self-reports of high 
blood pressure and diabetes. Thus, despite the present thesis’ reliance on estimates of self-
reported waist circumference, these are unlikely to have introduced any greater lack of 
precision to the specification of this component of MetS than that associated with the use of 
self-reported high blood pressure or diabetes. Therefore, notwithstanding the limited validity 
of self-reported MetS components per se (as assessed in Part I of the present Chapter), the 
approaches used to generate these in the present study resulted in self-reported measures 
of all three components that were broadly similar in terms of their validity and potential 
utility, based as they were on the limited data available from self-reported indicators in the 
UKHLS – items that are to a large extent comparable to those used by many other 
questionnaire-based population surveys, both in the UK and further afield. 
Finally, despite the potential benefits of using self-reported measures of MetS 
components for examining the prevalence of these (and any associations thereof with 
sociodemographic, lifestyle and other factors – including sleep, as in the present thesis) in 
far larger samples than might be possible using direct measurements alone, the power of 
any such analyses is inevitably determined not only by the total number of participants but 
by the prevalence of the key characteristics examined (in this instance both MetS and 
more/less favourable sleep). This is an issue in the present thesis, even though it 
deliberately chose the UKHLS as its data source on the basis that this offered not only the 
largest contemporary survey of sleep in the UK (using a sampling frame that aimed to be 
broadly representative of the UK population), but also provided directly measured data on 
three components of MetS from a sizeable subsample of participants (i.e. those selected for 
inclusion in its NHA). Indeed, even though the number of UKHLS participants with complete 
data on self-reported and directly measured MetS (Sample 1) and on self-reported variables 
from Wave 1 (Sample 2) were far higher than those achieved by most previous studies of 
the association between MetS and sleep, the low prevalence of some MetS components 
(and some combinations of these) mean that the analyses thereof may have been 
inadequately powered. For example, in the smaller of the two analytical samples (Sample 1, 
n=5,283) fewer than 3% of participants displayed MetS itself (i.e. the combination of all 
three MetS components: elevated waist circumference; and high blood pressure; and 
diabetes), fewer than 1.5% displayed diabetes alone (i.e. with neither of the other two 
components of MetS), and fewer than 1.0% displayed both high blood pressure and 
diabetes alone (i.e. with neither of these alone, or in combination with elevated waist 
circumference). Even in the larger of the two analytical samples (Sample 2, n=29,436) there 
were only n=393 participants with MetS itself, n=325 with diabetes alone, and only n=217 
with both high blood pressure and diabetes alone. These modest sample sizes are likely to 
explain why none of the effect estimates generated for the associations between MetS itself 
and three of the self-reported sleep characteristics (prolonged duration, >8hrs; latency, and 
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fragmentation) achieved strong associations except (for sleep fragmentation) in Sample 2, 
despite some evidence of strong trends for an decreased risk of prolonged sleep duration 
and an increased risk of sleep fragmentation amongst participants displaying MetS itself. 
The very different prevalence of each component of MetS (and each combination of these) 
is also likely to explain why some (particularly diabetes alone, and high blood pressure and 
diabetes alone) had so few associations with any sleep characteristics; and why others 
(particularly elevated waist circumference alone, by far the most prevalent component of 
MetS; see Tables 4.4 and 4.5) more commonly displayed associations with almost as many 
self-reported sleep characteristics as MetS itself. As with all epidemiological analyses, the 
impact of differences in statistical power on the patterns of ‘significant’ results in the present 
study emphasises the importance of focusing on effect size estimates rather than on any 
(statistical) confidence in these. This possibility warrants further investigation using larger 
samples of participants displaying these specific components of MetS (and/or combinations 
of these). Nevertheless, given that in both Sample 1 and 2 the prevalence of MetS itself (i.e. 
the combination of all three MetS components: elevated waist circumference;  and high 
blood pressure; and diabetes) was only consistently higher than that observed for three 
other components/combinations of MetS (diabetes alone; high blood pressure and diabetes; 
and elevated waist circumference and diabetes), the fact that MetS itself displayed a larger 
number of strong associations with different self-reported sleep characteristics than any of 
the remaining (more prevalent) components/combinations of MetS (elevated waist 
circumference alone; high blood pressure alone; and elevated waist circumference and high 
blood pressure) provides good evidence to suggest that MetS itself has association(s) with 
self-reported sleep across a broader range of sleep characteristics than that observed for 
any of the other three components/combinations of MetS. As such, Part II of the present 
Chapter’s analyses provide stronger evidence than might seem likely (given the modest 
prevalence of MetS) that self-reported sleep appears most sensitive to the combination of 
all three components of MetS rather than any other combination thereof. 
Generalizability 
Since the distribution of sociodemographic characteristics amongst participants in 
Sample 2 was very similar to that amongst those in Wave 1, the findings generated on data 
from Sample 2 are likely to be broadly generalizable to both the UKHLS and the wider UK 
population. Nevertheless, because these data did not include the lifestyle variables 
available to participants in Sample 1, and since the impact of adjusting for these variables in 
multivariable analyses of Sample 2 suggests that (contrary to the theoretical causal path 
diagram chosen to guide these analyses) these operated as confounders rather than 
mediators, it is likely that the effect estimates generated by the fully adjusted models used 
for Sample 2 (in which there was no adjustment for lifestyle factors) suffer from unadjusted 
confounding. However, given the efforts made to address possible confounding effects in 
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the analysis of data from Sample 1, and given the very similar results observed amongst 
both samples (Sample 1 and 2), the results from Sample 2 might still be broadly 
generalizable.   
Methodological considerations 
Notwithstanding these limitations, the comprehensive analyses conducted in Part II 
of the present Chapter successfully addressed two of the potential flaws identified in the 
thesis’ review of previous studies exploring the association between MetS and sleep (see 
Chapter 2):  
(i) the use of referent groups containing unhealthy vs. healthy participants; and  
(ii) the use of potentially inadequate and/or inappropriate adjustment sets:  
(i) A comparison of models analysing the association between MetS and sleep using 
different referent groups – those containing participants who did not display any of the three 
available components of MetS and those using referent groups containing some 
participants displaying components of MetS (and combinations of these) other than the 
particular component(s) being examined – found very similar associations for MetS itself 
(i.e. the classification based on elevated waist circumference and high blood pressure and 
diabetes), although these were somewhat attenuated when the referent group included 
some participants displaying other combinations of MetS components. This may not be 
surprising given that some of these combinations of MetS components (particularly those 
that included elevated waist circumference) also had strong associations with a number of 
self-reported sleep characteristics (regardless of the referent group used) – meaning that 
the inclusion of these participants in the referent group used to evaluate the association 
between MetS itself and sleep will have included (within the referent) participants with other 
combinations of MetS components that were, themselves, associated with unfavourable 
outcomes across a number of sleep characteristics. Another possibility is the contribution 
each MetS component might have made to another; obesity, for example, is known to 
contribute to both diabetes and hypertension (Han and Lean 2016).  
(ii) Meanwhile, the differential impact of adjustment for sociodemographic and 
contemporaneous lifestyle factors on the association between MetS itself and sleep 
demonstrates some of the challenges facing the identification of potential confounders and 
likely/possible mediators in analyses applying a causal path approach to cross-sectionally 
collected observational data. Setting aside the limited capacity for such data to generate 
persuasive evidence of causality, this thesis has argued consistently that even cross-
sectionally collected data should be amenable to temporal interpretation and analytical 
modelling using causal path diagrams wherever the information available on the timing and 
methods of data collection permit an assessment of ‘where’ each of the measured variables 
might be temporally arranged within the causal path diagram (Pearl 2000; Glass et al. 2013; 
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Rottman and Hastie 2014). It was on this basis that six separate directed acyclic graphs 
(DAGs) were presented in Chapter 2, and the plausibility of each discussed in relation to the 
datasets and statistical models used by each of the studies reviewed therein. It was also the 
basis on which the analyses undertaken for the present Chapter (Part II), using cross-
sectional data from the UKHLS, assumed that: sociodemographic factors were likely to act 
as potential confounders in the association between MetS and sleep; while 
contemporaneous lifestyle factors were likely to operate as possible mediators (variables 
falling on the causal path between the exposure and the outcome). 
 These assumptions were based on a theoretical understanding of the likely inter-
relationships between the four groups of variables available for inclusion in the present 
Chapter’s (Part II) analyses (i.e. sociodemographic factors, MetS components, 
contemporaneous lifestyle factors and self-reported sleep characteristics). Indeed, although 
it is likely that the last three of these groups of variables might, at different stages of the 
lifecourse, act as both cause and effect of one another, the simultaneous cross-sectional 
collection of these variables in the UKHLS means that, as measured therein, these 
variables are most likely to be arranged in a specific sequence: ‘sociodemographic factors’ 
preceding ‘MetS components’ preceding ‘contemporaneous lifestyle factors’ preceding 
‘sleep characteristics’. On a similar basis the present thesis was critical of many of the 
previous cross-sectional studies reviewed in Chapter 2, particularly when: these assumed 
that contemporaneous (or relatively recent) measures of sleep were possible causes of 
MetS components likely to have developed at some stage in the more distant past; and 
contemporaneous lifestyle factors were included in the adjustment sets of the multivariable 
analyses these studies undertook. Yet, in the absence of sleep, lifestyle and MetS 
component data collected throughout the lifecourse, all of these analyses (including those 
conducted in Part II of the present Chapter) overlook the potential role of these, preceding 
yet latent variables operating as confounders in any analysis of cross-sectionally measured 
MetS, sleep and lifestyle. With only cross-sectional measures of these three variables it is 
also hard to model the longer-term and shorter-term impacts of each group of variables 
given, for example, that there is substantial evidence that the development of central 
obesity (a key component of MetS) is accompanied by (subsequent) changes in self-
reported sleep (Ford et al. 2014), while acute changes in sleep duration (particularly 
experimental restriction of sleep duration) (Gonnissen et al. 2013) can cause immediate 
changes to glucose metabolism, appetite and satiety (and thereby, perhaps, short-term 
changes in body weight). 
Within the context of cross-sectionally collected data with little, if any, data collected 
throughout the lifecourse, the path diagrams used to support the modelling of likely causal 
relationships are severely limited by the absence of earlier measurements. As such, the 
DAGs used in the present thesis are not only speculative, but also severely limited in their 
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capacity to support the analysis of cross-sectionally measured data where previous 
measures of the exposure, outcome and other covariates are unavailable. Thus, while the 
present Chapter proposed, on ostensibly sound theoretical and functional grounds, that: 
sociodemographic factors are likely to precede the development of all three MetS 
components; these components are likely to precede self-reported sleep, and that 
contemporaneous lifestyle measures are likely to fall between MetS and sleep (thereby 
operating as likely mediators), the results of analyses examining the association between 
MetS components and sleep before and after adjusting for (first) sociodemographic and 
(then, also) lifestyle factors, do not entirely support these assumptions.  
Certainly, for most of the self-reported sleep characteristics with strong unadjusted 
relationships with MetS (i.e. short duration, loud coughing/snoring and medication), 
adjustment for sociodemographic factors led to the attenuation of the effect estimates 
observed, as might be expected were these factors to be operating as confounders. 
However, adjustment for sociodemographic factors strengthened the association between 
MetS and two other sleep characteristics (quality and daytime sleepiness), neither of which 
had had strong associations with MetS prior to adjustment. While, for the (subsequent, 
additional) adjustment for contemporaneous lifestyle factors, all of which were originally 
thought to be likely/possible mediators in the association between MetS and sleep, their 
inclusion in the adjustment sets used in the present Chapter’s analyses led to a consistent 
attenuation of the effect estimates between MetS and self-reported sleep. It is possible that 
this attenuation in the magnitude of some effect sizes and the strengthening observed in 
others, is an indication of suppression effects (Tu, Gunnell and Gilthorpe 2008). Such 
phenomena have been defined by Genger (Conger 1974) as: 
 ‘‘a variable which increases the predictive validity of another variable (or set of 
 variables) by its inclusion in a regression equation,’’ 
  
The potential utility of self-reported MetS components 
 Having somewhat resolved (or at least clarified) these two important methodological 
concerns, the present Chapter (Part II) made substantial progress assessing the analytical 
utility of MetS components generated from self-reported indicators (rather than from direct 
measurements of these). The broad comparability of self-reported and directly observed 
MetS components was established previously in Part I of the present Chapter, which 
contained analyses demonstrating a reasonable level of sensitivity, specificity and predictive 
value.  
Following on from these analyses, the analyses conducted in Part II of the present 
Chapter confirm that, to a large extent, the associations observed between directly 
measured MetS itself (i.e. the classification based on elevated waist circumference and high 
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blood pressure and diabetes) and self-reported sleep characteristics were very similar to 
those observed when self-reported MetS was used. In both sets of analyses, MetS itself 
was associated with an increased risk of the same four sleep characteristics (short duration, 
<6hrs; loud coughing/snoring; medication; and quality), and these effect estimates (and 
those for daytime sleepiness) responded similarly to adjustment for sociodemographic and 
lifestyle factors. While these analyses suggest that both sources of MetS data offer similar 
utility when exploring its association with self-reported sleep, the modest attenuation of 
effect estimates generated by models using self-reported, as opposed to directly measured, 
MetS indicates the impact of the finite level of agreement observed between these two 
sources of MetS data in Part I. This may have an impact on the precision of estimates 
generated by smaller samples of participants (where any association between MetS and 
sleep may be dwarfed by the additional variance attributable to incomplete the limited 
validity of self-reported MetS). However, since self-reported MetS components are likely to 
be of principal benefit to large-scale population-based studies where the costs of directly 
measuring large numbers of participants is likely to be prohibitive, the consistency observed 
in the results of models using directly-measured and self-reported MetS in the present study 
suggest that self-reported MetS may offer substantial scope for future population-based 
studies.  
This potential was demonstrated in the present study by repeating the analyses of 
self-reported MetS and self-reported sleep conducted on the n=5,283 participants in the 
UKHLS NHA (for whom data on both self-reported and directly measured components of 
MetS were available) on the far larger number of UKHLS participants (n=29,436) providing 
only data on self-reported MetS in Wave 1. Given the very similar findings generated by 
these models to those generated by analyses of the smaller number of (older, and 
potentially unhealthier) participants selected for inclusion in the UKHLS NHA, these offer 
the first population-based assessment of the association between MetS and sleep using 
self-reported indicators as measures of MetS components. They confirm that, even when 
using self-reported MetS components, these components are associated with an increased 
risk of short sleep, loud coughing/snoring, sleep medication use and (again, after 
adjustment for sociodemographic factors) sleep quality and daytime sleepiness.  
These analyses also found that MetS itself was associated with a higher risk of 
sleep fragmentation (waking up “in the middle of the night or early in the morning”) – 
suggesting the absence of this association among participants in Sample 1 (which was 
limited to those included in the UKHLS NHA) might reflect some of the differences in the 
distribution of sociodemographic factors amongst participants included Wave 1 and the 
NHA (see Table 4.4). Unfortunately, the absence of items on contemporaneous lifestyle 
factors in the UKHLS Wave 1 questionnaires meant that it was not possible to assess the 
impact of including these in the adjustment sets used in analyses of the larger sample 
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(Sample 2); but it was possible to run these analyses using both of the referent groups 
examined in analyses of the smaller (NHA) sample, and this again confirmed a very similar 
pattern of associations between MetS and self-reported sleep to that found in the earlier 
analyses. For these reasons, one can have substantial confidence that self-reported 
indicators of MetS components offer a sound basis for assessing the relationship between 
MetS and self-reported sleep in larger population-based samples (such as Wave 1 of the 
UKHLS) and that the analyses presented in the present Chapter (Part II) confirm that self-
reported MetS is associated with an increased risk of a number of self-reported sleep 
characteristics amongst UKHLS participants representative of the UK population. 
The differential association between different components (and combinations of 
components) of MetS and different self-reported sleep characteristics 
Although both sets of analyses involving UKHLS participants (whether from the NHA 
or Wave 1) suggest that MetS itself (i.e. the classification based on elevated waist 
circumference and high blood pressure and diabetes) is associated with an increased risk of 
up to five self-reported sleep characteristics (short duration, loud coughing/snoring, 
medication, quality and daytime sleepiness), it is also clear from these analyses that 
elevated waist circumference was the single most important component of MetS in terms of 
its association with sleep. This is because elevated waist circumference alone was 
consistently associated with more self-reported sleep characteristics than either of the other 
two MetS components (high blood pressure and diabetes), and that the pairs of MetS 
components containing elevated waist circumference (i.e. elevated waist circumference and 
high blood pressure; or elevated waist circumference and diabetes) tended to be associated 
with more self-reported sleep characteristics than the other MetS components alone or 
combined. Indeed, the only additional self-reported sleep characteristic associated with 
MetS itself that was not associated with elevated waist circumference alone was sleep 
quality, suggesting that self-reported sleep quality is particularly sensitive to the combination 
of MetS components included in the classification of MetS itself.  
 These findings indicate that the choice of MetS components, and the combinations 
of these, are likely to influence the associations observed with self-reported sleep. At the 
same time, these findings also indicate that: some self-reported sleep characteristics are 
more sensitive to individual MetS components (and to specific combinations thereof); and 
there are (at least) two self-reported sleep characteristics (prolonged sleep duration and 
sleep latency) that may not be associated with MetS, while a third (sleep fragmentation) that 
may only be associated with MetS in population-based analyses. As such, the meaning of 
these (present and absent) relationships between different components/combinations of 
MetS and different self-reported characteristics remains unclear. While it is possible that the 
relationship between MetS and sleep is MetS-component- and sleep characteristic-specific, 
it may also be that: these relationships are primarily driven by obesity (which in turn affects, 
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to differing degrees, both blood pressure and glucose metabolism); and/or some self-
reported sleep characteristics are more reliable measures of MetS-relevant sleep 
phenomena than others. These uncertainties require additional research beyond the scope 
of this thesis, not least because they are not amenable to investigation using analyses of 
observational data alone. Yet, they do to some extent explain the somewhat inconsistent 
findings reported by the studies reviewed in Chapter 2, which used a range of different 
MetS components and classifications, and focussed on a range of different sleep 
characteristics. The analyses presented in the present study make substantial progress 
towards explaining these inconsistencies and, by examining a comprehensive list of no 
fewer than seven self-reported sleep characteristics, reveal the extent of variation in their 
associations with MetS. In the process, the present Chapter has made a novel contribution 
to this area of study by helping to narrow down the scope of our uncertainty, and creating a 
firm basis upon which priorities for future research can be identified. These will be 
considered in greater detail in the final Discussion Chapter of this thesis. 
4.2.7 Summary and conclusion 
The analyses conducted in the present Chapter reveal that the associations observed 
between three key components of MetS (elevated waist circumference; high blood 
pressure; and diabetes – and different combinations of these three components) and seven 
different self-reported sleep characteristics are dependent upon: the choice of referent 
population used; adjustment for sociodemographic and lifestyle covariates; and the use of 
self-reported or directly measured data on each MetS component.  
When compared to healthy participants (i.e. those displaying none of the three MetS 
components), and following adjustment for sociodemographic and lifestyle factors, 
participants displaying all three MetS components had an elevated risk of: short sleep 
duration (<6hrs); trouble sleeping due to loud coughing and snoring; using medication to 
help them sleep; experiencing difficulty staying awake during the day; and reporting the 
quality of their sleep as less than ‘very good’.  
Elevated waist circumference (as a marker of central obesity) appeared to make the 
most important contribution to the associations observed between MetS and sleep; while 
short sleep duration, loud coughing/snoring and the use of sleep medication were the three 
sleep characteristics most strongly associated with MetS.  
These findings were somewhat attenuated, but otherwise largely unaffected, when 
MetS components were based on self-reported indicators as opposed to direct 
measurement of each MetS component; suggesting that self-reported MetS might have 
substantial utility in large-scale population-based surveys where it is not feasible to collect 
direct measurements of each component of MetS. 
204 
 
To demonstrate the potential utility of self-reported MetS components in such 
contexts, data on these were generated for a larger sample of survey participants, and their 
associations with self-reported sleep characteristics were found to be very similar to those 
observed in a smaller sample of the same participants for whom data on directly measured 
MetS components had been collected.  
Since this, larger sample of participants displayed a similar distribution of 
sociodemographic characteristics to those recruited to provide a representative sample of 
the UK population, it is likely that the associations between MetS and sleep observed in the 
analysis of this larger sample are broadly generalizable to the UK population as a whole.   
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Chapter 5 Discussion  
5.1 Summary of findings 
At the outset of the present thesis – which set as its overarching aim an improved 
understanding of the available evidence regarding the speculative relationship between 
sleep and the metabolic syndrome (MetS) – three key questions (KQs) were posed: 
KQ1:  “What methodological and empirical insights might be drawn from previous studies 
examining the relationship between sleep and the metabolic syndrome (MetS) to inform: the 
focus and conduct of future research; and our understanding of the evidence base 
regarding ‘unfavourable’ sleep as a possible cause and a possible consequence of MetS?” 
KQ2: “What UK-based datasets are available from which to examine the relationship 
between sleep and the metabolic syndrome (MetS) to inform: the focus and conduct of 
future research; and our understanding of the evidence base regarding ‘unfavourable’ sleep 
as a possible cause and a possible consequence of MetS?”  
KQ3: “To what extent might self-reported items relevant to identifying MetS in large 
datasets offer sufficiently valid measures of MetS symptoms/components to provide a basis 
upon which to generate a ‘self-reported’ classification of MetS suitable for use in population-
based analyses where direct measures of MetS components are not available/feasible?”   
and  
KQ4: “What methodological and aetiological insights into the association between sleep 
and MetS might be generated from analyses of such data?” 
Each of these four questions have been addressed in successive Chapters of the 
present thesis, using a range of different methods, including: KQ1 - a systematic review of 
published empirical studies (Chapter 2); KQ2 - exploring and identifying a UK based dataset 
that contains suitable data; KQ3 - the development of three self-reported measures of 
MetS-related symptoms/components, and comparing them to their direct/objective 
measures (Chapter 4, Part I); and KQ4 - novel analyses of a contemporary secondary 
dataset provided by the UK Household Longitudinal Study (UKHLS), addressing the flaws 
identified in the preceding systematic review (Chapter 2), and using the self-reported 
classification of MetS presented in (Chapter 4, Part II). 
The aims of the final Chapter of this thesis (i.e. the present Chapter) are to: 
summarise and synthesise the main findings from each of the preceding analytical 
Chapters; identify the limitations of these, and of the thesis as a whole; and make 
recommendations for further methodological and empirical research that lead on from, and  
build upon, the contribution made to research on the relationship between sleep and MetS 
by the present thesis. As such, the present study addressed the requirement for originality 
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by adopting a large-scale, mixed-methods epidemiological approach, using: a critical review 
of previous empirical studies; and observational analyses of large population datasets – the 
latter informed by cutting edge advances in the development of techniques to support the 
analysis of causal inference, developing, validating and applying a novel approach to the 
classification of MetS using self-reported information on clinical diagnoses of obesity, 
hypertension and diabetes (as markers for three key clinical components of MetS that would 
be difficult to obtain from direct measurements on the large population samples that are 
ideal for use in epidemiological analyses). Although the present thesis was unable to 
perform a confirmatory MI, and instead had to rely on complete-case based analyses, the 
present study nonetheless broke fresh ground by exploring in greater detail the 
epidemiological evidence for any association between MetS (both directly measured and 
self-reported) and seven different sleep characteristics amongst a representative sample of 
UK adults (the first such study to be conducted in the UK, and only the third such study 
outside of Asia and North America).  
5.1.1 The systematic review of previous empirical studies exploring the 
relationship between sleep and MetS 
The original contribution made by the present thesis draw and build upon the review, 
critical appraisal and detailed synthesis of previous studies exploring the association 
between sleep and MetS, as summarised in Chapter 2. This was the first review of its kind 
to attempt such a detailed critical assessment of the evidence to-date. However, while 
Chapter 2 adopted a deliberately broad search strategy – one that intended to capture 
evidence of association, directionality and effect from cross-sectional, longitudinal and 
experimental studies, respectively – the only studies it found that met its explicit inclusion 
criteria (which set a clear focus on: empirical studies exploring sleep-related characteristics 
rather than clinical conditions occurring during/associated with sleep [particularly OSA]; and 
studies using robust analytical designs) were those using a cross-sectional design.  
Since cross-sectional study designs can only provide evidence of association (and 
not of ‘directionality’ or ‘effect’) (Miller and Brewer 2003), the principal limitation of the 
synthesis of evidence presented in Chapter 2 stems from its reliance on previous studies 
adopting a cross-sectional design. Nonetheless, since this is the design used by the 
majority of speculative studies exploring the plausibility of existing (or novel) hypotheses – 
including, in this instance, the possibility that ‘unfavourable’ sleep might trigger, promote or 
facilitate the development of MetS – and since such studies are routinely used to generate 
and replicate hypotheses, and thereby establish the merits of conducting more resource-
intensive studies (i.e. those adopting longitudinal and experimental designs), there is still 
substantial value in critically appraising the methods used, and synthesising the findings 
reported by, empirical cross-sectional studies. Indeed, detailed examination of n=21 studies 
examining the association between sleep and MetS, each using ostensibly ‘cross-sectional’ 
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data (i.e. data collected cross-sectionally though, from a causal perspective, including 
variables relevant to events and phenomena emerging at different times across the 
lifecourse), identified a number of methodological flaws and sufficient variation in 
measurement and analytical approach to pose substantive challenges to the synthesis of 
their findings.  
Around half of the studies involved fewer than n=1,000 participants, and while none 
examined more than four sleep-related characteristics, most of the ten discrete 
characteristics examined by one or more of these studies had only been examined by a 
single study (the exceptions being: sleep duration, examined by n=14/21 studies; sleep 
quality by n=6/21; and snoring/sleep-related breathing difficulties by n=5/21). Few of the 
studies reported a comprehensive list of potential confounders amongst their 
measured/available covariates, and none included all of the covariates that were measured 
by/available to any of the other studies. This meant that none of the studies were able to 
adjust for all of the potential confounders that appeared to be available to/measureable by 
other studies, so that even the adjusted effect estimates presented by those studies 
reporting a good number (and range) of available/measured confounders are likely to have 
suffered from unadjusted confounding (Fewell, Smith and Sterne 2007). At the same time, 
almost all of the studies included likely mediators (identified using theoretical causal path 
diagrams, in the form of DAGs) in many of their covariate adjustment sets, so that the effect 
estimates these models provided are likely to have been subject to bias as a result of the 
so-called ‘ reversal paradox’ (Tu, Gunnell and Gilthorpe 2008). 
Evidence to support these analytical concerns was generated using meta-analyses of odds 
ratios reported by any two or more studies using sufficiently comparable measures of the 
same sleep characteristics to permit direct comparison – in this instance: n=9 studies 
examining the association between short and prolonged sleep duration and MetS; and n=3 
studies examining the association between poor sleep quality (as measured using the 
Pittsburgh Sleep Quality Index) and MetS. In three separate sets of meta-analyses, MetS 
was found to be associated with a higher combined odds of short/prolonged sleep duration 
and a higher combined odds of poor sleep quality. Although these combined estimates were 
substantially attenuated following adjustment for only those covariates considered likely to 
act as potential, the inclusion of covariates considered to act as likely mediators in the 
covariate adjustment sets used (together with components of sleep and/or MetS, in some of 
the adjustment sets used) tended to strengthen the combined odds obtained. In this way, 
the critical appraisal of these studies’ methods, and the synthesis of these studies’ findings, 
(as presented in Chapter 2 of the present thesis) cast considerable doubt on the evidence 
provided by the cross-sectional studies it reviewed. While, at face value, these studies 
seem to suggest that a variety of ‘unfavourable’ sleep characteristics are, at the very least, 
associated with an increased odds of MetS, the fact that none of these studies made much 
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effort to address the very real possibility of confounding, and that the strongest effect 
estimates reported were for studies with very small numbers of participants (and those 
using covariate adjustment sets containing likely mediators and components of the 
exposure and/or outcome) means that little confidence can be placed on the findings they 
report, however plausible and attractive their findings might seem.  
Nonetheless, Chapter 2’s critical appraisal of these studies’ methodological and 
analytical techniques did succeed in identifying a number of important issues that warranted 
serious consideration in the subsequent analyses envisaged for inclusion in the present 
thesis, particularly: 
 the value of examining large samples of participants to achieve sufficient 
statistical power (not least for potentially rare events, such as MetS 
symptoms/components occurring in isolation or in unusual combinations) to 
minimise the risk of type 1 statistical errors; 
 the need to carefully specify the composition of the referent groups used 
(particularly regarding their inclusion of: only those participants exhibiting 
none of the symptoms/components of MetS; or participants exhibiting ≤3 of 
the symptoms/components considered necessary to warrant a classification 
of MetS);  
 the benefit of using theoretically driven causal path diagrams to inform the 
identification of (a comprehensive list of) potential confounders and likely 
mediators, and thereby ensure that analyses of any association between 
MetS and each of the available/measured sleep characteristics could be 
optimally adjusted for a sufficiently broad range of potential confounders 
(thereby minimising the risk of unadjusted confounding, while avoiding the 
bias caused by adjustment for likely mediators); and 
 the value of comparing the association between MetS and a range of 
different sleep characteristics using data from the same source/participants 
(to facilitate an assessment of the relative importance of these characteristics 
as potential causes, consequences, or simply correlates, of MetS). 
5.1.2 The development and validation of ‘self-reported’ MetS based on 
self-reported indicators of key MetS symptoms/components 
The first of these issues was addressed in subsequent Chapters of the present 
thesis by selecting a large ongoing study (the UK Household Longitudinal Study; UKHLS) 
that had collected substantial data on a range of sleep characteristics and potential 
confounders, as well as direct measures of three key symptoms/components of MetS (waist 
circumference, blood pressure, markers of blood glucose levels, and prescribed medication 
for hypertension and diabetes). However, although these direct measures of MetS 
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symptoms/components were available on a sizeable subsample of UKHLS participants 
(n>5,000), the present thesis sought to extend its analyses to the much larger number of 
UKHLS participants providing data on self-reported sleep characteristics and potential 
confounders, by exploring the possibility of using self-reported anthropometric data and 
clinical diagnoses of high blood pressure and diabetes as the basis for developing a valid 
‘self-report’ of MetS (i.e. a classification of MetS based on self-reported indicators of these 
three components of MetS).  
To this end, Chapter 4 (Part I) presented the first attempt to develop a ‘self-report’ of 
MetS based on self-reported indicators available within the UKHLS dataset, and validate 
these by comparing them to the direct measures of MetS components collected from 
participants in the study’s Nurse Health Assessment (NHA). Despite the substantial interval 
between the collection of self-reported and directly measured data (which ranged from 5-
18months between the surveys in which these data were generated); and despite the 
necessity of estimating ‘self-reported’ waist circumference using self-reports of weight and 
height (which were the only two anthropometric variables included in the survey 
questionnaires used by the UKHLS), ‘self-reported’ MetS displayed a remarkably good level 
of agreement with ‘directly measured’ MetS. 
5.1.3 Cross-sectional analyses of the association between MetS and 
seven self-reported sleep characteristics using data from the 
UKHLS 
 The final analytical Chapter 4 (Part II) in the present thesis drew heavily on the 
findings of the two preceding Chapters to generate what aimed to be the most 
comprehensive and robust analyses to-date of cross-sectional data on self-reported sleep 
characteristics and both self-reports and direct measures of MetS. Incidentally, these were 
also the first such analyses undertaken on data from the UK, and since the UKHLS aimed 
to recruit participants providing a representative sample of UK adults, the results of these 
analyses are likely to be broadly generalizable to the adult population of the UK as a whole. 
Importantly, all of these analyses involved substantial numbers of participants (in excess of 
n=5,000 participants); and all were repeated using two precisely specified referent groups 
(the first comprising participants displaying none of the three MetS symptoms/components 
examined; the second comprising all ‘MetS-free’ participants, some of whom will have 
displayed one or two, though not all three, MetS symptoms/components). Great care was 
taken to identify as many covariates acting as potential confounders for inclusion in the 
covariate adjustment sets used in these analyses. Similar care was taken to identify 
covariates acting as likely mediators in the association between MetS and sleep, and while 
mediators were excluded from the adjustment sets used to assess the impact of 
confounding on the unadjusted associations observed, mediators were included in the 
adjustment sets used by a third set of models to confirm whether their inclusion might 
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strengthen the associations observed and thereby offer some reassurance that these 
covariates had been correctly specified as likely mediators. 
 In the event, the inclusion of lifestyle factors (i.e. the covariates considered likely to 
act as mediators in any association between MetS and sleep) in the covariate adjustment 
sets used by the multivariable models presented in Chapter 4 (Part II) did not tend to 
strengthen the associations observed; and instead the inclusion of covariates considered 
potential confounders or likely mediators was found to attenuate associations between 
MetS and some sleep characteristics, while strengthening those of others. These findings in 
part reflect the degree of guesswork (in other words, ‘imprecision’) involved when specifying 
the temporal positioning of cross-sectionally collected variables in theoretical causal path 
diagrams, and the use of these diagrams to identify which covariates are likely to act as 
confounders, and which as mediators. And while such an approach, at the very least, offers 
greater clarity to others regarding the rationale for including some covariates and excluding 
others from the adjustment sets used, this approach remains fraught with problems when 
cross-sectionally measured covariates are able to act as: both contemporaneous measures 
of the factor concerned; or proxies for past measures of these (or, indeed, other 
past/present events, characteristics or phenomena). The use of different adjustment sets in 
the multivariable models used in Chapter 4 (Part II) therefore throw some doubt on the 
covariates specified as mediators in Chapter 2, and on the reassurance the meta-analyses 
presented therein provide that these ‘mediators’ had been correctly specified (i.e. 
reassurance based on the observation that adjustment for these ‘mediators’ tended to 
strengthen the association between MetS and sleep). 
 Nonetheless, the multivariable models presented in Chapter 4 (Part II) do confirm 
that a range of different self-reported sleep characteristics display strong associations 
between MetS and sleep in which MetS is consistently associated with ‘less favourable’ 
sleep. Somewhat unsurprisingly, these associations were strongest when the referent group 
used comprised participants displaying none of the three MetS symptoms/components 
examined (i.e. neither elevated waist circumference; nor high blood pressure; nor diabetes) 
than when the referent group contained some participants displaying two or less of these 
symptoms/components (i.e. fewer than the three specified by the classification of MetS 
used). Since the latter is the approach assumed to have been used by the n=21 cross-
sectional studies reviewed in Chapter 2 (none of which provided unequivocal descriptions of 
the MetS symptoms/components displayed by participants in their ‘MetS-free’ referent 
groups), it is worth comparing the findings reported by these earlier studies to those 
provided by the adjusted models used in Chapter 4 (Part II) to re-evaluate the association 
between MetS (based on direct measures of MetS symptoms/components) and each of the 
seven self-reported sleep characteristics included in the UKHLS dataset.  
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In Chapter 2, the previous studies reviewed suggested there was evidence that 
MetS was associated with an increased risk of: short/prolonged sleep duration and MetS 
(based on the findings presented in n=9 separate studies); poor sleep quality (in n=6 
studies); snoring/sleep-disordered breathing (in n=5 studies); and habitual sleep latency, 
poor sleep efficiency, sleep medication use, Non-REM Beta and AHI events (each from the 
findings presented in just n=1 study). These are very different to the limited number of 
sleep-related characteristics found to be associated with MetS based on directly measured 
symptoms/components summarised in: Figure 4.6 (following adjustment for covariates 
considered potential confounders); and Figure 4.7 (following adjustment for covariates 
considered potential confounders or likely mediators) – in both of which the referent group 
contained some participants displaying up to two (though not all three) 
symptoms/components of MetS. In these Figures, MetS was only associated with two 
sleep-related characteristics (poor quality sleep, and a higher frequency of daytime 
sleepiness), and there was little substantive evidence of an association with any of the other 
five characteristics examined (sleep duration, latency, fragmentation, medication and 
coughing/snoring loudly). Short sleep duration, loud coughing/snoring and/or the use of 
sleep medication were also associated with MetS (i.e. in addition to the associations 
observed for daytime sleepiness and poor sleep quality in Figures 4.6 and 4.7) in analyses 
using participants displaying none of the three MetS symptoms/components as the referent 
(following adjustment for confounders and mediators; see Figures 4.3 and 4.4).  
This better reflects the range of sleep characteristics reportedly associated with 
MetS amongst the n=21 studies reviewed in Chapter 2. Indeed, the two previous studies 
(albeit, both using the same source of data) that had examined the association between 
daytime sleepiness and MetS in Chapter 2 (Roopa et al. 2010; Krishnan et al. 2012), and 
the single study examining the association between sleep fragmentation and MetS (Mesas 
et al. 2014), also reported no such associations – as did none of the analyses in Figures 
4.3, 4.4, 4.6 or 4.7 of Chapter 4 (Part II). Nonetheless, the single study included in Chapter 
2 that had examined the association between sleep latency and MetS (Mesas et al. 2014) 
did report a strong association between the two, while none of the analyses in Figures 4.3, 
4.4, 4.6 or 4.7 did so. 
 These disparities in the findings presented in Chapters 2 and 4 (Part II) may simply 
reflect the different methodological approaches used to measure and analyse both MetS 
and sleep in the previous studies reviewed (in Chapter 2) and in the subsequent de novo 
analyses conducted (for Chapter 4 Part II). It is therefore tempting to conclude (given the 
larger number of sleep characteristics showing a strong association with MetS when the 
referent group included only those participants who displayed none of the 
symptoms/components of MetS; see Figures 4.3 and 4.4) that the poorly 
specified/described referent groups used by the studies reviewed in Chapter 2 had actually 
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used referent groups comprising only ‘healthy’ participants (i.e. those displaying none of the 
symptoms/components of MetS examined). Yet, to a large extent the review assumed (on 
the basis of the limited descriptions these studies provided) that their referent groups had 
actually included some participants displaying one or two (though not three or more) of 
these symptoms/components. It certainly seems more likely that this was the case (if only 
on the basis of what could be construed from the limited information contained in each of 
the articles concerned), and that the larger number of sleep characteristics found to be 
associated with MetS in the review of the previous studies conducted in Chapter 2 simply 
reflects the tendency for publication bias; not least because, for most of these 
characteristics, these had only been examined by a single study. 
 This comparison of the results obtained from the review of previous studies 
exploring the association between MetS and sleep (in Chapter 2), and those generated from 
de novo analyses of seven sleep characteristics and direct measures of MetS based on 
data from the UKHLS (in Chapter 4 Part II), is nonetheless compromised by three further 
(and potentially key) differences between the datasets used: the first regarding the time 
interval between the measurement of sleep and the measurement of MetS; the second 
being the absence of dyslipidaemia from the classification of MetS applied to data from the 
UKHLS; and the third being the differential exclusion of unhealthy participants from the 
UKHLS Nurse Health Assessment (in which only a subsample of UKHLS participants took 
part) and from the samples examined by those studies reviewed in Chapter 2. 
While the vast majority of studies reviewed in Chapter 2 used/collected data on 
sleep and symptoms/components of MetS at the same point in time (see Table 2.2), the 
self-reported sleep data used in Chapter 4 Part II’s analyses examining their association 
with directly measured components of MetS had been collected around 18 months before 
the Nurse Health Assessment (when direct measurements of waist circumference, blood 
pressure, HbA1c levels and prescribed medication data were collected). This is a 
substantial amount of time, and any changes in sleep patterns or behaviours in the 
intervening period might substantially weaken any genuine association between these and 
directly measured MetS.  
At the same time, all of the studies reviewed in Chapter 2 had access to or directly 
measured lipid levels in fasting blood samples, and included criteria based on these levels a 
fourth (and occasionally a fifth) symptom/component in the classifications of MetS they 
used. In contrast, the UKHLS NHA did not collect the fasting blood samples required for the 
measurement of dyslipidaemia and for this reason the classification of MetS used in 
Chapters 4 (Part I) and (Part II) of the present study had to rely on only three 
symptoms/components of MetS (elevated waist circumference, high blood pressure and 
diabetes) rather than the four or five different components more commonly used (i.e. by the 
four different classificatory schemes used by the n=21 studies reviewed in Chapter 2). 
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Although this will have reduced the number of UKHLS participants who were classified as 
having/displaying MetS (since this would have excluded participants with two of the three 
measured symptoms/components dyslipidaemia who also displayed unmeasured 
dyslipidaemia) it would also have meant that participants displaying dyslipidaemia would 
have been included in the referent groups used in Figures 4.3-4.5 (who were intended to be 
free of any components of MetS). This may be a substantial limitation of the de novo 
analyses presented in Chapters 4 (Part I) and (Part II) of the present thesis, although the 
emphasis many classifications of MetS place on the three symptoms/components used to 
classify MetS in these Chapters’ analyses of UKHLS data (and particularly the importance 
of central obesity; see Table 1.3), means that the classification of MetS used in these 
Chapters is likely to be broadly comparable with those used by the previous studies 
reviewed in Chapter 2 (although further research is warranted to confirm this).  
 Finally, while it is certainly plausible that the differential exclusion of unhealthy 
UKHLS participants from that study’s NHA may mean that any associations between the 
sleep- and MetS-related characteristics of these participants were (far) less pronounced 
than those examined in the studies reviewed in Chapter 2, the latter also routinely excluded 
participants with severe, chronic and/or acute health conditions (see Table 2.1) or drew on 
secondary datasets from studies that had done so when recruiting/sampling their study 
participants. As such, it is possible that the associations observed between MetS and sleep 
in this subsample of UKHLS participants (Sample 1) was very different to those occurring 
across the UKHLS as a whole, or amongst the samples of participants examined by most (if 
not all) of the studies reviewed in Chapter 2. Nevertheless, this does seem the least likely 
reason for the very different patterns of association between MetS and sleep observed in 
the studies and analyses described in Chapters 2 and 4 (Part II). 
5.1.3.1 Towards consensus on evidence of associations between sleep and 
MetS generated by the studies reviewed in Chapter 2 and the analyses 
presented in Chapter 4 (Part II) 
 In part to address the first and third of the three potential limitations identified above, 
and in part to test the utility of ‘self-reported MetS’ in analyses examining the relationship 
between sleep and MetS, Chapter 4 (Part II) repeated the analyses conducted on ‘directly 
measured MetS’ using the classification of ‘self-reported MetS’ developed and validated in 
Chapter 4 (Part I). These analyses benefitted from the use of sociodemographic-, sleep- 
and MetS-related variables that had been recorded during the same wave of the UKHLS 
(i.e. using the Wave 1 interviewer- and self-administered questionnaires), for which there 
was no interval between the collection of sleep- and MetS-related data. These analyses 
also benefitted from the much larger number of UKHLS participants with complete data on 
self-reported variables (‘Sample 2’: n=29,436) than those with direct measures of MetS 
symptoms/components collected during the NHA (‘Sample 1’: n=5,283; see Table 4.4). And 
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although these analyses relied upon a classification of MetS based on self-reported 
indicators of elevated waist circumference (estimated from self-reports of height and 
weight), high blood pressure (derived from self-reported clinical diagnoses of hypertension) 
and diabetes (also derived from self-reported clinical diagnoses), this classification 
demonstrated substantial agreement with the directly measured symptoms/components of 
MetS (and the classification of MetS itself based thereon) in the detailed validation analyses 
conducted in Chapter 4 (Part I).  
Using the analyses of these data, then, as the basis for comparing the findings of 
previous studies (as summarised in Chapter 2) with those generated from analyses of (self-
reported) data from the UKHLS it is clear that these found very similar patterns of 
association to those identified in analyses focussing only on participants with direct 
measures of MetS (i.e. those involved in the UKHLS NHA; compare Figures 4.3 and 4.15 
[for those analyses using ‘MetS-free’ participants as referent], Figures 4.6 and 4.17 [for 
those analyses using participants with ≤two MetS symptoms/components as referent]). 
None of these analyses (all of which were adjusted for covariates considered potential 
confounders, though not for lifestyle factors considered likely mediators, since these were 
not available for the larger sample of participants from Wave 1 alone) found evidence of an 
association between MetS and prolonged sleep duration or extended sleep latency, though 
they did find that MetS was associated with an increased odds of: short sleep duration; loud 
coughing/snoring; sleep medication use; poor quality sleep; daytime sleepiness; and (in 
some, but not all models) sleep fragmentation. These therefore remain somewhat at odds 
with the associations reported by the studies reviewed in Chapter 2: none of which reported 
an association between MetS and sleep fragmentation or daytime sleepiness (though 
evidence on these were provided only by analyses using just one dataset each); while all 
n=3/3 of the comparable analyses identified in Chapter 2 (see Table 2.6) found that MetS 
was associated with a higher odds of prolonged sleep duration (Stefani et al. 2013; Arora et 
al. 2011; Choi et al. 2008). 
On the basis of these comparisons it is therefore difficult to provide an unequivocal 
assessment of the likely associations between different sleep characteristics and MetS, 
save to say that the best available evidence from cross-sectional studies using broadly 
comparable measurement and analytical techniques is that MetS is associated with a higher 
risk of ‘unfavourable sleep’ across a range of different sleep characteristics, and that the 
strength of these associations varies amongst: studies using direct measures and self-
reports of MetS; those conducted in different settings; and those using different covariate 
adjustment sets to reduce the likelihood of unadjusted confounding. It remains to be seen 
whether these associations simply reflect a correlation between sleep and cardiometabolic 
health characteristics resulting from unadjusted confounding (i.e. from unadjusted or latent 
confounding); or whether these associations reflect a causal relationship between all (or 
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even just some) of these sleep characteristics and MetS (and, if so, whether any sleep 
characteristics prove to be causes or consequences of MetS, or both). 
5.2 Recommendations for future research 
 Against the backdrop of the somewhat equivocal findings generated (from a review 
of existing studies exploring the association between MetS and sleep, and de novo 
analyses of this association using both directly measured and self-reported variables to 
classify MetS), the present thesis nonetheless sets a firm baseline upon which future 
research into this potentially important association might be based. Of particular 
importance, moving forwards, will be studies that address all of the principal flaws (and 
methodological challenges) identified in the review of previous studies summarised in 
Chapter 2 of the present thesis (many of which proved difficult to address in the de novo 
analyses undertaken in Chapter 4 Part II), namely: 
 studies examining sufficient numbers of participants (including sufficient numbers 
displaying both ‘unfavourable’ sleep and/or MetS) to minimise the risk of type 1 
error; 
 studies with access to data on a (much broader) range of potential confounders, 
including: a family and/or personal history of sleep- and MetS-related disorders and 
risks; more detailed data on lifestyle factors and living circumstances relevant to the 
development of ‘unfavourable’ sleep characteristics and the physiological 
triggers/modifiers of MetS-related symptoms and components; 
 studies capable of accurately distinguishing between (preceding) confounders and 
(interceding) mediators in any relationship between sleep and MetS (so that the 
adjustment sets used can include the former and exclude the latter); and 
 studies that more clearly describe, define and justify the inclusion and exclusion 
criteria used during both the recruitment of study participants and the specification of 
the referent groups used in subsequent analyses.  
While there would also be substantial benefit in establishing a limited number of 
instruments, techniques and classifications for the standardisation of measurements on 
sleep characteristics and MetS, the proliferation of instruments (and MetS classifications) 
available suggests this seems unlikely to occur. Instead it would be worth encouraging all 
future studies to use a limited number of such measures in addition to any others they are 
keen to explore (perhaps as a prerequisite to publication in the small number of journals 
where the majority of these studies have been published to-date; see (Chapter 2); or at the 
very least to present analyses that use/include standard cut-off points for some of the sleep 
characteristics used (most notably, for sleep duration) – an approach that benefitted the 
synthesis of findings from those studies using the Pittsburgh Sleep Quality Index (PSQI), all 
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of which used the same ‘PSQI Total Score’ cut-off point to distinguish between ‘good’ and 
‘poor’ sleep quality – thereby enabling direct comparisons to be made between the results 
of all of these studies. 
While addressing these methodological and analytical flaws, and some of the 
challenges facing comparisons and syntheses of findings generated by studies using very 
different techniques, the list of recommendations provided above will not alone move our 
understanding of the possible direction and mechanisms involved in any association 
between MetS and sleep. To make progress in these areas, future studies will be required 
to: 
 establish either standard and/or reference cut-off points for each of the sleep 
characteristics examined, in order to enhance the clinical utility of the thesis’ 
findings;  
 use data collected at three or more time points to conduct longitudinal 
analyses capable of demonstrating whether changes in sleep lead to 
changes in MetS and vice versa; 
 use interventions capable of improving specific sleep characteristics (beyond 
those addressing the clinical conditions that can affect sleep, such as 
obstructive sleep apnoea) in randomised control trials to establish their 
impact on MetS (particularly over a longer time period than that used by 
studies demonstrating that artificially shortened or artificially disturbed sleep 
causes short-term effects on cardiometabolic factors, appetite/satiety and 
related behaviours); 
 use interventions capable of addressing MetS itself (rather than just one or 
two symptoms/components thereof) in randomised control trials to establish 
their impact on a range of sleep-related characteristics; and  
 examining the plausibility of biochemical and physiological mechanisms in 
any relationship between sleep and MetS, using in vitro and in vivo studies 
as appropriate (with particular attention paid to the potential for therapeutic 
interventions aimed at attenuating or eliminating these processes or key 
steps therein). 
 Finally, one of the greatest challenges faced by this study was the impracticability of 
applying multiple imputation. Therefore, additional work is required to undertake multiple 
imputation on the UKHLS data to address the issue of extensive (and potentially non-
random) missingness in the datasets analysed – a necessary (yet potentially very time-
consuming) step that should precede any substantive interpretation and application of the 
analyses conducted on complete case data as currently reported in this thesis. 
 These, then, are what lies ahead for research into the association between sleep 
and MetS. With no pun intended (given that the name chosen for the team of students and 
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staff who have been researching this issue: the Temporal Influences on Metabolic Events’ 
Research Group; ‘TIME’), time will tell whether there is more to the associations between 
sleep and MetS reported by previous studies, and in the de novo analyses conducted for 
the present thesis, than meets the eye
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Chapter 6 Appendix 
6.1 Identifying suitable/necessary covariates 
To identify the suitable/necessary covariates to include in this analyses, a search 
for narrative reviews of both MetS and sleep were undertaken to provide a basis on 
which established/theoretical determinants and consequences of each might be 
identified. The results of the searches (for narrative reviews and information for 
determinants/consequences of sleep and MetS contained therein) are summarised in 
tables 7.1 and 7.2 respectively. For both topics, ‘saturation’ was achieved and 
confirmed once 11 narrative reviews had been close-read. (See figure 7.1 and 7.2) 
Table 6.1 Results from the narrative reviews search identifying the suitable/necessary 
sleep covariates. 
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Socioeconomic 
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Genetic 
determinants 
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Length of prior 
waking 
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Circadian 
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Restless Legs 
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*socioeconomic factors: income, education, poverty, ethnicity, and (nature, time, and duration of work) 
**environment: noise, light, bed partners with sleep disorders, TVs, computers, and work in the bedroom, sleeping 
Surface 
Table 6.2 Results from the narrative reviews search identifying the suitable/necessary 
MetS covariates. 
Covariates 
 
(T
im
ar, S
estier 
an
d
 L
evy 2000) 
(G
ru
n
d
y et al. 
2005) 
(L
o
p
ez-
C
an
d
ales 2001) 
(H
all et al. 
2002) 
(E
ckel, G
ru
n
d
y 
an
d
 Z
im
m
et 
2005) 
(G
ru
n
d
y et al. 
2005) 
(A
lb
erti et al. 
2009) 
(G
ru
n
d
y et al. 
2004) 
(D
ay 2007) 
(S
m
ith
 Jr 2007) 
(D
askalo
p
o
u
lo
u
, M
ikh
ailid
is 
an
d
 E
lisaf 
2004) 
Gender 
           
Physical inactivity 
           
Obesity 
           
Genetic  
           
Adipose tissue 
disorders 
           
Ethnicity 
           
Aging  
           
Endocrine disorders 
           
Lifestyle 
(diet,PA,smoking)  
           
 
Figure 6.1 Saturation of sleep search for suitable/necessary 
covariates 
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Figure 6.2 Saturation of MetS search for suitable/necessary 
covariates  
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6.2 Intervention studies 
6.2.1 Study and population characteristics  
Among the 9 articles that met inclusion criteria, majority of studies were 
conducted in European countries (n=6) while the rest (n=3) were conducted in Asian 
countries among them two in Japan and one in India. Seven studies were cohort 
studies (prospective observational studies), and only two studies were randomised 
control trails (RCT). Sample size ranged between studies from 20 to 86, while the 
average age ranged between 45 to 56 years old. Most of the studies recruited both 
male and female while only three studies recruited males only. All studies but two 
mentioned withdrawal rate that ranged from 4% to 47%. Only RCT’s reported power 
calculation for their sample size but none of the other studies.    
There was a diversity among population characteristics, n=6 studies mentioned 
that participants were recruited mainly from sleep clinics, while the remaining 3 studies 
recruited their participants one from outpatient clinic, one from respiratory outpatient 
clinic and one did not mention site of recruitment. With regards to inclusion criteria, 
three studies included patients with OSA and MetS, another four included only patients 
with OSA and one study included obese patients with MetS. The following Table 7.3, 
summarises above information. 
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Table 6.3 Study and population characteristics of intervention studies 
Citation  Study design Sample size  Population  Age  Sex  
Sharma et al.  
2011 India 
RCT 4/90 
Total=86 
 
Pt with moderate or greater 
severity OSA and excessive 
daytime somnolence from 
sleep laboratory  
45±8 77 M 
9 F 
 
Coughlin et al. 
2007 UK 
RCT 7/42 
Total=35 
Pt with OSA attending Sleep 
Disordered Breathing Clinic  
49±8 100% 
M 
lguchi et al.  
2013 Japan 
Longitudinal 27/60 
Total=33 
Obese patients who had MS 
at out-patient clinic 
51 11 M 
22 F 
Oyama et al.  
2011 Japan 
Single-arm 
prospective 
21/53 
Total=32 
Pt with MS and OSA 54±9 19 M 
13 F 
Grandi et al.  
2011 Italy 
Longitudinal 15/56 
Total=41 
Pt with OSA, obesity and 
non-diabetic at the 
respiratory out-patients clinic 
56±11 100% 
M 
Mota et al.  
2010 Portugal 
Prospective 
observational 
study 
74 Pt referred to Sleep-
Disordered Breathing Clinic, 
with newly diagnosed 
moderate/severe OSA  
50±8 100% 
M 
Oktay et al.  
2009 Turkey 
Single-arm 
prospective 
18/38 
Total=20 
Pt diagnosed with both OSA 
and MS attended at sleep 
disorders centre 
54±1 13 M 
7 F 
Sopkova et al. 
2009 Slovakia 
Prospective 
observational 
study 
51 Pt with OSA and MS 
attending at the sleep unit at 
a tertiary referral teaching 
hospital. 
54±10 42 M 
8 F 
Oktay et al.  
2009 Turkey 
Single-arm 
prospective 
34/66 
Total=32 
Pt with severe OSA and MS 
who’s attending the sleep 
unit at the tertiary referral 
teaching hospital 
54±10 27 M 
5 F 
 
6.2.2 MetS and sleep measures  
Different MetS definitions were used among studies, however the most 
frequently used criteria was the criteria proposed by the US National Cholesterol 
Education Program-Adult Treatment Panel III (NCPI-ATP III) that was used by six of 
the reviewed studies. Two studies followed the International Diabetes Federation (IDF) 
definition and one study followed the Japanese criteria. All of the nine interventional 
studies identified sleep disorder as OSA and it was assessed as apnoea-hyponea 
index score using polysomnography except for the study conducted by Mota et al. 
(Mota 2011) that was assessed as manual respiratory disturbance index. Similarly the 
Epworth Sleepiness Scale was used among most of the studies to assess daytime 
sleepiness.  
Out of the nine studies the majority (n=6) assessed the effectiveness of 
continues positive airway pressure (CPAP) treatment, while two studies assessed 
weight therapy (one assessed weight therapy and one weight therapy and CPAP) and 
finally only one study assessed the outcome of autoadjusting positive airway pressure 
(APAP) treatment. With regards to duration of intervention, there was variation among 
the period of intervention. It varied from 3 months to one year. Moreover, the degree of 
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assessment ranged from baseline, one week, one month, and up to 18 months. The 
following Table 7.4, summarises above information. 
Table 6.4 MetS and sleep measures of intervention studies  
Citation  Sleep classification  MetS 
definition  
Method of 
intervention  
Degree of assessment  
Criteria  Method of 
assessment  
(Sharma et al. 
2011) 
OSA  AHI NCEP ATP-III  CPAP for 3m 
followed by 
sham for 3m or 
vice versa with 
1m washout in 
between 
Baseline, 3 month, 6 
month Daytime 
sleep  
ESS 
(Coughlin et al. 
2007b) 
OSA  AHI  
NCEP ATP-III 
CPAP/sham for 
6 weeks   
Baseline and 6 weeks 
 
Daytime 
sleep  
ESS 
(Iguchi et al. 
2013) 
OSA  AHI 
ODI 
NCEP ATP-III 
(WC 
modification 
for Japan) 
Weight 
reduction 
therapy for 3 
months 
Baseline and 3 months 
(Oyama et al. 
2012) 
OSA  AHI Japanese 
criteria 
CPAP for 3 
months 
Baseline and after 
3months Daytime 
sleep 
ESS 
(Grandi et al. 
2012b) 
OSA  AHI NCEP ATP-III Weight 
management& 
CPAP for 18 
moth 
Baseline, 6 month, 18 
month 
 
Daytime 
sleep 
ESS 
(Mota et al. 
2011) 
OSA  RDI NCEP ATPIII APAP for 6 
months 
Baseline, 1 week, 1 
month, 3 months, 6 
months 
Daytime 
sleep 
ESS 
(Oktay et al. 
2009) 
OSA  AHI NCEP ATPIII CPAP for 1 year Baseline and 1 year  
 Sleep 
disorder 
standard 
questionnair
e 
(Sopkova, 
Dorkova and 
Tkacova 2009) 
OSA AHI IDF CPAP for 8 
weeks   
Baseline and 8 weeks 
 Sleep 
quality 
ESS 
(Dorkova et al. 
2008) 
OSA AHI  IDF CPAP for 8 
weeks   
Baseline and 8 weeks 
Daytime 
sleepiness 
ESS 
 
6.2.3 Analysis strategy and results from intervention studies 
a. Results from randomized controlled trials  
Both RCT’s conducted by Sharma et al. (Agrawal et al. 2011) and Coughlin et al. 
(Coughlin et al. 2007a) used placebo/sham CPAP therapy for control group and cross 
over the intervention and placebo group after 3 months and 6 weeks respectively. The 
primary outcome of both studies was to assess reduction in metabolic abnormalities. 
Sharma et al. (Agrawal et al. 2011) reported that CPAP treatment had significantly 
reduced systolic blood pressure, diastolic blood pressure, serum total cholesterol, non-
high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, 
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and glycated hemoglobin. They also reported that the frequency of the metabolic 
syndrome was reduced in 13% of intervention group. On the other hand, Coughlin et 
al. (Coughlin et al. 2007a) reported reduction in mean systolic and diastolic blood 
pressure in intervention group but no changes were observed in glucose, lipid, insulin 
resistance and metabolic syndrome. 
b. Results from other studies 
There was an inconsistency among the primary defined outcome, which varies 
between the effect of intervention on OSA and respiratory changes among patients 
with metabolic syndrome, or evaluating the improvement in MetS and its components 
after intervention. In general it was agreed among all reviewed studies that there was 
a significant association between metabolic syndrome and sleeping disorder (AHI). 
One example of that, Iguci et al. (Iguchi et al. 2013) reported that the log AHI was 
found to be associated with the number of MetS risk factors (log AHI, p<0.01; age and 
gender adjusted). Weight management therapy among both studies that followed this 
method (Iguchi et al. 2013; Grandi et al. 2012a) significantly decreased BMI, WC, and 
BP (p<0.05). However, while Iguchi et al. (Iguchi et al. 2013) found significant effect of 
weight management on AHI, Grandi et al. (Grandi et al. 2012a) referred the change in 
all respiratory parameters to the CPAP treatment alone rather than weight 
management. 
CPAP or APAP treatment significantly improve MetS by decreasing its prevalence 
among the studied populations a finding that was mentioned by some studies (Mota 
2011; Oktay et al. 2009; Dorkova et al. 2008). Moreover, CPAP and APAP significantly 
improves BMI, WC, BP and lipids a result that was agreed by (Oyama et al. 2012; 
Mota 2011; Oktay et al. 2009; Dorkova et al. 2008). On the other hand Oyama et al. 
and Oktay et al. found no significant association between the use of CPAP and blood 
glucose (Oyama et al. 2012; Oktay et al. 2009). With regards to the effect of CPAP on 
AHI and ESS there was an inequality among results. While Oyama et al. showed 
significant improve of AHI and ESS, Oktay et al. and Dorkova et al. found no 
significant changes (Oyama et al. 2012; Oktay et al. 2009; Dorkova et al. 2008). 
Finally compliance with CPAP treatment considered as the most important factor for 
positive outcomes (Dorkova et al. 2008; Sopkova, Dorkova and Tkacova 2009). The 
following Table 7.5, summarises above information. 
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Table 6.5 Analysis strategy and results from intervention studies  
Citation  Predefined outcome   Results   
Sharma et al.  
2011 India 
Reduction in the frequency of MetS CPAP treatment significantly decreases all MetS 
parameters. The frequency of the MetS was 
reduced after CPAP therapy, a reversal found in 
13% of pt undergoing CPAP therapy vs.1% of pt 
undergoing sham CPAP 
Coughlin et al. 
2007 UK 
The difference between data at the end of 
each treatment period, rather than the 
change from individual baseline values 
Mean waking systolic and diastolic blood pressure 
fell by 6.7 and 4.9 mmHg, respectively, compared 
with sham CPAP. No change was observed in 
glucose, lipids, insulin resistance or the proportion 
of patients with metabolic syndrome. 
lguchi et al.  
2013 Japan 
Effect of weight reduction therapy on OSA 
and arterial stiffness 
Log AHI sig associated with the number of MetS 
risk factors (adj age&sex). Sign effect of weight 
change on BP, BMI,WC, AHI  
Oyama et al.  
2011 Japan 
Change in vascular function and Biochemical 
markers 
CPAP markedly improved AHI. 
WC, body weight, BMI, and arterial blood pressure 
were decreased significantly after treatment with 
CPAP 
Grandi et al.  
2011 Italy 
changes of respiratory, BP, metabolic and LV 
parameters from basal to second evaluation 
Sig effect of weight therapy on BMI, WC, BP, TG, 
FG.  
CPAP sig effect on all respiratory parameters and 
only BMI and WC 
Mota et al.  
2010 Portugal 
therapy effectiveness with evaluation of the 
clinical symptoms and APAP compliance 
APAP sig decreased prevalence of MetS from 
63.5% to 47.3%, sig reduce BP (p=0.018) and TG 
(p=0.001). No sig change in Wt or BMI 
Oktay et al.  
2009 Turkey 
Improvement in MetS & its components  Prevalence of MetS decreased by 45%.Sig 
differences after CPAP in WC (p=0.002), HDL 
(p=0.001) and BMI (p=0.01) 
Sopkova et al. 
2009 Slovakia 
Improvement in MetS & its components  Obesity was present in all (100%), arterial 
hypertension in (94%); fasting plasma glucose 
levels were increased in (55%) patients and serum 
triglycerides in (71%); serum HDL cholesterol was 
reduced in (59%) patients. 
Dorkova et al.  
2008 Slovakia 
Assessed adherence, glucose and lipid 
profile, systemic inflammation, oxidative 
stress, and global CVD 
CPAP for > 4 h/night sig reduced systolic BP and 
diastolic BP (p = 0.001 and p = 0.006, 
respectively), total cholesterol (p =0.002), and 
reductions in the global CVD risk (from 18.8 ± 9.8 
to 13.9 ± 9.7%, p = 0.001). No sig changes with 
CPAP < 4 h/night. 
6.2.4 Discussion of intervention studies 
In this part of the review the focus was on experimental studies that 
implemented an intervention treatment to improve the association between metabolic 
syndrome and sleep disorders namely obstructive sleep apnea. 
While randomized control trials are well known for being a better experimental 
study design, most of the studies involved in this review were longitudinal in nature 
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and mainly single arm design. The two RCT studies (Sharma et al. 2011; Coughlin et 
al. 2007b) included in this review can be considered of good quality as they both 
mentioned sample size and power calculation, randomly allocated their participants to 
either intervention or control group, used double blinded method, used placebo, cross 
over the intervention and control group after a wash period, clearly define inclusion 
and exclusion criteria, and specify reason for withdrawal and dropout. Finally, the 
baseline characteristics of both RCT participants may differ in intervention and control 
group, but this was a cross-over design thus these differences had not affected the 
outcome of the studies.  
On the other hand, most of the retrieved intervention studies have been limited 
in a number of ways. Most of them were single arm prospective studies thus the 
absence of any control group could affect the study outcome. Moreover, none of these 
prospective studies describe sample size and power calculation. And some of them 
didn’t mention reason for withdrawal and dropout (Mota et al. 2011; Sopkova, Dorkova 
and Tkacova 2009). Nevertheless, short-term follow up were almost presented among 
all studies that were conducted on relatively small sample size. Withdrawal is another 
potential concern among these studies that may affect internal validity.  
Most of these studies have suffered from inconsistent assessment criteria for both 
MetS and sleep, however the majority of studies referred to the NCPI-ATP III 
definition, but different classification of AHI were used to define OSA. Nevertheless, 
another inconsistency is intervention method, one study evaluated the effect of APAP, 
and one study evaluated the effect of weight reduction therapy alone, while the rest 
studied the effect of CPAP on different outcomes. 
Notwithstanding these limitations, the present review was able to conclude that 
MetS was significantly correlated with OSA and that CPAP improved not only AHI but 
also some parameters of MetS such as BMI and blood pressure. On the other hand, 
weight reduction therapy even for short period of time improved metabolic dysfunction 
and severity of OSA. CPAP compliance was considered as important factor in 
achieving these outcomes. Finally, Large sample size, randomized studies with long 
follow up period that not only study the outcome of CPAP but also used multiple 
intervention along with CPAP with proper compliance are the need of current time. 
Moreover, the importance of screening programs for OSA is important for the early 
detection of cardio metabolic risk. In addition weight management programs are 
important to improve both metabolic and sleep disorders.  
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6.3 Cohort studies 
Out of total 31 observational studies, 3 were cohort studies 
6.3.1 Study and population characteristics  
Basic characteristics from cohort studies are summarised in Table 7.6. 
Table 6.6 Study and population characteristics of cohort studies  
Citation  Sample 
size  
Population  Age  Sex  Follow-
up 
period  
Chaput et al.  
Canada 2013 (Chaput 
et al. 2013a) 
293 Quebec Family 
Study 
Free of MetS at 
baseline   
18-65 M 136 
F 164 
6 years  
Choi et al. 
South Korea 2011 
(Choi et al. 2011) 
1107 Korean Genomic 
Rural cohort 
40-70 M 386  
F 721 
2-4 
years 
Troxel et al. 
USA 2010 (Troxel et 
al. 2010) 
812 Community-based 
prospective study. 
Free of MetS at 
baseline   
45-74 67% F 3 years  
6.3.2 MetS and sleep measures  
All selected studies looked for the changes in MetS at follow-up period as a 
result of changes in sleep parameters. Two studies considered sleep duration as the 
exposure variable but one considered the exposure as sleep disturbance related to 
insomnia and sleep disordered breathing. All sleep parameter were measured 
subjectively through self-administered questionnaires, two studies defined MetS based 
on the NCEP-ATP III definition and one refereed to the American Heart Association 
definition. The following Table 7.7 summarises these information. 
Table 6.7 MetS and sleep measures of observational cohort studies 
Citation Exposure 
(independent)  
Outcome 
(dependant)  
Sleep assessment 
method 
MS definition 
Chaput et al.  
Canada 2013 
(Chaput et al. 
2013a) 
Sleep duration  
(re=7-8hrs) 
MetS Self-administered 
questionnaire 
American Heart 
Association/National Heart, 
Lung, and Blood Institute’s 
criteria 
Choi et al. 
South Korea 
2011 (Choi et 
al. 2011) 
Sleep duration 
(ref=6-7.9hrs)  
MetS Self-administered 
questionnaire 
NCEP-ATP III 
Troxel et al. 
USA 2010 
(Troxel et al. 
2010) 
Sleep disturbance 
related to 
insomnia and 
SDB 
MetS Self-administered 
questionnaire 
NCEP-ATP III 
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6.3.3 Analysis strategy and results 
Among studies that looked for the association between MetS and sleep duration, 
after adjusting for potential confounders they reported significant association between 
short sleep duration and MetS. Chaput et al. (Chaput et al. 2013a) compare short 
sleep duration in referent to 7-8 hours’ sleep per night, while Choi et al. (Choi et al. 
2011) compared short sleepers to 6-7.9 hours per night. However, Choi et al. found no 
significant association between males’ short sleeper and MetS. On the other hand, 
Troxel et al. (Troxel et al. 2010) after considering potential confounders, found that 
disturbance in sleep significantly predicts MetS after follow-up (Table 7.8). 
Table 6.8 Analysis strategy and results from observational cohort studies  
Citation  Covariates  Adjusted covariates  Results 
Chaput et al.  
Canada 2013 
(Chaput et al. 
2013a) 
Age, sex, total annual family 
income, smoking, alcohol, 
coffee intake, daily caloric 
intake, and cardiorespiratory 
fitness. 
1st M: age & sex 
2nd M: Age, sex, smoking, total 
annual family income, alcohol, 
coffee intake, daily caloric intake, 
and cardiorespiratory fitness. 
Short sleep duration ≤ 6hrs 
significantly increase MetS 
RR 
1st M: RR: 2.01 (1.30-3.05) 
2nd M: RR: 1.74 (1.05-2.72) 
Choi et al. 
South Korea 
2011 (Choi et 
al. 2011) 
Age, BMI, Smoking, Alcohol, 
Physical activity, 
Menopause status  
1st M unadjusted  
2nd M: age, BMI, menopause (F)  
3rd M: age, BMI, Smoking, 
Alcohol, PA, and Menopause (F) 
*analysis was stratified by sex  
Short sleep duration < 6hrs 
significantly associated with 
HR of MetS in F only. 
1st M (HR: 1.83 CI 1.10-
3.05) 
2nd M ( HR: 1.89 CI 1.12-
3.18) 
3rd M (HR: 1.80 CI 1.06-
3.05) 
Troxel et al. 
USA 2010 
(Troxel et al. 
2010) 
 
Age, sex, race, marital 
status, smoking, alcohol, 
PA, depression, AHI 
1st M: Age, sex, race, marital 
status, study randomisation, 
smoking, alcohol, PA, depression 
2nd M: 1 + AHI 
Difficulty falling asleep, 
unrefreshing sleep, and 
loud snoring significantly 
predicted MetS. Adjusted 
OR=1.81 (1.08-3.05), 1.71 
(1.06-2.74), 2.30 (1.35-
3.93) respectively. AHI were 
as well associated 
significantly with MetS 
adjusted OR=1.23 (1.02-
1.74) 
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6.4 Results from the unadjusted and adjusted analyses of the 
association between sleep and MetS presented in Tables 
The three sets of logistic regression models (n=16 models in all) have been 
summarised in Table 5.1.
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Table 6-9 Summary of the statistical models used to examine whether any variation in the relationship between (different characteristics of) sleep 
and (different combinations of) MetS components was associated with: the use of different referent groups; the use of directly measured vs. self-
reported components of MetS; and the inclusion of contemporaneous lifestyle variables in any adjustment sets used. 
Table  Sample Measurement of MetS components Referent group used Adjustment for 
sociodemographic variables 
Adjustment for 
lifestyle variables 
6.10 
Sample 1 
(n=5,283) 
Directly measured Participants do not display any components of MetS No No 
6.11 
Sample 1 
(n=5,283) 
Directly measured Participants do not display any components of MetS Yes No 
6.12 
Sample 1 
(n=5,283) 
Directly measured Participants do not display any components of MetS Yes Yes 
6.13 
Sample 1 
(n=5,283) 
Directly measured 
Participants do not display the particular combination of MetS components 
being examined 
No No 
6.14 
Sample 1 
(n=5,283) 
Directly measured 
Participants do not display the particular combination of MetS components 
being examined 
Yes No 
6.15 
Sample 1 
(n=5,283) 
Directly measured 
Participants do not display the particular combination of MetS components 
being examined  
Yes Yes 
6.16 
Sample 1 
(n=5,283) 
Self-reported Participants do not display any components of MetS No No 
6.17 
Sample 1 
(n=5,283) 
Self-reported Participants do not display any components of MetS Yes No 
6.18 
Sample 1 
(n=5,283) 
Self-reported Participants do not display any components of MetS Yes Yes 
6.19 
Sample 1 
(n=5,283) 
Self-reported 
Participants do not display the particular combination of MetS components 
being examined 
No No 
6.20 
Sample 1 
(n=5,283) 
Self-reported 
Participants do not display the particular combination of MetS components 
being examined 
Yes No 
6.21 
Sample 1 
(n=5,283) 
Self-reported 
Participants do not display the particular combination of MetS components 
being examined  
Yes Yes 
6.22 
Sample 2 
(n=29,436) 
Self-reported Participants do not display any components of MetS No Not available 
6.23 
Sample 2 
(n=29,436) 
Self-reported Participants do not display any components of MetS Yes Not available 
6.24 
Sample 2 
(n=29,436) 
Self-reported 
Participants do not display the particular combination of MetS components 
being examined 
No Not available 
6.25 
Sample 2 
(n=29,436) 
Self-reported 
Participants do not display the particular combination of MetS components 
being examined  
Yes Not available 
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Table 6-10 Logistic regression analyses of the relationship between different directly measured components (and combinations of components) of 
MetS and seven self-reported sleep characteristics, amongst n=5,283 participants included in the UKHLS NHA, before adjustment for 
sociodemographic and contemporaneous lifestyle variables. The referent group comprised participants who did not display any of the three 
components of MetS examined (elevated waist circumference, diabetes and high blood pressure). All results are given as relative risk ratios 
(RRRs; for multinomial logistic analyses) or odds ratios (ORs; for binary logistic regression analyses), with 95% confidence intervals (95%CI) in 
parentheses. 
Sample 1 
(n=5,283) 
Sleep 
characteristics 
referent 
Sleep 
duration 
6-8hrs 
Sleep 
latency  
not during the 
past month 
Sleep 
fragmentation 
not during the 
past month 
Cough/snore  
loudly  
not during the 
past month 
Sleep 
medication 
not during the 
past month 
Daytime 
sleepiness 
not during the 
past month 
Sleep 
quality 
good quality  
No. of MetS 
components  
(referent: do not 
display any 
components of 
Mets) 
 
<6hrs >8hrs 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
Bad  
quality 
RRR (95%CI) RRR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) 
One 
Elevated WC 
1.75 
(1.42,2.16) 
0.99 
(0.80,1.22) 
1.01 
(0.89,1.16) 
1.21 
(1.03,1.43) 
1.54 
(1.35,1.76) 
1.36 
(1.14,1.63) 
1.02 
(0.85,1.22) 
1.09 
(0.94,1.27) 
High BP 
1.61 
(1.15,2.25) 
0.73 
(0.49,1.09) 
0.75 
(0.61,0.93) 
1.33 
(1.01,1.75) 
1.38 
(1.10,1.72) 
1.44 
(1.08,1.92) 
0.85 
(0.62,1.17) 
0.81 
(0.64,1.02) 
DM 
1.01 
(0.23,4.35) 
0.38 
(0.05,2.82) 
0.45 
(0.20,1.05) 
1.35 
(0.46,4.00) 
0.95 
(0.39,2.31) 
0.65 
(0.15,2.79) 
0.87 
(0.26,2.96) 
0.44 
(0.19,1.02) 
Two 
Elevated WC and 
high BP 
1.78 
(1.35,2.35) 
1.08 
(0.81,1.44) 
1.03 
(0.86,1.23) 
1.61 
(1.26,2.04) 
2.07 
(1.73,2.48) 
1.45 
(1.14,1.84) 
0.69 
(0.52,0.91) 
0.99 
(0.81,1.21) 
Elevated WC and 
DM 
3.70  
(2.23,6.16) 
1.38  
(0.72,2.66) 
1.02  
(0.67,1.56) 
1.27  
(0.74,2.16) 
2.75  
(1.81,4.18) 
2.25  
(1.38,3.65) 
1.50  
(0.89,2.51) 
1.10  
(0.68,1.80) 
High BP and DM 
1.63 
(0.63,4.24) 
0.73  
(0.22,2.40) 
1.30  
(0.59,2.16) 
1.30  
(0.57,2.95) 
1.35  
(0.71,2.60) 
3.83  
(1.97,7.45) 
0.31  
(0.75,1.31) 
1.33  
(0.61,2.90) 
Three MetS  
2.60 
(1.64,4.13) 
0.78 
(0.40,1.51) 
0.93 
(0.65,1.32) 
1.34 
(0.85,2.13) 
2.04 
(1.44,2.90) 
2.01 
(1.32,3.08) 
1.43 
(0.92,2.23) 
1.62 
(1.03,2.57) 
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Table 6-11 Logistic regression analyses of the relationship between different directly measured components (and combinations of components) of 
MetS and seven self-reported sleep characteristics, amongst n=5,283 participants included in the UKHLS NHA, after adjustment for 
sociodemographic variables. The referent group comprised participants who did not display any of the three components of MetS examined 
(elevated waist circumference, diabetes and high blood pressure). All results are given as relative risk ratios (RRRs; for multinomial logistic 
analyses) or odds ratios (ORs; for binary logistic regression analyses), with 95% confidence intervals (95%CI) in parentheses. 
Sample 1 
(n=5,283) 
Sleep 
characteristics 
referent 
Sleep 
duration 
6-8hrs 
Sleep 
latency  
not during the 
past month 
Sleep 
fragmentation 
not during the 
past month 
Cough/snore  
loudly  
not during the 
past month 
Sleep 
medication 
not during the 
past month 
Daytime 
sleepiness 
not during the 
past month 
Sleep 
quality 
good quality  
No. of MetS 
components  
(referent: do not 
display any 
components of 
Mets) 
 
<6hrs >8hrs 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
Bad  
Quality 
RRR (95%CI) RRR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) 
One 
Elevated WC 
1.54  
(1.24,1.92) 
1.06  
(0.85,1.33) 
0.98  
(0.86,1.13) 
1.04  
(0.88,1.24) 
1.54  
(1.34,1.78) 
1.29  
(1.07,1.56) 
1.21  
(1.01,1.46) 
1.12  
(0.96,1.30) 
High BP 
1.24  
(0.87,1.77) 
0.90  
(0.59,1.38) 
0.89  
(0.71,1.12) 
1.04  
(0.77,1.40) 
1.17  
(0.92,1.49) 
1.41  
(1.03,1.91) 
1.15  
(0.82,1.62) 
1.15  
(0.89,1.48) 
DM 
0.87  
(0.20,3.82) 
0.50  
(0.06,3.77) 
0.63  
(0.27,1.49) 
1.15  
(0.38,3.42) 
0.70  
(0.28,1.75) 
0.73  
(0.17,3.15) 
1.05  
(0.30,3.63) 
0.67  
(0.29,1.85) 
Two 
Elevated WC and 
high BP 
1.35  
(0.99,1.82) 
1.25  
(0.91,1.71) 
1.12  
(0.92,1.36) 
1.21 
(0.93,1.57) 
1.90  
(1.56,2.31) 
1.38  
(1.06,1.78) 
0.97  
(0.72,1.31) 
1.31  
(1.05,1.63) 
Elevated WC and 
DM 
2.77  
(1.63,4.72) 
1.52  
(0.77,2.99) 
1.10  
(0.71,1.69) 
1.04  
(0.60,1.79) 
2.34  
(1.52,3.61) 
2.04  
(1.24,3.35) 
2.06  
(1.21,3.51) 
1.35  
(0.82,2.23) 
High BP and DM 
1.36  
(0.51,3.65) 
0.97 
(0.29,3.28) 
1.50  
(0.77,2.92) 
1.08 
(0.47,2.49) 
1.04  
(0.53,2.04) 
4.14 
(2.09,8.20) 
0.37  
(0.09,1.59) 
2.12  
(0.96,4.69) 
Three MetS  
1.72  
(1.05,2.80) 
0.90  
(0.45,1.78) 
1.02 
(0.71,1.47) 
1.01  
(0.63,1.63) 
1.62  
(1.12,2.35) 
1.83  
(1.18,2.85) 
2.01  
(1.31,3.36) 
2.21 
(1.38,3.55) 
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Table 6-12 Logistic regression analyses of the relationship between different directly measured components (and combinations of components) of 
MetS and seven self-reported sleep characteristics, amongst n=5,283 participants included in the UKHLS NHA, after adjustment for 
sociodemographic and contemporaneous lifestyle variables. The referent group comprised participants who did not display any of the three 
components of MetS examined (elevated waist circumference, diabetes and high blood pressure). All results are given as relative risk ratios 
(RRRs; for multinomial logistic analyses) or odds ratios (ORs; for binary logistic regression analyses), with 95% confidence intervals (95%CI) in 
parentheses. 
Sample 1 
(n=5,283) 
Sleep 
characteristics 
referent 
Sleep 
duration 
6-8hrs 
Sleep 
latency  
not during the 
past month 
Sleep 
fragmentation 
not during the 
past month 
Cough/snore  
loudly  
not during the 
past month 
Sleep 
medication 
not during the 
past month 
Daytime 
sleepiness 
not during the 
past month 
Sleep 
quality 
good quality  
No. of MetS  
components  
(referent: do not 
display any 
components of 
Mets) 
 
<6hrs >8hrs 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
Bad  
Quality 
RRR (95%CI) RRR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) 
One 
Elevated WC 
1.43  
(1.15,1.78) 
1.03  
(0.82,1.30) 
0.96 
(0.84,1.10) 
1.03  
(0.87,1.22) 
1.50  
(1.30,1.73) 
1.25  
(1.04,1.52) 
1.14  
(0.94,1.38) 
1.06  
(0.91,1.25) 
High BP 
1.18  
(0.82,1.70) 
0.89  
(0.58,1.37) 
0.87 
(0.69,1.09) 
1.02  
(0.76,1.38) 
1.12 
(0.88,1.42) 
1.37  
(1.01,1.87) 
1.12  
(0.79,1.58) 
1.10  
(0.85,1.42) 
DM 
0.72  
(0.16,3.22) 
0.51  
(0.07,3.91) 
0.58 
(0.24,1.37) 
1.11  
(0.37,3.33) 
0.60  
(0.23,1.51) 
0.68  
(0.16,2.98) 
0.93 
(0.27,3.26) 
0.62  
(0.26,1.46) 
Two 
Elevated WC and 
high BP 
1.23  
(0.91,1.67) 
1.17  
(0.85,1.62) 
1.09  
(0.89,1.32) 
1.17 
(0.90,1.52) 
1.83  
(1.50,2.24) 
1.33  
(1.02,1.73) 
0.90  
(0.66,1.21) 
1.21  
(0.97,1.51) 
Elevated WC and 
DM 
2.32 
(1.35,3.97) 
1.40  
(0.71,2.77) 
1.03  
(0.67,1.60) 
1.06  
(0.61,1.84) 
2.24  
(1.44,3.49) 
1.92 
(1.16,3.18) 
1.85 
(1.08,3.18) 
1.26  
(0.76,2.08) 
High BP and DM 
1.13  
(0.42,3.08) 
0.90 
(0.26,3.04) 
1.42  
(0.73,2.77) 
1.10 
(0.48,2.54) 
0.97 
(0.49,1.93) 
3.84 
(1.93,7.64) 
0.35  
(0.08,1.49) 
1.96 
(0.88,4.35) 
Three MetS  
1.41  
(0.86,2.31) 
0.78  
(0.39,1.57) 
0.95 
(0.65,1.37) 
1.02  
(0.63,1.65) 
1.52  
(1.04,2.22) 
1.65  
(1.05,2.58) 
1.83 
(1.13,2.94) 
2.01 
(1.25,3.23) 
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Table 6-13 Logistic regression analyses of the relationship between different directly measured components (and combinations of components) of 
MetS and seven self-reported sleep characteristics, amongst n=5,283 participants included in the UKHLS NHA, before adjustment for 
sociodemographic and contemporaneous lifestyle variables. The referent group comprised participants who do not display the particular 
component (or combination of components) of MetS being examined (but may have displayed none, one or all of the others). All results are given 
as relative risk ratios (RRRs; for multinomial logistic analyses) or odds ratios (ORs; for binary logistic regression analyses), with 95% confidence 
intervals (95%CI) in parentheses. 
Sample 1 
(n=5,283) 
Sleep 
characteristics 
referent 
Sleep 
duration 
6-8hrs 
Sleep 
latency  
not during the 
past month 
Sleep 
fragmentation 
not during the 
past month 
Cough/snore  
loudly  
not during the 
past month 
Sleep 
medication 
not during the 
past month 
Daytime 
sleepiness 
not during the 
past month 
Sleep 
quality 
good quality  
No. of MetS 
components  
(referent: do not 
display the 
particular MetS 
component[s] 
being examined)  
 
<6hrs >8hrs 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
Bad  
Quality 
RRR (95%CI) RRR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) 
One 
Elevated WC 
1.36 
(1.13,1.63) 
1.01 
(0.82,1.23) 
1.05 
(0.93,1.18) 
1.08 
(0.93,1.26) 
1.25 
(1.10,1.41) 
1.14 
(0.97,1.35) 
1.07 
(0.90,1.27) 
1.10 
(0.96,1.27) 
High BP 
1.15 
(0.84,1.58) 
0.73 
(0.50,1.08) 
0.75 
(0.61,0.92) 
1.17 
(0.89,1.54) 
1.05 
(0.85,1.30) 
1.18 
(0.89,1.55) 
0.87 
(0.64,1.18) 
0.78 
(0.62,0.98) 
DM 
0.71 
(0.16,3.06) 
0.38 
(0.05,2.85) 
0.46 
(0.20,1.07) 
1.18 
(0.40,3.47) 
0.72 
(0.30,1.76) 
0.53 
(0.12,2.25) 
0.90 
(0.27,3.05) 
0.44 
(0.19,0.99) 
Two 
Elevated WC and 
high BP 
1.30 
(1.01,1.68) 
1.12 
(0.85,1.47) 
1.05 
(0.88,1.25) 
1.46 
(1.15,1.84) 
1.68 
(1.41,1.99) 
1.20 
(0.96,1.50) 
0.68 
(0.52,0.89) 
0.97 
(0.80,1.18) 
Elevated WC and 
DM 
2.68 
(1.63,4.41) 
1.41 
(0.74,2.71) 
1.04 
(0.69,1.58) 
1.11 
(0.65,1.88) 
2.12 
(1.40,3.21) 
1.84 
(1.14,2.97) 
1.56 
(0.94,2.60) 
1.09 
(0.67,1.76) 
High BP and DM 
1.15 
(0.45,2.98) 
0.75 
(0.22,2.43) 
1.15 
(0.60,2.20) 
1.13 
(0.50,2.57) 
1.03 
(0.54,1.97) 
3.14 
(1.62,6.06) 
0.32 
(0.08,1.35) 
1.30 
(0.60,2.85) 
Three MetS  
1.88 
(1.20,2.94) 
0.79 
(0.41,1.52) 
0.94 
(0.67,1.34) 
1.18 
(0.75,1.86) 
1.57 
(1.11,2.22) 
1.65 
(1.09,2.50) 
1.49 
(0.97,2.31) 
1.61 
(1.02,2.54) 
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Table 6-14 Logistic regression analyses of the relationship between different directly measured components (and combinations of components) of 
MetS and seven self-reported sleep characteristics, amongst n=5,283 participants included in the UKHLS NHA, after adjustment for 
sociodemographic variables. The referent group comprised participants who do not display the particular component (or combination of 
components) of MetS being examined (but may have displayed none, one or all of the others). All results are given as relative risk ratios (RRRs; for 
multinomial logistic analyses) or odds ratios (ORs; for binary logistic regression analyses), with 95% confidence intervals (95%CI) in parentheses. 
Sample 1 
(n=5,283) 
Sleep 
characteristics 
referent 
Sleep 
duration 
6-8hrs 
Sleep 
latency  
not during the 
past month 
Sleep 
fragmentation 
not during the 
past month 
Cough/snore  
loudly  
not during the 
past month 
Sleep 
medication 
not during the 
past month 
Daytime 
sleepiness 
not during the 
past month 
Sleep 
quality 
good quality  
No. of MetS 
components  
(referent: do not 
display the 
particular MetS 
component[s] 
being examined)  
 
<6hrs >8hrs 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
Bad  
Quality 
RRR (95%CI) RRR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) 
One 
Elevated WC 
1.34 
(1.11,1.63) 
1.03 
(0.84,1.27) 
0.97 
(0.85,1.11) 
1.01 
(0.86,1.19) 
1.32 
(1.16,1.50) 
1.11 
(0.94,1.32) 
1.15 
(0.97,1.37) 
1.02 
(0.88,1.18) 
High BP 
0.94 
(0.67,1.31) 
0.84 
(0.56,1.26) 
0.87 
(0.70,1.08) 
0.99 
(0.74,1.31) 
0.86 
(0.68,1.07) 
1.11 
(0.83,1.48) 
1.03 
(0.74,1.43) 
0.99 
(0.78,1.26) 
DM 
0.67 
(0.15,2.96) 
0.47 
(0.06,3.58) 
0.63 
(0.27,1.47) 
1.09 
(0.37,3.25) 
0.53 
(0.21,1.33) 
0.57 
(0.13,2.46) 
0.95 
(0.28,3.27) 
0.59 
(0.25,1.37) 
Two 
Elevated WC and 
high BP 
1.04 
(0.79,1.36) 
1.23 
(0.92,1.66) 
1.14 
(0.95,1.36) 
1.18 
(0.93,1.51) 
1.53 
(1.28,1.83) 
1.10 
(0.87,1.39) 
0.85 
(0.64,1.12) 
1.18 
(0.96,1.44) 
Elevated WC and 
DM 
2.20 
(1.31,3.68) 
1.46 
(0.75,2.84) 
1.09 
(0.71,1.68) 
0.99 
(0.58,1.70) 
1.80 
(1.17,2.75) 
1.64 
(1.01,2.67) 
1.87 
(1.11,3.16) 
1.19 
(0.73,1.94) 
High BP and DM 
1.06 
(0.40,2.81) 
0.93 
(0.28,3.11) 
1.50 
(0.78,2.91) 
1.03 
(0.45,2.36) 
0.79 
(0.40,1.53) 
3.33 
(1.70,6.53) 
0.33 
(0.08,1.40) 
1.86 
(0.85,4.10) 
Three MetS  
1.33 
(0.83,2.12) 
0.84 
(0.43,1.65) 
1.01 
(0.71,1.45) 
0.95 
(0.60,1.52) 
1.21 
(0.84,1.73) 
1.44 
(0.94,2.21) 
1.93 
(1.22,3.04) 
1.96 
(1.23,3.11) 
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Table 6-15 Logistic regression analyses of the relationship between different directly measured components (and combinations of components) of 
MetS and seven self-reported sleep characteristics, amongst n=5,283 participants included in the UKHLS NHA, after adjustment for 
sociodemographic and contemporaneous lifestyle variables. The referent group comprised participants who do not display the particular 
component (or combination of components) of MetS being examined (but may have displayed none, one or all of the others). All results are given 
as relative risk ratios (RRRs; for multinomial logistic analyses) or odds ratios (ORs; for binary logistic regression analyses), with 95% confidence 
intervals (95%CI) in parentheses. 
Sample 1 
(n=5,283) 
Sleep 
characteristics 
referent 
Sleep 
duration 
6-8hrs 
Sleep 
latency  
not during the 
past month 
Sleep 
fragmentation 
not during the 
past month 
Cough/snore  
loudly  
not during the 
past month 
Sleep 
medication 
not during the 
past month 
Daytime 
sleepiness 
not during the 
past month 
Sleep 
quality 
good quality  
No. of MetS 
components  
(referent: do not 
display the 
particular MetS 
component[s] 
being examined)  
 
<6hrs >8hrs 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
Bad  
Quality 
RRR (95%CI) RRR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) 
One 
Elevated WC 
1.29 
(1.06,1.57) 
1.02 
(0.82,1.25) 
0.96 
(0.85,1.09) 
1.00 
(0.85,1.17) 
1.29 
(1.13,1.47) 
1.09 
(0.92,1.30) 
1.11 
(0.93,1.32) 
0.99 
(0.86,1.15) 
High BP 
0.96 
(0.69,1.35) 
0.86 
(0.57,1.29) 
0.86 
(0.69,1.07) 
0.98 
(0.73,1.30) 
0.84 
(0.67,1.06) 
1.12 
(0.84,1.49) 
1.05 
(0.76,1.46) 
0.99 
(0.78,1.26) 
DM 
0.59 
(0.13,2.65) 
0.50 
(0.07,3.82) 
0.58 
(0.25,1.38) 
1.07 
(0.36,3.20) 
0.47 
(0.18,1.18) 
0.55 
(0.13,2.39) 
0.87 
(0.25,3.03) 
0.56 
(0.24,1.32) 
Two 
Elevated WC and 
high BP 
0.99 
(0.76,1.30) 
1.19 
(0.88,1.60) 
1.12 
(0.94,1.35) 
1.15 
(0.90,1.47) 
1.50 
(1.25,1.80) 
1.08 
(0.85,1.37) 
0.80 
(0.60,1.07) 
1.11 
(0.91,1.37) 
Elevated WC and 
DM 
1.93 
(1.14,3.25) 
1.38 
(0.71,2.70) 
1.05 
(0.68,1.61) 
1.02 
(0.60,1.76) 
1.74 
(1.13,2.68) 
1.57 
(0.96,2.56) 
1.74 
(1.03,2.95) 
1.14 
(0.69,1.86) 
High BP and DM 
0.93 
(0.34,2.49) 
0.88 
(0.26,2.96) 
1.45 
(0.74,2.82) 
1.05 
(0.46,2.42) 
0.75 
(0.38,1.48) 
3.14 
(1.59,6.20) 
0.32 
(0.08,1.36) 
1.79 
(0.81,3.95) 
Three MetS  
1.14 
(0.71,1.83) 
0.75 
(0.38,1.48) 
0.96 
(0.67,1.37) 
0.97 
(0.61,1.55) 
1.14 
(0.79,1.64) 
1.31 
(0.85,2.02) 
1.74 
(1.10,2.75) 
1.84 
(1.16,2.93) 
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Table 6-16 Logistic regression analyses of the relationship between different self-reported components (and combinations of components) of MetS 
and seven self-reported sleep characteristics, amongst n=5,283 participants included in the UKHLS NHA, before adjustment for sociodemographic 
and contemporaneous lifestyle variables. The referent group comprised participants who did not display any of the three components of MetS 
examined (elevated waist circumference, diabetes and high blood pressure). All results are given as relative risk ratios (RRRs; for multinomial 
logistic analyses) or odds ratios (ORs; for binary logistic regression analyses), with 95% confidence intervals (95%CI) in parentheses. 
Sample 1 
(n=5,283) 
Sleep 
characteristics 
referent 
Sleep 
duration 
6-8hrs 
Sleep 
latency  
not during the 
past month 
Sleep 
fragmentation 
not during the 
past month 
Cough/snore  
loudly  
not during the 
past month 
Sleep 
medication 
not during the 
past month 
Daytime 
sleepiness 
not during the 
past month 
Sleep 
quality 
good quality  
No. of MetS 
components  
(referent: do not 
display any 
components of 
Mets) 
 
<6hrs >8hrs 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
Bad  
Quality 
RRR (95%CI) RRR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) 
One 
Elevated WC 
1.72  
(1.39,2.13) 
0.98 
(0.78,1.23) 
1.07  
(0.93,1.23) 
1.21  
(1.02,1.44) 
1.86  
(1.62,2.14) 
1.25  
(1.03,1.51) 
1.09  
(0.90,1.32) 
1.14  
(0.98,1.22) 
High BP 
1.91  
(1.38,2.63) 
1.05 
(0.73,1.51) 
0.92  
(0.74,1.15) 
1.48  
(1.10,2.00) 
1.49  
(1.19,1.86) 
1.63  
(1.23,2.16) 
0.99  
(0.72,1.37) 
0.95  
(0.74,1.22) 
DM 
0.60  
(0.18,1.94) 
0.95 
(0.40,2.25) 
1.08  
(0.63,1.84) 
1.30  
(0.65,2.58) 
2.36  
(1.40,4.00) 
2.33  
(1.28,4.24) 
1.30  
(0.65,2.59) 
0.71  
(0.41,1.23) 
Two 
Elevated WC and 
high BP 
2.34  
(1.71,3.21) 
1.01  
(0.68,1.49) 
1.11  
(0.88,1.40) 
1.74  
(1.26,2.42) 
2.44  
(1.94,3.07) 
1.53  
(1.13,2.05) 
0.89  
(0.63,1.26) 
1.23  
(0.93,1.62) 
Elevated WC and 
DM 
2.90  
(1.64,5.14) 
0.58  
(0.21,1.60) 
1.59  
(0.96,2.62) 
1.56  
(0.81,2.97) 
2.44  
(1.53,3.89) 
2.46  
(1.46,4.16) 
1.32  
(0.72,2.43) 
1.80 
(0.96,3.36) 
High BP and DM 
2.80  
(1.0,6.57) 
0.95 
(0.28,3.18) 
0.65  
(0.33,1.28) 
2.07  
(0.73,5.90) 
1.02  
(0.49,2.09) 
1.40  
(0.58,3.40) 
0.81  
(0.29,2.33) 
1.15  
(0.52,2.55) 
Three MetS  
3.41  
(2.06,5.63) 
1.11 
(0.54,2.25) 
0.89  
(0.59,1.34) 
1.23  
(0.72,2.10) 
1.75  
(1.16,2.65) 
2.67  
(1.69,4.21) 
0.91  
(0.49,1.67) 
1.84  
(1.05,3.22) 
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Table 6-17 Logistic regression analyses of the relationship between different self-reported components (and combinations of components) of MetS 
and seven self-reported sleep characteristics, amongst n=5,283 participants included in the UKHLS NHA, after adjustment for sociodemographic 
variables. The referent group comprised participants who did not display any of the three components of MetS examined (elevated waist 
circumference, diabetes and high blood pressure). All results are given as relative risk ratios (RRRs; for multinomial logistic analyses) or odds ratios 
(ORs; for binary logistic regression analyses), with 95% confidence intervals (95%CI) in parentheses. 
Sample 1 
(n=5,283) 
Sleep 
characteristics 
referent 
Sleep 
duration 
6-8hrs 
Sleep 
latency  
not during the 
past month 
Sleep 
fragmentation 
not during the 
past month 
Cough/snore  
loudly  
not during the 
past month 
Sleep 
medication 
not during the 
past month 
Daytime 
sleepiness 
not during the 
past month 
Sleep 
quality 
good quality  
No. of MetS 
components  
(referent: do not 
display any 
components of 
Mets) 
 
<6hrs >8hrs 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
Bad  
Quality 
RRR (95%CI) RRR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) 
One 
Elevated WC 
1.53  
(1.23,1.91) 
1.06  
(0.83,1.35) 
1.04  
(0.90,1.20) 
1.05  
(0.87,1.25) 
1.88  
(1.62,2.17) 
1.17  
(0.96,1.42) 
1.30  
(1.07,1.59) 
1.19  
(1.01,1.40) 
High BP 
1.64  
(1.16,2.31) 
1.26  
(0.86,1.87) 
1.09 
(0.86,1.38) 
1.19  
(0.87,1.63) 
1.32  
(1.04,1.68) 
1.65  
(1.22,2.22) 
1.35  
(0.96,1.90) 
1.33  
(1.03,1.73) 
DM 
0.50  
(0.15,1.63) 
1.17  
(0.49,2.80) 
1.41  
(0.82,2.43) 
1.12  
(0.56,2.26) 
1.82  
(1.05,3.13) 
2.49  
(1.35,4.59) 
1.69  
(0.83,3.44) 
1.07  
(0.60,1.88) 
Two 
Elevated WC and 
high BP 
1.82  
(1.30,2.54) 
1.12 
(0.74,1.69) 
1.15  
(0.90,1.46) 
1.35  
(0.96,1.90) 
2.39  
(1.87,3.05) 
1.43  
(1.05,1.95) 
1.24  
(0.86,1.77) 
1.51  
(1.14,2.00) 
Elevated WC and 
DM 
2.24  
(1.24,4.06) 
0.60  
(0.21,1.70) 
1.69  
(1.01,2.82) 
1.25  
(0.65,2.42) 
2.03  
(1.25,3.30) 
2.21  
(1.29,3.78) 
1.91 
(1.02,3.58) 
2.29 
(1.21,4.32) 
High BP and DM 
2.26  
(0.93,5.48) 
1.18  
(0.35,4.04) 
0.87  
(0.44,1.75) 
1.71  
(0.59,4.91) 
0.82  
(0.39,1.72) 
1.53  
(0.62,3.78) 
1.19  
(0.41,3.49) 
1.91  
(0.85,4.29) 
Three MetS  
2.28  
(1.35,3.87) 
1.20 
(0.58,2.49) 
0.89  
(0.58,1.37) 
0.96  
(0.55,1.65) 
1.56  
(1.01,2.41) 
2.38 
(1.48,3.83) 
1.20  
(0.64,2.28) 
2.30  
(1.31,4.07) 
 
  
251 
 
Table 6-18 Logistic regression analyses of the relationship between different self-reported components (and combinations of components) of MetS 
and seven self-reported sleep characteristics, amongst n=5,283 participants included in the UKHLS NHA, after adjustment for sociodemographic 
and contemporaneous lifestyle variables. The referent group comprised participants who did not display any of the three components of MetS 
examined (elevated waist circumference, diabetes and high blood pressure). All results are given as relative risk ratios (RRRs; for multinomial 
logistic analyses) or odds ratios (ORs; for binary logistic regression analyses), with 95% confidence intervals (95%CI) in parentheses. 
Sample 1 
(n=5,283) 
Sleep 
characteristics 
referent 
Sleep 
duration 
6-8hrs 
Sleep 
latency  
not during the 
past month 
Sleep 
fragmentation 
not during the 
past month 
Cough/snore  
loudly  
not during the 
past month 
Sleep 
medication 
not during the 
past month 
Daytime 
sleepiness 
not during the 
past month 
Sleep 
quality 
good quality  
No. of MetS 
components  
(referent: do not 
display any 
components of 
Mets) 
 
<6hrs >8hrs 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
Bad  
Quality 
RRR (95%CI) RRR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) 
One 
Elevated WC 
1.50  
(1.20,1.88) 
0.99 
(0.78,1.27) 
1.03  
(0.89,1.19) 
1.04  
(0.86,1.24) 
1.91  
(1.65,2.22) 
1.15  
(0.94,1.41) 
1.23  
(1.01,1.51) 
1.16  
(0.98,1.37) 
High BP 
1.62  
(1.14,2.29) 
1.25  
(0.84,1.84) 
1.08 
(0.85,1.37) 
1.15  
(0.84,1.58) 
1.29 
(1.01,1.65) 
1.64  
(1.21,2.21) 
1.31  
(0.94,1.84) 
1.29  
(0.99,1.68) 
DM 
0.44  
(0.13,1.46) 
1.14  
(0.47,2.74) 
1.36  
(0.79,2.35) 
1.15  
(0.57,2.32) 
1.77  
(1.02,3.07) 
2.34  
(1.27,4.33) 
1.65  
(0.81,3.37) 
1.03  
(0.58,1.82) 
Two 
Elevated WC and 
high BP 
1.71  
(1.22,2.40) 
1.03 
(0.68,1.56) 
1.12  
(0.88,1.44) 
1.34  
(0.95,1.89) 
2.43  
(1.90,3.12) 
1.38  
(1.01,1.89) 
1.14  
(0.80,1.64) 
1.44  
(1.08,1.92) 
Elevated WC and 
DM 
1.90 
(1.04,3.48) 
0.55  
(0.19,1.56) 
1.61  
(0.96,2.69) 
1.32  
(0.68,2.56) 
2.03  
(1.24,3.32) 
1.99 
(1.15,3.43) 
1.71 
(0.91,3.23) 
2.17 
(1.15,4.10) 
High BP and DM 
2.14 
(0.87,5.27) 
1.15  
(0.33,3.95) 
0.88  
(0.44,1.77) 
1.66  
(0.58,4.80) 
0.80  
(0.38,1.70) 
1.51  
(0.61,3.74) 
1.13  
(0.39,3.34) 
1.83  
(0.81,4.12) 
Three MetS  
1.90 
(1.11,3.25) 
0.99 
(0.47,2.07) 
0.84  
(0.54,1.29) 
0.99  
(0.57,1.72) 
1.51  
(0.97,2.36) 
2.16 
(1.34,3.50) 
1.02  
(0.54,1.94) 
2.16  
(1.22,3.84) 
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Table 6-19 Logistic regression analyses of the relationship between different self-reported components (and combinations of components) of MetS 
and seven self-reported sleep characteristics, amongst n=5,283 participants included in the UKHLS NHA, before adjustment for sociodemographic 
and contemporaneous lifestyle variables. The referent group comprised participants who do not display the particular component (or combination of 
components) of MetS being examined (but may have displayed none, one or all of the others). All results are given as relative risk ratios (RRRs; for 
multinomial logistic analyses) or odds ratios (ORs; for binary logistic regression analyses), with 95% confidence intervals (95%CI) in parentheses. 
Sample 1 
(n=5,283) 
Sleep 
characteristics 
referent 
Sleep 
duration 
6-8hrs 
Sleep 
latency  
not during the 
past month 
Sleep 
fragmentation 
not during the 
past month 
Cough/snore  
loudly  
not during the 
past month 
Sleep 
medication 
not during the 
past month 
Daytime 
sleepiness 
not during the 
past month 
Sleep 
quality 
good quality  
No. of MetS 
components  
(referent: do not 
display the 
particular MetS 
component[s] 
being examined)  
 
<6hrs >8hrs 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
Bad  
Quality 
RRR (95%CI) RRR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) 
One 
Elevated WC 
1.38 
(1.13,1.69) 
0.98 
(0.78,1.23) 
1.07 
(0.93,1.22) 
1.11 
(0.94,1.32) 
1.60 
(1.40,1.83) 
1.08 
(0.90,1.29) 
1.09 
(0.90,1.31) 
1.11 
(0.95,1.30) 
High BP 
1.46 
(1.07,1.99) 
1.06 
(0.74,1.52) 
0.90 
(0.72,1.12) 
1.35 
(1.01,1.82) 
1.17 
(0.93,1.45) 
1.42 
(1.08,1.87) 
0.98 
(0.72,1.34) 
0.90 
(0.70,1.15) 
DM 
0.44 
(0.14,1.43) 
0.96 
(0.41,2.25) 
1.06 
(0.62,1.81) 
1.17 
(0.85,2.31) 
1.85 
(1.09,3.12) 
2.00 
(1.10,3.62) 
1.28 
(0.65,2.55) 
0.67 
(0.38,1.17) 
Two 
Elevated WC and 
high BP 
1.82 
(1.34,2.47) 
1.02 
(0.69,1.50) 
1.10 
(0.87,1.38) 
1.60 
(1.16,2.22) 
1.98 
(1.58,2.48) 
1.32 
(0.99,1.76) 
0.87 
(0.62,1.22) 
1.18 
(0.90,1.55) 
Elevated WC and 
DM 
2.19 
(1.24,3.86) 
0.57 
(0.21,1.60) 
1.57 
(0.96,2.58) 
1.40 
(0.73,2.67) 
1.91 
(1.20,3.04) 
2.12 
(1.26,3.56) 
1.31 
(0.72,2.40) 
1.72 
(0.92,3.21) 
High BP and DM 
2.10 
(0.90,4.89) 
0.95 
(0.29,3.19) 
0.64 
(0.32,1.25) 
1.86 
(0.65,5.30) 
0.79 
(0.38,1.62) 
1.19 
(0.49,2.88) 
0.80 
(0.28,2.28) 
1.01 
(0.49,2.43) 
Three MetS  
2.60 
(1.58,4.25) 
1.11 
(0.55,2.26) 
0.87 
(0.58,1.31) 
1.11 
(0.65,1.88) 
1.37 
(0.91,2.07) 
2.31 
(1.47,3.64) 
0.89 
(0.48,1.64) 
1.77 
(1.01,3.08) 
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Table 6-20 Logistic regression analyses of the relationship between different self-reported components (and combinations of components) of MetS 
and seven self-reported sleep characteristics, amongst n=5,283 participants included in the UKHLS NHA, after adjustment for sociodemographic 
variables. The referent group comprised participants who do not display the particular component (or combination of components) of MetS being 
examined (but may have displayed none, one or all of the others). All results are given as relative risk ratios (RRRs; for multinomial logistic 
analyses) or odds ratios (ORs; for binary logistic regression analyses), with 95% confidence intervals (95%CI) in parentheses. 
Sample 1 
(n=5,283) 
Sleep 
characteristics 
referent 
Sleep 
duration 
6-8hrs 
Sleep 
latency  
not during the 
past month 
Sleep 
fragmentation 
not during the 
past month 
Cough/snore  
loudly  
not during the 
past month 
Sleep 
medication 
not during the 
past month 
Daytime 
sleepiness 
not during the 
past month 
Sleep 
quality 
good quality  
No. of MetS 
components  
(referent: do not 
display the 
particular MetS 
component[s] 
being examined)  
 
<6hrs >8hrs 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
Bad  
Quality 
RRR (95%CI) RRR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) 
One 
Elevated WC 
1.30 
(1.06,1.60) 
1.03 
(0.82,1.30) 
1.01 
(0.88,1.16) 
1.00 
(0.84,1.19) 
1.64 
(1.43,1.89) 
1.01 
(0.84,1.22) 
1.22 
(1.01,1.48) 
1.08 
(0.92,1.26) 
High BP 
1.27 
(0.92,1.77) 
1.23 
(0.84,1.80) 
1.05 
(0.83,1.32) 
1.13 
(0.83,1.54) 
0.99 
(0.78,1.25) 
1.39 
(1.04,1.85) 
1.20 
(0.86,1.66) 
1.17 
(0.90,1.50) 
DM 
0.37 
(0.11,1.23) 
1.11 
(0.47,2.65) 
1.36 
(0.79,2.34) 
1.06 
(0.53,2.12) 
1.40 
(0.82,2.41) 
2.06 
(1.12,3.77) 
1.49 
(0.73,3.00) 
0.92 
(0.52,1.61) 
Two 
Elevated WC and 
high BP 
1.42 
(1.04,1.96) 
1.07 
(0.72,1.60) 
1.11 
(0.88,1.41) 
1.30 
(0.93,1.81) 
1.89 
(1.50,2.40) 
1.19 
(0.88,1.60) 
1.09 
(0.77,1.54) 
1.33 
(1.01,1.76) 
Elevated WC and 
DM 
1.72 
(0.96,3.09) 
0.57 
(0.20,1.60) 
1.64 
(0.99,2.72) 
1.18 
(0.61,2.27) 
1.53 
(0.95,2.47) 
1.83 
(1.08,3.11) 
1.67 
(0.90,3.11) 
1.99 
(1.06,3.74) 
High BP and DM 
1.71 
(0.71,4.11) 
1.12 
(0.33,3.79) 
0.83 
(0.42,1.65) 
1.60 
(0.56,4.58) 
0.61 
(0.29,1.27) 
1.21 
(0.49,2.96) 
1.02 
(0.35,2.96) 
1.63 
(0.73,3.65) 
Three MetS  
1.75 
(1.04,2.93) 
1.15 
(0.56,2.36) 
0.85 
(0.56,1.30) 
0.89 
(0.51,1.53) 
1.16 
(0.75,1.77) 
1.97 
(1.24,3.14) 
1.04 
(0.55,1.95) 
2.00 
(1.14,3.52) 
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Table 6-21 Logistic regression analyses of the relationship between different self-reported components (and combinations of components) of MetS 
and seven self-reported sleep characteristics, amongst n=5,283 participants included in the UKHLS NHA, after adjustment for sociodemographic 
and contemporaneous lifestyle variables. The referent group comprised participants who do not display the particular component (or combination of 
components) of MetS being examined (but may have displayed none, one or all of the others). All results are given as relative risk ratios (RRRs; for 
multinomial logistic analyses) or odds ratios (ORs; for binary logistic regression analyses), with 95% confidence intervals (95%CI) in parentheses. 
Sample 1 
(n=5,283) 
Sleep 
characteristics 
referent 
Sleep 
duration 
6-8hrs 
Sleep 
latency  
not during the 
past month 
Sleep 
fragmentation 
not during the 
past month 
Cough/snore  
loudly  
not during the 
past month 
Sleep 
medication 
not during the 
past month 
Daytime 
sleepiness 
not during the 
past month 
Sleep 
quality 
good quality  
No. of MetS 
components  
(referent: do not 
display the 
particular MetS 
component[s] 
being examined)  
 
<6hrs >8hrs 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
Bad  
Quality 
RRR (95%CI) RRR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) 
One 
Elevated WC 
1.28 
(1.04,1.58) 
0.98 
(0.78,1.24) 
1.00 
(0.87,1.15) 
0.99 
(0.83,1.18) 
1.66 
(1.44,1.91) 
1.00 
(0.83,1.21) 
1.17 
(0.96,1.42) 
1.05 
(0.90,1.24) 
High BP 
1.30 
(0.93,1.80) 
1.26 
(0.86,1.84) 
1.05 
(0.84,1.32) 
1.09 
(0.80,1.49) 
0.97 
(0.76,1.22) 
1.41 
(1.06,1.87) 
1.20 
(0.86,1.67) 
1.15 
(0.89,1.48) 
DM 
0.34 
(0.10,1.13) 
1.12 
(0.47,2.67) 
1.32 
(0.77,2.27) 
1.09 
(0.54,2.18) 
1.37 
(0.79,2.36) 
1.96 
(1.06,3.60) 
1.49 
(0.74,3.03) 
0.90 
(0.51,1.58) 
Two 
Elevated WC and 
high BP 
1.36 
(0.98,1.87) 
1.01 
(0.68,1.52) 
1.09 
(0.86,1.39) 
1.29 
(0.93,1.81) 
1.90 
(1.49,2.41) 
1.15 
(0.85,1.55) 
1.02 
(0.72,1.45) 
1.28 
(0.97,1.69) 
Elevated WC and 
DM 
1.48 
(0.82,2.67) 
0.54 
(0.19,1.52) 
1.57 
(0.94,2.61) 
1.25 
(0.65,2.41) 
1.49 
(0.92,2.42) 
1.65 
(0.97,2.83) 
1.54 
(0.83,2.88) 
1.89 
(1.01,3.57) 
High BP and DM 
1.64 
(0.67,4.03) 
1.12 
(0.33,3.84) 
0.84 
(0.42,1.69) 
1.56 
(0.54,4.48) 
0.56 
(0.28,1.24) 
1.20 
(0.48,2.96) 
1.00 
(0.34,2.92) 
1.59 
(0.71,3.56) 
Three MetS  
1.47 
(0.87,2.48) 
0 .98 
(0.47,2.03) 
0.80 
(0.52,1.22) 
0.92 
(0.54,1.59) 
1.08 
(0.70,1.68) 
1.79 
(1.12,2.87) 
0.90 
(0.48,1.69) 
1.88 
(1.07,3.32) 
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Table 6-22 Logistic regression analyses of the relationship between different self-reported measured components (and combinations of 
components) of MetS and seven self-reported sleep characteristics, amongst n=29,436 participants included in Wave 1 of the UKHLS, before 
adjustment for sociodemographic and contemporaneous lifestyle variables. The referent group comprised participants who did not display any of 
the three components of MetS examined (elevated waist circumference, diabetes and high blood pressure). All results are given as relative risk 
ratios (RRRs; for multinomial logistic analyses) or odds ratios (ORs; for binary logistic regression analyses), with 95% confidence intervals (95%CI) 
in parentheses. 
Sample 2 
(n=29,436) 
Sleep parameter 
referent 
Sleep 
duration 
6-8hrs 
Sleep 
latency  
not during 
the past 
month 
Sleep 
fragmentatio
n 
not during 
the past 
month 
Cough/snore  
loudly  
not during 
the past 
month 
Sleep 
medication 
not during 
the past 
month 
Daytime 
sleepiness 
not during 
the past 
month 
Sleep 
quality 
good quality  
No. of MetS 
components  
(referent: do 
not display any 
components of 
Mets) 
 
<6hrs >8hrs 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
Bad  
quality 
RRR (95%CI) RRR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) 
One 
Elevated WC 
1.50  
(1.37,1.65) 
0.79  
(0.72,0.87) 
1.03  
(0.97,1.09) 
1.36  
(1.26,1.46) 
2.00  
(1.88,2.13) 
1.37  
(1.26,1.48) 
1.08  
(0.99,1.16) 
1.15  
(1.07,1.23) 
High BP 
1.63  
(1.18,2.24) 
0.80  
(0.56,1.14) 
0.93  
(0.74,1.14) 
1.31  
(1.01,1.71) 
1.67  
(1.34,2.13) 
1.93  
(1.49,2.51) 
0.98  
(0.72,1.32) 
0.88  
(0.69,1.12) 
DM 
1.61  
(1.38,1.88) 
0.76  
(0.64,0.90) 
1.02  
(0.92,1.14) 
1.71  
(1.50,1.96) 
1.76  
(1.58,1.95) 
1.94  
(1.71,2.20) 
0.88  
(0.76,1.02) 
0.98  
(0.87,1.10) 
Two 
Elevated WC and 
high BP 
2.24  
(1.93,2.58) 
0.74  
(0.62,0.89) 
1.23  
(1.10,1.37) 
1.99  
(1.72,2.30) 
2.41  
(2.16,2.68) 
2.03  
(1.78,2.31) 
0.88  
(0.76,1.03) 
1.17  
(1.03,1.33) 
Elevated WC and 
DM 
2.76  
(2.13,3.58) 
1.09  
(0.80,1.48) 
1.18  
(0.95,1.45) 
1.72  
(1.31,2.25) 
2.42  
(1.97,2.97) 
2.59  
(2.03,3.17) 
0.94  
(0.71,1.26) 
1.28  
(0.99,1.64) 
High BP and DM 
2.42  
(1.70,3.43) 
1.11  
(0.75,1.65) 
0.89  
(0.68,1.17) 
1.60  
(1.14,2.25) 
2.40  
(1.84,3.14) 
2.58  
(1.91,3.47) 
1.10  
(0.77,1.58) 
1.23  
(0.89,1.69) 
Three MetS  
3.06  
(2.40,3.90) 
0.87  
(0.63,1.22) 
1.08  
(0.88,1.32) 
1.96  
(1.49,2.56) 
3.17  
(2.59,3.88) 
2.54  
(2.03,3.17) 
1.04  
(0.80,1.37) 
1.14  
(0.90,1.44) 
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Table 6-23 Logistic regression analyses of the relationship between different self-reported measured components (and combinations of 
components) of MetS and seven self-reported sleep characteristics, amongst n=29,436 participants included in Wave 1 of the UKHLS, after 
adjustment for sociodemographic variables. The referent group comprised participants who did not display any of the three components of MetS 
examined (elevated waist circumference, diabetes and high blood pressure). All results are given as relative risk ratios (RRRs; for multinomial 
logistic analyses) or odds ratios (ORs; for binary logistic regression analyses), with 95% confidence intervals (95%CI) in parentheses. 
Sample 2 
(n=29,436) 
Sleep parameter 
referent 
Sleep 
duration 
6-8hrs 
Sleep 
latency  
not during 
the past 
month 
Sleep 
fragmentatio
n 
not during 
the past 
month 
Cough/snore  
loudly  
not during 
the past 
month 
Sleep 
medication 
not during 
the past 
month 
Daytime 
sleepiness 
not during 
the past 
month 
Sleep 
quality 
good quality  
No. of MetS 
components  
(referent: do 
not display any 
components of 
Mets) 
 
<6hrs >8hrs 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
Bad  
quality 
RRR (95%CI) RRR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) 
One 
Elevated WC 
1.32  
(1.20,1.46) 
1.01  
(0.92,1.12) 
1.07  
(1.00,1.14) 
1.15  
(1.07,1.24) 
1.88  
(1.77,2.01) 
1.28  
(1.18,1.39) 
1.29  
(1.19,1.41) 
1.22  
(1.13,1.31) 
High BP 
1.35  
(1.14,1.59) 
1.06  
(0.89,1.28) 
1.21  
(1.08,1.35) 
1.30  
(1.13,1.50) 
1.39  
(1.24,1.56) 
1.85  
(1.62,2.12) 
1.29  
(1.10,1.52) 
1.30  
(1.15,1.47) 
DM 
1.38  
(0.99,1.91) 
1.14  
(0.79,1.63) 
1.15  
(0.92,1.44) 
1.13  
(0.86,1.47) 
1.17  
(0.93,1.47) 
1.88  
(1.44 ,2.46) 
1.28  
(0.92,1.71) 
1.12  
(0.88,1.44) 
Two 
Elevated WC and 
high BP 
1.77  
(1.51,2.07) 
0.98  
(0.81,1.19) 
1.37  
(1.22,1.54) 
1.44  
(1.24,1.68) 
2.08  
(1.85,2.34) 
1.82  
(1.59,2.09) 
1.35  
(1.14,1.59) 
1.52  
(1.33,1.73) 
Elevated WC and 
DM 
2.14  
(1.64,2.80) 
1.42  
(1.03,1.95) 
1.33  
(1.08,1.65) 
1.37  
(1.04,1.79) 
1.88  
(1.52,2.33) 
2.28  
(1.80,2.89) 
1.33  
(0.99,1.79) 
1.64  
(1.27,2.11) 
High BP and DM 
1.79  
(1.25,2.57) 
1.44  
(0.96,2.16) 
1.11  
(0.84,1.46) 
1.25  
(0.88,1.77) 
1.71  
(1.30,2.25) 
2.38  
(1.75,3.23) 
1.72  
(1.19,2.48) 
1.74  
(1.26,2.40) 
Three MetS  
2.32  
(1.80,2.99) 
1.12  
(0.80,1.57) 
1.22  
(0.99,1.51) 
1.44  
(1.09,1.92) 
2.53  
(2.05,3.12) 
2.25  
(1.79,2.84) 
1.59  
(1.21,2.11) 
1.53  
(1.20,1.94) 
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Table 6-24 Logistic regression analyses of the relationship between different self-reported measured components (and combinations of 
components) of MetS and seven self-reported sleep characteristics, amongst n=29,436 participants included in Wave 1 of the UKHLS, before 
adjustment for sociodemographic and contemporaneous lifestyle variables. The referent group comprised participants who do not display the 
particular component (or combination of components) of MetS being examined (but may have displayed none, one or all of the others). All results 
are given as relative risk ratios (RRRs; for multinomial logistic analyses) or odds ratios (ORs; for binary logistic regression analyses), with 95% 
confidence intervals (95%CI) in parentheses. 
Sample 2 
(n=29,436) 
Sleep parameter 
referent 
Sleep 
duration 
6-8hrs 
Sleep 
latency  
not during 
the past 
month 
Sleep 
fragmentatio
n 
not during 
the past 
month 
Cough/snore  
loudly  
not during 
the past 
month 
Sleep 
medication 
not during 
the past 
month 
Daytime 
sleepiness 
not during 
the past 
month 
Sleep 
quality 
good quality  
No. of MetS 
components  
(referent: do not 
display the 
particular MetS 
component[s] 
being examined) 
 
<6hrs >8hrs 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
Bad  
quality 
RRR (95%CI) RRR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) 
One 
Elevated WC 
1.27 
(1.17,1.39) 
0.82 
(0.75,0.90) 
1.01 
(0.96,1.07) 
1.24 
(1.16,1.33) 
1.73 
(1.62,1.83) 
1.16 
(1.08,1.26) 
1.09 
(1.01,1.18) 
1.13 
(1.06,1.21) 
High BP 
1.31 
(1.13,1.53) 
0. 81 
(0.68,0.95) 
1.00 
(0.90,1.11) 
1.53 
(1.34,1.75) 
1.38 
(1.25,1.53) 
1.65 
(1.45,1.86) 
0.87 
(0.75,1.01) 
0.94 
(0.84,1.06) 
DM 
1.32 
(0.96,1.81) 
0.85 
(0.60,1.21) 
0.91 
(0.73,1.14) 
1.15 
(0.89,1.50) 
1.30 
(1.04,1.62) 
1.60 
(1.24,2.08) 
0.97 
(0.72,1.32) 
0.85 
(0.67,1.08) 
Two 
Elevated WC and 
high BP 
1.87 
(1.62,2.15) 
0.78 
(0.65,0.94) 
1.22 
(1.09,1.36) 
1.80 
(1.55,2.08) 
1.93 
(1.73,2.14) 
1.73 
(1.53,1.96) 
0.88 
(0.75,1.02) 
1.13 
(1.01,1.29) 
Elevated WC and 
DM 
2.25 
(1.74,2.92) 
1.17 
(0.86,1.59) 
1.16 
(0.94,1.43) 
1.52 
(1.16,1.98) 
1.89 
(1.54,2.32) 
2.16 
(1.72,2.71) 
0.93 
(0.70,1.25) 
1.24 
(0.96,1.58) 
High BP and DM 
1.96 
(1.38,2.77) 
1.19 
(0.80,1.76) 
0.88 
(0.67,1.15) 
1.41 
(1.01,1.98) 
1.87 
(1.43,2.44) 
2.14 
(1.59,2.88) 
1.10 
(0.77,1.57) 
1.19 
(0.86,1.63) 
Three MetS  
2.50  
(1.97,3.19) 
0.93 
(0.67,1.30) 
1.06 
(0.87,1.30) 
1.73 
(1.32,2.27) 
2.48 
(2.03,3.04) 
2.12 
(1.70,2.65) 
1.04 
(0.80,1.37) 
1.10 
(0.87,1.39) 
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Table 6-25 Logistic regression analyses of the relationship between different self-reported measured components (and combinations of 
components) of MetS and seven self-reported sleep characteristics, amongst n=29,436 participants included in Wave 1 of the UKHLS, after 
adjustment for sociodemographic lifestyle variables. The referent group comprised participants who do not display the particular component (or 
combination of components) of MetS being examined (but may have displayed none, one or all of the others). All results are given as relative risk 
ratios (RRRs; for multinomial logistic analyses) or odds ratios (ORs; for binary logistic regression analyses), with 95% confidence intervals (95%CI) 
in parentheses. 
Sample 2 
(n=29,436) 
Sleep parameter 
referent 
Sleep 
duration 
6-8hrs 
Sleep 
latency  
not during 
the past 
month 
Sleep 
fragmentatio
n 
not during 
the past 
month 
Cough/snore  
loudly  
not during 
the past 
month 
Sleep 
medication 
not during 
the past 
month 
Daytime 
sleepiness 
not during 
the past 
month 
Sleep 
quality 
good quality  
No. of MetS 
components  
(referent: do not 
display the 
particular MetS 
component[s] 
being examined) 
 
<6hrs >8hrs 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
During the 
past month 
Bad  
quality 
RRR (95%CI) RRR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) 
One 
Elevated WC 
1.17 
(1.07,1.28) 
0.99 
(0.90,1.09) 
1.02 
(0.96,1.08) 
1.10 
(1.02,1.18) 
1.68 
(1.58,1.79) 
1.09 
(1.01,1.18) 
1.22 
(1.13,1.33) 
1.14 
(1.06,1.22) 
High BP 
1.05 
(0.90,1.23) 
1.10 
(0.92,1.31) 
1.14 
(1.02,1.27) 
1.18 
(1.03,1.35) 
1.04 
(0.93,1.16) 
1.44 
(1.26,1.64) 
1.13 
(0.97,1.13) 
1.15 
(1.02,1.30) 
DM 
1.10 
(0.79,1.52) 
1.15 
(0.80,1.65) 
1.08 
(0.86,1.35) 
1.01 
(0.77,1.32) 
0.89 
(0.71,1.12) 
1.45 
(1.11,1.89) 
1.12 
(0.82,1.52) 
0.99 
(0.77,1.26) 
Two 
Elevated WC and 
high BP 
1.45 
(1.25,1.68) 
0.98 
(0.81,1.18) 
1.29 
(1.15,1.44) 
1.32 
(1.14,1.54) 
1.61 
(1.44,1.80) 
1.41 
(1.23,1.60) 
1.17 
(0.99,1.137) 
1.34 
(1.18,1.53) 
Elevated WC and 
DM 
1.73 
(1.33,2.25) 
1.41 
(1.03,1.93) 
1.23 
(0.99,1.53) 
1.23 
(0.94,1.62) 
1.41 
(1.14,1.74) 
1.76 
(1.39,2.21) 
1.15 
(0.86,1.54) 
1.42 
(1.11,1.83) 
High BP and DM 
1.35 
(0.95,1.94) 
1.51 
(1.01,2.26) 
1.01 
(0.77,1.33) 
1.09 
(0.77,1.54) 
1.23 
(0.93,1.62) 
1.71 
(1.26,2.31) 
1.45 
(1.01,2.09) 
1.49 
(1.08,2.06) 
Three MetS  
1.85 
(1.44,2.37) 
1.12 
(0.80,1.57) 
1.12 
(0.91,1.37) 
1.30 
(0.99,1.72) 
1.89 
(1.54,2.33) 
1.68 
(1.34,2.11) 
1.36 
(1.04,1.80) 
1.31 
(1.04,1.66) 
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